Datasets:
Tasks:
Token Classification
Modalities:
Text
Formats:
parquet
Sub-tasks:
named-entity-recognition
Languages:
English
Size:
1K - 10K
ArXiv:
License:
dipteshkanojia
commited on
Commit
•
c40ba19
1
Parent(s):
a8017ff
Upload 3 files
Browse files- data/data_dev.conll +5126 -0
- data/data_test.conll +5152 -0
- data/data_train.conll +0 -0
data/data_dev.conll
ADDED
@@ -0,0 +1,5126 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
= PUNCT B-O
|
2 |
+
Manual PROPN B-LF
|
3 |
+
Ability PROPN I-LF
|
4 |
+
Classification PROPN I-LF
|
5 |
+
System PROPN I-LF
|
6 |
+
; PUNCT B-O
|
7 |
+
QUEST PROPN B-AC
|
8 |
+
= PUNCT B-O
|
9 |
+
Quest PROPN B-LF
|
10 |
+
- ADJ I-LF
|
11 |
+
Quality PROPN I-LF
|
12 |
+
of ADP I-LF
|
13 |
+
upper ADJ I-LF
|
14 |
+
extremity NOUN I-LF
|
15 |
+
skills NOUN I-LF
|
16 |
+
test NOUN I-LF
|
17 |
+
; PUNCT B-O
|
18 |
+
Cont PROPN B-O
|
19 |
+
= PUNCT B-O
|
20 |
+
control NOUN B-O
|
21 |
+
; PUNCT B-O
|
22 |
+
M NOUN B-O
|
23 |
+
= PUNCT B-O
|
24 |
+
male NOUN B-O
|
25 |
+
, PUNCT B-O
|
26 |
+
F NOUN B-O
|
27 |
+
= PUNCT B-O
|
28 |
+
female ADJ B-O
|
29 |
+
, PUNCT B-O
|
30 |
+
V NOUN B-O
|
31 |
+
= PUNCT B-O
|
32 |
+
verbal ADJ B-O
|
33 |
+
, PUNCT B-O
|
34 |
+
nonV NOUN B-O
|
35 |
+
= PUNCT B-O
|
36 |
+
non ADJ B-O
|
37 |
+
- ADJ B-O
|
38 |
+
Verbal ADJ B-O
|
39 |
+
, PUNCT B-O
|
40 |
+
|Quad NOUN B-O
|
41 |
+
= PUNCT B-O
|
42 |
+
quadriplegia NOUN B-O
|
43 |
+
, PUNCT B-O
|
44 |
+
Di NOUN B-O
|
45 |
+
= PUNCT B-O
|
46 |
+
Diplegia NOUN B-O
|
47 |
+
, PUNCT B-O
|
48 |
+
Hemi NOUN B-O
|
49 |
+
= PUNCT B-O
|
50 |
+
hemiplegia NOUN B-O
|
51 |
+
. PUNCT B-O
|
52 |
+
|
53 |
+
Electro NOUN B-LF
|
54 |
+
- PUNCT I-LF
|
55 |
+
oculography NOUN I-LF
|
56 |
+
( PUNCT B-O
|
57 |
+
EOG PROPN B-AC
|
58 |
+
) PUNCT B-O
|
59 |
+
( PUNCT B-O
|
60 |
+
RetiPort32 PROPN B-O
|
61 |
+
, PUNCT B-O
|
62 |
+
Roland PROPN B-O
|
63 |
+
Consult PROPN B-O
|
64 |
+
, PUNCT B-O
|
65 |
+
Wiesbaden PROPN B-O
|
66 |
+
, PUNCT B-O
|
67 |
+
Germany PROPN B-O
|
68 |
+
) PUNCT B-O
|
69 |
+
was AUX B-O
|
70 |
+
performed VERB B-O
|
71 |
+
in ADP B-O
|
72 |
+
all DET B-O
|
73 |
+
patients NOUN B-O
|
74 |
+
according VERB B-O
|
75 |
+
to ADP B-O
|
76 |
+
the DET B-O
|
77 |
+
guidelines NOUN B-O
|
78 |
+
of ADP B-O
|
79 |
+
the DET B-O
|
80 |
+
International PROPN B-O
|
81 |
+
Society PROPN B-O
|
82 |
+
for ADP B-O
|
83 |
+
Clinical PROPN B-O
|
84 |
+
Electrophysiology PROPN B-O
|
85 |
+
of ADP B-O
|
86 |
+
Vision PROPN B-O
|
87 |
+
( PUNCT B-O
|
88 |
+
ISCEV).[12 PROPN B-O
|
89 |
+
] PUNCT B-O
|
90 |
+
Arden NOUN B-O
|
91 |
+
ratios NOUN B-O
|
92 |
+
below ADP B-O
|
93 |
+
1.8 NUM B-O
|
94 |
+
were AUX B-O
|
95 |
+
rated VERB B-O
|
96 |
+
as ADP B-O
|
97 |
+
pathologic ADJ B-O
|
98 |
+
. PUNCT B-O
|
99 |
+
|
100 |
+
Soluble ADJ B-LF
|
101 |
+
N NOUN I-LF
|
102 |
+
- NOUN I-LF
|
103 |
+
ethylmaleimide NOUN I-LF
|
104 |
+
- NOUN I-LF
|
105 |
+
sensitive ADJ I-LF
|
106 |
+
factor NOUN I-LF
|
107 |
+
attachment NOUN I-LF
|
108 |
+
protein NOUN I-LF
|
109 |
+
receptor NOUN I-LF
|
110 |
+
( PUNCT B-O
|
111 |
+
SNARE PROPN B-AC
|
112 |
+
) PUNCT B-O
|
113 |
+
proteins NOUN B-O
|
114 |
+
, PUNCT B-O
|
115 |
+
including VERB B-O
|
116 |
+
target- NOUN B-O
|
117 |
+
( PUNCT B-O
|
118 |
+
t- NOUN B-O
|
119 |
+
) PUNCT B-O
|
120 |
+
membrane NOUN B-O
|
121 |
+
SNAREs PROPN B-AC
|
122 |
+
( PUNCT B-O
|
123 |
+
Syntaxins PROPN B-LF
|
124 |
+
[ X B-O
|
125 |
+
Syn PROPN B-AC
|
126 |
+
] PUNCT B-O
|
127 |
+
) PUNCT B-O
|
128 |
+
and CCONJ B-O
|
129 |
+
synaptosomal NOUN B-O
|
130 |
+
- NOUN B-O
|
131 |
+
associated VERB B-O
|
132 |
+
proteins NOUN B-O
|
133 |
+
of ADP B-O
|
134 |
+
25 NUM B-O
|
135 |
+
kDa NOUN B-O
|
136 |
+
( PUNCT B-O
|
137 |
+
SNAP25 PROPN B-O
|
138 |
+
) PUNCT B-O
|
139 |
+
and CCONJ B-O
|
140 |
+
vesicle NOUN B-LF
|
141 |
+
- NOUN I-LF
|
142 |
+
associated VERB I-LF
|
143 |
+
membrane NOUN I-LF
|
144 |
+
proteins NOUN I-LF
|
145 |
+
( PUNCT B-O
|
146 |
+
VAMPs PROPN B-AC
|
147 |
+
) PUNCT B-O
|
148 |
+
, PUNCT B-O
|
149 |
+
are AUX B-O
|
150 |
+
the DET B-O
|
151 |
+
fundamental ADJ B-O
|
152 |
+
components NOUN B-O
|
153 |
+
of ADP B-O
|
154 |
+
the DET B-O
|
155 |
+
exocytotic ADJ B-O
|
156 |
+
machinery NOUN B-O
|
157 |
+
required VERB B-O
|
158 |
+
for ADP B-O
|
159 |
+
the DET B-O
|
160 |
+
docking NOUN B-O
|
161 |
+
and CCONJ B-O
|
162 |
+
fusion NOUN B-O
|
163 |
+
of ADP B-O
|
164 |
+
secretory ADJ B-O
|
165 |
+
granules NOUN B-O
|
166 |
+
( PUNCT B-O
|
167 |
+
SGs PROPN B-AC
|
168 |
+
) PUNCT B-O
|
169 |
+
with ADP B-O
|
170 |
+
the DET B-O
|
171 |
+
plasma NOUN B-LF
|
172 |
+
membrane NOUN I-LF
|
173 |
+
( PUNCT B-O
|
174 |
+
PM PROPN B-AC
|
175 |
+
) PUNCT B-O
|
176 |
+
, PUNCT B-O
|
177 |
+
which PRON B-O
|
178 |
+
have AUX B-O
|
179 |
+
been AUX B-O
|
180 |
+
well ADV B-O
|
181 |
+
studied VERB B-O
|
182 |
+
in ADP B-O
|
183 |
+
neurons NOUN B-O
|
184 |
+
[ X B-O
|
185 |
+
1 NUM B-O
|
186 |
+
, PUNCT B-O
|
187 |
+
2 NUM B-O
|
188 |
+
] PUNCT B-O
|
189 |
+
and CCONJ B-O
|
190 |
+
neuroendocrine ADJ B-O
|
191 |
+
cells NOUN B-O
|
192 |
+
, PUNCT B-O
|
193 |
+
particularly ADV B-O
|
194 |
+
pancreatic ADJ B-O
|
195 |
+
islet NOUN B-O
|
196 |
+
β PUNCT B-O
|
197 |
+
- NOUN B-O
|
198 |
+
cells NOUN B-O
|
199 |
+
[ X B-O
|
200 |
+
3–5 NUM B-O
|
201 |
+
] PUNCT B-O
|
202 |
+
. PUNCT B-O
|
203 |
+
|
204 |
+
t PROPN B-AC
|
205 |
+
-SNAREs PROPN B-AC
|
206 |
+
Syn-1A PROPN B-AC
|
207 |
+
and CCONJ B-O
|
208 |
+
SNAP25 PROPN B-O
|
209 |
+
through ADP B-O
|
210 |
+
their PRON B-O
|
211 |
+
interactions NOUN B-O
|
212 |
+
with ADP B-O
|
213 |
+
PM PROPN B-AC
|
214 |
+
- NOUN B-O
|
215 |
+
bound VERB B-O
|
216 |
+
voltage NOUN B-LF
|
217 |
+
- NOUN I-LF
|
218 |
+
gated VERB I-LF
|
219 |
+
calcium NOUN I-LF
|
220 |
+
channels NOUN I-LF
|
221 |
+
( PUNCT B-O
|
222 |
+
Cav PROPN B-AC
|
223 |
+
) PUNCT B-O
|
224 |
+
, PUNCT B-O
|
225 |
+
L NOUN B-O
|
226 |
+
- NOUN B-O
|
227 |
+
type NOUN B-O
|
228 |
+
in ADP B-O
|
229 |
+
β PUNCT B-O
|
230 |
+
- NOUN B-O
|
231 |
+
cells NOUN B-O
|
232 |
+
and CCONJ B-O
|
233 |
+
N NOUN B-O
|
234 |
+
- NOUN B-O
|
235 |
+
type NOUN B-O
|
236 |
+
in ADP B-O
|
237 |
+
neurons NOUN B-O
|
238 |
+
, PUNCT B-O
|
239 |
+
position VERB B-O
|
240 |
+
the DET B-O
|
241 |
+
predocked VERB B-O
|
242 |
+
SGs PROPN B-AC
|
243 |
+
to ADP B-O
|
244 |
+
the DET B-O
|
245 |
+
site NOUN B-O
|
246 |
+
of ADP B-O
|
247 |
+
maximum ADJ B-O
|
248 |
+
Ca2 NOUN B-O
|
249 |
+
+ NOUN B-O
|
250 |
+
influx NOUN B-O
|
251 |
+
for ADP B-O
|
252 |
+
efficient ADJ B-O
|
253 |
+
exocytosis NOUN B-O
|
254 |
+
[ X B-O
|
255 |
+
6–12 NUM B-O
|
256 |
+
] PUNCT B-O
|
257 |
+
. PUNCT B-O
|
258 |
+
|
259 |
+
Large ADJ B-O
|
260 |
+
whole ADJ B-LF
|
261 |
+
genome NOUN I-LF
|
262 |
+
sequencing NOUN I-LF
|
263 |
+
( PUNCT B-O
|
264 |
+
WGS PROPN B-AC
|
265 |
+
) PUNCT B-O
|
266 |
+
and CCONJ B-O
|
267 |
+
whole ADJ B-LF
|
268 |
+
exome NOUN I-LF
|
269 |
+
sequencing NOUN I-LF
|
270 |
+
( PUNCT B-O
|
271 |
+
WES PROPN B-AC
|
272 |
+
) PUNCT B-O
|
273 |
+
studies NOUN B-O
|
274 |
+
in ADP B-O
|
275 |
+
IBD PROPN B-AC
|
276 |
+
are AUX B-O
|
277 |
+
in ADP B-O
|
278 |
+
progress NOUN B-O
|
279 |
+
. PUNCT B-O
|
280 |
+
|
281 |
+
Welsh PROPN B-O
|
282 |
+
and CCONJ B-O
|
283 |
+
coworkers NOUN B-O
|
284 |
+
first ADV B-O
|
285 |
+
reported VERB B-O
|
286 |
+
that SCONJ B-O
|
287 |
+
neurons NOUN B-O
|
288 |
+
within ADP B-O
|
289 |
+
the DET B-O
|
290 |
+
suprachiasmatic ADJ B-LF
|
291 |
+
nucleus NOUN I-LF
|
292 |
+
( PUNCT B-O
|
293 |
+
SCN PROPN B-AC
|
294 |
+
; PUNCT B-O
|
295 |
+
the DET B-O
|
296 |
+
master NOUN B-O
|
297 |
+
pacemaker NOUN B-O
|
298 |
+
in ADP B-O
|
299 |
+
the DET B-O
|
300 |
+
hypothalamus NOUN B-O
|
301 |
+
of ADP B-O
|
302 |
+
mammals NOUN B-O
|
303 |
+
) PUNCT B-O
|
304 |
+
are AUX B-O
|
305 |
+
surprisingly ADV B-O
|
306 |
+
heterogeneous ADJ B-O
|
307 |
+
in ADP B-O
|
308 |
+
their PRON B-O
|
309 |
+
intrinsic ADJ B-O
|
310 |
+
periods NOUN B-O
|
311 |
+
of ADP B-O
|
312 |
+
circadian ADJ B-O
|
313 |
+
firing NOUN B-O
|
314 |
+
pattern NOUN B-O
|
315 |
+
[ PUNCT B-O
|
316 |
+
4 NUM B-O
|
317 |
+
] PUNCT B-O
|
318 |
+
. PUNCT B-O
|
319 |
+
|
320 |
+
So ADV B-O
|
321 |
+
far ADV B-O
|
322 |
+
, PUNCT B-O
|
323 |
+
reviews NOUN B-O
|
324 |
+
investigating VERB B-O
|
325 |
+
insulin NOUN B-O
|
326 |
+
pump NOUN B-O
|
327 |
+
therapy NOUN B-O
|
328 |
+
showed VERB B-O
|
329 |
+
mixed ADJ B-O
|
330 |
+
results NOUN B-O
|
331 |
+
regarding VERB B-O
|
332 |
+
the DET B-O
|
333 |
+
health NOUN B-LF
|
334 |
+
- PUNCT I-LF
|
335 |
+
related VERB I-LF
|
336 |
+
quality NOUN I-LF
|
337 |
+
of ADP I-LF
|
338 |
+
life NOUN I-LF
|
339 |
+
( PUNCT B-O
|
340 |
+
HRQOL PROPN B-AC
|
341 |
+
) PUNCT B-O
|
342 |
+
in ADP B-O
|
343 |
+
paediatric ADJ B-O
|
344 |
+
diabetes NOUN B-O
|
345 |
+
patients.[13 NOUN B-O
|
346 |
+
, PUNCT B-O
|
347 |
+
16 NUM B-O
|
348 |
+
, PUNCT B-O
|
349 |
+
17 NUM B-O
|
350 |
+
] PUNCT B-O
|
351 |
+
According VERB B-O
|
352 |
+
to ADP B-O
|
353 |
+
recent ADJ B-O
|
354 |
+
publications,[15 NOUN B-O
|
355 |
+
, PUNCT B-O
|
356 |
+
18–20 NUM B-O
|
357 |
+
] PUNCT B-O
|
358 |
+
there PRON B-O
|
359 |
+
is VERB B-O
|
360 |
+
still ADV B-O
|
361 |
+
a DET B-O
|
362 |
+
lack NOUN B-O
|
363 |
+
of ADP B-O
|
364 |
+
adequately ADV B-O
|
365 |
+
powered VERB B-O
|
366 |
+
studies NOUN B-O
|
367 |
+
to ADP B-O
|
368 |
+
underpin VERB B-O
|
369 |
+
the DET B-O
|
370 |
+
advantages NOUN B-O
|
371 |
+
of ADP B-O
|
372 |
+
CSII PROPN B-AC
|
373 |
+
regarding VERB B-O
|
374 |
+
QoL PROPN B-AC
|
375 |
+
improvement NOUN B-O
|
376 |
+
for ADP B-O
|
377 |
+
children NOUN B-O
|
378 |
+
diagnosed VERB B-O
|
379 |
+
with ADP B-O
|
380 |
+
DM PROPN B-AC
|
381 |
+
and CCONJ B-O
|
382 |
+
to ADP B-O
|
383 |
+
potentially ADV B-O
|
384 |
+
balance VERB B-O
|
385 |
+
the DET B-O
|
386 |
+
higher ADJ B-O
|
387 |
+
treatment NOUN B-O
|
388 |
+
cost NOUN B-O
|
389 |
+
attached VERB B-O
|
390 |
+
to ADP B-O
|
391 |
+
it.[8 PRON B-O
|
392 |
+
] PUNCT B-O
|
393 |
+
Thus ADV B-O
|
394 |
+
, PUNCT B-O
|
395 |
+
insulin NOUN B-O
|
396 |
+
pumps NOUN B-O
|
397 |
+
are AUX B-O
|
398 |
+
– PUNCT B-O
|
399 |
+
forty NUM B-O
|
400 |
+
years NOUN B-O
|
401 |
+
after SCONJ B-O
|
402 |
+
they PRON B-O
|
403 |
+
were AUX B-O
|
404 |
+
first ADJ B-O
|
405 |
+
introduced VERB B-O
|
406 |
+
to ADP B-O
|
407 |
+
the DET B-O
|
408 |
+
market NOUN B-O
|
409 |
+
– PUNCT B-O
|
410 |
+
still ADV B-O
|
411 |
+
not PART B-O
|
412 |
+
part NOUN B-O
|
413 |
+
of ADP B-O
|
414 |
+
first ADJ B-O
|
415 |
+
- PUNCT B-O
|
416 |
+
line NOUN B-O
|
417 |
+
recommendations NOUN B-O
|
418 |
+
in ADP B-O
|
419 |
+
most ADJ B-O
|
420 |
+
countries NOUN B-O
|
421 |
+
around ADP B-O
|
422 |
+
the DET B-O
|
423 |
+
world NOUN B-O
|
424 |
+
. PUNCT B-O
|
425 |
+
|
426 |
+
The DET B-O
|
427 |
+
data NOUN B-O
|
428 |
+
are AUX B-O
|
429 |
+
reported VERB B-O
|
430 |
+
as ADP B-O
|
431 |
+
mean NOUN B-O
|
432 |
+
± SYM B-O
|
433 |
+
standard ADJ B-LF
|
434 |
+
deviation NOUN I-LF
|
435 |
+
( PUNCT B-O
|
436 |
+
SD PROPN B-AC
|
437 |
+
) PUNCT B-O
|
438 |
+
( PUNCT B-O
|
439 |
+
n NOUN B-O
|
440 |
+
≥ PUNCT B-O
|
441 |
+
3 NUM B-O
|
442 |
+
) PUNCT B-O
|
443 |
+
. PUNCT B-O
|
444 |
+
|
445 |
+
The DET B-O
|
446 |
+
lack NOUN B-O
|
447 |
+
of ADP B-O
|
448 |
+
dystrophin NOUN B-O
|
449 |
+
in ADP B-O
|
450 |
+
Duchenne PROPN B-LF
|
451 |
+
muscular ADJ I-LF
|
452 |
+
dystrophy NOUN I-LF
|
453 |
+
( PUNCT B-O
|
454 |
+
DMD PROPN B-AC
|
455 |
+
) PUNCT B-O
|
456 |
+
compromises VERB B-O
|
457 |
+
the DET B-O
|
458 |
+
integrity NOUN B-O
|
459 |
+
and CCONJ B-O
|
460 |
+
function NOUN B-O
|
461 |
+
of ADP B-O
|
462 |
+
muscle NOUN B-O
|
463 |
+
fibers NOUN B-O
|
464 |
+
. PUNCT B-O
|
465 |
+
|
466 |
+
The DET B-O
|
467 |
+
respondents NOUN B-O
|
468 |
+
consisted VERB B-O
|
469 |
+
of ADP B-O
|
470 |
+
20 NUM B-O
|
471 |
+
to PART B-O
|
472 |
+
42 NUM B-O
|
473 |
+
years NOUN B-O
|
474 |
+
of ADP B-O
|
475 |
+
age NOUN B-O
|
476 |
+
with ADP B-O
|
477 |
+
a DET B-O
|
478 |
+
mean ADJ B-O
|
479 |
+
age NOUN B-O
|
480 |
+
and CCONJ B-O
|
481 |
+
standard ADJ B-LF
|
482 |
+
deviation NOUN I-LF
|
483 |
+
( PUNCT B-O
|
484 |
+
SD PROPN B-AC
|
485 |
+
) PUNCT B-O
|
486 |
+
of ADP B-O
|
487 |
+
25.95±3.81 NUM B-O
|
488 |
+
. PUNCT B-O
|
489 |
+
|
490 |
+
Here ADV B-O
|
491 |
+
we PRON B-O
|
492 |
+
provide VERB B-O
|
493 |
+
a DET B-O
|
494 |
+
direct ADJ B-O
|
495 |
+
demonstration NOUN B-O
|
496 |
+
, PUNCT B-O
|
497 |
+
based VERB B-O
|
498 |
+
on ADP B-O
|
499 |
+
our PRON B-O
|
500 |
+
analysis NOUN B-O
|
501 |
+
of ADP B-O
|
502 |
+
rad-50 NOUN B-O
|
503 |
+
mutants NOUN B-O
|
504 |
+
, PUNCT B-O
|
505 |
+
that SCONJ B-O
|
506 |
+
the DET B-O
|
507 |
+
meiotic ADJ B-O
|
508 |
+
program NOUN B-O
|
509 |
+
in ADP B-O
|
510 |
+
Caenorhabditis PROPN B-O
|
511 |
+
elegans NOUN B-O
|
512 |
+
involves VERB B-O
|
513 |
+
both DET B-O
|
514 |
+
acquisition NOUN B-O
|
515 |
+
and CCONJ B-O
|
516 |
+
loss NOUN B-O
|
517 |
+
of ADP B-O
|
518 |
+
a DET B-O
|
519 |
+
specialized ADJ B-O
|
520 |
+
mode NOUN B-O
|
521 |
+
of ADP B-O
|
522 |
+
double ADJ B-LF
|
523 |
+
- PUNCT I-LF
|
524 |
+
strand NOUN I-LF
|
525 |
+
break NOUN I-LF
|
526 |
+
repair NOUN I-LF
|
527 |
+
( PUNCT B-O
|
528 |
+
DSBR PROPN B-AC
|
529 |
+
) PUNCT B-O
|
530 |
+
. PUNCT B-O
|
531 |
+
|
532 |
+
In ADP B-O
|
533 |
+
premeiotic ADJ B-O
|
534 |
+
germ NOUN B-O
|
535 |
+
cells NOUN B-O
|
536 |
+
, PUNCT B-O
|
537 |
+
RAD-50 PROPN B-O
|
538 |
+
is AUX B-O
|
539 |
+
not PART B-O
|
540 |
+
required VERB B-O
|
541 |
+
to PART B-O
|
542 |
+
load VERB B-O
|
543 |
+
strand NOUN B-O
|
544 |
+
- PUNCT B-O
|
545 |
+
exchange NOUN B-O
|
546 |
+
protein NOUN B-O
|
547 |
+
RAD-51 PROPN B-O
|
548 |
+
at ADP B-O
|
549 |
+
sites NOUN B-O
|
550 |
+
of ADP B-O
|
551 |
+
spontaneous ADJ B-O
|
552 |
+
or CCONJ B-O
|
553 |
+
ionizing ADJ B-LF
|
554 |
+
radiation NOUN I-LF
|
555 |
+
( PUNCT B-O
|
556 |
+
IR)-inducedDSBs PROPN B-AC
|
557 |
+
. PUNCT B-O
|
558 |
+
|
559 |
+
A DET B-O
|
560 |
+
specialized ADJ B-O
|
561 |
+
meiotic ADJ B-O
|
562 |
+
DSBR PROPN B-AC
|
563 |
+
mode NOUN B-O
|
564 |
+
is AUX B-O
|
565 |
+
engaged VERB B-O
|
566 |
+
at ADP B-O
|
567 |
+
the DET B-O
|
568 |
+
onset NOUN B-O
|
569 |
+
of ADP B-O
|
570 |
+
meiotic ADJ B-O
|
571 |
+
prophase NOUN B-O
|
572 |
+
, PUNCT B-O
|
573 |
+
coincident ADJ B-O
|
574 |
+
with ADP B-O
|
575 |
+
assembly NOUN B-O
|
576 |
+
of ADP B-O
|
577 |
+
meiotic ADJ B-O
|
578 |
+
chromosome NOUN B-O
|
579 |
+
axis NOUN B-O
|
580 |
+
structures NOUN B-O
|
581 |
+
. PUNCT B-O
|
582 |
+
|
583 |
+
Figure NOUN B-O
|
584 |
+
3 NUM B-O
|
585 |
+
illustrates VERB B-O
|
586 |
+
the DET B-O
|
587 |
+
differences NOUN B-O
|
588 |
+
in ADP B-O
|
589 |
+
the DET B-O
|
590 |
+
estimates NOUN B-O
|
591 |
+
of ADP B-O
|
592 |
+
the DET B-O
|
593 |
+
annual ADJ B-LF
|
594 |
+
rate NOUN I-LF
|
595 |
+
of ADP I-LF
|
596 |
+
reduction NOUN I-LF
|
597 |
+
( PUNCT B-O
|
598 |
+
ARR PROPN B-AC
|
599 |
+
) PUNCT B-O
|
600 |
+
from ADP B-O
|
601 |
+
1990 NUM B-O
|
602 |
+
to ADP B-O
|
603 |
+
2010 NUM B-O
|
604 |
+
for ADP B-O
|
605 |
+
all DET B-O
|
606 |
+
countries NOUN B-O
|
607 |
+
. PUNCT B-O
|
608 |
+
|
609 |
+
In ADP B-O
|
610 |
+
order NOUN B-O
|
611 |
+
to PART B-O
|
612 |
+
further ADV B-O
|
613 |
+
confirm VERB B-O
|
614 |
+
that SCONJ B-O
|
615 |
+
the DET B-O
|
616 |
+
interaction NOUN B-O
|
617 |
+
of ADP B-O
|
618 |
+
the DET B-O
|
619 |
+
η8 NUM B-O
|
620 |
+
helix NOUN B-O
|
621 |
+
with ADP B-O
|
622 |
+
Rps14 NOUN B-O
|
623 |
+
is AUX B-O
|
624 |
+
not PART B-O
|
625 |
+
an DET B-O
|
626 |
+
artifact NOUN B-O
|
627 |
+
of ADP B-O
|
628 |
+
crystal NOUN B-O
|
629 |
+
packing NOUN B-O
|
630 |
+
, PUNCT B-O
|
631 |
+
we PRON B-O
|
632 |
+
have AUX B-O
|
633 |
+
conducted VERB B-O
|
634 |
+
structural ADJ B-O
|
635 |
+
studies NOUN B-O
|
636 |
+
in ADP B-O
|
637 |
+
solution NOUN B-O
|
638 |
+
by ADP B-O
|
639 |
+
small ADJ B-LF
|
640 |
+
angle NOUN I-LF
|
641 |
+
X NOUN I-LF
|
642 |
+
- NOUN I-LF
|
643 |
+
ray NOUN I-LF
|
644 |
+
scattering NOUN I-LF
|
645 |
+
( PUNCT B-O
|
646 |
+
SAXS PROPN B-AC
|
647 |
+
) PUNCT B-O
|
648 |
+
on ADP B-O
|
649 |
+
the DET B-O
|
650 |
+
aFap7 NOUN B-O
|
651 |
+
– PUNCT B-O
|
652 |
+
aRps14 NOUN B-O
|
653 |
+
complex NOUN B-O
|
654 |
+
. PUNCT B-O
|
655 |
+
|
656 |
+
To PART B-O
|
657 |
+
identify VERB B-O
|
658 |
+
the DET B-O
|
659 |
+
BDNF PROPN B-AC
|
660 |
+
- PUNCT B-O
|
661 |
+
responsive ADJ B-O
|
662 |
+
proliferating VERB B-O
|
663 |
+
cells NOUN B-O
|
664 |
+
, PUNCT B-O
|
665 |
+
we PRON B-O
|
666 |
+
performed VERB B-O
|
667 |
+
co NOUN B-O
|
668 |
+
- PUNCT B-O
|
669 |
+
staining NOUN B-O
|
670 |
+
with ADP B-O
|
671 |
+
astrocyte NOUN B-O
|
672 |
+
marker NOUN B-O
|
673 |
+
GFAP PROPN B-O
|
674 |
+
and CCONJ B-O
|
675 |
+
found VERB B-O
|
676 |
+
that SCONJ B-O
|
677 |
+
the DET B-O
|
678 |
+
cells NOUN B-O
|
679 |
+
positive ADJ B-O
|
680 |
+
for ADP B-O
|
681 |
+
Ki67 PROPN B-AC
|
682 |
+
( PUNCT B-O
|
683 |
+
antigen NOUN B-LF
|
684 |
+
identified VERB I-LF
|
685 |
+
by ADP I-LF
|
686 |
+
monoclonal ADJ I-LF
|
687 |
+
antibody NOUN I-LF
|
688 |
+
Ki-67 PROPN I-LF
|
689 |
+
, PUNCT B-O
|
690 |
+
a DET B-O
|
691 |
+
marker NOUN B-O
|
692 |
+
for ADP B-O
|
693 |
+
proliferating VERB B-O
|
694 |
+
cells NOUN B-O
|
695 |
+
) PUNCT B-O
|
696 |
+
are AUX B-O
|
697 |
+
GFAP PROPN B-O
|
698 |
+
negative ADJ B-O
|
699 |
+
, PUNCT B-O
|
700 |
+
suggesting VERB B-O
|
701 |
+
that SCONJ B-O
|
702 |
+
BDNF PROPN B-AC
|
703 |
+
- PUNCT B-O
|
704 |
+
responsive ADJ B-O
|
705 |
+
proliferating VERB B-O
|
706 |
+
cells NOUN B-O
|
707 |
+
are AUX B-O
|
708 |
+
not PART B-O
|
709 |
+
astrocytes NOUN B-O
|
710 |
+
( PUNCT B-O
|
711 |
+
S7 NUM B-O
|
712 |
+
Fig NOUN B-O
|
713 |
+
, PUNCT B-O
|
714 |
+
S10 NUM B-O
|
715 |
+
Fig NOUN B-O
|
716 |
+
) PUNCT B-O
|
717 |
+
. PUNCT B-O
|
718 |
+
|
719 |
+
In ADP B-O
|
720 |
+
particular ADJ B-O
|
721 |
+
, PUNCT B-O
|
722 |
+
experiencing VERB B-O
|
723 |
+
moderate ADJ B-O
|
724 |
+
/ SYM B-O
|
725 |
+
high ADJ B-O
|
726 |
+
levels NOUN B-O
|
727 |
+
of ADP B-O
|
728 |
+
perceived VERB B-O
|
729 |
+
stress NOUN B-O
|
730 |
+
was AUX B-O
|
731 |
+
associated VERB B-O
|
732 |
+
with ADP B-O
|
733 |
+
a DET B-O
|
734 |
+
1.61 ADJ B-O
|
735 |
+
- ADJ B-O
|
736 |
+
fold ADJ B-O
|
737 |
+
increase NOUN B-O
|
738 |
+
in ADP B-O
|
739 |
+
the DET B-O
|
740 |
+
odds NOUN B-LF
|
741 |
+
ratio NOUN I-LF
|
742 |
+
( PUNCT B-O
|
743 |
+
OR PROPN B-AC
|
744 |
+
) PUNCT B-O
|
745 |
+
of ADP B-O
|
746 |
+
having AUX B-O
|
747 |
+
ever ADV B-O
|
748 |
+
smoked VERB B-O
|
749 |
+
( PUNCT B-O
|
750 |
+
95%CI PROPN B-AC
|
751 |
+
1.42 NUM B-O
|
752 |
+
, PUNCT B-O
|
753 |
+
1.83 NUM B-O
|
754 |
+
; PUNCT B-O
|
755 |
+
P<0.001 NUM B-O
|
756 |
+
) PUNCT B-O
|
757 |
+
, PUNCT B-O
|
758 |
+
and CCONJ B-O
|
759 |
+
a DET B-O
|
760 |
+
1.67 ADJ B-O
|
761 |
+
- ADJ B-O
|
762 |
+
fold ADJ B-O
|
763 |
+
increase NOUN B-O
|
764 |
+
in ADP B-O
|
765 |
+
having AUX B-O
|
766 |
+
been AUX B-O
|
767 |
+
diagnosed VERB B-O
|
768 |
+
or CCONJ B-O
|
769 |
+
treated VERB B-O
|
770 |
+
for ADP B-O
|
771 |
+
hypertension NOUN B-O
|
772 |
+
( PUNCT B-O
|
773 |
+
95%CI PROPN B-AC
|
774 |
+
1.46 NUM B-O
|
775 |
+
, PUNCT B-O
|
776 |
+
1.90 NUM B-O
|
777 |
+
; PUNCT B-O
|
778 |
+
P<0.001 NUM B-O
|
779 |
+
) PUNCT B-O
|
780 |
+
. PUNCT B-O
|
781 |
+
|
782 |
+
Kaposi PROPN B-LF
|
783 |
+
's PART I-LF
|
784 |
+
sarcoma NOUN I-LF
|
785 |
+
- PUNCT I-LF
|
786 |
+
associated VERB I-LF
|
787 |
+
herpesvirus NOUN I-LF
|
788 |
+
( PUNCT B-O
|
789 |
+
KSHV PROPN B-AC
|
790 |
+
) PUNCT B-O
|
791 |
+
is AUX B-O
|
792 |
+
the DET B-O
|
793 |
+
most ADV B-O
|
794 |
+
recently ADV B-O
|
795 |
+
discovered VERB B-O
|
796 |
+
human ADJ B-O
|
797 |
+
herpesvirus NOUN B-O
|
798 |
+
and CCONJ B-O
|
799 |
+
the DET B-O
|
800 |
+
etiologic ADJ B-O
|
801 |
+
agent NOUN B-O
|
802 |
+
of ADP B-O
|
803 |
+
several ADJ B-O
|
804 |
+
neoplasms NOUN B-O
|
805 |
+
, PUNCT B-O
|
806 |
+
the DET B-O
|
807 |
+
most ADV B-O
|
808 |
+
prominent ADJ B-O
|
809 |
+
of ADP B-O
|
810 |
+
which PRON B-O
|
811 |
+
is AUX B-O
|
812 |
+
Kaposi PROPN B-O
|
813 |
+
's PART B-O
|
814 |
+
sarcoma NOUN B-O
|
815 |
+
( PUNCT B-O
|
816 |
+
KS PROPN B-O
|
817 |
+
) PUNCT B-O
|
818 |
+
[ PUNCT B-O
|
819 |
+
1 NUM B-O
|
820 |
+
] PUNCT B-O
|
821 |
+
. PUNCT B-O
|
822 |
+
|
823 |
+
Other ADJ B-O
|
824 |
+
methods NOUN B-O
|
825 |
+
of ADP B-O
|
826 |
+
assaying VERB B-O
|
827 |
+
recombination NOUN B-O
|
828 |
+
in ADP B-O
|
829 |
+
A. NOUN B-O
|
830 |
+
thaliana PROPN B-O
|
831 |
+
have AUX B-O
|
832 |
+
been AUX B-O
|
833 |
+
developed VERB B-O
|
834 |
+
, PUNCT B-O
|
835 |
+
and CCONJ B-O
|
836 |
+
one NUM B-O
|
837 |
+
in ADP B-O
|
838 |
+
particular ADJ B-O
|
839 |
+
involving VERB B-O
|
840 |
+
a DET B-O
|
841 |
+
tandem NOUN B-O
|
842 |
+
disrupted VERB B-O
|
843 |
+
beta NOUN B-LF
|
844 |
+
- PUNCT I-LF
|
845 |
+
D NOUN I-LF
|
846 |
+
- PUNCT I-LF
|
847 |
+
glucuronidase NOUN I-LF
|
848 |
+
( PUNCT B-O
|
849 |
+
GUS PROPN B-AC
|
850 |
+
) PUNCT B-O
|
851 |
+
gene NOUN B-O
|
852 |
+
[ X B-O
|
853 |
+
43 X B-O
|
854 |
+
] PUNCT B-O
|
855 |
+
was AUX B-O
|
856 |
+
recently ADV B-O
|
857 |
+
applied VERB B-O
|
858 |
+
to PART B-O
|
859 |
+
study VERB B-O
|
860 |
+
recombination NOUN B-O
|
861 |
+
in ADP B-O
|
862 |
+
Atmus81 PROPN B-O
|
863 |
+
mutants NOUN B-O
|
864 |
+
[ X B-O
|
865 |
+
27 NUM B-O
|
866 |
+
] PUNCT B-O
|
867 |
+
. PUNCT B-O
|
868 |
+
|
869 |
+
Although SCONJ B-O
|
870 |
+
one PRON B-O
|
871 |
+
should AUX B-O
|
872 |
+
be AUX B-O
|
873 |
+
careful ADJ B-O
|
874 |
+
to ADP B-O
|
875 |
+
relate VERB B-O
|
876 |
+
absolute ADJ B-O
|
877 |
+
concentrations NOUN B-O
|
878 |
+
from ADP B-O
|
879 |
+
an DET B-O
|
880 |
+
in ADP B-O
|
881 |
+
vitro X B-O
|
882 |
+
assay NOUN B-O
|
883 |
+
to ADP B-O
|
884 |
+
actual ADJ B-O
|
885 |
+
drug NOUN B-O
|
886 |
+
concentrations NOUN B-O
|
887 |
+
administered VERB B-O
|
888 |
+
to ADP B-O
|
889 |
+
patients NOUN B-O
|
890 |
+
and CCONJ B-O
|
891 |
+
clinical ADJ B-O
|
892 |
+
antibiotic ADJ B-O
|
893 |
+
breakpoints NOUN B-O
|
894 |
+
[ PUNCT B-O
|
895 |
+
61 NUM B-O
|
896 |
+
] PUNCT B-O
|
897 |
+
, PUNCT B-O
|
898 |
+
we PRON B-O
|
899 |
+
found VERB B-O
|
900 |
+
that SCONJ B-O
|
901 |
+
the DET B-O
|
902 |
+
dose NOUN B-O
|
903 |
+
- PUNCT B-O
|
904 |
+
responses NOUN B-O
|
905 |
+
of ADP B-O
|
906 |
+
our PRON B-O
|
907 |
+
PAO1 PROPN B-O
|
908 |
+
WT PROPN B-AC
|
909 |
+
strain NOUN B-O
|
910 |
+
( PUNCT B-O
|
911 |
+
and CCONJ B-O
|
912 |
+
the DET B-O
|
913 |
+
resulting VERB B-O
|
914 |
+
minimal ADJ B-LF
|
915 |
+
inhibitory ADJ I-LF
|
916 |
+
concentrations NOUN I-LF
|
917 |
+
[ PUNCT B-O
|
918 |
+
MICs PROPN B-AC
|
919 |
+
] PUNCT B-O
|
920 |
+
, PUNCT B-O
|
921 |
+
Fig NUM B-O
|
922 |
+
1 NUM B-O
|
923 |
+
) PUNCT B-O
|
924 |
+
are AUX B-O
|
925 |
+
close ADJ B-O
|
926 |
+
to ADP B-O
|
927 |
+
the DET B-O
|
928 |
+
average ADJ B-O
|
929 |
+
MIC PROPN B-AC
|
930 |
+
values NOUN B-O
|
931 |
+
( PUNCT B-O
|
932 |
+
MIC50 NUM B-O
|
933 |
+
) PUNCT B-O
|
934 |
+
reported VERB B-O
|
935 |
+
in ADP B-O
|
936 |
+
a DET B-O
|
937 |
+
study NOUN B-O
|
938 |
+
across ADP B-O
|
939 |
+
7,452 NUM B-O
|
940 |
+
clinical ADJ B-O
|
941 |
+
P. PROPN B-O
|
942 |
+
aeruginosa PROPN B-O
|
943 |
+
isolates NOUN B-O
|
944 |
+
[ PUNCT B-O
|
945 |
+
62 NUM B-O
|
946 |
+
] PUNCT B-O
|
947 |
+
. PUNCT B-O
|
948 |
+
|
949 |
+
A DET B-O
|
950 |
+
15 NUM B-O
|
951 |
+
- PUNCT B-O
|
952 |
+
s NOUN B-O
|
953 |
+
rest NOUN B-O
|
954 |
+
period NOUN B-O
|
955 |
+
preceded VERB B-O
|
956 |
+
and CCONJ B-O
|
957 |
+
followed VERB B-O
|
958 |
+
each DET B-O
|
959 |
+
block NOUN B-O
|
960 |
+
. PUNCT B-O
|
961 |
+
|
962 |
+
( PUNCT B-O
|
963 |
+
C X B-O
|
964 |
+
) PUNCT B-O
|
965 |
+
Functional ADJ B-O
|
966 |
+
axial ADJ B-O
|
967 |
+
slices NOUN B-O
|
968 |
+
( PUNCT B-O
|
969 |
+
displayed VERB B-O
|
970 |
+
here ADV B-O
|
971 |
+
over ADP B-O
|
972 |
+
the DET B-O
|
973 |
+
anatomical ADJ B-O
|
974 |
+
image NOUN B-O
|
975 |
+
of ADP B-O
|
976 |
+
a DET B-O
|
977 |
+
representative ADJ B-O
|
978 |
+
subject NOUN B-O
|
979 |
+
) PUNCT B-O
|
980 |
+
were AUX B-O
|
981 |
+
acquired VERB B-O
|
982 |
+
and CCONJ B-O
|
983 |
+
covered VERB B-O
|
984 |
+
both CCONJ B-O
|
985 |
+
brain NOUN B-O
|
986 |
+
and CCONJ B-O
|
987 |
+
cervical ADJ B-O
|
988 |
+
spinal ADJ B-O
|
989 |
+
cord NOUN B-O
|
990 |
+
up ADP B-O
|
991 |
+
to ADP B-O
|
992 |
+
the DET B-O
|
993 |
+
first ADJ B-LF
|
994 |
+
thoracic ADJ I-LF
|
995 |
+
( PUNCT B-O
|
996 |
+
T1 PROPN B-AC
|
997 |
+
) PUNCT B-O
|
998 |
+
segment NOUN B-O
|
999 |
+
, PUNCT B-O
|
1000 |
+
and CCONJ B-O
|
1001 |
+
they PRON B-O
|
1002 |
+
were AUX B-O
|
1003 |
+
placed VERB B-O
|
1004 |
+
at ADP B-O
|
1005 |
+
an DET B-O
|
1006 |
+
angle NOUN B-O
|
1007 |
+
that SCONJ B-O
|
1008 |
+
was AUX B-O
|
1009 |
+
perpendicular ADJ B-O
|
1010 |
+
to ADP B-O
|
1011 |
+
the DET B-O
|
1012 |
+
C4 NOUN B-O
|
1013 |
+
vertebral ADJ B-O
|
1014 |
+
segment NOUN B-O
|
1015 |
+
. PUNCT B-O
|
1016 |
+
|
1017 |
+
( PUNCT B-O
|
1018 |
+
D NOUN B-O
|
1019 |
+
) PUNCT B-O
|
1020 |
+
Performance NOUN B-O
|
1021 |
+
speeds NOUN B-O
|
1022 |
+
( PUNCT B-O
|
1023 |
+
i.e. X B-O
|
1024 |
+
, PUNCT B-O
|
1025 |
+
block NOUN B-O
|
1026 |
+
duration NOUN B-O
|
1027 |
+
) PUNCT B-O
|
1028 |
+
averaged VERB B-O
|
1029 |
+
across ADP B-O
|
1030 |
+
all DET B-O
|
1031 |
+
subjects NOUN B-O
|
1032 |
+
show VERB B-O
|
1033 |
+
that SCONJ B-O
|
1034 |
+
the DET B-O
|
1035 |
+
learning NOUN B-O
|
1036 |
+
curves NOUN B-O
|
1037 |
+
differed VERB B-O
|
1038 |
+
between ADP B-O
|
1039 |
+
the DET B-O
|
1040 |
+
CS PROPN B-AC
|
1041 |
+
( PUNCT B-O
|
1042 |
+
red ADJ B-O
|
1043 |
+
) PUNCT B-O
|
1044 |
+
and CCONJ B-O
|
1045 |
+
SS PROPN B-AC
|
1046 |
+
( PUNCT B-O
|
1047 |
+
blue ADJ B-O
|
1048 |
+
) PUNCT B-O
|
1049 |
+
conditions NOUN B-O
|
1050 |
+
. PUNCT B-O
|
1051 |
+
|
1052 |
+
We PRON B-O
|
1053 |
+
found VERB B-O
|
1054 |
+
that SCONJ B-O
|
1055 |
+
SOCS1 PROPN B-O
|
1056 |
+
- PUNCT B-O
|
1057 |
+
silenced VERB B-O
|
1058 |
+
DCs PROPN B-AC
|
1059 |
+
broadly ADV B-O
|
1060 |
+
induced VERB B-O
|
1061 |
+
enhanced ADJ B-O
|
1062 |
+
envelope NOUN B-LF
|
1063 |
+
HIV-1 PROPN B-AC
|
1064 |
+
( PUNCT B-O
|
1065 |
+
Env)-specific PROPN B-AC
|
1066 |
+
CD8 NOUN B-O
|
1067 |
+
+ NOUN B-O
|
1068 |
+
cytotoxic ADJ B-O
|
1069 |
+
T NOUN B-O
|
1070 |
+
lymphocytes NOUN B-O
|
1071 |
+
and CCONJ B-O
|
1072 |
+
CD4 NOUN B-O
|
1073 |
+
+ NOUN B-O
|
1074 |
+
T NOUN B-O
|
1075 |
+
helper NOUN B-O
|
1076 |
+
cells NOUN B-O
|
1077 |
+
, PUNCT B-O
|
1078 |
+
as ADP B-O
|
1079 |
+
well ADV B-O
|
1080 |
+
as ADP B-O
|
1081 |
+
antibody NOUN B-O
|
1082 |
+
responses NOUN B-O
|
1083 |
+
, PUNCT B-O
|
1084 |
+
in ADP B-O
|
1085 |
+
mice NOUN B-O
|
1086 |
+
. PUNCT B-O
|
1087 |
+
|
1088 |
+
This PRON B-O
|
1089 |
+
is AUX B-O
|
1090 |
+
potentially ADV B-O
|
1091 |
+
attributed VERB B-O
|
1092 |
+
to ADP B-O
|
1093 |
+
decreased VERB B-O
|
1094 |
+
T PROPN B-LF
|
1095 |
+
cell NOUN I-LF
|
1096 |
+
receptor NOUN I-LF
|
1097 |
+
( PUNCT B-O
|
1098 |
+
TCR PROPN B-AC
|
1099 |
+
) PUNCT B-O
|
1100 |
+
signaling NOUN B-O
|
1101 |
+
strength NOUN B-O
|
1102 |
+
due ADP B-O
|
1103 |
+
to ADP B-O
|
1104 |
+
inefficiency NOUN B-O
|
1105 |
+
in ADP B-O
|
1106 |
+
promiscuous ADJ B-O
|
1107 |
+
expression NOUN B-O
|
1108 |
+
of ADP B-O
|
1109 |
+
self NOUN B-O
|
1110 |
+
- PUNCT B-O
|
1111 |
+
antigens NOUN B-O
|
1112 |
+
or CCONJ B-O
|
1113 |
+
presenting VERB B-O
|
1114 |
+
a DET B-O
|
1115 |
+
neo NOUN B-O
|
1116 |
+
- PUNCT B-O
|
1117 |
+
self NOUN B-O
|
1118 |
+
- PUNCT B-O
|
1119 |
+
antigen NOUN B-O
|
1120 |
+
by ADP B-O
|
1121 |
+
medullary ADJ B-O
|
1122 |
+
TECs PROPN B-AC
|
1123 |
+
, PUNCT B-O
|
1124 |
+
displaying VERB B-O
|
1125 |
+
decreased VERB B-O
|
1126 |
+
negative ADJ B-O
|
1127 |
+
selection NOUN B-O
|
1128 |
+
- PUNCT B-O
|
1129 |
+
related VERB B-O
|
1130 |
+
marker NOUN B-O
|
1131 |
+
genes NOUN B-O
|
1132 |
+
( PUNCT B-O
|
1133 |
+
Nur77 PROPN B-O
|
1134 |
+
and CCONJ B-O
|
1135 |
+
CD5high PROPN B-O
|
1136 |
+
) PUNCT B-O
|
1137 |
+
in ADP B-O
|
1138 |
+
CD4 PROPN B-O
|
1139 |
+
single ADJ B-LF
|
1140 |
+
positive ADJ I-LF
|
1141 |
+
( PUNCT B-O
|
1142 |
+
SP PROPN B-AC
|
1143 |
+
) PUNCT B-O
|
1144 |
+
thymocytes NOUN B-O
|
1145 |
+
. PUNCT B-O
|
1146 |
+
|
1147 |
+
Members NOUN B-O
|
1148 |
+
of ADP B-O
|
1149 |
+
the DET B-O
|
1150 |
+
plant NOUN B-O
|
1151 |
+
Heme PROPN B-LF
|
1152 |
+
Activator PROPN I-LF
|
1153 |
+
Protein PROPN I-LF
|
1154 |
+
( PUNCT B-O
|
1155 |
+
HAP PROPN B-AC
|
1156 |
+
) PUNCT B-O
|
1157 |
+
or CCONJ B-O
|
1158 |
+
NUCLEAR PROPN B-O
|
1159 |
+
FACTOR PROPN B-O
|
1160 |
+
Y PROPN B-O
|
1161 |
+
( PUNCT B-O
|
1162 |
+
NF PROPN B-O
|
1163 |
+
- PUNCT B-O
|
1164 |
+
Y PROPN B-O
|
1165 |
+
) PUNCT B-O
|
1166 |
+
are AUX B-O
|
1167 |
+
trimeric ADJ B-O
|
1168 |
+
transcription NOUN B-O
|
1169 |
+
factor NOUN B-O
|
1170 |
+
complexes NOUN B-O
|
1171 |
+
composed VERB B-O
|
1172 |
+
of ADP B-O
|
1173 |
+
the DET B-O
|
1174 |
+
NF PROPN B-O
|
1175 |
+
- PUNCT B-O
|
1176 |
+
YA PROPN B-O
|
1177 |
+
, PUNCT B-O
|
1178 |
+
NF PROPN B-O
|
1179 |
+
- PUNCT B-O
|
1180 |
+
YB PROPN B-O
|
1181 |
+
and CCONJ B-O
|
1182 |
+
NF PROPN B-O
|
1183 |
+
- PUNCT B-O
|
1184 |
+
YC PROPN B-O
|
1185 |
+
subfamilies NOUN B-O
|
1186 |
+
. PUNCT B-O
|
1187 |
+
|
1188 |
+
The DET B-O
|
1189 |
+
wing NOUN B-O
|
1190 |
+
cuticle NOUN B-O
|
1191 |
+
is AUX B-O
|
1192 |
+
a DET B-O
|
1193 |
+
multilayered ADJ B-O
|
1194 |
+
structure NOUN B-O
|
1195 |
+
, PUNCT B-O
|
1196 |
+
and CCONJ B-O
|
1197 |
+
its PRON B-O
|
1198 |
+
formation NOUN B-O
|
1199 |
+
requires VERB B-O
|
1200 |
+
the DET B-O
|
1201 |
+
proper ADJ B-O
|
1202 |
+
expression NOUN B-O
|
1203 |
+
of ADP B-O
|
1204 |
+
cuticle NOUN B-O
|
1205 |
+
- PUNCT B-O
|
1206 |
+
related VERB B-O
|
1207 |
+
genes NOUN B-O
|
1208 |
+
, PUNCT B-O
|
1209 |
+
such ADJ B-O
|
1210 |
+
as ADP B-O
|
1211 |
+
enzymes NOUN B-O
|
1212 |
+
involved VERB B-O
|
1213 |
+
in ADP B-O
|
1214 |
+
cuticle NOUN B-O
|
1215 |
+
deposition NOUN B-O
|
1216 |
+
, PUNCT B-O
|
1217 |
+
and CCONJ B-O
|
1218 |
+
zona NOUN B-LF
|
1219 |
+
pellucida NOUN I-LF
|
1220 |
+
( PUNCT B-O
|
1221 |
+
ZP PROPN B-AC
|
1222 |
+
) PUNCT B-O
|
1223 |
+
domain NOUN B-O
|
1224 |
+
proteins NOUN B-O
|
1225 |
+
, PUNCT B-O
|
1226 |
+
which PRON B-O
|
1227 |
+
link VERB B-O
|
1228 |
+
the DET B-O
|
1229 |
+
apical ADJ B-O
|
1230 |
+
surface NOUN B-O
|
1231 |
+
of ADP B-O
|
1232 |
+
wing NOUN B-O
|
1233 |
+
cells NOUN B-O
|
1234 |
+
to ADP B-O
|
1235 |
+
the DET B-O
|
1236 |
+
overlying VERB B-O
|
1237 |
+
cuticle NOUN B-O
|
1238 |
+
[ PUNCT B-O
|
1239 |
+
37 NUM B-O
|
1240 |
+
] PUNCT B-O
|
1241 |
+
. PUNCT B-O
|
1242 |
+
|
1243 |
+
After ADP B-O
|
1244 |
+
confirming VERB B-O
|
1245 |
+
this DET B-O
|
1246 |
+
result NOUN B-O
|
1247 |
+
by ADP B-O
|
1248 |
+
quantitative ADJ B-LF
|
1249 |
+
real ADJ I-LF
|
1250 |
+
- PUNCT I-LF
|
1251 |
+
time NOUN I-LF
|
1252 |
+
reverse ADJ I-LF
|
1253 |
+
transcription NOUN I-LF
|
1254 |
+
polymerase NOUN I-LF
|
1255 |
+
chain NOUN I-LF
|
1256 |
+
reaction NOUN I-LF
|
1257 |
+
( PUNCT B-O
|
1258 |
+
qRT-PCR PROPN B-AC
|
1259 |
+
) PUNCT B-O
|
1260 |
+
, PUNCT B-O
|
1261 |
+
we PRON B-O
|
1262 |
+
extended VERB B-O
|
1263 |
+
the DET B-O
|
1264 |
+
qRT PROPN B-AC
|
1265 |
+
analysis NOUN B-O
|
1266 |
+
to ADP B-O
|
1267 |
+
other ADJ B-O
|
1268 |
+
kidney NOUN B-O
|
1269 |
+
diseases NOUN B-O
|
1270 |
+
and CCONJ B-O
|
1271 |
+
found VERB B-O
|
1272 |
+
that SCONJ B-O
|
1273 |
+
-PCRIFI27 PROPN B-AC
|
1274 |
+
mRNA NOUN B-O
|
1275 |
+
levels NOUN B-O
|
1276 |
+
were AUX B-O
|
1277 |
+
reduced VERB B-O
|
1278 |
+
in ADP B-O
|
1279 |
+
PBMCs PROPN B-AC
|
1280 |
+
of ADP B-O
|
1281 |
+
many ADJ B-O
|
1282 |
+
patients NOUN B-O
|
1283 |
+
. PUNCT B-O
|
1284 |
+
|
1285 |
+
a X B-O
|
1286 |
+
) PUNCT B-O
|
1287 |
+
correlation NOUN B-LF
|
1288 |
+
coefficient NOUN B-O
|
1289 |
+
r PROPN B-AC
|
1290 |
+
, PUNCT B-O
|
1291 |
+
which PRON B-O
|
1292 |
+
ranges VERB B-O
|
1293 |
+
between ADP B-O
|
1294 |
+
0 NUM B-O
|
1295 |
+
( PUNCT B-O
|
1296 |
+
no DET B-O
|
1297 |
+
relationship NOUN B-O
|
1298 |
+
) PUNCT B-O
|
1299 |
+
to ADP B-O
|
1300 |
+
1 NUM B-O
|
1301 |
+
( PUNCT B-O
|
1302 |
+
perfect ADJ B-O
|
1303 |
+
relationship NOUN B-O
|
1304 |
+
) PUNCT B-O
|
1305 |
+
or CCONJ B-O
|
1306 |
+
-1 NUM B-O
|
1307 |
+
( PUNCT B-O
|
1308 |
+
perfect ADJ B-O
|
1309 |
+
negative ADJ B-O
|
1310 |
+
relationship NOUN B-O
|
1311 |
+
) PUNCT B-O
|
1312 |
+
respectively ADV B-O
|
1313 |
+
. PUNCT B-O
|
1314 |
+
|
1315 |
+
Therefore ADV B-O
|
1316 |
+
, PUNCT B-O
|
1317 |
+
the DET B-O
|
1318 |
+
aim NOUN B-O
|
1319 |
+
of ADP B-O
|
1320 |
+
this DET B-O
|
1321 |
+
study NOUN B-O
|
1322 |
+
was AUX B-O
|
1323 |
+
to ADP B-O
|
1324 |
+
evaluate VERB B-O
|
1325 |
+
the DET B-O
|
1326 |
+
importance NOUN B-O
|
1327 |
+
of ADP B-O
|
1328 |
+
both CCONJ B-O
|
1329 |
+
systemic ADJ B-O
|
1330 |
+
oxygen NOUN B-O
|
1331 |
+
delivery NOUN B-O
|
1332 |
+
factors NOUN B-O
|
1333 |
+
and CCONJ B-O
|
1334 |
+
peripheral ADJ B-O
|
1335 |
+
factors NOUN B-O
|
1336 |
+
for ADP B-O
|
1337 |
+
aerobic ADJ B-O
|
1338 |
+
ExCap PROPN B-AC
|
1339 |
+
in ADP B-O
|
1340 |
+
mild ADJ B-O
|
1341 |
+
- ADJ B-O
|
1342 |
+
to ADP B-O
|
1343 |
+
- ADJ B-O
|
1344 |
+
severe ADJ B-O
|
1345 |
+
non ADJ B-O
|
1346 |
+
- ADJ B-O
|
1347 |
+
dialysis ADJ B-O
|
1348 |
+
CKD PROPN B-AC
|
1349 |
+
. PUNCT B-O
|
1350 |
+
|
1351 |
+
Handgrip NOUN B-O
|
1352 |
+
strength NOUN B-O
|
1353 |
+
, PUNCT B-O
|
1354 |
+
lean ADJ B-LF
|
1355 |
+
body NOUN I-LF
|
1356 |
+
mass NOUN I-LF
|
1357 |
+
( PUNCT B-O
|
1358 |
+
LBM PROPN B-AC
|
1359 |
+
) PUNCT B-O
|
1360 |
+
and CCONJ B-O
|
1361 |
+
vascular ADJ B-O
|
1362 |
+
stiffness NOUN B-O
|
1363 |
+
represent VERB B-O
|
1364 |
+
peripheral ADJ B-O
|
1365 |
+
factors NOUN B-O
|
1366 |
+
in ADP B-O
|
1367 |
+
the DET B-O
|
1368 |
+
present ADJ B-O
|
1369 |
+
study NOUN B-O
|
1370 |
+
. PUNCT B-O
|
1371 |
+
|
1372 |
+
To PART B-O
|
1373 |
+
further ADV B-O
|
1374 |
+
investigate VERB B-O
|
1375 |
+
whether SCONJ B-O
|
1376 |
+
BMAL1 PROPN B-O
|
1377 |
+
- PUNCT B-O
|
1378 |
+
K537 PROPN B-O
|
1379 |
+
acetylation NOUN B-O
|
1380 |
+
up ADV B-O
|
1381 |
+
- PUNCT B-O
|
1382 |
+
regulates VERB B-O
|
1383 |
+
BMAL1 PROPN B-O
|
1384 |
+
– PUNCT B-O
|
1385 |
+
CK2β NOUN B-O
|
1386 |
+
binding VERB B-O
|
1387 |
+
and CCONJ B-O
|
1388 |
+
subsequently ADV B-O
|
1389 |
+
represses VERB B-O
|
1390 |
+
BMAL1 PROPN B-O
|
1391 |
+
- PUNCT B-O
|
1392 |
+
S90 NOUN B-O
|
1393 |
+
phosphorylation NOUN B-O
|
1394 |
+
, PUNCT B-O
|
1395 |
+
we PRON B-O
|
1396 |
+
utilized VERB B-O
|
1397 |
+
a DET B-O
|
1398 |
+
mouse NOUN B-O
|
1399 |
+
fibroblast NOUN B-O
|
1400 |
+
cell NOUN B-O
|
1401 |
+
line NOUN B-O
|
1402 |
+
deficient ADJ B-O
|
1403 |
+
in ADP B-O
|
1404 |
+
silent ADJ B-O
|
1405 |
+
information NOUN B-O
|
1406 |
+
regulator NOUN B-O
|
1407 |
+
1 NUM B-O
|
1408 |
+
( PUNCT B-O
|
1409 |
+
SIRT1 PROPN B-O
|
1410 |
+
) PUNCT B-O
|
1411 |
+
, PUNCT B-O
|
1412 |
+
a DET B-O
|
1413 |
+
member NOUN B-O
|
1414 |
+
of ADP B-O
|
1415 |
+
the DET B-O
|
1416 |
+
sirtuin NOUN B-O
|
1417 |
+
family NOUN B-O
|
1418 |
+
of ADP B-O
|
1419 |
+
NAD+-dependent PROPN B-O
|
1420 |
+
histone NOUN B-LF
|
1421 |
+
deacetylases NOUN I-LF
|
1422 |
+
( PUNCT B-O
|
1423 |
+
HDACs PROPN B-AC
|
1424 |
+
) PUNCT B-O
|
1425 |
+
that PRON B-O
|
1426 |
+
also ADV B-O
|
1427 |
+
targets VERB B-O
|
1428 |
+
acetyl NOUN B-O
|
1429 |
+
BMAL1 PROPN B-O
|
1430 |
+
- PUNCT B-O
|
1431 |
+
K537 PROPN B-O
|
1432 |
+
[ PUNCT B-O
|
1433 |
+
30 NUM B-O
|
1434 |
+
] PUNCT B-O
|
1435 |
+
. PUNCT B-O
|
1436 |
+
|
1437 |
+
EP PROPN B-AC
|
1438 |
+
: PUNCT B-O
|
1439 |
+
Group NOUN B-O
|
1440 |
+
: PUNCT B-O
|
1441 |
+
extra ADJ B-LF
|
1442 |
+
- ADJ I-LF
|
1443 |
+
perigastric ADJ I-LF
|
1444 |
+
lymph NOUN B-O
|
1445 |
+
node NOUN B-O
|
1446 |
+
group NOUN B-O
|
1447 |
+
A DET B-O
|
1448 |
+
recent ADJ B-O
|
1449 |
+
result NOUN B-O
|
1450 |
+
from ADP B-O
|
1451 |
+
S. PROPN B-O
|
1452 |
+
pombe PROPN B-O
|
1453 |
+
suggests VERB B-O
|
1454 |
+
that SCONJ B-O
|
1455 |
+
in ADP B-O
|
1456 |
+
this DET B-O
|
1457 |
+
organism NOUN B-O
|
1458 |
+
, PUNCT B-O
|
1459 |
+
in ADP B-O
|
1460 |
+
which PRON B-O
|
1461 |
+
all DET B-O
|
1462 |
+
COs PROPN B-AC
|
1463 |
+
are AUX B-O
|
1464 |
+
mediated VERB B-O
|
1465 |
+
by ADP B-O
|
1466 |
+
Mus81 PROPN B-O
|
1467 |
+
- PUNCT B-O
|
1468 |
+
Eme1 PROPN B-O
|
1469 |
+
, PUNCT B-O
|
1470 |
+
the DET B-O
|
1471 |
+
predominant ADJ B-O
|
1472 |
+
meiotic ADJ B-O
|
1473 |
+
recombination NOUN B-O
|
1474 |
+
intermediate NOUN B-O
|
1475 |
+
is AUX B-O
|
1476 |
+
a DET B-O
|
1477 |
+
single ADJ B-LF
|
1478 |
+
Holliday PROPN I-LF
|
1479 |
+
junction NOUN I-LF
|
1480 |
+
( PUNCT B-O
|
1481 |
+
sHJ PROPN B-AC
|
1482 |
+
) PUNCT B-O
|
1483 |
+
[ PUNCT B-O
|
1484 |
+
26 NUM B-O
|
1485 |
+
] PUNCT B-O
|
1486 |
+
. PUNCT B-O
|
1487 |
+
|
1488 |
+
Ab PROPN B-AC
|
1489 |
+
, PUNCT B-O
|
1490 |
+
antibody NOUN B-LF
|
1491 |
+
; PUNCT B-O
|
1492 |
+
EC50 PROPN B-AC
|
1493 |
+
, PUNCT B-O
|
1494 |
+
half ADJ B-LF
|
1495 |
+
- PUNCT I-LF
|
1496 |
+
maximal ADJ I-LF
|
1497 |
+
effective ADJ I-LF
|
1498 |
+
concentration NOUN I-LF
|
1499 |
+
; PUNCT B-O
|
1500 |
+
IL-6R PROPN B-AC
|
1501 |
+
, PUNCT B-O
|
1502 |
+
interleukin-6 NOUN B-LF
|
1503 |
+
receptor NOUN I-LF
|
1504 |
+
; PUNCT B-O
|
1505 |
+
MMP PROPN B-AC
|
1506 |
+
, PUNCT B-O
|
1507 |
+
matrix NOUN B-LF
|
1508 |
+
metalloproteinase NOUN I-LF
|
1509 |
+
. PUNCT B-O
|
1510 |
+
|
1511 |
+
QALY PROPN B-AC
|
1512 |
+
, PUNCT B-O
|
1513 |
+
quality NOUN B-LF
|
1514 |
+
- PUNCT I-LF
|
1515 |
+
adjusted VERB I-LF
|
1516 |
+
life NOUN I-LF
|
1517 |
+
year NOUN I-LF
|
1518 |
+
; PUNCT B-O
|
1519 |
+
USD PROPN B-O
|
1520 |
+
, PUNCT B-O
|
1521 |
+
US PROPN B-O
|
1522 |
+
dollars NOUN B-O
|
1523 |
+
. PUNCT B-O
|
1524 |
+
|
1525 |
+
We PRON B-O
|
1526 |
+
adapted VERB B-O
|
1527 |
+
the DET B-O
|
1528 |
+
Preferred ADJ B-LF
|
1529 |
+
Reporting PROPN I-LF
|
1530 |
+
Items PROPN I-LF
|
1531 |
+
for ADP I-LF
|
1532 |
+
Systematic PROPN I-LF
|
1533 |
+
Reviews PROPN I-LF
|
1534 |
+
and CCONJ I-LF
|
1535 |
+
Meta PROPN I-LF
|
1536 |
+
- PUNCT I-LF
|
1537 |
+
Analyses PROPN I-LF
|
1538 |
+
( PUNCT B-O
|
1539 |
+
PRISMA PROPN B-AC
|
1540 |
+
) PUNCT B-O
|
1541 |
+
statement NOUN B-O
|
1542 |
+
for ADP B-O
|
1543 |
+
scoping NOUN B-O
|
1544 |
+
reviews NOUN B-O
|
1545 |
+
to PART B-O
|
1546 |
+
report VERB B-O
|
1547 |
+
our PRON B-O
|
1548 |
+
systematic ADJ B-O
|
1549 |
+
review NOUN B-O
|
1550 |
+
of ADP B-O
|
1551 |
+
observational ADJ B-O
|
1552 |
+
and CCONJ B-O
|
1553 |
+
interventional ADJ B-O
|
1554 |
+
studies NOUN B-O
|
1555 |
+
[ X B-O
|
1556 |
+
19 X B-O
|
1557 |
+
] X B-O
|
1558 |
+
( PUNCT B-O
|
1559 |
+
S1 PROPN B-O
|
1560 |
+
Table NOUN B-O
|
1561 |
+
) PUNCT B-O
|
1562 |
+
. PUNCT B-O
|
1563 |
+
|
1564 |
+
Plates NOUN B-O
|
1565 |
+
were AUX B-O
|
1566 |
+
developed VERB B-O
|
1567 |
+
, PUNCT B-O
|
1568 |
+
and CCONJ B-O
|
1569 |
+
the DET B-O
|
1570 |
+
optical ADJ B-LF
|
1571 |
+
density NOUN I-LF
|
1572 |
+
( PUNCT B-O
|
1573 |
+
OD PROPN B-AC
|
1574 |
+
) PUNCT B-O
|
1575 |
+
was AUX B-O
|
1576 |
+
read VERB B-O
|
1577 |
+
using VERB B-O
|
1578 |
+
a DET B-O
|
1579 |
+
spectrophotometer NOUN B-O
|
1580 |
+
( PUNCT B-O
|
1581 |
+
microplate NOUN B-O
|
1582 |
+
reader NOUN B-O
|
1583 |
+
; PUNCT B-O
|
1584 |
+
Molecular PROPN B-O
|
1585 |
+
Devices PROPN B-O
|
1586 |
+
, PUNCT B-O
|
1587 |
+
Sunnyvale PROPN B-O
|
1588 |
+
, PUNCT B-O
|
1589 |
+
CA PROPN B-O
|
1590 |
+
, PUNCT B-O
|
1591 |
+
US PROPN B-O
|
1592 |
+
) PUNCT B-O
|
1593 |
+
. PUNCT B-O
|
1594 |
+
|
1595 |
+
Raw ADJ B-O
|
1596 |
+
OD PROPN B-AC
|
1597 |
+
for ADP B-O
|
1598 |
+
each DET B-O
|
1599 |
+
specimen NOUN B-O
|
1600 |
+
was AUX B-O
|
1601 |
+
normalized VERB B-O
|
1602 |
+
using VERB B-O
|
1603 |
+
the DET B-O
|
1604 |
+
calibrator NOUN B-O
|
1605 |
+
OD PROPN B-AC
|
1606 |
+
on ADP B-O
|
1607 |
+
each DET B-O
|
1608 |
+
plate NOUN B-O
|
1609 |
+
as ADP B-O
|
1610 |
+
a DET B-O
|
1611 |
+
ratio NOUN B-O
|
1612 |
+
, PUNCT B-O
|
1613 |
+
such ADJ B-O
|
1614 |
+
that SCONJ B-O
|
1615 |
+
normalized VERB B-O
|
1616 |
+
OD PROPN B-AC
|
1617 |
+
= SYM B-O
|
1618 |
+
OD PROPN B-AC
|
1619 |
+
of ADP B-O
|
1620 |
+
specimen NOUN B-O
|
1621 |
+
/ SYM B-O
|
1622 |
+
median NOUN B-O
|
1623 |
+
OD PROPN B-AC
|
1624 |
+
of ADP B-O
|
1625 |
+
calibrator NOUN B-O
|
1626 |
+
. PUNCT B-O
|
1627 |
+
|
1628 |
+
Hemophagocytic ADJ B-LF
|
1629 |
+
lymphohistiocytosis NOUN I-LF
|
1630 |
+
( PUNCT B-O
|
1631 |
+
HLH PROPN B-AC
|
1632 |
+
) PUNCT B-O
|
1633 |
+
, PUNCT B-O
|
1634 |
+
also ADV B-O
|
1635 |
+
known VERB B-O
|
1636 |
+
as ADP B-O
|
1637 |
+
hemophagocytic ADJ B-O
|
1638 |
+
syndrome NOUN B-O
|
1639 |
+
, PUNCT B-O
|
1640 |
+
is AUX B-O
|
1641 |
+
a DET B-O
|
1642 |
+
rare ADJ B-O
|
1643 |
+
, PUNCT B-O
|
1644 |
+
life NOUN B-O
|
1645 |
+
threatening VERB B-O
|
1646 |
+
hyperinflammatory ADJ B-O
|
1647 |
+
syndrome NOUN B-O
|
1648 |
+
characterized VERB B-O
|
1649 |
+
by ADP B-O
|
1650 |
+
excessive ADJ B-O
|
1651 |
+
activation NOUN B-O
|
1652 |
+
of ADP B-O
|
1653 |
+
histiocytes NOUN B-O
|
1654 |
+
and CCONJ B-O
|
1655 |
+
T NOUN B-O
|
1656 |
+
lymphocytes NOUN B-O
|
1657 |
+
leading VERB B-O
|
1658 |
+
to ADP B-O
|
1659 |
+
highly ADV B-O
|
1660 |
+
active ADJ B-O
|
1661 |
+
but CCONJ B-O
|
1662 |
+
ineffective ADJ B-O
|
1663 |
+
immune ADJ B-O
|
1664 |
+
response NOUN B-O
|
1665 |
+
[ PUNCT B-O
|
1666 |
+
1 NUM B-O
|
1667 |
+
] PUNCT B-O
|
1668 |
+
. PUNCT B-O
|
1669 |
+
|
1670 |
+
Our PRON B-O
|
1671 |
+
assumption NOUN B-O
|
1672 |
+
of ADP B-O
|
1673 |
+
constant ADJ B-O
|
1674 |
+
As PROPN B-AC
|
1675 |
+
levels NOUN B-O
|
1676 |
+
throughout ADP B-O
|
1677 |
+
the DET B-O
|
1678 |
+
study NOUN B-O
|
1679 |
+
period NOUN B-O
|
1680 |
+
is AUX B-O
|
1681 |
+
supported VERB B-O
|
1682 |
+
by ADP B-O
|
1683 |
+
geological ADJ B-O
|
1684 |
+
data NOUN B-O
|
1685 |
+
which PRON B-O
|
1686 |
+
document VERB B-O
|
1687 |
+
stable ADJ B-O
|
1688 |
+
arsenic NOUN B-LF
|
1689 |
+
contamination NOUN B-O
|
1690 |
+
of ADP B-O
|
1691 |
+
the DET B-O
|
1692 |
+
hydrothermal ADJ B-O
|
1693 |
+
system NOUN B-O
|
1694 |
+
that DET B-O
|
1695 |
+
has AUX B-O
|
1696 |
+
supplied VERB B-O
|
1697 |
+
drinking NOUN B-O
|
1698 |
+
water NOUN B-O
|
1699 |
+
in ADP B-O
|
1700 |
+
the DET B-O
|
1701 |
+
study NOUN B-O
|
1702 |
+
area NOUN B-O
|
1703 |
+
since SCONJ B-O
|
1704 |
+
the DET B-O
|
1705 |
+
‘ PUNCT B-O
|
1706 |
+
70s NOUN B-O
|
1707 |
+
[ PUNCT B-O
|
1708 |
+
14 NUM B-O
|
1709 |
+
, PUNCT B-O
|
1710 |
+
15 NUM B-O
|
1711 |
+
, PUNCT B-O
|
1712 |
+
17–19 NUM B-O
|
1713 |
+
] PUNCT B-O
|
1714 |
+
and CCONJ B-O
|
1715 |
+
to ADP B-O
|
1716 |
+
the DET B-O
|
1717 |
+
lack NOUN B-O
|
1718 |
+
of ADP B-O
|
1719 |
+
any DET B-O
|
1720 |
+
remediation NOUN B-O
|
1721 |
+
treatment NOUN B-O
|
1722 |
+
in ADP B-O
|
1723 |
+
that DET B-O
|
1724 |
+
time NOUN B-O
|
1725 |
+
due ADP B-O
|
1726 |
+
to ADP B-O
|
1727 |
+
the DET B-O
|
1728 |
+
long ADJ B-O
|
1729 |
+
period NOUN B-O
|
1730 |
+
of ADP B-O
|
1731 |
+
derogations NOUN B-O
|
1732 |
+
[ PUNCT B-O
|
1733 |
+
68 NUM B-O
|
1734 |
+
] PUNCT B-O
|
1735 |
+
. PUNCT B-O
|
1736 |
+
|
1737 |
+
NCD PROPN B-AC
|
1738 |
+
, PUNCT B-O
|
1739 |
+
noncommunicable ADJ B-LF
|
1740 |
+
disease NOUN I-LF
|
1741 |
+
; PUNCT B-O
|
1742 |
+
OLS PROPN B-AC
|
1743 |
+
, PUNCT B-O
|
1744 |
+
ordinary ADJ B-LF
|
1745 |
+
least ADJ I-LF
|
1746 |
+
squares NOUN I-LF
|
1747 |
+
. PUNCT B-O
|
1748 |
+
|
1749 |
+
To PART B-O
|
1750 |
+
further ADV B-O
|
1751 |
+
identify VERB B-O
|
1752 |
+
the DET B-O
|
1753 |
+
molecular ADJ B-O
|
1754 |
+
mechanism NOUN B-O
|
1755 |
+
of ADP B-O
|
1756 |
+
sIBM PROPN B-AC
|
1757 |
+
, PUNCT B-O
|
1758 |
+
we PRON B-O
|
1759 |
+
amplified VERB B-O
|
1760 |
+
whole ADJ B-O
|
1761 |
+
mitochondrial ADJ B-LF
|
1762 |
+
DNA NOUN I-LF
|
1763 |
+
( PUNCT B-O
|
1764 |
+
mtDNA PROPN B-AC
|
1765 |
+
) PUNCT B-O
|
1766 |
+
from ADP B-O
|
1767 |
+
myoblasts NOUN B-O
|
1768 |
+
from ADP B-O
|
1769 |
+
normal ADJ B-O
|
1770 |
+
controls NOUN B-O
|
1771 |
+
and CCONJ B-O
|
1772 |
+
3 NUM B-O
|
1773 |
+
sIBM PROPN B-AC
|
1774 |
+
patients NOUN B-O
|
1775 |
+
. PUNCT B-O
|
1776 |
+
|
1777 |
+
To PART B-O
|
1778 |
+
test VERB B-O
|
1779 |
+
whether SCONJ B-O
|
1780 |
+
F NOUN B-O
|
1781 |
+
- PUNCT B-O
|
1782 |
+
actin NOUN B-O
|
1783 |
+
polymerization NOUN B-O
|
1784 |
+
dynamics NOUN B-O
|
1785 |
+
are AUX B-O
|
1786 |
+
required VERB B-O
|
1787 |
+
for ADP B-O
|
1788 |
+
proper ADJ B-O
|
1789 |
+
VP26 PROPN B-O
|
1790 |
+
organization NOUN B-O
|
1791 |
+
, PUNCT B-O
|
1792 |
+
we PRON B-O
|
1793 |
+
treated VERB B-O
|
1794 |
+
cells NOUN B-O
|
1795 |
+
with ADP B-O
|
1796 |
+
the DET B-O
|
1797 |
+
actin NOUN B-O
|
1798 |
+
filament NOUN B-O
|
1799 |
+
- PUNCT B-O
|
1800 |
+
stabilizing VERB B-O
|
1801 |
+
drug NOUN B-O
|
1802 |
+
jasplakinolide PROPN B-LF
|
1803 |
+
( PUNCT B-O
|
1804 |
+
jasp PROPN B-AC
|
1805 |
+
) PUNCT B-O
|
1806 |
+
. PUNCT B-O
|
1807 |
+
|
1808 |
+
There PRON B-O
|
1809 |
+
were VERB B-O
|
1810 |
+
no DET B-O
|
1811 |
+
reported VERB B-O
|
1812 |
+
differences NOUN B-O
|
1813 |
+
between ADP B-O
|
1814 |
+
deaths NOUN B-O
|
1815 |
+
in ADP B-O
|
1816 |
+
males NOUN B-O
|
1817 |
+
and CCONJ B-O
|
1818 |
+
females NOUN B-O
|
1819 |
+
in ADP B-O
|
1820 |
+
Boukoki PROPN B-O
|
1821 |
+
( PUNCT B-O
|
1822 |
+
male NOUN B-LF
|
1823 |
+
- PUNCT I-LF
|
1824 |
+
to ADP I-LF
|
1825 |
+
- PUNCT I-LF
|
1826 |
+
female NOUN I-LF
|
1827 |
+
ratio NOUN I-LF
|
1828 |
+
[ PUNCT B-O
|
1829 |
+
M:Fratio PROPN B-AC
|
1830 |
+
] PUNCT B-O
|
1831 |
+
1.3:1 NUM B-O
|
1832 |
+
[ PUNCT B-O
|
1833 |
+
17:13 NUM B-O
|
1834 |
+
, PUNCT B-O
|
1835 |
+
p NOUN B-O
|
1836 |
+
= SYM B-O
|
1837 |
+
0.79 NUM B-O
|
1838 |
+
] PUNCT B-O
|
1839 |
+
) PUNCT B-O
|
1840 |
+
or CCONJ B-O
|
1841 |
+
in ADP B-O
|
1842 |
+
Moursal PROPN B-O
|
1843 |
+
( PUNCT B-O
|
1844 |
+
M PROPN B-AC
|
1845 |
+
1.5:1 NUM B-O
|
1846 |
+
[ PUNCT B-O
|
1847 |
+
12:8 NUM B-O
|
1848 |
+
, PUNCT B-O
|
1849 |
+
p NOUN B-O
|
1850 |
+
= SYM B-O
|
1851 |
+
0.75 NUM B-O
|
1852 |
+
] PUNCT B-O
|
1853 |
+
) PUNCT B-O
|
1854 |
+
. PUNCT B-O
|
1855 |
+
|
1856 |
+
Rev NOUN B-O
|
1857 |
+
# NOUN B-O
|
1858 |
+
3 NUM B-O
|
1859 |
+
: PUNCT B-O
|
1860 |
+
“ PUNCT B-O
|
1861 |
+
Is AUX B-O
|
1862 |
+
GAL PROPN B-AC
|
1863 |
+
gene NOUN B-O
|
1864 |
+
optimization NOUN B-O
|
1865 |
+
not PART B-O
|
1866 |
+
correlated VERB B-O
|
1867 |
+
with ADP B-O
|
1868 |
+
growth NOUN B-O
|
1869 |
+
under ADP B-O
|
1870 |
+
other ADJ B-O
|
1871 |
+
( PUNCT B-O
|
1872 |
+
non ADJ B-O
|
1873 |
+
- ADJ B-O
|
1874 |
+
galactose ADJ B-LF
|
1875 |
+
) PUNCT B-O
|
1876 |
+
growth NOUN B-O
|
1877 |
+
conditions NOUN B-O
|
1878 |
+
? PUNCT B-O
|
1879 |
+
” PUNCT B-O
|
1880 |
+
As SCONJ B-O
|
1881 |
+
the DET B-O
|
1882 |
+
world NOUN B-O
|
1883 |
+
edges VERB B-O
|
1884 |
+
closer ADV B-O
|
1885 |
+
to ADP B-O
|
1886 |
+
global ADJ B-O
|
1887 |
+
polio NOUN B-O
|
1888 |
+
eradication NOUN B-O
|
1889 |
+
and CCONJ B-O
|
1890 |
+
continues VERB B-O
|
1891 |
+
the DET B-O
|
1892 |
+
strategic ADJ B-O
|
1893 |
+
withdrawal NOUN B-O
|
1894 |
+
of ADP B-O
|
1895 |
+
the DET B-O
|
1896 |
+
Oral PROPN B-LF
|
1897 |
+
Polio PROPN I-LF
|
1898 |
+
Vaccine PROPN I-LF
|
1899 |
+
( PUNCT B-O
|
1900 |
+
OPV PROPN B-AC
|
1901 |
+
) PUNCT B-O
|
1902 |
+
, PUNCT B-O
|
1903 |
+
the DET B-O
|
1904 |
+
regular ADJ B-O
|
1905 |
+
identification NOUN B-O
|
1906 |
+
of ADP B-O
|
1907 |
+
, PUNCT B-O
|
1908 |
+
and CCONJ B-O
|
1909 |
+
rapid ADJ B-O
|
1910 |
+
response NOUN B-O
|
1911 |
+
to ADP B-O
|
1912 |
+
, PUNCT B-O
|
1913 |
+
these DET B-O
|
1914 |
+
silent ADJ B-O
|
1915 |
+
chains NOUN B-O
|
1916 |
+
of ADP B-O
|
1917 |
+
transmission NOUN B-O
|
1918 |
+
is AUX B-O
|
1919 |
+
of ADP B-O
|
1920 |
+
the DET B-O
|
1921 |
+
utmost ADJ B-O
|
1922 |
+
importance NOUN B-O
|
1923 |
+
. PUNCT B-O
|
1924 |
+
|
1925 |
+
ABA PROPN B-AC
|
1926 |
+
, PUNCT B-O
|
1927 |
+
abscisic NOUN B-LF
|
1928 |
+
acid NOUN I-LF
|
1929 |
+
; PUNCT B-O
|
1930 |
+
BR PROPN B-AC
|
1931 |
+
, PUNCT B-O
|
1932 |
+
brassinosteroid NOUN B-LF
|
1933 |
+
; PUNCT B-O
|
1934 |
+
GA3 PROPN B-AC
|
1935 |
+
, PUNCT B-O
|
1936 |
+
gibberellic NOUN B-LF
|
1937 |
+
acid3 NOUN I-LF
|
1938 |
+
; PUNCT B-O
|
1939 |
+
ZR PROPN B-AC
|
1940 |
+
, PUNCT B-O
|
1941 |
+
zeatin NOUN B-LF
|
1942 |
+
riboside NOUN I-LF
|
1943 |
+
Green ADJ B-LF
|
1944 |
+
tea NOUN I-LF
|
1945 |
+
( PUNCT B-O
|
1946 |
+
GT PROPN B-AC
|
1947 |
+
) PUNCT B-O
|
1948 |
+
catechins NOUN B-O
|
1949 |
+
have VERB B-O
|
1950 |
+
been AUX B-O
|
1951 |
+
shown VERB B-O
|
1952 |
+
to PART B-O
|
1953 |
+
have VERB B-O
|
1954 |
+
anti ADJ B-O
|
1955 |
+
- ADJ B-O
|
1956 |
+
obesity ADJ B-O
|
1957 |
+
effects NOUN B-O
|
1958 |
+
in ADP B-O
|
1959 |
+
humans NOUN B-O
|
1960 |
+
. PUNCT B-O
|
1961 |
+
|
1962 |
+
We PRON B-O
|
1963 |
+
inserted VERB B-O
|
1964 |
+
the DET B-O
|
1965 |
+
CAN1 PROPN B-O
|
1966 |
+
and CCONJ B-O
|
1967 |
+
URA3 PROPN B-O
|
1968 |
+
genes NOUN B-O
|
1969 |
+
, PUNCT B-O
|
1970 |
+
two NUM B-O
|
1971 |
+
counter ADJ B-O
|
1972 |
+
- PUNCT B-O
|
1973 |
+
selectable ADJ B-O
|
1974 |
+
markers NOUN B-O
|
1975 |
+
, PUNCT B-O
|
1976 |
+
∼10 NUM B-O
|
1977 |
+
kb NOUN B-O
|
1978 |
+
from ADP B-O
|
1979 |
+
the DET B-O
|
1980 |
+
telomere NOUN B-O
|
1981 |
+
of ADP B-O
|
1982 |
+
ChrXV PROPN B-O
|
1983 |
+
- PUNCT B-O
|
1984 |
+
L PROPN B-O
|
1985 |
+
( PUNCT B-O
|
1986 |
+
Figure PROPN B-O
|
1987 |
+
1A NUM B-O
|
1988 |
+
) PUNCT B-O
|
1989 |
+
. PUNCT B-O
|
1990 |
+
|
1991 |
+
The DET B-O
|
1992 |
+
simultaneous ADJ B-O
|
1993 |
+
loss NOUN B-O
|
1994 |
+
of ADP B-O
|
1995 |
+
CAN1 PROPN B-O
|
1996 |
+
and CCONJ B-O
|
1997 |
+
URA3 PROPN B-O
|
1998 |
+
( PUNCT B-O
|
1999 |
+
detected VERB B-O
|
2000 |
+
on ADP B-O
|
2001 |
+
media NOUN B-O
|
2002 |
+
containing VERB B-O
|
2003 |
+
canavinine NOUN B-LF
|
2004 |
+
[ X B-O
|
2005 |
+
can PROPN B-AC
|
2006 |
+
] PUNCT B-O
|
2007 |
+
and CCONJ B-O
|
2008 |
+
5 NUM B-O
|
2009 |
+
- PUNCT B-O
|
2010 |
+
fluoro NOUN B-O
|
2011 |
+
- PUNCT B-O
|
2012 |
+
orotic ADJ B-O
|
2013 |
+
acid NOUN B-O
|
2014 |
+
[ X B-O
|
2015 |
+
5 NUM B-O
|
2016 |
+
- PUNCT B-O
|
2017 |
+
FOA NOUN B-O
|
2018 |
+
] PUNCT B-O
|
2019 |
+
) PUNCT B-O
|
2020 |
+
at ADP B-O
|
2021 |
+
this DET B-O
|
2022 |
+
locus NOUN B-O
|
2023 |
+
occurs VERB B-O
|
2024 |
+
at ADP B-O
|
2025 |
+
a DET B-O
|
2026 |
+
rate NOUN B-O
|
2027 |
+
of ADP B-O
|
2028 |
+
8.9 NUM B-O
|
2029 |
+
× PUNCT B-O
|
2030 |
+
10−8 NUM B-O
|
2031 |
+
( PUNCT B-O
|
2032 |
+
Table PROPN B-O
|
2033 |
+
1 NUM B-O
|
2034 |
+
) PUNCT B-O
|
2035 |
+
, PUNCT B-O
|
2036 |
+
approximately ADV B-O
|
2037 |
+
250 NUM B-O
|
2038 |
+
- PUNCT B-O
|
2039 |
+
fold ADJ B-O
|
2040 |
+
higher ADJ B-O
|
2041 |
+
than ADP B-O
|
2042 |
+
the DET B-O
|
2043 |
+
rate NOUN B-O
|
2044 |
+
observed VERB B-O
|
2045 |
+
at ADP B-O
|
2046 |
+
ChrV PROPN B-O
|
2047 |
+
- PUNCT B-O
|
2048 |
+
L PROPN B-O
|
2049 |
+
( PUNCT B-O
|
2050 |
+
3.5 NUM B-O
|
2051 |
+
× PUNCT B-O
|
2052 |
+
10−10 NUM B-O
|
2053 |
+
; PUNCT B-O
|
2054 |
+
Table PROPN B-O
|
2055 |
+
2 NUM B-O
|
2056 |
+
) PUNCT B-O
|
2057 |
+
. PUNCT B-O
|
2058 |
+
|
2059 |
+
Pilot NOUN B-O
|
2060 |
+
studies NOUN B-O
|
2061 |
+
with ADP B-O
|
2062 |
+
exhaustive ADJ B-O
|
2063 |
+
sampling NOUN B-O
|
2064 |
+
, PUNCT B-O
|
2065 |
+
progressive ADJ B-O
|
2066 |
+
means NOUN B-O
|
2067 |
+
analysis NOUN B-O
|
2068 |
+
, PUNCT B-O
|
2069 |
+
and CCONJ B-O
|
2070 |
+
the DET B-O
|
2071 |
+
formula NOUN B-O
|
2072 |
+
of ADP B-O
|
2073 |
+
West PROPN B-O
|
2074 |
+
et PROPN B-O
|
2075 |
+
al PROPN B-O
|
2076 |
+
. PUNCT B-O
|
2077 |
+
|
2078 |
+
, PUNCT B-O
|
2079 |
+
[ PUNCT B-O
|
2080 |
+
166 NUM B-O
|
2081 |
+
] PUNCT B-O
|
2082 |
+
, PUNCT B-O
|
2083 |
+
as ADP B-O
|
2084 |
+
well ADV B-O
|
2085 |
+
as ADP B-O
|
2086 |
+
a PRON B-O
|
2087 |
+
posteriori X B-O
|
2088 |
+
power NOUN B-O
|
2089 |
+
analysis NOUN B-O
|
2090 |
+
, PUNCT B-O
|
2091 |
+
using VERB B-O
|
2092 |
+
data NOUN B-O
|
2093 |
+
from ADP B-O
|
2094 |
+
our PRON B-O
|
2095 |
+
previous ADJ B-O
|
2096 |
+
studies NOUN B-O
|
2097 |
+
of ADP B-O
|
2098 |
+
cell NOUN B-O
|
2099 |
+
and CCONJ B-O
|
2100 |
+
axon NOUN B-O
|
2101 |
+
densities NOUN B-O
|
2102 |
+
, PUNCT B-O
|
2103 |
+
or CCONJ B-O
|
2104 |
+
tract NOUN B-O
|
2105 |
+
tracing NOUN B-O
|
2106 |
+
of ADP B-O
|
2107 |
+
pathways NOUN B-O
|
2108 |
+
, PUNCT B-O
|
2109 |
+
took VERB B-O
|
2110 |
+
into ADP B-O
|
2111 |
+
consideration NOUN B-O
|
2112 |
+
all DET B-O
|
2113 |
+
known VERB B-O
|
2114 |
+
and CCONJ B-O
|
2115 |
+
estimated VERB B-O
|
2116 |
+
variables NOUN B-O
|
2117 |
+
, PUNCT B-O
|
2118 |
+
including VERB B-O
|
2119 |
+
age NOUN B-O
|
2120 |
+
, PUNCT B-O
|
2121 |
+
sex NOUN B-O
|
2122 |
+
, PUNCT B-O
|
2123 |
+
postmortem ADJ B-LF
|
2124 |
+
interval NOUN I-LF
|
2125 |
+
( PUNCT B-O
|
2126 |
+
PMI PROPN B-AC
|
2127 |
+
) PUNCT B-O
|
2128 |
+
, PUNCT B-O
|
2129 |
+
and CCONJ B-O
|
2130 |
+
other ADJ B-O
|
2131 |
+
diagnoses NOUN B-O
|
2132 |
+
. PUNCT B-O
|
2133 |
+
|
2134 |
+
A DET B-O
|
2135 |
+
series NOUN B-O
|
2136 |
+
of ADP B-O
|
2137 |
+
computer NOUN B-O
|
2138 |
+
- PUNCT B-O
|
2139 |
+
aided VERB B-O
|
2140 |
+
virtual ADJ B-O
|
2141 |
+
screening VERB B-O
|
2142 |
+
techniques NOUN B-O
|
2143 |
+
were AUX B-O
|
2144 |
+
utilized VERB B-O
|
2145 |
+
to PART B-O
|
2146 |
+
identify VERB B-O
|
2147 |
+
potential ADJ B-O
|
2148 |
+
agonists NOUN B-O
|
2149 |
+
of ADP B-O
|
2150 |
+
STING PROPN B-AC
|
2151 |
+
. PUNCT B-O
|
2152 |
+
|
2153 |
+
Structure NOUN B-O
|
2154 |
+
- PUNCT B-O
|
2155 |
+
based VERB B-O
|
2156 |
+
screening VERB B-O
|
2157 |
+
using VERB B-O
|
2158 |
+
Libdock PROPN B-O
|
2159 |
+
was AUX B-O
|
2160 |
+
carried VERB B-O
|
2161 |
+
out ADP B-O
|
2162 |
+
followed VERB B-O
|
2163 |
+
by ADP B-O
|
2164 |
+
ADME PROPN B-AC
|
2165 |
+
( PUNCT B-O
|
2166 |
+
absorption NOUN B-LF
|
2167 |
+
, PUNCT I-LF
|
2168 |
+
distribution NOUN I-LF
|
2169 |
+
, PUNCT I-LF
|
2170 |
+
metabolism NOUN I-LF
|
2171 |
+
, PUNCT I-LF
|
2172 |
+
excretion NOUN I-LF
|
2173 |
+
) PUNCT B-O
|
2174 |
+
and CCONJ B-O
|
2175 |
+
toxicity NOUN B-O
|
2176 |
+
prediction NOUN B-O
|
2177 |
+
. PUNCT B-O
|
2178 |
+
|
2179 |
+
Since SCONJ B-O
|
2180 |
+
the DET B-O
|
2181 |
+
absolute ADJ B-O
|
2182 |
+
precision NOUN B-O
|
2183 |
+
is AUX B-O
|
2184 |
+
depending VERB B-O
|
2185 |
+
on ADP B-O
|
2186 |
+
prevalence NOUN B-O
|
2187 |
+
of ADP B-O
|
2188 |
+
atrial ADJ B-LF
|
2189 |
+
fibrillation NOUN I-LF
|
2190 |
+
, PUNCT B-O
|
2191 |
+
which PRON B-O
|
2192 |
+
was AUX B-O
|
2193 |
+
low ADJ B-O
|
2194 |
+
in ADP B-O
|
2195 |
+
the DET B-O
|
2196 |
+
screened VERB B-O
|
2197 |
+
population NOUN B-O
|
2198 |
+
, PUNCT B-O
|
2199 |
+
one PRON B-O
|
2200 |
+
must AUX B-O
|
2201 |
+
consider VERB B-O
|
2202 |
+
sample NOUN B-O
|
2203 |
+
size NOUN B-O
|
2204 |
+
, PUNCT B-O
|
2205 |
+
i.e. X B-O
|
2206 |
+
what PRON B-O
|
2207 |
+
is AUX B-O
|
2208 |
+
the DET B-O
|
2209 |
+
absolute ADJ B-O
|
2210 |
+
precision NOUN B-O
|
2211 |
+
in ADP B-O
|
2212 |
+
the DET B-O
|
2213 |
+
validation NOUN B-O
|
2214 |
+
trial NOUN B-O
|
2215 |
+
with ADP B-O
|
2216 |
+
the DET B-O
|
2217 |
+
reported VERB B-O
|
2218 |
+
sample NOUN B-O
|
2219 |
+
size NOUN B-O
|
2220 |
+
and CCONJ B-O
|
2221 |
+
AF PROPN B-AC
|
2222 |
+
prevalence NOUN B-O
|
2223 |
+
? PUNCT B-O
|
2224 |
+
We PRON B-O
|
2225 |
+
also ADV B-O
|
2226 |
+
described VERB B-O
|
2227 |
+
the DET B-O
|
2228 |
+
dilutions NOUN B-O
|
2229 |
+
of ADP B-O
|
2230 |
+
the DET B-O
|
2231 |
+
antibody NOUN B-O
|
2232 |
+
in ADP B-O
|
2233 |
+
the DET B-O
|
2234 |
+
“ PUNCT B-O
|
2235 |
+
Results NOUN B-O
|
2236 |
+
” PUNCT B-O
|
2237 |
+
section NOUN B-O
|
2238 |
+
under ADP B-O
|
2239 |
+
the DET B-O
|
2240 |
+
heading NOUN B-O
|
2241 |
+
“ PUNCT B-O
|
2242 |
+
Detection NOUN B-O
|
2243 |
+
of ADP B-O
|
2244 |
+
anti ADJ B-O
|
2245 |
+
- PUNCT B-O
|
2246 |
+
FXIII/13 PROPN B-AC
|
2247 |
+
- PUNCT B-O
|
2248 |
+
A NOUN B-O
|
2249 |
+
autoantibodies NOUN B-O
|
2250 |
+
using VERB B-O
|
2251 |
+
enzyme NOUN B-LF
|
2252 |
+
- PUNCT I-LF
|
2253 |
+
linked VERB I-LF
|
2254 |
+
immunosorbent ADJ I-LF
|
2255 |
+
assay NOUN I-LF
|
2256 |
+
( PUNCT B-O
|
2257 |
+
ELISA PROPN B-AC
|
2258 |
+
) PUNCT B-O
|
2259 |
+
” PUNCT B-O
|
2260 |
+
( PUNCT B-O
|
2261 |
+
p.12 NOUN B-O
|
2262 |
+
, PUNCT B-O
|
2263 |
+
lane NOUN B-O
|
2264 |
+
3 NUM B-O
|
2265 |
+
) PUNCT B-O
|
2266 |
+
. PUNCT B-O
|
2267 |
+
|
2268 |
+
They PRON B-O
|
2269 |
+
invade VERB B-O
|
2270 |
+
primary ADJ B-O
|
2271 |
+
tumors NOUN B-O
|
2272 |
+
, PUNCT B-O
|
2273 |
+
where SCONJ B-O
|
2274 |
+
they PRON B-O
|
2275 |
+
promote VERB B-O
|
2276 |
+
angiogenesis NOUN B-O
|
2277 |
+
, PUNCT B-O
|
2278 |
+
via ADP B-O
|
2279 |
+
Matrix PROPN B-LF
|
2280 |
+
Metaloproteinases PROPN I-LF
|
2281 |
+
( PUNCT B-O
|
2282 |
+
MMP PROPN B-AC
|
2283 |
+
) PUNCT B-O
|
2284 |
+
secretion NOUN B-O
|
2285 |
+
and CCONJ B-O
|
2286 |
+
Vascular PROPN B-LF
|
2287 |
+
Endothelial PROPN I-LF
|
2288 |
+
Growth PROPN I-LF
|
2289 |
+
Factor PROPN I-LF
|
2290 |
+
( PUNCT B-O
|
2291 |
+
VEGF PROPN B-AC
|
2292 |
+
) PUNCT B-O
|
2293 |
+
production NOUN B-O
|
2294 |
+
[ PUNCT B-O
|
2295 |
+
24 NUM B-O
|
2296 |
+
] PUNCT B-O
|
2297 |
+
. PUNCT B-O
|
2298 |
+
|
2299 |
+
All DET B-O
|
2300 |
+
AmpC NOUN B-LF
|
2301 |
+
beta NOUN I-LF
|
2302 |
+
AmpC PROPN B-AC
|
2303 |
+
- PUNCT I-LF
|
2304 |
+
lactamase NOUN I-LF
|
2305 |
+
producing VERB B-O
|
2306 |
+
GNB PROPN B-AC
|
2307 |
+
were AUX B-O
|
2308 |
+
detected VERB B-O
|
2309 |
+
in ADP B-O
|
2310 |
+
urine NOUN B-O
|
2311 |
+
specimens NOUN B-O
|
2312 |
+
3.3 NUM B-O
|
2313 |
+
% PUNCT B-O
|
2314 |
+
( PUNCT B-O
|
2315 |
+
8/244 NUM B-O
|
2316 |
+
) PUNCT B-O
|
2317 |
+
and CCONJ B-O
|
2318 |
+
in ADP B-O
|
2319 |
+
patients NOUN B-O
|
2320 |
+
whose DET B-O
|
2321 |
+
age NOUN B-O
|
2322 |
+
group NOUN B-O
|
2323 |
+
was AUX B-O
|
2324 |
+
above ADP B-O
|
2325 |
+
61 NUM B-O
|
2326 |
+
years NOUN B-O
|
2327 |
+
( PUNCT B-O
|
2328 |
+
40.1 NUM B-O
|
2329 |
+
% PUNCT B-O
|
2330 |
+
) PUNCT B-O
|
2331 |
+
. PUNCT B-O
|
2332 |
+
|
2333 |
+
Temperature NOUN B-O
|
2334 |
+
data NOUN B-O
|
2335 |
+
such ADJ B-O
|
2336 |
+
as ADP B-O
|
2337 |
+
the DET B-O
|
2338 |
+
decadal ADJ B-O
|
2339 |
+
( PUNCT B-O
|
2340 |
+
10 NUM B-O
|
2341 |
+
- PUNCT B-O
|
2342 |
+
day NOUN B-O
|
2343 |
+
) PUNCT B-O
|
2344 |
+
mean ADJ B-O
|
2345 |
+
daily ADJ B-O
|
2346 |
+
maximum ADJ B-O
|
2347 |
+
air NOUN B-O
|
2348 |
+
temperature NOUN B-O
|
2349 |
+
( PUNCT B-O
|
2350 |
+
DMDMAT PROPN B-AC
|
2351 |
+
) PUNCT B-O
|
2352 |
+
were AUX B-O
|
2353 |
+
obtained VERB B-O
|
2354 |
+
from ADP B-O
|
2355 |
+
a DET B-O
|
2356 |
+
nearby ADJ B-O
|
2357 |
+
weather NOUN B-O
|
2358 |
+
station NOUN B-O
|
2359 |
+
and CCONJ B-O
|
2360 |
+
statistical ADJ B-O
|
2361 |
+
correlations NOUN B-O
|
2362 |
+
between ADP B-O
|
2363 |
+
tick NOUN B-O
|
2364 |
+
occurrence NOUN B-O
|
2365 |
+
and CCONJ B-O
|
2366 |
+
minimal ADJ B-LF
|
2367 |
+
infection NOUN I-LF
|
2368 |
+
rates NOUN I-LF
|
2369 |
+
( PUNCT B-O
|
2370 |
+
MIR PROPN B-AC
|
2371 |
+
) PUNCT B-O
|
2372 |
+
were AUX B-O
|
2373 |
+
calculated VERB B-O
|
2374 |
+
. PUNCT B-O
|
2375 |
+
|
2376 |
+
In ADP B-O
|
2377 |
+
the DET B-O
|
2378 |
+
case NOUN B-O
|
2379 |
+
of ADP B-O
|
2380 |
+
the DET B-O
|
2381 |
+
Schizophrenia PROPN B-LF
|
2382 |
+
( PUNCT B-O
|
2383 |
+
SZ PROPN B-AC
|
2384 |
+
) PUNCT B-O
|
2385 |
+
GWAS PROPN B-AC
|
2386 |
+
original ADJ B-O
|
2387 |
+
report NOUN B-O
|
2388 |
+
, PUNCT B-O
|
2389 |
+
16 NUM B-O
|
2390 |
+
% NOUN B-O
|
2391 |
+
of ADP B-O
|
2392 |
+
the DET B-O
|
2393 |
+
findings NOUN B-O
|
2394 |
+
were AUX B-O
|
2395 |
+
shown VERB B-O
|
2396 |
+
to PART B-O
|
2397 |
+
have VERB B-O
|
2398 |
+
brain NOUN B-O
|
2399 |
+
eQTL PROPN B-AC
|
2400 |
+
effects NOUN B-O
|
2401 |
+
at ADP B-O
|
2402 |
+
the DET B-O
|
2403 |
+
gene NOUN B-O
|
2404 |
+
level NOUN B-O
|
2405 |
+
[ PUNCT B-O
|
2406 |
+
1 NUM B-O
|
2407 |
+
] PUNCT B-O
|
2408 |
+
, PUNCT B-O
|
2409 |
+
but CCONJ B-O
|
2410 |
+
further ADJ B-O
|
2411 |
+
studies NOUN B-O
|
2412 |
+
are AUX B-O
|
2413 |
+
increasing VERB B-O
|
2414 |
+
this DET B-O
|
2415 |
+
number NOUN B-O
|
2416 |
+
[ PUNCT B-O
|
2417 |
+
6 NUM B-O
|
2418 |
+
, PUNCT B-O
|
2419 |
+
7 NUM B-O
|
2420 |
+
] PUNCT B-O
|
2421 |
+
. PUNCT B-O
|
2422 |
+
|
2423 |
+
To PART B-O
|
2424 |
+
explore VERB B-O
|
2425 |
+
the DET B-O
|
2426 |
+
relationships NOUN B-O
|
2427 |
+
between ADP B-O
|
2428 |
+
HP1 PROPN B-AC
|
2429 |
+
and CCONJ B-O
|
2430 |
+
these DET B-O
|
2431 |
+
marks NOUN B-O
|
2432 |
+
, PUNCT B-O
|
2433 |
+
we PRON B-O
|
2434 |
+
re VERB B-O
|
2435 |
+
- PUNCT B-O
|
2436 |
+
analyzed VERB B-O
|
2437 |
+
available ADJ B-O
|
2438 |
+
high ADJ B-O
|
2439 |
+
- PUNCT B-O
|
2440 |
+
resolution NOUN B-O
|
2441 |
+
chromosomal ADJ B-O
|
2442 |
+
maps NOUN B-O
|
2443 |
+
of ADP B-O
|
2444 |
+
dimethylated VERB B-LF
|
2445 |
+
histone NOUN I-LF
|
2446 |
+
3 NUM I-LF
|
2447 |
+
lysine NOUN I-LF
|
2448 |
+
4 NUM I-LF
|
2449 |
+
( PUNCT B-O
|
2450 |
+
H3K4me2 PROPN B-AC
|
2451 |
+
) PUNCT B-O
|
2452 |
+
and CCONJ B-O
|
2453 |
+
H3.3 NOUN B-O
|
2454 |
+
, PUNCT B-O
|
2455 |
+
which PRON B-O
|
2456 |
+
were AUX B-O
|
2457 |
+
generated VERB B-O
|
2458 |
+
in ADP B-O
|
2459 |
+
the DET B-O
|
2460 |
+
Drosophila PROPN B-O
|
2461 |
+
Kc PROPN B-O
|
2462 |
+
cell NOUN B-O
|
2463 |
+
line NOUN B-O
|
2464 |
+
or CCONJ B-O
|
2465 |
+
in ADP B-O
|
2466 |
+
the DET B-O
|
2467 |
+
closely ADV B-O
|
2468 |
+
related VERB B-O
|
2469 |
+
S2 PROPN B-O
|
2470 |
+
cell NOUN B-O
|
2471 |
+
line NOUN B-O
|
2472 |
+
[ X B-O
|
2473 |
+
51,53 X B-O
|
2474 |
+
] X B-O
|
2475 |
+
( PUNCT B-O
|
2476 |
+
see VERB B-O
|
2477 |
+
Materials NOUN B-O
|
2478 |
+
and CCONJ B-O
|
2479 |
+
Methods PROPN B-O
|
2480 |
+
) PUNCT B-O
|
2481 |
+
. PUNCT B-O
|
2482 |
+
|
2483 |
+
This DET B-O
|
2484 |
+
virus NOUN B-O
|
2485 |
+
quickly ADV B-O
|
2486 |
+
spread VERB B-O
|
2487 |
+
globally ADV B-O
|
2488 |
+
, PUNCT B-O
|
2489 |
+
and CCONJ B-O
|
2490 |
+
on ADP B-O
|
2491 |
+
June PROPN B-O
|
2492 |
+
11 NUM B-O
|
2493 |
+
, PUNCT B-O
|
2494 |
+
2009 NUM B-O
|
2495 |
+
, PUNCT B-O
|
2496 |
+
the DET B-O
|
2497 |
+
World PROPN B-LF
|
2498 |
+
Health PROPN I-LF
|
2499 |
+
Organization PROPN I-LF
|
2500 |
+
( PUNCT B-O
|
2501 |
+
WHO PROPN B-AC
|
2502 |
+
) PUNCT B-O
|
2503 |
+
declared VERB B-O
|
2504 |
+
a DET B-O
|
2505 |
+
pandemic NOUN B-O
|
2506 |
+
alert NOUN B-O
|
2507 |
+
phase NOUN B-O
|
2508 |
+
6 NUM B-O
|
2509 |
+
, PUNCT B-O
|
2510 |
+
indicating VERB B-O
|
2511 |
+
that SCONJ B-O
|
2512 |
+
the DET B-O
|
2513 |
+
first ADJ B-O
|
2514 |
+
influenza NOUN B-O
|
2515 |
+
pandemic NOUN B-O
|
2516 |
+
of ADP B-O
|
2517 |
+
the DET B-O
|
2518 |
+
21st ADJ B-O
|
2519 |
+
century NOUN B-O
|
2520 |
+
had AUX B-O
|
2521 |
+
begun VERB B-O
|
2522 |
+
[ X B-O
|
2523 |
+
1]–[3 X B-O
|
2524 |
+
] PUNCT B-O
|
2525 |
+
. PUNCT B-O
|
2526 |
+
|
2527 |
+
Between ADP B-O
|
2528 |
+
1990 NUM B-O
|
2529 |
+
and CCONJ B-O
|
2530 |
+
2014 NUM B-O
|
2531 |
+
the DET B-O
|
2532 |
+
world NOUN B-O
|
2533 |
+
prevalence NOUN B-O
|
2534 |
+
of ADP B-O
|
2535 |
+
cesarean ADJ B-LF
|
2536 |
+
section NOUN I-LF
|
2537 |
+
( PUNCT B-O
|
2538 |
+
CS PROPN B-AC
|
2539 |
+
) PUNCT B-O
|
2540 |
+
increased VERB B-O
|
2541 |
+
by ADP B-O
|
2542 |
+
285 NUM B-O
|
2543 |
+
% NOUN B-O
|
2544 |
+
( PUNCT B-O
|
2545 |
+
6.7 NUM B-O
|
2546 |
+
% NOUN B-O
|
2547 |
+
versus ADP B-O
|
2548 |
+
19.1 NUM B-O
|
2549 |
+
% NOUN B-O
|
2550 |
+
of ADP B-O
|
2551 |
+
all DET B-O
|
2552 |
+
births NOUN B-O
|
2553 |
+
) PUNCT B-O
|
2554 |
+
[ PUNCT B-O
|
2555 |
+
1 NUM B-O
|
2556 |
+
] PUNCT B-O
|
2557 |
+
, PUNCT B-O
|
2558 |
+
albeit SCONJ B-O
|
2559 |
+
with ADP B-O
|
2560 |
+
large ADJ B-O
|
2561 |
+
regional ADJ B-O
|
2562 |
+
disparities NOUN B-O
|
2563 |
+
. PUNCT B-O
|
2564 |
+
|
2565 |
+
Note VERB B-O
|
2566 |
+
that SCONJ B-O
|
2567 |
+
as ADP B-O
|
2568 |
+
a DET B-O
|
2569 |
+
consequence NOUN B-O
|
2570 |
+
of ADP B-O
|
2571 |
+
standardization NOUN B-O
|
2572 |
+
of ADP B-O
|
2573 |
+
the DET B-O
|
2574 |
+
continuous ADJ B-O
|
2575 |
+
variables NOUN B-O
|
2576 |
+
( PUNCT B-O
|
2577 |
+
age NOUN B-O
|
2578 |
+
, PUNCT B-O
|
2579 |
+
waist NOUN B-O
|
2580 |
+
circumference NOUN B-O
|
2581 |
+
, PUNCT B-O
|
2582 |
+
fasting VERB B-O
|
2583 |
+
plasma NOUN B-O
|
2584 |
+
glucose NOUN B-O
|
2585 |
+
, PUNCT B-O
|
2586 |
+
total ADJ B-O
|
2587 |
+
- PUNCT B-O
|
2588 |
+
to ADP B-O
|
2589 |
+
- PUNCT B-O
|
2590 |
+
HDL NOUN B-O
|
2591 |
+
cholesterol NOUN B-O
|
2592 |
+
, PUNCT B-O
|
2593 |
+
24 NUM B-O
|
2594 |
+
- PUNCT B-O
|
2595 |
+
h NOUN B-O
|
2596 |
+
systolic ADJ B-O
|
2597 |
+
blood NOUN B-O
|
2598 |
+
pressure NOUN B-O
|
2599 |
+
) PUNCT B-O
|
2600 |
+
the DET B-O
|
2601 |
+
regression NOUN B-O
|
2602 |
+
coefficient NOUN B-O
|
2603 |
+
( PUNCT B-O
|
2604 |
+
B NOUN B-O
|
2605 |
+
) PUNCT B-O
|
2606 |
+
for ADP B-O
|
2607 |
+
continuous ADJ B-O
|
2608 |
+
variables NOUN B-O
|
2609 |
+
equals VERB B-O
|
2610 |
+
the DET B-O
|
2611 |
+
standardized ADJ B-O
|
2612 |
+
beta NOUN B-O
|
2613 |
+
. PUNCT B-O
|
2614 |
+
|
2615 |
+
* PUNCT B-O
|
2616 |
+
P<0.05 NUM B-O
|
2617 |
+
, PUNCT B-O
|
2618 |
+
SD PROPN B-AC
|
2619 |
+
, PUNCT B-O
|
2620 |
+
standard ADJ B-LF
|
2621 |
+
deviation NOUN I-LF
|
2622 |
+
; PUNCT B-O
|
2623 |
+
CI NOUN B-O
|
2624 |
+
, PUNCT B-O
|
2625 |
+
confidence NOUN B-O
|
2626 |
+
interval NOUN B-O
|
2627 |
+
; PUNCT B-O
|
2628 |
+
HDL NOUN B-O
|
2629 |
+
, PUNCT B-O
|
2630 |
+
high ADJ B-O
|
2631 |
+
- PUNCT B-O
|
2632 |
+
density NOUN B-O
|
2633 |
+
lipoprotein NOUN B-O
|
2634 |
+
. PUNCT B-O
|
2635 |
+
|
2636 |
+
For ADP B-O
|
2637 |
+
this DET B-O
|
2638 |
+
interim ADJ B-O
|
2639 |
+
analysis NOUN B-O
|
2640 |
+
, PUNCT B-O
|
2641 |
+
we PRON B-O
|
2642 |
+
excluded VERB B-O
|
2643 |
+
patients NOUN B-O
|
2644 |
+
treated VERB B-O
|
2645 |
+
with ADP B-O
|
2646 |
+
different ADJ B-O
|
2647 |
+
therapies NOUN B-O
|
2648 |
+
other ADJ B-O
|
2649 |
+
than ADP B-O
|
2650 |
+
standard ADJ B-O
|
2651 |
+
chemotherapy NOUN B-O
|
2652 |
+
including VERB B-O
|
2653 |
+
anthracycline NOUN B-O
|
2654 |
+
and/or CCONJ B-O
|
2655 |
+
trastuzumab NOUN B-O
|
2656 |
+
( PUNCT B-O
|
2657 |
+
n NOUN B-O
|
2658 |
+
= SYM B-O
|
2659 |
+
2,929 NUM B-O
|
2660 |
+
) PUNCT B-O
|
2661 |
+
, PUNCT B-O
|
2662 |
+
patients NOUN B-O
|
2663 |
+
with ADP B-O
|
2664 |
+
no DET B-O
|
2665 |
+
left ADJ B-LF
|
2666 |
+
ventricular ADJ I-LF
|
2667 |
+
ejection NOUN I-LF
|
2668 |
+
fraction NOUN I-LF
|
2669 |
+
( PUNCT B-O
|
2670 |
+
LVEF PROPN B-AC
|
2671 |
+
) PUNCT B-O
|
2672 |
+
measurement NOUN B-O
|
2673 |
+
at ADP B-O
|
2674 |
+
baseline NOUN B-O
|
2675 |
+
( PUNCT B-O
|
2676 |
+
n NOUN B-O
|
2677 |
+
= SYM B-O
|
2678 |
+
918)or NUM B-O
|
2679 |
+
no DET B-O
|
2680 |
+
available ADJ B-O
|
2681 |
+
follow VERB B-O
|
2682 |
+
- PUNCT B-O
|
2683 |
+
up ADP B-O
|
2684 |
+
measurements NOUN B-O
|
2685 |
+
( PUNCT B-O
|
2686 |
+
n NOUN B-O
|
2687 |
+
= SYM B-O
|
2688 |
+
799 NUM B-O
|
2689 |
+
) PUNCT B-O
|
2690 |
+
, PUNCT B-O
|
2691 |
+
patients NOUN B-O
|
2692 |
+
with ADP B-O
|
2693 |
+
LVEF PROPN B-AC
|
2694 |
+
at ADP B-O
|
2695 |
+
baseline NOUN B-O
|
2696 |
+
< ADP B-O
|
2697 |
+
50 NUM B-O
|
2698 |
+
% NOUN B-O
|
2699 |
+
( PUNCT B-O
|
2700 |
+
n NOUN B-O
|
2701 |
+
= SYM B-O
|
2702 |
+
13 NUM B-O
|
2703 |
+
) PUNCT B-O
|
2704 |
+
, PUNCT B-O
|
2705 |
+
patients NOUN B-O
|
2706 |
+
with ADP B-O
|
2707 |
+
BMI PROPN B-AC
|
2708 |
+
< ADP B-O
|
2709 |
+
18.5 NUM B-O
|
2710 |
+
kg NOUN B-O
|
2711 |
+
/ SYM B-O
|
2712 |
+
m2 NOUN B-O
|
2713 |
+
( PUNCT B-O
|
2714 |
+
n NOUN B-O
|
2715 |
+
= SYM B-O
|
2716 |
+
32 NUM B-O
|
2717 |
+
) PUNCT B-O
|
2718 |
+
, PUNCT B-O
|
2719 |
+
and CCONJ B-O
|
2720 |
+
patients NOUN B-O
|
2721 |
+
with ADP B-O
|
2722 |
+
evidence NOUN B-O
|
2723 |
+
of ADP B-O
|
2724 |
+
local ADJ B-O
|
2725 |
+
, PUNCT B-O
|
2726 |
+
regional ADJ B-O
|
2727 |
+
, PUNCT B-O
|
2728 |
+
or CCONJ B-O
|
2729 |
+
metastatic ADJ B-O
|
2730 |
+
recurrence NOUN B-O
|
2731 |
+
of ADP B-O
|
2732 |
+
BC PROPN B-AC
|
2733 |
+
( PUNCT B-O
|
2734 |
+
n NOUN B-O
|
2735 |
+
= SYM B-O
|
2736 |
+
181 NUM B-O
|
2737 |
+
) PUNCT B-O
|
2738 |
+
. PUNCT B-O
|
2739 |
+
|
2740 |
+
Meanwhile ADV B-O
|
2741 |
+
, PUNCT B-O
|
2742 |
+
it PRON B-O
|
2743 |
+
lowered VERB B-O
|
2744 |
+
malondialdehyde NOUN B-LF
|
2745 |
+
( PUNCT B-O
|
2746 |
+
MDA PROPN B-AC
|
2747 |
+
) PUNCT B-O
|
2748 |
+
, PUNCT B-O
|
2749 |
+
nitric NOUN B-LF
|
2750 |
+
oxide NOUN I-LF
|
2751 |
+
( PUNCT B-O
|
2752 |
+
NO PROPN B-AC
|
2753 |
+
) PUNCT B-O
|
2754 |
+
and CCONJ B-O
|
2755 |
+
nuclear ADJ B-LF
|
2756 |
+
factor NOUN I-LF
|
2757 |
+
erythroid NOUN I-LF
|
2758 |
+
2 NUM I-LF
|
2759 |
+
- PUNCT I-LF
|
2760 |
+
related VERB I-LF
|
2761 |
+
factor NOUN I-LF
|
2762 |
+
2 NUM I-LF
|
2763 |
+
( PUNCT B-O
|
2764 |
+
NRF-2 PROPN B-AC
|
2765 |
+
) PUNCT B-O
|
2766 |
+
levels NOUN B-O
|
2767 |
+
with ADP B-O
|
2768 |
+
restoration NOUN B-O
|
2769 |
+
of ADP B-O
|
2770 |
+
glutathione NOUN B-LF
|
2771 |
+
( PUNCT B-O
|
2772 |
+
GSH PROPN B-AC
|
2773 |
+
) PUNCT B-O
|
2774 |
+
, PUNCT B-O
|
2775 |
+
and CCONJ B-O
|
2776 |
+
glutathione NOUN B-LF
|
2777 |
+
peroxidase NOUN I-LF
|
2778 |
+
( PUNCT B-O
|
2779 |
+
GPx PROPN B-AC
|
2780 |
+
) PUNCT B-O
|
2781 |
+
. PUNCT B-O
|
2782 |
+
|
2783 |
+
CD PROPN B-AC
|
2784 |
+
, PUNCT B-O
|
2785 |
+
change NOUN B-LF
|
2786 |
+
- PUNCT I-LF
|
2787 |
+
detection NOUN I-LF
|
2788 |
+
. PUNCT B-O
|
2789 |
+
|
2790 |
+
As SCONJ B-O
|
2791 |
+
the DET B-O
|
2792 |
+
transfer NOUN B-O
|
2793 |
+
of ADP B-O
|
2794 |
+
bacteria NOUN B-O
|
2795 |
+
to ADP B-O
|
2796 |
+
the DET B-O
|
2797 |
+
embryo NOUN B-O
|
2798 |
+
is AUX B-O
|
2799 |
+
being AUX B-O
|
2800 |
+
completed VERB B-O
|
2801 |
+
, PUNCT B-O
|
2802 |
+
expression NOUN B-O
|
2803 |
+
of ADP B-O
|
2804 |
+
the DET B-O
|
2805 |
+
Engrailed PROPN B-LF
|
2806 |
+
( PUNCT B-O
|
2807 |
+
En PROPN B-AC
|
2808 |
+
) PUNCT B-O
|
2809 |
+
protein NOUN B-O
|
2810 |
+
( PUNCT B-O
|
2811 |
+
FBgn0000577 NOUN B-O
|
2812 |
+
) PUNCT B-O
|
2813 |
+
( PUNCT B-O
|
2814 |
+
Patel PROPN B-O
|
2815 |
+
et NOUN B-O
|
2816 |
+
al NOUN B-O
|
2817 |
+
. PUNCT B-O
|
2818 |
+
|
2819 |
+
1989 NUM B-O
|
2820 |
+
) PUNCT B-O
|
2821 |
+
is AUX B-O
|
2822 |
+
detected VERB B-O
|
2823 |
+
( PUNCT B-O
|
2824 |
+
Figure NOUN B-O
|
2825 |
+
1 NUM B-O
|
2826 |
+
G NOUN B-O
|
2827 |
+
) PUNCT B-O
|
2828 |
+
. PUNCT B-O
|
2829 |
+
|
2830 |
+
Knowledge NOUN B-LF
|
2831 |
+
translation NOUN I-LF
|
2832 |
+
( PUNCT B-O
|
2833 |
+
KT PROPN B-AC
|
2834 |
+
) PUNCT B-O
|
2835 |
+
is AUX B-O
|
2836 |
+
one NUM B-O
|
2837 |
+
of ADP B-O
|
2838 |
+
a DET B-O
|
2839 |
+
host NOUN B-O
|
2840 |
+
of ADP B-O
|
2841 |
+
terms NOUN B-O
|
2842 |
+
( PUNCT B-O
|
2843 |
+
e.g. X B-O
|
2844 |
+
, PUNCT B-O
|
2845 |
+
implementation NOUN B-O
|
2846 |
+
, PUNCT B-O
|
2847 |
+
knowledge NOUN B-O
|
2848 |
+
transfer NOUN B-O
|
2849 |
+
) PUNCT B-O
|
2850 |
+
used VERB B-O
|
2851 |
+
to PART B-O
|
2852 |
+
describe VERB B-O
|
2853 |
+
“ PUNCT B-O
|
2854 |
+
a DET B-O
|
2855 |
+
dynamic ADJ B-O
|
2856 |
+
and CCONJ B-O
|
2857 |
+
iterative ADJ B-O
|
2858 |
+
process NOUN B-O
|
2859 |
+
that PRON B-O
|
2860 |
+
includes VERB B-O
|
2861 |
+
the DET B-O
|
2862 |
+
synthesis NOUN B-O
|
2863 |
+
, PUNCT B-O
|
2864 |
+
dissemination NOUN B-O
|
2865 |
+
, PUNCT B-O
|
2866 |
+
exchange NOUN B-O
|
2867 |
+
and CCONJ B-O
|
2868 |
+
ethically ADV B-O
|
2869 |
+
sound ADJ B-O
|
2870 |
+
application NOUN B-O
|
2871 |
+
of ADP B-O
|
2872 |
+
knowledge NOUN B-O
|
2873 |
+
to PART B-O
|
2874 |
+
improve VERB B-O
|
2875 |
+
health NOUN B-O
|
2876 |
+
, PUNCT B-O
|
2877 |
+
provide VERB B-O
|
2878 |
+
more ADV B-O
|
2879 |
+
effective ADJ B-O
|
2880 |
+
health NOUN B-O
|
2881 |
+
services NOUN B-O
|
2882 |
+
and CCONJ B-O
|
2883 |
+
products NOUN B-O
|
2884 |
+
, PUNCT B-O
|
2885 |
+
and CCONJ B-O
|
2886 |
+
strengthen VERB B-O
|
2887 |
+
the DET B-O
|
2888 |
+
healthcare NOUN B-O
|
2889 |
+
system NOUN B-O
|
2890 |
+
. PUNCT B-O
|
2891 |
+
|
2892 |
+
”[6 X B-O
|
2893 |
+
] X B-O
|
2894 |
+
This DET B-O
|
2895 |
+
value NOUN B-O
|
2896 |
+
is AUX B-O
|
2897 |
+
in ADP B-O
|
2898 |
+
excellent ADJ B-O
|
2899 |
+
agreement NOUN B-O
|
2900 |
+
with ADP B-O
|
2901 |
+
the DET B-O
|
2902 |
+
expected VERB B-O
|
2903 |
+
molecular ADJ B-O
|
2904 |
+
weight NOUN B-O
|
2905 |
+
of ADP B-O
|
2906 |
+
the DET B-O
|
2907 |
+
holoenzyme NOUN B-O
|
2908 |
+
, PUNCT B-O
|
2909 |
+
28,705.88 NUM B-O
|
2910 |
+
Da PROPN B-AC
|
2911 |
+
. PUNCT B-O
|
2912 |
+
|
2913 |
+
As ADP B-O
|
2914 |
+
an DET B-O
|
2915 |
+
independent ADJ B-O
|
2916 |
+
confirmation NOUN B-O
|
2917 |
+
of ADP B-O
|
2918 |
+
these DET B-O
|
2919 |
+
results NOUN B-O
|
2920 |
+
, PUNCT B-O
|
2921 |
+
an DET B-O
|
2922 |
+
electrospray NOUN B-LF
|
2923 |
+
ionization NOUN I-LF
|
2924 |
+
( PUNCT B-O
|
2925 |
+
ESI PROPN B-AC
|
2926 |
+
) PUNCT B-O
|
2927 |
+
mass NOUN B-O
|
2928 |
+
spectrum NOUN B-O
|
2929 |
+
was AUX B-O
|
2930 |
+
acquired VERB B-O
|
2931 |
+
for ADP B-O
|
2932 |
+
APS PROPN B-AC
|
2933 |
+
reductase NOUN B-O
|
2934 |
+
. PUNCT B-O
|
2935 |
+
|
2936 |
+
Real ADJ B-O
|
2937 |
+
- PUNCT B-O
|
2938 |
+
time NOUN B-O
|
2939 |
+
reverse ADJ B-O
|
2940 |
+
transcription NOUN B-O
|
2941 |
+
PCR NOUN B-O
|
2942 |
+
( PUNCT B-O
|
2943 |
+
qPCR NOUN B-O
|
2944 |
+
) PUNCT B-O
|
2945 |
+
normalized VERB B-O
|
2946 |
+
to ADP B-O
|
2947 |
+
an DET B-O
|
2948 |
+
internal ADJ B-O
|
2949 |
+
reference NOUN B-LF
|
2950 |
+
gene NOUN I-LF
|
2951 |
+
( PUNCT B-O
|
2952 |
+
RG PROPN B-AC
|
2953 |
+
) PUNCT B-O
|
2954 |
+
, PUNCT B-O
|
2955 |
+
is AUX B-O
|
2956 |
+
a DET B-O
|
2957 |
+
frequently ADV B-O
|
2958 |
+
used VERB B-O
|
2959 |
+
method NOUN B-O
|
2960 |
+
for ADP B-O
|
2961 |
+
quantifying VERB B-O
|
2962 |
+
gene NOUN B-O
|
2963 |
+
expression NOUN B-O
|
2964 |
+
changes NOUN B-O
|
2965 |
+
in ADP B-O
|
2966 |
+
neuroscience NOUN B-O
|
2967 |
+
. PUNCT B-O
|
2968 |
+
|
2969 |
+
Consensus NOUN B-O
|
2970 |
+
documents NOUN B-O
|
2971 |
+
developed VERB B-O
|
2972 |
+
by ADP B-O
|
2973 |
+
professional ADJ B-O
|
2974 |
+
societies NOUN B-O
|
2975 |
+
from ADP B-O
|
2976 |
+
the DET B-O
|
2977 |
+
US PROPN B-O
|
2978 |
+
, PUNCT B-O
|
2979 |
+
Europe PROPN B-O
|
2980 |
+
, PUNCT B-O
|
2981 |
+
and CCONJ B-O
|
2982 |
+
Canada PROPN B-O
|
2983 |
+
[ X B-O
|
2984 |
+
9–12 NUM B-O
|
2985 |
+
] X B-O
|
2986 |
+
have AUX B-O
|
2987 |
+
cautioned VERB B-O
|
2988 |
+
against ADP B-O
|
2989 |
+
generic ADJ B-O
|
2990 |
+
immunosuppressant ADJ B-O
|
2991 |
+
use NOUN B-O
|
2992 |
+
, PUNCT B-O
|
2993 |
+
citing VERB B-O
|
2994 |
+
( PUNCT B-O
|
2995 |
+
1 X B-O
|
2996 |
+
) PUNCT B-O
|
2997 |
+
the DET B-O
|
2998 |
+
lack NOUN B-O
|
2999 |
+
of ADP B-O
|
3000 |
+
data NOUN B-O
|
3001 |
+
in ADP B-O
|
3002 |
+
transplant NOUN B-O
|
3003 |
+
recipients NOUN B-O
|
3004 |
+
, PUNCT B-O
|
3005 |
+
especially ADV B-O
|
3006 |
+
“ PUNCT B-O
|
3007 |
+
high ADJ B-O
|
3008 |
+
risk NOUN B-O
|
3009 |
+
” PUNCT B-O
|
3010 |
+
transplant NOUN B-O
|
3011 |
+
recipients NOUN B-O
|
3012 |
+
; PUNCT B-O
|
3013 |
+
( PUNCT B-O
|
3014 |
+
2 X B-O
|
3015 |
+
) PUNCT B-O
|
3016 |
+
the DET B-O
|
3017 |
+
need NOUN B-O
|
3018 |
+
to PART B-O
|
3019 |
+
implement VERB B-O
|
3020 |
+
stricter ADJ B-O
|
3021 |
+
bioequivalence NOUN B-O
|
3022 |
+
standards NOUN B-O
|
3023 |
+
, PUNCT B-O
|
3024 |
+
as SCONJ B-O
|
3025 |
+
tacrolimus PROPN B-O
|
3026 |
+
is AUX B-O
|
3027 |
+
a DET B-O
|
3028 |
+
narrow ADJ B-LF
|
3029 |
+
therapeutic ADJ I-LF
|
3030 |
+
index NOUN I-LF
|
3031 |
+
( PUNCT B-O
|
3032 |
+
NTI PROPN B-AC
|
3033 |
+
) PUNCT B-O
|
3034 |
+
drug NOUN B-O
|
3035 |
+
for ADP B-O
|
3036 |
+
which PRON B-O
|
3037 |
+
small ADJ B-O
|
3038 |
+
changes NOUN B-O
|
3039 |
+
in ADP B-O
|
3040 |
+
dose NOUN B-O
|
3041 |
+
or CCONJ B-O
|
3042 |
+
exposure NOUN B-O
|
3043 |
+
can AUX B-O
|
3044 |
+
result VERB B-O
|
3045 |
+
in ADP B-O
|
3046 |
+
therapeutic ADJ B-O
|
3047 |
+
failure NOUN B-O
|
3048 |
+
or CCONJ B-O
|
3049 |
+
toxicity NOUN B-O
|
3050 |
+
; PUNCT B-O
|
3051 |
+
and CCONJ B-O
|
3052 |
+
( PUNCT B-O
|
3053 |
+
3 X B-O
|
3054 |
+
) PUNCT B-O
|
3055 |
+
the DET B-O
|
3056 |
+
lack NOUN B-O
|
3057 |
+
of ADP B-O
|
3058 |
+
bioequivalence NOUN B-O
|
3059 |
+
data NOUN B-O
|
3060 |
+
between ADP B-O
|
3061 |
+
generics NOUN B-O
|
3062 |
+
. PUNCT B-O
|
3063 |
+
|
3064 |
+
Ductal ADJ B-LF
|
3065 |
+
carcinoma NOUN I-LF
|
3066 |
+
in ADP I-LF
|
3067 |
+
situ NOUN I-LF
|
3068 |
+
( PUNCT B-O
|
3069 |
+
DCIS PROPN B-AC
|
3070 |
+
) PUNCT B-O
|
3071 |
+
, PUNCT B-O
|
3072 |
+
a DET B-O
|
3073 |
+
noninvasive ADJ B-O
|
3074 |
+
nonobligate ADJ B-O
|
3075 |
+
precursor NOUN B-O
|
3076 |
+
of ADP B-O
|
3077 |
+
breast NOUN B-O
|
3078 |
+
cancer NOUN B-O
|
3079 |
+
, PUNCT B-O
|
3080 |
+
accounts VERB B-O
|
3081 |
+
for ADP B-O
|
3082 |
+
about ADV B-O
|
3083 |
+
25 NUM B-O
|
3084 |
+
% NOUN B-O
|
3085 |
+
of ADP B-O
|
3086 |
+
all DET B-O
|
3087 |
+
breast NOUN B-O
|
3088 |
+
cancer NOUN B-O
|
3089 |
+
cases NOUN B-O
|
3090 |
+
[ PUNCT B-O
|
3091 |
+
38 NUM B-O
|
3092 |
+
] PUNCT B-O
|
3093 |
+
. PUNCT B-O
|
3094 |
+
|
3095 |
+
Indeed ADV B-O
|
3096 |
+
, PUNCT B-O
|
3097 |
+
as SCONJ B-O
|
3098 |
+
expected VERB B-O
|
3099 |
+
, PUNCT B-O
|
3100 |
+
pretreatment NOUN B-O
|
3101 |
+
of ADP B-O
|
3102 |
+
Hsp26 PROPN B-O
|
3103 |
+
for ADP B-O
|
3104 |
+
10 NUM B-O
|
3105 |
+
min NOUN B-O
|
3106 |
+
at ADP B-O
|
3107 |
+
45 NUM B-O
|
3108 |
+
° NOUN B-O
|
3109 |
+
C NOUN B-O
|
3110 |
+
increased VERB B-O
|
3111 |
+
the DET B-O
|
3112 |
+
ability NOUN B-O
|
3113 |
+
of ADP B-O
|
3114 |
+
Hsp26 PROPN B-O
|
3115 |
+
to ADP B-O
|
3116 |
+
suppress VERB B-O
|
3117 |
+
aggregation NOUN B-O
|
3118 |
+
of ADP B-O
|
3119 |
+
glutamate NOUN B-LF
|
3120 |
+
dehydrogenase NOUN I-LF
|
3121 |
+
( PUNCT B-O
|
3122 |
+
GDH PROPN B-AC
|
3123 |
+
) PUNCT B-O
|
3124 |
+
( PUNCT B-O
|
3125 |
+
Figure PROPN B-O
|
3126 |
+
6D NUM B-O
|
3127 |
+
) PUNCT B-O
|
3128 |
+
. PUNCT B-O
|
3129 |
+
|
3130 |
+
By ADP B-O
|
3131 |
+
contrast NOUN B-O
|
3132 |
+
, PUNCT B-O
|
3133 |
+
the DET B-O
|
3134 |
+
same ADJ B-O
|
3135 |
+
pretreatment NOUN B-O
|
3136 |
+
reduced VERB B-O
|
3137 |
+
the DET B-O
|
3138 |
+
ability NOUN B-O
|
3139 |
+
of ADP B-O
|
3140 |
+
Hsp26 PROPN B-O
|
3141 |
+
to ADP B-O
|
3142 |
+
inhibit VERB B-O
|
3143 |
+
spontaneous ADJ B-O
|
3144 |
+
NM NOUN B-O
|
3145 |
+
assembly NOUN B-O
|
3146 |
+
( PUNCT B-O
|
3147 |
+
Figure PROPN B-O
|
3148 |
+
6D NUM B-O
|
3149 |
+
) PUNCT B-O
|
3150 |
+
. PUNCT B-O
|
3151 |
+
|
3152 |
+
Thus ADV B-O
|
3153 |
+
, PUNCT B-O
|
3154 |
+
at ADP B-O
|
3155 |
+
elevated VERB B-O
|
3156 |
+
temperatures NOUN B-O
|
3157 |
+
Hsp26 PROPN B-O
|
3158 |
+
might AUX B-O
|
3159 |
+
switch VERB B-O
|
3160 |
+
from ADP B-O
|
3161 |
+
inhibiting VERB B-O
|
3162 |
+
prion NOUN B-O
|
3163 |
+
assembly NOUN B-O
|
3164 |
+
to ADP B-O
|
3165 |
+
suppressing VERB B-O
|
3166 |
+
aggregation NOUN B-O
|
3167 |
+
of ADP B-O
|
3168 |
+
denatured VERB B-O
|
3169 |
+
substrates NOUN B-O
|
3170 |
+
. PUNCT B-O
|
3171 |
+
|
3172 |
+
The DET B-O
|
3173 |
+
results NOUN B-O
|
3174 |
+
demonstrated VERB B-O
|
3175 |
+
that SCONJ B-O
|
3176 |
+
this DET B-O
|
3177 |
+
human ADJ B-O
|
3178 |
+
LCM PROPN B-AC
|
3179 |
+
gene NOUN B-O
|
3180 |
+
set NOUN B-O
|
3181 |
+
was AUX B-O
|
3182 |
+
significantly ADV B-O
|
3183 |
+
decreased VERB B-O
|
3184 |
+
in ADP B-O
|
3185 |
+
the DET B-O
|
3186 |
+
STHdhQ111 NOUN B-O
|
3187 |
+
/ SYM B-O
|
3188 |
+
Q111 NOUN B-O
|
3189 |
+
cells NOUN B-O
|
3190 |
+
( PUNCT B-O
|
3191 |
+
enrichment NOUN B-LF
|
3192 |
+
score NOUN I-LF
|
3193 |
+
[ X B-O
|
3194 |
+
ES PROPN B-AC
|
3195 |
+
] X B-O
|
3196 |
+
0.51 NUM B-O
|
3197 |
+
, PUNCT B-O
|
3198 |
+
p NOUN B-O
|
3199 |
+
- NOUN B-O
|
3200 |
+
value NOUN B-O
|
3201 |
+
0.000 NUM B-O
|
3202 |
+
, PUNCT B-O
|
3203 |
+
FDR PROPN B-AC
|
3204 |
+
q NOUN B-O
|
3205 |
+
- NOUN B-O
|
3206 |
+
value NOUN B-O
|
3207 |
+
0.180 NUM B-O
|
3208 |
+
) PUNCT B-O
|
3209 |
+
but CCONJ B-O
|
3210 |
+
was AUX B-O
|
3211 |
+
not PART B-O
|
3212 |
+
altered VERB B-O
|
3213 |
+
in ADP B-O
|
3214 |
+
the DET B-O
|
3215 |
+
3 PROPN B-AC
|
3216 |
+
treated VERB B-O
|
3217 |
+
cells NOUN B-O
|
3218 |
+
( PUNCT B-O
|
3219 |
+
-NPES PROPN B-AC
|
3220 |
+
0.38 NUM B-O
|
3221 |
+
, PUNCT B-O
|
3222 |
+
p NOUN B-O
|
3223 |
+
- NOUN B-O
|
3224 |
+
value NOUN B-O
|
3225 |
+
0.271 NUM B-O
|
3226 |
+
, PUNCT B-O
|
3227 |
+
FDR PROPN B-AC
|
3228 |
+
q NOUN B-O
|
3229 |
+
- NOUN B-O
|
3230 |
+
value NOUN B-O
|
3231 |
+
0.713 NUM B-O
|
3232 |
+
) PUNCT B-O
|
3233 |
+
. PUNCT B-O
|
3234 |
+
|
3235 |
+
BP PROPN B-AC
|
3236 |
+
: PUNCT B-O
|
3237 |
+
blood NOUN B-LF
|
3238 |
+
pressure NOUN I-LF
|
3239 |
+
. PUNCT B-O
|
3240 |
+
|
3241 |
+
In ADP B-O
|
3242 |
+
pemphigus NOUN B-LF
|
3243 |
+
vulgaris PROPN I-LF
|
3244 |
+
( PUNCT B-O
|
3245 |
+
PV PROPN B-AC
|
3246 |
+
) PUNCT B-O
|
3247 |
+
, PUNCT B-O
|
3248 |
+
the DET B-O
|
3249 |
+
most ADV B-O
|
3250 |
+
common ADJ B-O
|
3251 |
+
clinical ADJ B-O
|
3252 |
+
variant NOUN B-O
|
3253 |
+
of ADP B-O
|
3254 |
+
pemphigus NOUN B-O
|
3255 |
+
, PUNCT B-O
|
3256 |
+
several ADJ B-O
|
3257 |
+
in ADP B-O
|
3258 |
+
vitro ADJ B-O
|
3259 |
+
and CCONJ B-O
|
3260 |
+
in ADP B-O
|
3261 |
+
vivo ADJ B-O
|
3262 |
+
studies NOUN B-O
|
3263 |
+
demonstrated VERB B-O
|
3264 |
+
the DET B-O
|
3265 |
+
critical ADJ B-O
|
3266 |
+
role NOUN B-O
|
3267 |
+
of ADP B-O
|
3268 |
+
Dsg3 NOUN B-O
|
3269 |
+
- NOUN B-O
|
3270 |
+
specific ADJ B-O
|
3271 |
+
CD4 NOUN B-O
|
3272 |
+
+ NOUN B-O
|
3273 |
+
T NOUN B-O
|
3274 |
+
cells NOUN B-O
|
3275 |
+
in ADP B-O
|
3276 |
+
the DET B-O
|
3277 |
+
generation NOUN B-O
|
3278 |
+
of ADP B-O
|
3279 |
+
Dsg3 NOUN B-O
|
3280 |
+
- NOUN B-O
|
3281 |
+
specific ADJ B-O
|
3282 |
+
auto-ab PROPN B-AC
|
3283 |
+
[ X B-O
|
3284 |
+
4–9 NUM B-O
|
3285 |
+
] PUNCT B-O
|
3286 |
+
. PUNCT B-O
|
3287 |
+
|
3288 |
+
I PRON B-O
|
3289 |
+
employed VERB B-O
|
3290 |
+
a DET B-O
|
3291 |
+
Z NOUN B-O
|
3292 |
+
- PUNCT B-O
|
3293 |
+
score NOUN B-O
|
3294 |
+
measure NOUN B-O
|
3295 |
+
of ADP B-O
|
3296 |
+
structural ADJ B-O
|
3297 |
+
proximity NOUN B-O
|
3298 |
+
as ADP B-O
|
3299 |
+
weight NOUN B-O
|
3300 |
+
for ADP B-O
|
3301 |
+
the DET B-O
|
3302 |
+
edges NOUN B-O
|
3303 |
+
to PART B-O
|
3304 |
+
create VERB B-O
|
3305 |
+
a DET B-O
|
3306 |
+
protein NOUN B-LF
|
3307 |
+
domains NOUN I-LF
|
3308 |
+
universe NOUN I-LF
|
3309 |
+
graph NOUN I-LF
|
3310 |
+
( PUNCT B-O
|
3311 |
+
PDUG PROPN B-AC
|
3312 |
+
[ PUNCT B-O
|
3313 |
+
19 NUM B-O
|
3314 |
+
] PUNCT B-O
|
3315 |
+
) PUNCT B-O
|
3316 |
+
. PUNCT B-O
|
3317 |
+
|
3318 |
+
The DET B-O
|
3319 |
+
VHL PROPN B-AC
|
3320 |
+
mutation NOUN B-O
|
3321 |
+
diminishes VERB B-O
|
3322 |
+
VHL PROPN B-AC
|
3323 |
+
's PART B-O
|
3324 |
+
binding VERB B-O
|
3325 |
+
affinity NOUN B-O
|
3326 |
+
for ADP B-O
|
3327 |
+
hydroxylated VERB B-O
|
3328 |
+
HIF PROPN B-AC
|
3329 |
+
- PUNCT B-O
|
3330 |
+
α PUNCT B-O
|
3331 |
+
, PUNCT B-O
|
3332 |
+
thereby ADV B-O
|
3333 |
+
partially ADV B-O
|
3334 |
+
inhibiting VERB B-O
|
3335 |
+
HIF PROPN B-AC
|
3336 |
+
- PUNCT B-O
|
3337 |
+
α PUNCT B-O
|
3338 |
+
degradation NOUN B-O
|
3339 |
+
and CCONJ B-O
|
3340 |
+
pathologically ADV B-O
|
3341 |
+
up ADV B-O
|
3342 |
+
- PUNCT B-O
|
3343 |
+
regulating VERB B-O
|
3344 |
+
HIF PROPN B-AC
|
3345 |
+
target NOUN B-O
|
3346 |
+
genes NOUN B-O
|
3347 |
+
including VERB B-O
|
3348 |
+
erythropoietin NOUN B-LF
|
3349 |
+
( PUNCT B-O
|
3350 |
+
EPO PROPN B-AC
|
3351 |
+
) PUNCT B-O
|
3352 |
+
[ PUNCT B-O
|
3353 |
+
8 NUM B-O
|
3354 |
+
] PUNCT B-O
|
3355 |
+
. PUNCT B-O
|
3356 |
+
|
3357 |
+
Abbreviations NOUN B-O
|
3358 |
+
: PUNCT B-O
|
3359 |
+
BMI PROPN B-AC
|
3360 |
+
, PUNCT B-O
|
3361 |
+
body NOUN B-LF
|
3362 |
+
mass NOUN I-LF
|
3363 |
+
index NOUN I-LF
|
3364 |
+
; PUNCT B-O
|
3365 |
+
HR NOUN B-O
|
3366 |
+
, PUNCT B-O
|
3367 |
+
hazard NOUN B-O
|
3368 |
+
ratio NOUN B-O
|
3369 |
+
; PUNCT B-O
|
3370 |
+
ICS PROPN B-AC
|
3371 |
+
, PUNCT B-O
|
3372 |
+
inhaled VERB B-LF
|
3373 |
+
corticosteroid NOUN I-LF
|
3374 |
+
; PUNCT B-O
|
3375 |
+
LABA PROPN B-AC
|
3376 |
+
, PUNCT B-O
|
3377 |
+
long ADV B-LF
|
3378 |
+
- PUNCT I-LF
|
3379 |
+
acting VERB I-LF
|
3380 |
+
beta NOUN I-LF
|
3381 |
+
- PUNCT I-LF
|
3382 |
+
agonist NOUN I-LF
|
3383 |
+
. PUNCT B-O
|
3384 |
+
|
3385 |
+
Information NOUN B-O
|
3386 |
+
is AUX B-O
|
3387 |
+
available ADJ B-O
|
3388 |
+
from ADP B-O
|
3389 |
+
Avert PROPN B-O
|
3390 |
+
, PUNCT B-O
|
3391 |
+
an DET B-O
|
3392 |
+
international ADJ B-O
|
3393 |
+
AIDS PROPN B-O
|
3394 |
+
charity NOUN B-O
|
3395 |
+
, PUNCT B-O
|
3396 |
+
on ADP B-O
|
3397 |
+
many ADJ B-O
|
3398 |
+
aspects NOUN B-O
|
3399 |
+
of ADP B-O
|
3400 |
+
HIV PROPN B-O
|
3401 |
+
/ SYM B-O
|
3402 |
+
AIDS PROPN B-O
|
3403 |
+
, PUNCT B-O
|
3404 |
+
including VERB B-O
|
3405 |
+
information NOUN B-O
|
3406 |
+
on ADP B-O
|
3407 |
+
antiretroviral ADJ B-LF
|
3408 |
+
drugs NOUN B-O
|
3409 |
+
and CCONJ B-O
|
3410 |
+
on ADP B-O
|
3411 |
+
universal ADJ B-O
|
3412 |
+
access NOUN B-O
|
3413 |
+
to ADP B-O
|
3414 |
+
ARV PROPN B-AC
|
3415 |
+
therapy NOUN B-O
|
3416 |
+
; PUNCT B-O
|
3417 |
+
Avert PROPN B-O
|
3418 |
+
also ADV B-O
|
3419 |
+
provides VERB B-O
|
3420 |
+
personal ADJ B-O
|
3421 |
+
stories NOUN B-O
|
3422 |
+
about ADP B-O
|
3423 |
+
living VERB B-O
|
3424 |
+
with ADP B-O
|
3425 |
+
HIV PROPN B-O
|
3426 |
+
/ SYM B-O
|
3427 |
+
AIDS PROPN B-O
|
3428 |
+
The DET B-O
|
3429 |
+
efficiency NOUN B-O
|
3430 |
+
of ADP B-O
|
3431 |
+
siRNA NOUN B-O
|
3432 |
+
delivery NOUN B-O
|
3433 |
+
was AUX B-O
|
3434 |
+
checked VERB B-O
|
3435 |
+
with ADP B-O
|
3436 |
+
fluorescent ADJ B-O
|
3437 |
+
siGLO NOUN B-O
|
3438 |
+
. PUNCT B-O
|
3439 |
+
|
3440 |
+
Among ADP B-O
|
3441 |
+
these DET B-O
|
3442 |
+
siRNAs NOUN B-O
|
3443 |
+
, PUNCT B-O
|
3444 |
+
only ADV B-O
|
3445 |
+
those PRON B-O
|
3446 |
+
silencing VERB B-O
|
3447 |
+
the DET B-O
|
3448 |
+
Ca2 NOUN B-O
|
3449 |
+
+ NOUN B-O
|
3450 |
+
-independent ADJ B-O
|
3451 |
+
Group PROPN B-LF
|
3452 |
+
VIIIA PROPN I-LF
|
3453 |
+
( PUNCT B-O
|
3454 |
+
GVIIIA)-PLA2 PROPN B-AC
|
3455 |
+
inhibited VERB B-O
|
3456 |
+
VSVG PROPN B-AC
|
3457 |
+
transport NOUN B-O
|
3458 |
+
, PUNCT B-O
|
3459 |
+
resulting VERB B-O
|
3460 |
+
in ADP B-O
|
3461 |
+
accumulation NOUN B-O
|
3462 |
+
of ADP B-O
|
3463 |
+
cargo NOUN B-O
|
3464 |
+
within ADP B-O
|
3465 |
+
the DET B-O
|
3466 |
+
Golgi PROPN B-O
|
3467 |
+
complex NOUN B-O
|
3468 |
+
( PUNCT B-O
|
3469 |
+
Figure NOUN B-O
|
3470 |
+
8L NUM B-O
|
3471 |
+
and CCONJ B-O
|
3472 |
+
8P NOUN B-O
|
3473 |
+
) PUNCT B-O
|
3474 |
+
. PUNCT B-O
|
3475 |
+
|
3476 |
+
Strikingly ADV B-O
|
3477 |
+
, PUNCT B-O
|
3478 |
+
this DET B-O
|
3479 |
+
PLA2 PROPN B-AC
|
3480 |
+
isoform NOUN B-O
|
3481 |
+
has AUX B-O
|
3482 |
+
been AUX B-O
|
3483 |
+
detected VERB B-O
|
3484 |
+
by ADP B-O
|
3485 |
+
others NOUN B-O
|
3486 |
+
at ADP B-O
|
3487 |
+
the DET B-O
|
3488 |
+
Golgi PROPN B-O
|
3489 |
+
membranes NOUN B-O
|
3490 |
+
and CCONJ B-O
|
3491 |
+
appears VERB B-O
|
3492 |
+
to PART B-O
|
3493 |
+
be AUX B-O
|
3494 |
+
important ADJ B-O
|
3495 |
+
for ADP B-O
|
3496 |
+
maintenance NOUN B-O
|
3497 |
+
of ADP B-O
|
3498 |
+
the DET B-O
|
3499 |
+
tubular ADJ B-O
|
3500 |
+
elements NOUN B-O
|
3501 |
+
of ADP B-O
|
3502 |
+
the DET B-O
|
3503 |
+
Golgi PROPN B-O
|
3504 |
+
complex NOUN B-O
|
3505 |
+
( PUNCT B-O
|
3506 |
+
W. PROPN B-O
|
3507 |
+
The DET B-O
|
3508 |
+
main ADJ B-O
|
3509 |
+
outcome NOUN B-O
|
3510 |
+
is AUX B-O
|
3511 |
+
whether SCONJ B-O
|
3512 |
+
baseline NOUN B-O
|
3513 |
+
participants NOUN B-O
|
3514 |
+
received VERB B-O
|
3515 |
+
RPC PROPN B-AC
|
3516 |
+
( PUNCT B-O
|
3517 |
+
includes VERB B-O
|
3518 |
+
both CCONJ B-O
|
3519 |
+
pan ADJ B-O
|
3520 |
+
- PUNCT B-O
|
3521 |
+
retinal ADJ B-LF
|
3522 |
+
photocoagulation NOUN I-LF
|
3523 |
+
and CCONJ B-O
|
3524 |
+
focal ADJ B-O
|
3525 |
+
retinal ADJ B-O
|
3526 |
+
treatment NOUN B-O
|
3527 |
+
for ADP B-O
|
3528 |
+
macular ADJ B-O
|
3529 |
+
edema NOUN B-O
|
3530 |
+
) PUNCT B-O
|
3531 |
+
during ADP B-O
|
3532 |
+
the DET B-O
|
3533 |
+
follow NOUN B-O
|
3534 |
+
- PUNCT B-O
|
3535 |
+
up ADP B-O
|
3536 |
+
period NOUN B-O
|
3537 |
+
, PUNCT B-O
|
3538 |
+
which PRON B-O
|
3539 |
+
is AUX B-O
|
3540 |
+
an DET B-O
|
3541 |
+
indicator NOUN B-O
|
3542 |
+
of ADP B-O
|
3543 |
+
progression NOUN B-O
|
3544 |
+
to ADP B-O
|
3545 |
+
sNPDR PROPN B-AC
|
3546 |
+
or CCONJ B-O
|
3547 |
+
PDR PROPN B-AC
|
3548 |
+
. PUNCT B-O
|
3549 |
+
|
3550 |
+
A DET B-O
|
3551 |
+
participant NOUN B-O
|
3552 |
+
who PRON B-O
|
3553 |
+
had AUX B-O
|
3554 |
+
at ADV B-O
|
3555 |
+
least ADV B-O
|
3556 |
+
one NUM B-O
|
3557 |
+
retinal ADJ B-O
|
3558 |
+
laser NOUN B-O
|
3559 |
+
treatment NOUN B-O
|
3560 |
+
record NOUN B-O
|
3561 |
+
in ADP B-O
|
3562 |
+
the DET B-O
|
3563 |
+
MBS PROPN B-AC
|
3564 |
+
database NOUN B-O
|
3565 |
+
( PUNCT B-O
|
3566 |
+
MBS PROPN B-AC
|
3567 |
+
code NOUN B-O
|
3568 |
+
for ADP B-O
|
3569 |
+
RPC PROPN B-AC
|
3570 |
+
: PUNCT B-O
|
3571 |
+
42809 NUM B-O
|
3572 |
+
) PUNCT B-O
|
3573 |
+
were AUX B-O
|
3574 |
+
defined VERB B-O
|
3575 |
+
as SCONJ B-O
|
3576 |
+
had AUX B-O
|
3577 |
+
undergone VERB B-O
|
3578 |
+
RPC PROPN B-AC
|
3579 |
+
. PUNCT B-O
|
3580 |
+
|
3581 |
+
The DET B-O
|
3582 |
+
date NOUN B-O
|
3583 |
+
of ADP B-O
|
3584 |
+
first ADJ B-O
|
3585 |
+
laser NOUN B-O
|
3586 |
+
treatment NOUN B-O
|
3587 |
+
was AUX B-O
|
3588 |
+
utilized VERB B-O
|
3589 |
+
for ADP B-O
|
3590 |
+
analysis NOUN B-O
|
3591 |
+
if SCONJ B-O
|
3592 |
+
the DET B-O
|
3593 |
+
patient NOUN B-O
|
3594 |
+
underwent VERB B-O
|
3595 |
+
multiple ADJ B-O
|
3596 |
+
RPC PROPN B-AC
|
3597 |
+
treatments NOUN B-O
|
3598 |
+
. PUNCT B-O
|
3599 |
+
|
3600 |
+
Chronic ADJ B-O
|
3601 |
+
airflow NOUN B-O
|
3602 |
+
limitation NOUN B-O
|
3603 |
+
was AUX B-O
|
3604 |
+
defined VERB B-O
|
3605 |
+
as ADP B-O
|
3606 |
+
FEV1 PROPN B-AC
|
3607 |
+
/ SYM B-O
|
3608 |
+
FVC PROPN B-AC
|
3609 |
+
below ADP B-O
|
3610 |
+
the DET B-O
|
3611 |
+
5th ADJ B-O
|
3612 |
+
percentile NOUN B-O
|
3613 |
+
( PUNCT B-O
|
3614 |
+
lower ADJ B-O
|
3615 |
+
limit NOUN B-O
|
3616 |
+
of ADP B-O
|
3617 |
+
normal ADJ B-O
|
3618 |
+
; PUNCT B-O
|
3619 |
+
LLN PROPN B-AC
|
3620 |
+
) PUNCT B-O
|
3621 |
+
. PUNCT B-O
|
3622 |
+
|
3623 |
+
Diffusing VERB B-LF
|
3624 |
+
lung NOUN I-LF
|
3625 |
+
capacity NOUN I-LF
|
3626 |
+
for ADP I-LF
|
3627 |
+
carbon NOUN I-LF
|
3628 |
+
monoxide NOUN I-LF
|
3629 |
+
( PUNCT B-O
|
3630 |
+
DLCO PROPN B-AC
|
3631 |
+
) PUNCT B-O
|
3632 |
+
and CCONJ B-O
|
3633 |
+
the DET B-O
|
3634 |
+
DLCO PROPN B-AC
|
3635 |
+
corrected VERB B-O
|
3636 |
+
for ADP B-O
|
3637 |
+
lung NOUN B-O
|
3638 |
+
volume NOUN B-O
|
3639 |
+
( PUNCT B-O
|
3640 |
+
DLCO PROPN B-AC
|
3641 |
+
) PUNCT B-O
|
3642 |
+
were AUX B-O
|
3643 |
+
measured VERB B-O
|
3644 |
+
using VERB B-O
|
3645 |
+
a DET B-O
|
3646 |
+
single ADJ B-O
|
3647 |
+
breath NOUN B-O
|
3648 |
+
carbon NOUN B-O
|
3649 |
+
monoxide NOUN B-O
|
3650 |
+
diffusion NOUN B-O
|
3651 |
+
test NOUN B-O
|
3652 |
+
and CCONJ B-O
|
3653 |
+
were AUX B-O
|
3654 |
+
adjusted VERB B-O
|
3655 |
+
for ADP B-O
|
3656 |
+
plasma NOUN B-O
|
3657 |
+
haemoglobin NOUN B-O
|
3658 |
+
level.[20 NOUN B-O
|
3659 |
+
] X B-O
|
3660 |
+
Inspiratory ADJ B-LF
|
3661 |
+
capacity NOUN I-LF
|
3662 |
+
( PUNCT B-O
|
3663 |
+
/VAIC PROPN B-AC
|
3664 |
+
) PUNCT B-O
|
3665 |
+
was AUX B-O
|
3666 |
+
calculated VERB B-O
|
3667 |
+
as ADP B-O
|
3668 |
+
the DET B-O
|
3669 |
+
total ADJ B-LF
|
3670 |
+
lung NOUN I-LF
|
3671 |
+
capacity NOUN I-LF
|
3672 |
+
( PUNCT B-O
|
3673 |
+
TLC PROPN B-AC
|
3674 |
+
) PUNCT B-O
|
3675 |
+
minus CCONJ B-O
|
3676 |
+
the DET B-O
|
3677 |
+
functional ADJ B-LF
|
3678 |
+
residual ADJ I-LF
|
3679 |
+
capacity NOUN I-LF
|
3680 |
+
( PUNCT B-O
|
3681 |
+
FRC PROPN B-AC
|
3682 |
+
) PUNCT B-O
|
3683 |
+
. PUNCT B-O
|
3684 |
+
|
3685 |
+
All DET B-O
|
3686 |
+
lung NOUN B-O
|
3687 |
+
function NOUN B-O
|
3688 |
+
measures NOUN B-O
|
3689 |
+
were AUX B-O
|
3690 |
+
expressed VERB B-O
|
3691 |
+
as ADP B-O
|
3692 |
+
absolute ADJ B-O
|
3693 |
+
values NOUN B-O
|
3694 |
+
and CCONJ B-O
|
3695 |
+
relative ADJ B-O
|
3696 |
+
values NOUN B-O
|
3697 |
+
( PUNCT B-O
|
3698 |
+
percentage NOUN B-O
|
3699 |
+
of ADP B-O
|
3700 |
+
predicted VERB B-O
|
3701 |
+
; PUNCT B-O
|
3702 |
+
% NOUN B-O
|
3703 |
+
pred).[20–24 X B-O
|
3704 |
+
] X B-O
|
3705 |
+
The DET B-O
|
3706 |
+
extent NOUN B-O
|
3707 |
+
of ADP B-O
|
3708 |
+
dysanapsis NOUN B-O
|
3709 |
+
was AUX B-O
|
3710 |
+
calculated VERB B-O
|
3711 |
+
using VERB B-O
|
3712 |
+
the DET B-O
|
3713 |
+
formula NOUN B-O
|
3714 |
+
of ADP B-O
|
3715 |
+
Mead PROPN B-O
|
3716 |
+
et PROPN B-O
|
3717 |
+
al.[8 X B-O
|
3718 |
+
, PUNCT B-O
|
3719 |
+
9 NUM B-O
|
3720 |
+
, PUNCT B-O
|
3721 |
+
25 NUM B-O
|
3722 |
+
] X B-O
|
3723 |
+
Results NOUN B-O
|
3724 |
+
from ADP B-O
|
3725 |
+
the DET B-O
|
3726 |
+
PSA PROPN B-AC
|
3727 |
+
give VERB B-O
|
3728 |
+
slightly ADV B-O
|
3729 |
+
greater ADJ B-O
|
3730 |
+
mean ADJ B-O
|
3731 |
+
effects NOUN B-O
|
3732 |
+
for ADP B-O
|
3733 |
+
both CCONJ B-O
|
3734 |
+
the DET B-O
|
3735 |
+
routine ADJ B-O
|
3736 |
+
/ SYM B-O
|
3737 |
+
manual ADJ B-O
|
3738 |
+
( PUNCT B-O
|
3739 |
+
current ADJ B-O
|
3740 |
+
tax NOUN B-O
|
3741 |
+
increase NOUN B-O
|
3742 |
+
, NOUN B-O
|
3743 |
+
−3.6 NUM B-O
|
3744 |
+
% NOUN B-O
|
3745 |
+
[ PUNCT B-O
|
3746 |
+
95 NUM B-O
|
3747 |
+
% NOUN B-O
|
3748 |
+
uncertainty NOUN B-LF
|
3749 |
+
interval NOUN I-LF
|
3750 |
+
( PUNCT B-O
|
3751 |
+
UI PROPN B-AC
|
3752 |
+
) PUNCT B-O
|
3753 |
+
−6.1 NUM B-O
|
3754 |
+
% NOUN B-O
|
3755 |
+
, NOUN B-O
|
3756 |
+
−0.6 NUM B-O
|
3757 |
+
% NOUN B-O
|
3758 |
+
] PUNCT B-O
|
3759 |
+
; PUNCT B-O
|
3760 |
+
value NOUN B-O
|
3761 |
+
- PUNCT B-O
|
3762 |
+
based VERB B-O
|
3763 |
+
tax NOUN B-O
|
3764 |
+
, NOUN B-O
|
3765 |
+
−3.3 NUM B-O
|
3766 |
+
% NOUN B-O
|
3767 |
+
[ PUNCT B-O
|
3768 |
+
UI PROPN B-AC
|
3769 |
+
−5.1 NUM B-O
|
3770 |
+
% NOUN B-O
|
3771 |
+
, NOUN B-O
|
3772 |
+
−1.7 NUM B-O
|
3773 |
+
% NOUN B-O
|
3774 |
+
] PUNCT B-O
|
3775 |
+
; PUNCT B-O
|
3776 |
+
strength NOUN B-O
|
3777 |
+
- PUNCT B-O
|
3778 |
+
based VERB B-O
|
3779 |
+
tax NOUN B-O
|
3780 |
+
, NOUN B-O
|
3781 |
+
−7.5 NUM B-O
|
3782 |
+
% NOUN B-O
|
3783 |
+
[ PUNCT B-O
|
3784 |
+
UI PROPN B-AC
|
3785 |
+
−13.7 NUM B-O
|
3786 |
+
% NOUN B-O
|
3787 |
+
, NOUN B-O
|
3788 |
+
−3.9 NUM B-O
|
3789 |
+
% NOUN B-O
|
3790 |
+
] PUNCT B-O
|
3791 |
+
; PUNCT B-O
|
3792 |
+
minimum ADJ B-O
|
3793 |
+
unit NOUN B-O
|
3794 |
+
pricing NOUN B-O
|
3795 |
+
, NOUN B-O
|
3796 |
+
−10.3 NUM B-O
|
3797 |
+
% NOUN B-O
|
3798 |
+
[ PUNCT B-O
|
3799 |
+
UI PROPN B-AC
|
3800 |
+
−10.3 NUM B-O
|
3801 |
+
% NOUN B-O
|
3802 |
+
, NOUN B-O
|
3803 |
+
−7.0 NUM B-O
|
3804 |
+
% NOUN B-O
|
3805 |
+
] PUNCT B-O
|
3806 |
+
) PUNCT B-O
|
3807 |
+
and CCONJ B-O
|
3808 |
+
professional ADJ B-O
|
3809 |
+
/ SYM B-O
|
3810 |
+
managerial ADJ B-O
|
3811 |
+
occupation NOUN B-O
|
3812 |
+
groups NOUN B-O
|
3813 |
+
( PUNCT B-O
|
3814 |
+
current ADJ B-O
|
3815 |
+
tax NOUN B-O
|
3816 |
+
increase NOUN B-O
|
3817 |
+
, NOUN B-O
|
3818 |
+
−1.8 NUM B-O
|
3819 |
+
% NOUN B-O
|
3820 |
+
[ PUNCT B-O
|
3821 |
+
UI PROPN B-AC
|
3822 |
+
−4.7 NUM B-O
|
3823 |
+
% NOUN B-O
|
3824 |
+
, NOUN B-O
|
3825 |
+
+1.6 NUM B-O
|
3826 |
+
% NOUN B-O
|
3827 |
+
] PUNCT B-O
|
3828 |
+
; PUNCT B-O
|
3829 |
+
value NOUN B-O
|
3830 |
+
- PUNCT B-O
|
3831 |
+
based VERB B-O
|
3832 |
+
tax NOUN B-O
|
3833 |
+
, NOUN B-O
|
3834 |
+
−1.9 NUM B-O
|
3835 |
+
% NOUN B-O
|
3836 |
+
[ PUNCT B-O
|
3837 |
+
UI PROPN B-AC
|
3838 |
+
−3.6 NUM B-O
|
3839 |
+
% NOUN B-O
|
3840 |
+
, NOUN B-O
|
3841 |
+
+0.4 NUM B-O
|
3842 |
+
% NOUN B-O
|
3843 |
+
] PUNCT B-O
|
3844 |
+
; PUNCT B-O
|
3845 |
+
strength NOUN B-O
|
3846 |
+
- PUNCT B-O
|
3847 |
+
based VERB B-O
|
3848 |
+
tax NOUN B-O
|
3849 |
+
, NOUN B-O
|
3850 |
+
−0.8 NUM B-O
|
3851 |
+
% NOUN B-O
|
3852 |
+
[ PUNCT B-O
|
3853 |
+
UI PROPN B-AC
|
3854 |
+
−6.9 NUM B-O
|
3855 |
+
% NOUN B-O
|
3856 |
+
, NOUN B-O
|
3857 |
+
+4.0 NUM B-O
|
3858 |
+
% NOUN B-O
|
3859 |
+
] PUNCT B-O
|
3860 |
+
; PUNCT B-O
|
3861 |
+
minimum ADJ B-O
|
3862 |
+
unit NOUN B-O
|
3863 |
+
pricing NOUN B-O
|
3864 |
+
, NOUN B-O
|
3865 |
+
−0.7 NUM B-O
|
3866 |
+
% NOUN B-O
|
3867 |
+
[ PUNCT B-O
|
3868 |
+
UI PROPN B-AC
|
3869 |
+
−5.6 NUM B-O
|
3870 |
+
% NOUN B-O
|
3871 |
+
, NOUN B-O
|
3872 |
+
+3.6 NUM B-O
|
3873 |
+
% NOUN B-O
|
3874 |
+
] PUNCT B-O
|
3875 |
+
) PUNCT B-O
|
3876 |
+
. PUNCT B-O
|
3877 |
+
|
3878 |
+
Chronic ADJ B-O
|
3879 |
+
hepatitis NOUN B-LF
|
3880 |
+
C PROPN I-LF
|
3881 |
+
virus NOUN I-LF
|
3882 |
+
( PUNCT B-O
|
3883 |
+
HCV PROPN B-AC
|
3884 |
+
) PUNCT B-O
|
3885 |
+
infection NOUN B-O
|
3886 |
+
is AUX B-O
|
3887 |
+
a DET B-O
|
3888 |
+
leading VERB B-O
|
3889 |
+
cause NOUN B-O
|
3890 |
+
of ADP B-O
|
3891 |
+
cirrhosis NOUN B-O
|
3892 |
+
, PUNCT B-O
|
3893 |
+
liver NOUN B-O
|
3894 |
+
failure NOUN B-O
|
3895 |
+
, PUNCT B-O
|
3896 |
+
and CCONJ B-O
|
3897 |
+
hepatocellular ADJ B-LF
|
3898 |
+
carcinoma NOUN I-LF
|
3899 |
+
( PUNCT B-O
|
3900 |
+
HCC PROPN B-AC
|
3901 |
+
) PUNCT B-O
|
3902 |
+
[ PUNCT B-O
|
3903 |
+
1 NUM B-O
|
3904 |
+
, PUNCT B-O
|
3905 |
+
2 NUM B-O
|
3906 |
+
] PUNCT B-O
|
3907 |
+
. PUNCT B-O
|
3908 |
+
|
3909 |
+
DUSP1 PROPN B-AC
|
3910 |
+
has AUX B-O
|
3911 |
+
been AUX B-O
|
3912 |
+
shown VERB B-O
|
3913 |
+
to PART B-O
|
3914 |
+
attenuate VERB B-O
|
3915 |
+
MAPK PROPN B-AC
|
3916 |
+
signaling NOUN B-O
|
3917 |
+
, PUNCT B-O
|
3918 |
+
effectively ADV B-O
|
3919 |
+
reducing VERB B-O
|
3920 |
+
osteolysis NOUN B-O
|
3921 |
+
and CCONJ B-O
|
3922 |
+
cartilage NOUN B-O
|
3923 |
+
degeneration NOUN B-O
|
3924 |
+
in ADP B-O
|
3925 |
+
studies NOUN B-O
|
3926 |
+
utilizing VERB B-O
|
3927 |
+
mouse NOUN B-O
|
3928 |
+
models NOUN B-O
|
3929 |
+
of ADP B-O
|
3930 |
+
lipopolysaccharide NOUN B-O
|
3931 |
+
( PUNCT B-O
|
3932 |
+
LPS PROPN B-AC
|
3933 |
+
) PUNCT B-O
|
3934 |
+
induced VERB B-O
|
3935 |
+
inflammatory ADJ B-O
|
3936 |
+
bone NOUN B-O
|
3937 |
+
loss NOUN B-O
|
3938 |
+
and CCONJ B-O
|
3939 |
+
collagen NOUN B-LF
|
3940 |
+
induced VERB I-LF
|
3941 |
+
arthritis NOUN I-LF
|
3942 |
+
( PUNCT B-O
|
3943 |
+
CIA PROPN B-AC
|
3944 |
+
) PUNCT B-O
|
3945 |
+
[ PUNCT B-O
|
3946 |
+
16,19,20 NUM B-O
|
3947 |
+
] PUNCT B-O
|
3948 |
+
. PUNCT B-O
|
3949 |
+
|
3950 |
+
Genomic ADJ B-O
|
3951 |
+
DNA PROPN B-O
|
3952 |
+
was AUX B-O
|
3953 |
+
extracted VERB B-O
|
3954 |
+
from ADP B-O
|
3955 |
+
young ADJ B-O
|
3956 |
+
leaves NOUN B-O
|
3957 |
+
of ADP B-O
|
3958 |
+
these DET B-O
|
3959 |
+
above ADV B-O
|
3960 |
+
mentioned VERB B-O
|
3961 |
+
accessions NOUN B-O
|
3962 |
+
using VERB B-O
|
3963 |
+
a DET B-O
|
3964 |
+
modified VERB B-O
|
3965 |
+
cetyltrimethyl NOUN B-LF
|
3966 |
+
ammonium NOUN I-LF
|
3967 |
+
bromide NOUN I-LF
|
3968 |
+
( PUNCT B-O
|
3969 |
+
CTAB PROPN B-AC
|
3970 |
+
) PUNCT B-O
|
3971 |
+
method NOUN B-O
|
3972 |
+
. PUNCT B-O
|
3973 |
+
|
3974 |
+
The DET B-O
|
3975 |
+
median ADJ B-O
|
3976 |
+
age NOUN B-O
|
3977 |
+
at ADP B-O
|
3978 |
+
first ADJ B-O
|
3979 |
+
admission NOUN B-O
|
3980 |
+
was AUX B-O
|
3981 |
+
6 NUM B-O
|
3982 |
+
months NOUN B-O
|
3983 |
+
( PUNCT B-O
|
3984 |
+
interquartile ADJ B-LF
|
3985 |
+
range NOUN I-LF
|
3986 |
+
[ X B-O
|
3987 |
+
IQR PROPN B-AC
|
3988 |
+
] X B-O
|
3989 |
+
2–14 NUM B-O
|
3990 |
+
) PUNCT B-O
|
3991 |
+
, PUNCT B-O
|
3992 |
+
and CCONJ B-O
|
3993 |
+
the DET B-O
|
3994 |
+
commonest ADJ B-O
|
3995 |
+
code NOUN B-O
|
3996 |
+
linked VERB B-O
|
3997 |
+
to ADP B-O
|
3998 |
+
the DET B-O
|
3999 |
+
first ADJ B-O
|
4000 |
+
and CCONJ B-O
|
4001 |
+
all DET B-O
|
4002 |
+
admissions NOUN B-O
|
4003 |
+
was AUX B-O
|
4004 |
+
urinary ADJ B-LF
|
4005 |
+
tract NOUN I-LF
|
4006 |
+
infection NOUN I-LF
|
4007 |
+
( PUNCT B-O
|
4008 |
+
UTI PROPN B-AC
|
4009 |
+
; PUNCT B-O
|
4010 |
+
ICD-10 PROPN B-AC
|
4011 |
+
codes NOUN B-O
|
4012 |
+
N39.0 NUM B-O
|
4013 |
+
, PUNCT B-O
|
4014 |
+
N39.1 NUM B-O
|
4015 |
+
, PUNCT B-O
|
4016 |
+
or CCONJ B-O
|
4017 |
+
P39.3 NUM B-O
|
4018 |
+
) PUNCT B-O
|
4019 |
+
. PUNCT B-O
|
4020 |
+
|
4021 |
+
RS PROPN B-AC
|
4022 |
+
: PUNCT B-O
|
4023 |
+
retrospective ADJ B-LF
|
4024 |
+
. PUNCT B-O
|
4025 |
+
|
4026 |
+
These DET B-O
|
4027 |
+
two NUM B-O
|
4028 |
+
regions NOUN B-O
|
4029 |
+
of ADP B-O
|
4030 |
+
the DET B-O
|
4031 |
+
VE PROPN B-AC
|
4032 |
+
also ADV B-O
|
4033 |
+
show VERB B-O
|
4034 |
+
differences NOUN B-O
|
4035 |
+
in ADP B-O
|
4036 |
+
localisation NOUN B-O
|
4037 |
+
of ADP B-O
|
4038 |
+
the DET B-O
|
4039 |
+
molecular ADJ B-O
|
4040 |
+
motors NOUN B-O
|
4041 |
+
F PROPN B-O
|
4042 |
+
- NOUN B-O
|
4043 |
+
actin NOUN B-O
|
4044 |
+
and CCONJ B-O
|
4045 |
+
Myosin PROPN B-O
|
4046 |
+
IIA PROPN B-O
|
4047 |
+
, PUNCT B-O
|
4048 |
+
and CCONJ B-O
|
4049 |
+
the DET B-O
|
4050 |
+
Planar PROPN B-LF
|
4051 |
+
Cell PROPN I-LF
|
4052 |
+
Polarity PROPN I-LF
|
4053 |
+
( PUNCT B-O
|
4054 |
+
PCP PROPN B-AC
|
4055 |
+
) PUNCT B-O
|
4056 |
+
signalling NOUN B-O
|
4057 |
+
molecules NOUN B-O
|
4058 |
+
Dishevelled-2 PROPN B-LF
|
4059 |
+
( PUNCT B-O
|
4060 |
+
Dvl-2 PROPN B-AC
|
4061 |
+
) PUNCT B-O
|
4062 |
+
and CCONJ B-O
|
4063 |
+
Vangl2 PROPN B-O
|
4064 |
+
[ PUNCT B-O
|
4065 |
+
20 NUM B-O
|
4066 |
+
] PUNCT B-O
|
4067 |
+
. PUNCT B-O
|
4068 |
+
|
4069 |
+
Human ADJ B-O
|
4070 |
+
and CCONJ B-O
|
4071 |
+
mouse NOUN B-O
|
4072 |
+
B PROPN B-O
|
4073 |
+
cells NOUN B-O
|
4074 |
+
were AUX B-O
|
4075 |
+
activated VERB B-O
|
4076 |
+
with ADP B-O
|
4077 |
+
membrane NOUN B-O
|
4078 |
+
- PUNCT B-O
|
4079 |
+
tethered VERB B-O
|
4080 |
+
or CCONJ B-O
|
4081 |
+
soluble ADJ B-O
|
4082 |
+
mB PROPN B-O
|
4083 |
+
- PUNCT B-O
|
4084 |
+
Fab′–anti NOUN B-O
|
4085 |
+
- PUNCT B-O
|
4086 |
+
Ig NOUN B-O
|
4087 |
+
plus CCONJ B-O
|
4088 |
+
streptavidin NOUN B-O
|
4089 |
+
before ADP B-O
|
4090 |
+
staining VERB B-O
|
4091 |
+
for ADP B-O
|
4092 |
+
phosphorylated VERB B-LF
|
4093 |
+
WASP NOUN I-LF
|
4094 |
+
WASP PROPN B-AC
|
4095 |
+
( PUNCT B-O
|
4096 |
+
pWASP PROPN B-AC
|
4097 |
+
) PUNCT B-O
|
4098 |
+
and CCONJ B-O
|
4099 |
+
N-WASP PROPN B-AC
|
4100 |
+
( PUNCT B-O
|
4101 |
+
pN PROPN B-AC
|
4102 |
+
) PUNCT B-O
|
4103 |
+
. PUNCT B-O
|
4104 |
+
|
4105 |
+
Using VERB B-O
|
4106 |
+
total ADJ B-O
|
4107 |
+
internal ADJ B-O
|
4108 |
+
reflection NOUN B-O
|
4109 |
+
fluorescence NOUN B-O
|
4110 |
+
microscopy NOUN B-O
|
4111 |
+
( PUNCT B-O
|
4112 |
+
TIRFM PROPN B-O
|
4113 |
+
) PUNCT B-O
|
4114 |
+
, PUNCT B-O
|
4115 |
+
we PRON B-O
|
4116 |
+
analyzed VERB B-O
|
4117 |
+
the DET B-O
|
4118 |
+
distribution NOUN B-O
|
4119 |
+
and CCONJ B-O
|
4120 |
+
the DET B-O
|
4121 |
+
relative ADJ B-O
|
4122 |
+
levels NOUN B-O
|
4123 |
+
of ADP B-O
|
4124 |
+
-WASPpWASP PROPN B-AC
|
4125 |
+
and CCONJ B-O
|
4126 |
+
pN PROPN B-AC
|
4127 |
+
at ADP B-O
|
4128 |
+
the DET B-O
|
4129 |
+
surface NOUN B-O
|
4130 |
+
of ADP B-O
|
4131 |
+
B PROPN B-O
|
4132 |
+
cells NOUN B-O
|
4133 |
+
in ADP B-O
|
4134 |
+
contact NOUN B-O
|
4135 |
+
with ADP B-O
|
4136 |
+
the DET B-O
|
4137 |
+
mB PROPN B-O
|
4138 |
+
- PUNCT B-O
|
4139 |
+
Fab′–anti NOUN B-O
|
4140 |
+
- PUNCT B-O
|
4141 |
+
Ig NOUN B-O
|
4142 |
+
– PUNCT B-O
|
4143 |
+
tethered VERB B-O
|
4144 |
+
lipid NOUN B-O
|
4145 |
+
bilayer NOUN B-O
|
4146 |
+
( PUNCT B-O
|
4147 |
+
B PROPN B-O
|
4148 |
+
- PUNCT B-O
|
4149 |
+
cell NOUN B-O
|
4150 |
+
contact NOUN B-O
|
4151 |
+
zone NOUN B-O
|
4152 |
+
) PUNCT B-O
|
4153 |
+
. PUNCT B-O
|
4154 |
+
|
4155 |
+
This DET B-O
|
4156 |
+
study NOUN B-O
|
4157 |
+
is AUX B-O
|
4158 |
+
reported VERB B-O
|
4159 |
+
as ADP B-O
|
4160 |
+
per ADP B-O
|
4161 |
+
the DET B-O
|
4162 |
+
Strengthening VERB B-LF
|
4163 |
+
the DET I-LF
|
4164 |
+
Reporting PROPN I-LF
|
4165 |
+
of ADP I-LF
|
4166 |
+
Observational PROPN I-LF
|
4167 |
+
Studies PROPN I-LF
|
4168 |
+
in ADP I-LF
|
4169 |
+
Epidemiology PROPN I-LF
|
4170 |
+
( PUNCT B-O
|
4171 |
+
STROBE PROPN B-AC
|
4172 |
+
) PUNCT B-O
|
4173 |
+
guidelines NOUN B-O
|
4174 |
+
( PUNCT B-O
|
4175 |
+
S1 PROPN B-O
|
4176 |
+
STROBE PROPN B-AC
|
4177 |
+
Checklist PROPN B-O
|
4178 |
+
) PUNCT B-O
|
4179 |
+
. PUNCT B-O
|
4180 |
+
|
4181 |
+
SARS PROPN B-AC
|
4182 |
+
-CoV-2 PROPN B-AC
|
4183 |
+
entry NOUN B-O
|
4184 |
+
into ADP B-O
|
4185 |
+
cells NOUN B-O
|
4186 |
+
depends VERB B-O
|
4187 |
+
on ADP B-O
|
4188 |
+
the DET B-O
|
4189 |
+
binding NOUN B-O
|
4190 |
+
of ADP B-O
|
4191 |
+
the DET B-O
|
4192 |
+
viral ADJ B-O
|
4193 |
+
spike NOUN B-O
|
4194 |
+
( PUNCT B-O
|
4195 |
+
S NOUN B-O
|
4196 |
+
) PUNCT B-O
|
4197 |
+
protein NOUN B-O
|
4198 |
+
to ADP B-O
|
4199 |
+
its PRON B-O
|
4200 |
+
cognate NOUN B-O
|
4201 |
+
receptor NOUN B-O
|
4202 |
+
angiotensin NOUN B-LF
|
4203 |
+
converting VERB I-LF
|
4204 |
+
enzyme NOUN I-LF
|
4205 |
+
II NUM I-LF
|
4206 |
+
( PUNCT B-O
|
4207 |
+
ACE2 PROPN B-AC
|
4208 |
+
) PUNCT B-O
|
4209 |
+
on ADP B-O
|
4210 |
+
the DET B-O
|
4211 |
+
cell NOUN B-O
|
4212 |
+
surface NOUN B-O
|
4213 |
+
[ X B-O
|
4214 |
+
6,10 NUM B-O
|
4215 |
+
] PUNCT B-O
|
4216 |
+
. PUNCT B-O
|
4217 |
+
|
4218 |
+
This DET B-O
|
4219 |
+
study NOUN B-O
|
4220 |
+
is AUX B-O
|
4221 |
+
reported VERB B-O
|
4222 |
+
as ADP B-O
|
4223 |
+
per ADP B-O
|
4224 |
+
the DET B-O
|
4225 |
+
Strengthening VERB B-LF
|
4226 |
+
the DET I-LF
|
4227 |
+
Reporting PROPN I-LF
|
4228 |
+
of ADP I-LF
|
4229 |
+
Observational PROPN I-LF
|
4230 |
+
Studies PROPN I-LF
|
4231 |
+
in ADP I-LF
|
4232 |
+
Epidemiology PROPN I-LF
|
4233 |
+
( PUNCT B-O
|
4234 |
+
STROBE PROPN B-AC
|
4235 |
+
) PUNCT B-O
|
4236 |
+
guidelines NOUN B-O
|
4237 |
+
( PUNCT B-O
|
4238 |
+
S1 PROPN B-O
|
4239 |
+
STROBE PROPN B-AC
|
4240 |
+
Checklist PROPN B-O
|
4241 |
+
) PUNCT B-O
|
4242 |
+
[ PUNCT B-O
|
4243 |
+
18 NUM B-O
|
4244 |
+
] PUNCT B-O
|
4245 |
+
. PUNCT B-O
|
4246 |
+
|
4247 |
+
As ADP B-O
|
4248 |
+
a DET B-O
|
4249 |
+
first ADJ B-O
|
4250 |
+
line NOUN B-O
|
4251 |
+
, PUNCT B-O
|
4252 |
+
countries NOUN B-O
|
4253 |
+
should AUX B-O
|
4254 |
+
follow VERB B-O
|
4255 |
+
Food PROPN B-LF
|
4256 |
+
and CCONJ I-LF
|
4257 |
+
Agriculture PROPN I-LF
|
4258 |
+
Organization PROPN I-LF
|
4259 |
+
( PUNCT B-O
|
4260 |
+
FAO PROPN B-AC
|
4261 |
+
) PUNCT B-O
|
4262 |
+
advice NOUN B-O
|
4263 |
+
[ X B-O
|
4264 |
+
6 X B-O
|
4265 |
+
] X B-O
|
4266 |
+
and CCONJ B-O
|
4267 |
+
withdraw VERB B-O
|
4268 |
+
the DET B-O
|
4269 |
+
most ADV B-O
|
4270 |
+
toxic ADJ B-O
|
4271 |
+
WHO PROPN B-AC
|
4272 |
+
/ SYM B-O
|
4273 |
+
US PROPN B-O
|
4274 |
+
Environmental PROPN B-LF
|
4275 |
+
Protection PROPN I-LF
|
4276 |
+
Agency PROPN I-LF
|
4277 |
+
( PUNCT B-O
|
4278 |
+
EPA PROPN B-AC
|
4279 |
+
) PUNCT B-O
|
4280 |
+
class NOUN B-O
|
4281 |
+
I NUM B-O
|
4282 |
+
pesticides NOUN B-O
|
4283 |
+
( PUNCT B-O
|
4284 |
+
see VERB B-O
|
4285 |
+
Table NOUN B-O
|
4286 |
+
1 NUM B-O
|
4287 |
+
for ADP B-O
|
4288 |
+
description NOUN B-O
|
4289 |
+
of ADP B-O
|
4290 |
+
toxicity NOUN B-O
|
4291 |
+
classifications NOUN B-O
|
4292 |
+
) PUNCT B-O
|
4293 |
+
from ADP B-O
|
4294 |
+
agricultural ADJ B-O
|
4295 |
+
practice NOUN B-O
|
4296 |
+
. PUNCT B-O
|
4297 |
+
|
4298 |
+
Patients NOUN B-O
|
4299 |
+
underwent VERB B-O
|
4300 |
+
our PRON B-O
|
4301 |
+
standardized ADJ B-O
|
4302 |
+
diagnostic ADJ B-O
|
4303 |
+
protocol NOUN B-O
|
4304 |
+
encompassing VERB B-O
|
4305 |
+
clinical ADJ B-O
|
4306 |
+
evaluation NOUN B-O
|
4307 |
+
with ADP B-O
|
4308 |
+
assessment NOUN B-O
|
4309 |
+
of ADP B-O
|
4310 |
+
subjective ADJ B-O
|
4311 |
+
sleepiness NOUN B-O
|
4312 |
+
by ADP B-O
|
4313 |
+
means NOUN B-O
|
4314 |
+
of ADP B-O
|
4315 |
+
Epworth PROPN B-LF
|
4316 |
+
Sleepiness PROPN I-LF
|
4317 |
+
Scale PROPN I-LF
|
4318 |
+
( PUNCT B-O
|
4319 |
+
ESS PROPN B-AC
|
4320 |
+
) PUNCT B-O
|
4321 |
+
[ PUNCT B-O
|
4322 |
+
24 NUM B-O
|
4323 |
+
] PUNCT B-O
|
4324 |
+
, PUNCT B-O
|
4325 |
+
cerebral ADJ B-O
|
4326 |
+
magnetic ADJ B-O
|
4327 |
+
resonance NOUN B-O
|
4328 |
+
imaging NOUN B-O
|
4329 |
+
, PUNCT B-O
|
4330 |
+
hospitalization NOUN B-O
|
4331 |
+
with ADP B-O
|
4332 |
+
48 NUM B-O
|
4333 |
+
- PUNCT B-O
|
4334 |
+
hr NOUN B-O
|
4335 |
+
continuous ADJ B-O
|
4336 |
+
polysomnographic ADJ B-O
|
4337 |
+
recording NOUN B-O
|
4338 |
+
, PUNCT B-O
|
4339 |
+
Multiple PROPN B-LF
|
4340 |
+
Sleep PROPN I-LF
|
4341 |
+
Latency PROPN I-LF
|
4342 |
+
Test PROPN I-LF
|
4343 |
+
( PUNCT B-O
|
4344 |
+
MSLT PROPN B-AC
|
4345 |
+
) PUNCT B-O
|
4346 |
+
, PUNCT B-O
|
4347 |
+
cataplexy NOUN B-O
|
4348 |
+
video NOUN B-O
|
4349 |
+
- PUNCT B-O
|
4350 |
+
documentation NOUN B-O
|
4351 |
+
, PUNCT B-O
|
4352 |
+
human ADJ B-LF
|
4353 |
+
leukocyte NOUN I-LF
|
4354 |
+
antigen NOUN I-LF
|
4355 |
+
( PUNCT B-O
|
4356 |
+
HLA PROPN B-AC
|
4357 |
+
) PUNCT B-O
|
4358 |
+
typing NOUN B-O
|
4359 |
+
and CCONJ B-O
|
4360 |
+
lumbar NOUN B-O
|
4361 |
+
puncture NOUN B-O
|
4362 |
+
for ADP B-O
|
4363 |
+
CSF PROPN B-O
|
4364 |
+
Hcrt-1 PROPN B-AC
|
4365 |
+
assay NOUN B-O
|
4366 |
+
[ PUNCT B-O
|
4367 |
+
25 NUM B-O
|
4368 |
+
] PUNCT B-O
|
4369 |
+
. PUNCT B-O
|
4370 |
+
|
4371 |
+
Although SCONJ B-O
|
4372 |
+
none NOUN B-O
|
4373 |
+
were AUX B-O
|
4374 |
+
capable ADJ B-O
|
4375 |
+
of ADP B-O
|
4376 |
+
complete ADJ B-O
|
4377 |
+
control NOUN B-O
|
4378 |
+
, PUNCT B-O
|
4379 |
+
all DET B-O
|
4380 |
+
policies NOUN B-O
|
4381 |
+
substantially ADV B-O
|
4382 |
+
reduced VERB B-O
|
4383 |
+
IAR PROPN B-AC
|
4384 |
+
. PUNCT B-O
|
4385 |
+
|
4386 |
+
The DET B-O
|
4387 |
+
baseline ADJ B-O
|
4388 |
+
IAR PROPN B-AC
|
4389 |
+
of ADP B-O
|
4390 |
+
74 NUM B-O
|
4391 |
+
% NOUN B-O
|
4392 |
+
was AUX B-O
|
4393 |
+
reduced VERB B-O
|
4394 |
+
to ADP B-O
|
4395 |
+
49 NUM B-O
|
4396 |
+
% NOUN B-O
|
4397 |
+
when SCONJ B-O
|
4398 |
+
voluntary ADJ B-LF
|
4399 |
+
household NOUN I-LF
|
4400 |
+
quarantine NOUN I-LF
|
4401 |
+
( PUNCT B-O
|
4402 |
+
Q PROPN B-AC
|
4403 |
+
) PUNCT B-O
|
4404 |
+
alone ADV B-O
|
4405 |
+
was AUX B-O
|
4406 |
+
in ADP B-O
|
4407 |
+
effect NOUN B-O
|
4408 |
+
. PUNCT B-O
|
4409 |
+
|
4410 |
+
Stevens PROPN B-LF
|
4411 |
+
- PUNCT I-LF
|
4412 |
+
Johnson PROPN I-LF
|
4413 |
+
syndrome NOUN I-LF
|
4414 |
+
( PUNCT B-O
|
4415 |
+
SJS PROPN B-AC
|
4416 |
+
) PUNCT B-O
|
4417 |
+
and CCONJ B-O
|
4418 |
+
its PRON B-O
|
4419 |
+
severe ADJ B-O
|
4420 |
+
variant NOUN B-O
|
4421 |
+
, PUNCT B-O
|
4422 |
+
toxic ADJ B-LF
|
4423 |
+
epidermal ADJ I-LF
|
4424 |
+
necrolysis NOUN I-LF
|
4425 |
+
( PUNCT B-O
|
4426 |
+
TEN PROPN B-AC
|
4427 |
+
) PUNCT B-O
|
4428 |
+
, PUNCT B-O
|
4429 |
+
are AUX B-O
|
4430 |
+
drug NOUN B-O
|
4431 |
+
- PUNCT B-O
|
4432 |
+
induced VERB B-O
|
4433 |
+
acute ADJ B-O
|
4434 |
+
inflammatory ADJ B-O
|
4435 |
+
vesiculobullous ADJ B-O
|
4436 |
+
reactions NOUN B-O
|
4437 |
+
of ADP B-O
|
4438 |
+
the DET B-O
|
4439 |
+
skin NOUN B-O
|
4440 |
+
and CCONJ B-O
|
4441 |
+
mucous ADJ B-O
|
4442 |
+
membranes NOUN B-O
|
4443 |
+
, PUNCT B-O
|
4444 |
+
including VERB B-O
|
4445 |
+
the DET B-O
|
4446 |
+
ocular ADJ B-O
|
4447 |
+
surface NOUN B-O
|
4448 |
+
. PUNCT B-O
|
4449 |
+
|
4450 |
+
Previous ADJ B-O
|
4451 |
+
analysis NOUN B-O
|
4452 |
+
has AUX B-O
|
4453 |
+
shown VERB B-O
|
4454 |
+
that PRON B-O
|
4455 |
+
neutrophils NOUN B-O
|
4456 |
+
from ADP B-O
|
4457 |
+
healthy ADJ B-LF
|
4458 |
+
controls NOUN I-LF
|
4459 |
+
( PUNCT B-O
|
4460 |
+
HCs PROPN B-AC
|
4461 |
+
) PUNCT B-O
|
4462 |
+
are AUX B-O
|
4463 |
+
capable ADJ B-O
|
4464 |
+
of ADP B-O
|
4465 |
+
efficiently ADV B-O
|
4466 |
+
binding VERB B-O
|
4467 |
+
Gal-9 PROPN B-AC
|
4468 |
+
; PUNCT B-O
|
4469 |
+
however ADV B-O
|
4470 |
+
, PUNCT B-O
|
4471 |
+
the DET B-O
|
4472 |
+
receptor NOUN B-O
|
4473 |
+
that PRON B-O
|
4474 |
+
facilitate VERB B-O
|
4475 |
+
this DET B-O
|
4476 |
+
binding VERB B-O
|
4477 |
+
activity NOUN B-O
|
4478 |
+
was AUX B-O
|
4479 |
+
not PART B-O
|
4480 |
+
identified VERB B-O
|
4481 |
+
[ PUNCT B-O
|
4482 |
+
50 NUM B-O
|
4483 |
+
] PUNCT B-O
|
4484 |
+
. PUNCT B-O
|
4485 |
+
|
4486 |
+
Identification NOUN B-O
|
4487 |
+
of ADP B-O
|
4488 |
+
new ADJ B-O
|
4489 |
+
genes NOUN B-O
|
4490 |
+
from ADP B-O
|
4491 |
+
the DET B-O
|
4492 |
+
sequence NOUN B-O
|
4493 |
+
data NOUN B-O
|
4494 |
+
and CCONJ B-O
|
4495 |
+
placement NOUN B-O
|
4496 |
+
of ADP B-O
|
4497 |
+
all DET B-O
|
4498 |
+
genes NOUN B-O
|
4499 |
+
, PUNCT B-O
|
4500 |
+
along ADP B-O
|
4501 |
+
with ADP B-O
|
4502 |
+
genetic ADJ B-O
|
4503 |
+
markers NOUN B-O
|
4504 |
+
, PUNCT B-O
|
4505 |
+
on ADP B-O
|
4506 |
+
a DET B-O
|
4507 |
+
physical ADJ B-O
|
4508 |
+
assembly NOUN B-O
|
4509 |
+
has AUX B-O
|
4510 |
+
greatly ADV B-O
|
4511 |
+
aided VERB B-O
|
4512 |
+
in ADP B-O
|
4513 |
+
the DET B-O
|
4514 |
+
search NOUN B-O
|
4515 |
+
for ADP B-O
|
4516 |
+
phenotypically ADV B-O
|
4517 |
+
important ADJ B-O
|
4518 |
+
genes NOUN B-O
|
4519 |
+
in ADP B-O
|
4520 |
+
both CCONJ B-O
|
4521 |
+
quantitative ADJ B-LF
|
4522 |
+
trait NOUN I-LF
|
4523 |
+
loci NOUN I-LF
|
4524 |
+
( PUNCT B-O
|
4525 |
+
QTL PROPN B-AC
|
4526 |
+
) PUNCT B-O
|
4527 |
+
and CCONJ B-O
|
4528 |
+
mutagenesis NOUN B-O
|
4529 |
+
- PUNCT B-O
|
4530 |
+
based VERB B-O
|
4531 |
+
mapping NOUN B-O
|
4532 |
+
. PUNCT B-O
|
4533 |
+
|
4534 |
+
Individuals NOUN B-O
|
4535 |
+
can AUX B-O
|
4536 |
+
be AUX B-O
|
4537 |
+
diagnosed VERB B-O
|
4538 |
+
when SCONJ B-O
|
4539 |
+
they PRON B-O
|
4540 |
+
develop VERB B-O
|
4541 |
+
symptoms NOUN B-O
|
4542 |
+
and CCONJ B-O
|
4543 |
+
present VERB B-O
|
4544 |
+
at ADP B-O
|
4545 |
+
a DET B-O
|
4546 |
+
clinic NOUN B-O
|
4547 |
+
, PUNCT B-O
|
4548 |
+
or CCONJ B-O
|
4549 |
+
when SCONJ B-O
|
4550 |
+
they PRON B-O
|
4551 |
+
are AUX B-O
|
4552 |
+
referred VERB B-O
|
4553 |
+
from ADP B-O
|
4554 |
+
an DET B-O
|
4555 |
+
antenatal ADJ B-LF
|
4556 |
+
clinic NOUN I-LF
|
4557 |
+
( PUNCT B-O
|
4558 |
+
ANC PROPN B-AC
|
4559 |
+
) PUNCT B-O
|
4560 |
+
, PUNCT B-O
|
4561 |
+
or CCONJ B-O
|
4562 |
+
when SCONJ B-O
|
4563 |
+
they PRON B-O
|
4564 |
+
voluntarily ADV B-O
|
4565 |
+
get AUX B-O
|
4566 |
+
tested VERB B-O
|
4567 |
+
for ADP B-O
|
4568 |
+
HIV PROPN B-O
|
4569 |
+
( PUNCT B-O
|
4570 |
+
voluntary ADJ B-LF
|
4571 |
+
counselling NOUN I-LF
|
4572 |
+
and CCONJ I-LF
|
4573 |
+
testing NOUN I-LF
|
4574 |
+
, PUNCT B-O
|
4575 |
+
VCT PROPN B-AC
|
4576 |
+
) PUNCT B-O
|
4577 |
+
. PUNCT B-O
|
4578 |
+
|
4579 |
+
For ADP B-O
|
4580 |
+
simplicity NOUN B-O
|
4581 |
+
, PUNCT B-O
|
4582 |
+
we PRON B-O
|
4583 |
+
investigated VERB B-O
|
4584 |
+
circumstances NOUN B-O
|
4585 |
+
that PRON B-O
|
4586 |
+
range VERB B-O
|
4587 |
+
from ADP B-O
|
4588 |
+
the DET B-O
|
4589 |
+
worst ADJ B-O
|
4590 |
+
- PUNCT B-O
|
4591 |
+
case NOUN B-O
|
4592 |
+
to ADP B-O
|
4593 |
+
the DET B-O
|
4594 |
+
achievable ADJ B-O
|
4595 |
+
best ADJ B-O
|
4596 |
+
- PUNCT B-O
|
4597 |
+
case NOUN B-O
|
4598 |
+
scenario NOUN B-O
|
4599 |
+
. PUNCT B-O
|
4600 |
+
|
4601 |
+
TBC PROPN B-AC
|
4602 |
+
, PUNCT B-O
|
4603 |
+
Tre2 PROPN B-LF
|
4604 |
+
- PUNCT I-LF
|
4605 |
+
Bub2 PROPN I-LF
|
4606 |
+
- PUNCT I-LF
|
4607 |
+
Cdc16 PROPN I-LF
|
4608 |
+
. PUNCT B-O
|
4609 |
+
|
4610 |
+
* PUNCT B-O
|
4611 |
+
* PUNCT B-O
|
4612 |
+
* PUNCT B-O
|
4613 |
+
p NOUN B-O
|
4614 |
+
< SYM B-O
|
4615 |
+
0.001 NUM B-O
|
4616 |
+
LAD PROPN B-AC
|
4617 |
+
, PUNCT B-O
|
4618 |
+
left ADJ B-LF
|
4619 |
+
atrial ADJ I-LF
|
4620 |
+
diameter NOUN I-LF
|
4621 |
+
; PUNCT B-O
|
4622 |
+
LVDd PROPN B-AC
|
4623 |
+
, PUNCT B-O
|
4624 |
+
left ADJ B-LF
|
4625 |
+
ventricular ADJ I-LF
|
4626 |
+
end NOUN I-LF
|
4627 |
+
- PUNCT I-LF
|
4628 |
+
diastolic ADJ I-LF
|
4629 |
+
diameter NOUN I-LF
|
4630 |
+
; PUNCT B-O
|
4631 |
+
LVDs PROPN B-AC
|
4632 |
+
, PUNCT B-O
|
4633 |
+
left ADJ B-LF
|
4634 |
+
ventricular ADJ I-LF
|
4635 |
+
end NOUN I-LF
|
4636 |
+
- PUNCT I-LF
|
4637 |
+
systolic ADJ I-LF
|
4638 |
+
diameter NOUN I-LF
|
4639 |
+
; PUNCT B-O
|
4640 |
+
IVSth PROPN B-AC
|
4641 |
+
, PUNCT B-O
|
4642 |
+
intraventricular ADJ B-LF
|
4643 |
+
septum NOUN I-LF
|
4644 |
+
thickness NOUN I-LF
|
4645 |
+
; PUNCT B-O
|
4646 |
+
PWth PROPN B-AC
|
4647 |
+
, PUNCT B-O
|
4648 |
+
posterior ADJ B-LF
|
4649 |
+
wall NOUN I-LF
|
4650 |
+
thickness NOUN I-LF
|
4651 |
+
; PUNCT B-O
|
4652 |
+
LVEF PROPN B-AC
|
4653 |
+
, PUNCT B-O
|
4654 |
+
LV NOUN B-LF
|
4655 |
+
ejection NOUN I-LF
|
4656 |
+
LV PROPN B-AC
|
4657 |
+
fraction NOUN I-LF
|
4658 |
+
; PUNCT B-O
|
4659 |
+
LVM PROPN B-AC
|
4660 |
+
, PUNCT B-O
|
4661 |
+
LV NOUN B-LF
|
4662 |
+
mass NOUN I-LF
|
4663 |
+
LV PROPN B-AC
|
4664 |
+
; PUNCT B-O
|
4665 |
+
LVMI PROPN B-AC
|
4666 |
+
, PUNCT B-O
|
4667 |
+
LV NOUN B-LF
|
4668 |
+
mass NOUN I-LF
|
4669 |
+
LV PROPN B-AC
|
4670 |
+
index NOUN I-LF
|
4671 |
+
; PUNCT B-O
|
4672 |
+
E PROPN B-AC
|
4673 |
+
/ SYM B-O
|
4674 |
+
e NOUN B-O
|
4675 |
+
’ PUNCT B-O
|
4676 |
+
, PUNCT B-O
|
4677 |
+
the DET B-O
|
4678 |
+
ratio NOUN B-O
|
4679 |
+
of ADP B-O
|
4680 |
+
early ADJ B-LF
|
4681 |
+
- PUNCT I-LF
|
4682 |
+
diastolic ADJ I-LF
|
4683 |
+
left ADJ I-LF
|
4684 |
+
ventricular ADJ I-LF
|
4685 |
+
inflow ADJ I-LF
|
4686 |
+
velocity NOUN I-LF
|
4687 |
+
( PUNCT B-O
|
4688 |
+
E PROPN B-AC
|
4689 |
+
) PUNCT B-O
|
4690 |
+
to ADP B-O
|
4691 |
+
early ADJ B-O
|
4692 |
+
- PUNCT B-O
|
4693 |
+
diastolic ADJ B-O
|
4694 |
+
mitral ADJ B-O
|
4695 |
+
annular ADJ B-O
|
4696 |
+
velocity NOUN B-O
|
4697 |
+
( PUNCT B-O
|
4698 |
+
e′ NOUN B-O
|
4699 |
+
): PUNCT B-O
|
4700 |
+
LAVI PROPN B-AC
|
4701 |
+
, PUNCT B-O
|
4702 |
+
left ADJ B-LF
|
4703 |
+
atrial ADJ I-LF
|
4704 |
+
mass NOUN I-LF
|
4705 |
+
index NOUN I-LF
|
4706 |
+
; PUNCT B-O
|
4707 |
+
other ADJ B-O
|
4708 |
+
abbreviations NOUN B-O
|
4709 |
+
as ADP B-O
|
4710 |
+
in ADP B-O
|
4711 |
+
Table NOUN B-O
|
4712 |
+
2 NUM B-O
|
4713 |
+
. PUNCT B-O
|
4714 |
+
|
4715 |
+
LDL PROPN B-AC
|
4716 |
+
, PUNCT B-O
|
4717 |
+
low ADJ B-LF
|
4718 |
+
- PUNCT I-LF
|
4719 |
+
density NOUN I-LF
|
4720 |
+
lipoprotein NOUN I-LF
|
4721 |
+
. PUNCT B-O
|
4722 |
+
|
4723 |
+
( PUNCT B-O
|
4724 |
+
A X B-O
|
4725 |
+
) PUNCT B-O
|
4726 |
+
Confocal ADJ B-O
|
4727 |
+
fluorescence NOUN B-O
|
4728 |
+
image NOUN B-O
|
4729 |
+
of ADP B-O
|
4730 |
+
miniSOG PROPN B-AC
|
4731 |
+
targeted VERB B-O
|
4732 |
+
to ADP B-O
|
4733 |
+
the DET B-O
|
4734 |
+
mitochondria NOUN B-O
|
4735 |
+
in ADP B-O
|
4736 |
+
body NOUN B-O
|
4737 |
+
wall NOUN B-O
|
4738 |
+
muscles NOUN B-O
|
4739 |
+
of ADP B-O
|
4740 |
+
C. NOUN B-O
|
4741 |
+
elegans NOUN B-O
|
4742 |
+
. PUNCT B-O
|
4743 |
+
|
4744 |
+
( PUNCT B-O
|
4745 |
+
B X B-O
|
4746 |
+
– PUNCT B-O
|
4747 |
+
C NOUN B-O
|
4748 |
+
) PUNCT B-O
|
4749 |
+
Thin ADJ B-O
|
4750 |
+
section NOUN B-O
|
4751 |
+
EM PROPN B-AC
|
4752 |
+
images NOUN B-O
|
4753 |
+
of ADP B-O
|
4754 |
+
a DET B-O
|
4755 |
+
portion NOUN B-O
|
4756 |
+
of ADP B-O
|
4757 |
+
C. NOUN B-O
|
4758 |
+
elegans NOUN B-O
|
4759 |
+
showing VERB B-O
|
4760 |
+
a DET B-O
|
4761 |
+
subset NOUN B-O
|
4762 |
+
of ADP B-O
|
4763 |
+
labeled VERB B-O
|
4764 |
+
mitochondria NOUN B-O
|
4765 |
+
in ADP B-O
|
4766 |
+
the DET B-O
|
4767 |
+
body NOUN B-O
|
4768 |
+
wall NOUN B-O
|
4769 |
+
muscle NOUN B-O
|
4770 |
+
( PUNCT B-O
|
4771 |
+
arrow NOUN B-O
|
4772 |
+
) PUNCT B-O
|
4773 |
+
and CCONJ B-O
|
4774 |
+
adjacent ADJ B-O
|
4775 |
+
unlabeled VERB B-O
|
4776 |
+
mitochondria NOUN B-O
|
4777 |
+
in ADP B-O
|
4778 |
+
a DET B-O
|
4779 |
+
different ADJ B-O
|
4780 |
+
cell NOUN B-O
|
4781 |
+
type NOUN B-O
|
4782 |
+
( PUNCT B-O
|
4783 |
+
arrowheads NOUN B-O
|
4784 |
+
) PUNCT B-O
|
4785 |
+
. PUNCT B-O
|
4786 |
+
|
4787 |
+
( PUNCT B-O
|
4788 |
+
D X B-O
|
4789 |
+
– PUNCT B-O
|
4790 |
+
E X B-O
|
4791 |
+
) PUNCT B-O
|
4792 |
+
Ultrastructural ADJ B-O
|
4793 |
+
localization NOUN B-O
|
4794 |
+
of ADP B-O
|
4795 |
+
miniSOG PROPN B-AC
|
4796 |
+
- PUNCT B-O
|
4797 |
+
labeled VERB B-O
|
4798 |
+
synaptic ADJ B-LF
|
4799 |
+
cell NOUN I-LF
|
4800 |
+
- PUNCT I-LF
|
4801 |
+
adhesion NOUN I-LF
|
4802 |
+
molecules NOUN I-LF
|
4803 |
+
( PUNCT B-O
|
4804 |
+
SynCAMs PROPN B-AC
|
4805 |
+
) PUNCT B-O
|
4806 |
+
in ADP B-O
|
4807 |
+
cultured VERB B-O
|
4808 |
+
cortical ADJ B-O
|
4809 |
+
neurons NOUN B-O
|
4810 |
+
. PUNCT B-O
|
4811 |
+
|
4812 |
+
( PUNCT B-O
|
4813 |
+
D X B-O
|
4814 |
+
) PUNCT B-O
|
4815 |
+
SynCAM1 PROPN B-O
|
4816 |
+
fusion NOUN B-O
|
4817 |
+
reveals VERB B-O
|
4818 |
+
uniform ADJ B-O
|
4819 |
+
membrane NOUN B-O
|
4820 |
+
labeling NOUN B-O
|
4821 |
+
at ADP B-O
|
4822 |
+
the DET B-O
|
4823 |
+
presynaptic ADJ B-O
|
4824 |
+
apposition NOUN B-O
|
4825 |
+
( PUNCT B-O
|
4826 |
+
arrow NOUN B-O
|
4827 |
+
) PUNCT B-O
|
4828 |
+
. PUNCT B-O
|
4829 |
+
|
4830 |
+
( PUNCT B-O
|
4831 |
+
E X B-O
|
4832 |
+
) PUNCT B-O
|
4833 |
+
SynCAM2 PROPN B-O
|
4834 |
+
fusion NOUN B-O
|
4835 |
+
shows VERB B-O
|
4836 |
+
postsynaptic ADJ B-O
|
4837 |
+
membrane NOUN B-O
|
4838 |
+
labeling NOUN B-O
|
4839 |
+
( PUNCT B-O
|
4840 |
+
pointed VERB B-O
|
4841 |
+
by ADP B-O
|
4842 |
+
arrow NOUN B-O
|
4843 |
+
) PUNCT B-O
|
4844 |
+
. PUNCT B-O
|
4845 |
+
|
4846 |
+
Att PROPN B-O
|
4847 |
+
, PUNCT B-O
|
4848 |
+
Attacin PROPN B-O
|
4849 |
+
A PROPN B-O
|
4850 |
+
; PUNCT B-O
|
4851 |
+
Dpt PROPN B-O
|
4852 |
+
, PUNCT B-O
|
4853 |
+
Diptericin PROPN B-O
|
4854 |
+
; PUNCT B-O
|
4855 |
+
Drs NOUN B-O
|
4856 |
+
, PUNCT B-O
|
4857 |
+
Drosomycin PROPN B-O
|
4858 |
+
; PUNCT B-O
|
4859 |
+
IMD PROPN B-O
|
4860 |
+
/ SYM B-O
|
4861 |
+
NFkB PROPN B-AC
|
4862 |
+
, PUNCT B-O
|
4863 |
+
immune ADJ B-O
|
4864 |
+
deficiency NOUN B-O
|
4865 |
+
/ SYM B-O
|
4866 |
+
nuclear ADJ B-LF
|
4867 |
+
factor NOUN I-LF
|
4868 |
+
kappa NOUN I-LF
|
4869 |
+
B PROPN I-LF
|
4870 |
+
; PUNCT B-O
|
4871 |
+
qRT PROPN B-AC
|
4872 |
+
, PUNCT B-O
|
4873 |
+
quantitative ADJ B-LF
|
4874 |
+
real ADJ I-LF
|
4875 |
+
- PUNCT I-LF
|
4876 |
+
time NOUN I-LF
|
4877 |
+
PCR NOUN I-LF
|
4878 |
+
; PUNCT B-O
|
4879 |
+
-PCRRNAi PROPN B-AC
|
4880 |
+
, PUNCT B-O
|
4881 |
+
RNA NOUN B-LF
|
4882 |
+
interference NOUN I-LF
|
4883 |
+
. PUNCT B-O
|
4884 |
+
|
4885 |
+
We PRON B-O
|
4886 |
+
sought VERB B-O
|
4887 |
+
to ADP B-O
|
4888 |
+
develop VERB B-O
|
4889 |
+
and CCONJ B-O
|
4890 |
+
validate VERB B-O
|
4891 |
+
an DET B-O
|
4892 |
+
outcomes NOUN B-O
|
4893 |
+
model NOUN B-O
|
4894 |
+
for ADP B-O
|
4895 |
+
the DET B-O
|
4896 |
+
development NOUN B-O
|
4897 |
+
of ADP B-O
|
4898 |
+
diabetes NOUN B-O
|
4899 |
+
and CCONJ B-O
|
4900 |
+
related ADJ B-O
|
4901 |
+
complications NOUN B-O
|
4902 |
+
derived VERB B-O
|
4903 |
+
from ADP B-O
|
4904 |
+
Chinese ADJ B-O
|
4905 |
+
( PUNCT B-O
|
4906 |
+
East ADJ B-O
|
4907 |
+
Asian ADJ B-O
|
4908 |
+
) PUNCT B-O
|
4909 |
+
populations NOUN B-O
|
4910 |
+
and CCONJ B-O
|
4911 |
+
compare VERB B-O
|
4912 |
+
this DET B-O
|
4913 |
+
new ADJ B-O
|
4914 |
+
Chinese ADJ B-LF
|
4915 |
+
Hong PROPN I-LF
|
4916 |
+
Kong PROPN I-LF
|
4917 |
+
Integrated PROPN I-LF
|
4918 |
+
Modeling PROPN I-LF
|
4919 |
+
and CCONJ I-LF
|
4920 |
+
Evaluation PROPN I-LF
|
4921 |
+
( PUNCT B-O
|
4922 |
+
CHIME PROPN B-AC
|
4923 |
+
) PUNCT B-O
|
4924 |
+
model NOUN B-O
|
4925 |
+
to ADP B-O
|
4926 |
+
the DET B-O
|
4927 |
+
existing VERB B-O
|
4928 |
+
UKPDS PROPN B-AC
|
4929 |
+
and CCONJ B-O
|
4930 |
+
-OM2RECODe PROPN B-AC
|
4931 |
+
models NOUN B-O
|
4932 |
+
. PUNCT B-O
|
4933 |
+
|
4934 |
+
( PUNCT B-O
|
4935 |
+
A X B-O
|
4936 |
+
) PUNCT B-O
|
4937 |
+
Immunoblot NOUN B-O
|
4938 |
+
analysis NOUN B-O
|
4939 |
+
of ADP B-O
|
4940 |
+
acetylation NOUN B-O
|
4941 |
+
levels NOUN B-O
|
4942 |
+
of ADP B-O
|
4943 |
+
7 NUM B-O
|
4944 |
+
lysine NOUN B-O
|
4945 |
+
residues NOUN B-O
|
4946 |
+
on ADP B-O
|
4947 |
+
histone NOUN B-O
|
4948 |
+
H3 NOUN B-O
|
4949 |
+
protein NOUN B-O
|
4950 |
+
in ADP B-O
|
4951 |
+
the DET B-O
|
4952 |
+
wild ADJ B-LF
|
4953 |
+
- PUNCT I-LF
|
4954 |
+
type NOUN I-LF
|
4955 |
+
( PUNCT B-O
|
4956 |
+
WT PROPN B-AC
|
4957 |
+
) PUNCT B-O
|
4958 |
+
strain NOUN B-O
|
4959 |
+
and CCONJ B-O
|
4960 |
+
the DET B-O
|
4961 |
+
mutants NOUN B-O
|
4962 |
+
ΔHdac1 NOUN B-O
|
4963 |
+
and CCONJ B-O
|
4964 |
+
ΔHat1 NOUN B-O
|
4965 |
+
. PUNCT B-O
|
4966 |
+
|
4967 |
+
Different ADJ B-O
|
4968 |
+
subtypes NOUN B-O
|
4969 |
+
of ADP B-O
|
4970 |
+
T NOUN B-LF
|
4971 |
+
helper NOUN I-LF
|
4972 |
+
( PUNCT B-O
|
4973 |
+
Th PROPN B-AC
|
4974 |
+
) PUNCT B-O
|
4975 |
+
cells NOUN B-O
|
4976 |
+
are AUX B-O
|
4977 |
+
activated VERB B-O
|
4978 |
+
in ADP B-O
|
4979 |
+
different ADJ B-O
|
4980 |
+
types NOUN B-O
|
4981 |
+
of ADP B-O
|
4982 |
+
chronic ADJ B-O
|
4983 |
+
intestinal ADJ B-O
|
4984 |
+
inflammation NOUN B-O
|
4985 |
+
. PUNCT B-O
|
4986 |
+
|
4987 |
+
For ADP B-O
|
4988 |
+
encoding NOUN B-O
|
4989 |
+
and CCONJ B-O
|
4990 |
+
consolidation NOUN B-O
|
4991 |
+
, PUNCT B-O
|
4992 |
+
we PRON B-O
|
4993 |
+
compared VERB B-O
|
4994 |
+
30 NUM B-O
|
4995 |
+
min NOUN B-O
|
4996 |
+
and CCONJ B-O
|
4997 |
+
5 NUM B-O
|
4998 |
+
h NOUN B-O
|
4999 |
+
after ADP B-O
|
5000 |
+
the DET B-O
|
5001 |
+
watermaze NOUN B-LF
|
5002 |
+
encoding NOUN B-O
|
5003 |
+
session NOUN B-O
|
5004 |
+
animals NOUN B-O
|
5005 |
+
that PRON B-O
|
5006 |
+
experienced VERB B-O
|
5007 |
+
the DET B-O
|
5008 |
+
watermaze NOUN B-LF
|
5009 |
+
( PUNCT B-O
|
5010 |
+
WM PROPN B-AC
|
5011 |
+
) PUNCT B-O
|
5012 |
+
directly ADV B-O
|
5013 |
+
with ADP B-O
|
5014 |
+
animals NOUN B-O
|
5015 |
+
that PRON B-O
|
5016 |
+
had AUX B-O
|
5017 |
+
not PART B-O
|
5018 |
+
experienced VERB B-O
|
5019 |
+
the DET B-O
|
5020 |
+
watermaze NOUN B-LF
|
5021 |
+
( PUNCT B-O
|
5022 |
+
NoWM PROPN B-AC
|
5023 |
+
) PUNCT B-O
|
5024 |
+
. PUNCT B-O
|
5025 |
+
|
5026 |
+
Thus ADV B-O
|
5027 |
+
, PUNCT B-O
|
5028 |
+
positive ADJ B-O
|
5029 |
+
values NOUN B-O
|
5030 |
+
on ADP B-O
|
5031 |
+
the DET B-O
|
5032 |
+
y NOUN B-O
|
5033 |
+
- NOUN B-O
|
5034 |
+
axis NOUN B-O
|
5035 |
+
show VERB B-O
|
5036 |
+
that PRON B-O
|
5037 |
+
animals NOUN B-O
|
5038 |
+
consolidating VERB B-O
|
5039 |
+
a DET B-O
|
5040 |
+
memory NOUN B-O
|
5041 |
+
( PUNCT B-O
|
5042 |
+
WM PROPN B-AC
|
5043 |
+
) PUNCT B-O
|
5044 |
+
show VERB B-O
|
5045 |
+
higher ADJ B-O
|
5046 |
+
gene NOUN B-O
|
5047 |
+
expression NOUN B-O
|
5048 |
+
than ADP B-O
|
5049 |
+
animals NOUN B-O
|
5050 |
+
that PRON B-O
|
5051 |
+
are AUX B-O
|
5052 |
+
not PART B-O
|
5053 |
+
consolidating VERB B-O
|
5054 |
+
a DET B-O
|
5055 |
+
memory NOUN B-O
|
5056 |
+
( PUNCT B-O
|
5057 |
+
NoWM PROPN B-AC
|
5058 |
+
) PUNCT B-O
|
5059 |
+
, PUNCT B-O
|
5060 |
+
independent ADJ B-O
|
5061 |
+
of ADP B-O
|
5062 |
+
what PRON B-O
|
5063 |
+
they PRON B-O
|
5064 |
+
are AUX B-O
|
5065 |
+
doing VERB B-O
|
5066 |
+
at ADP B-O
|
5067 |
+
the DET B-O
|
5068 |
+
moment NOUN B-O
|
5069 |
+
( PUNCT B-O
|
5070 |
+
sleep NOUN B-O
|
5071 |
+
/ SYM B-O
|
5072 |
+
N+SD PROPN B-AC
|
5073 |
+
) PUNCT B-O
|
5074 |
+
. PUNCT B-O
|
5075 |
+
|
5076 |
+
Additionally ADV B-O
|
5077 |
+
, PUNCT B-O
|
5078 |
+
to PART B-O
|
5079 |
+
investigate VERB B-O
|
5080 |
+
the DET B-O
|
5081 |
+
differences NOUN B-O
|
5082 |
+
between ADP B-O
|
5083 |
+
sleep NOUN B-O
|
5084 |
+
and CCONJ B-O
|
5085 |
+
N PROPN B-AC
|
5086 |
+
animals NOUN B-O
|
5087 |
+
at ADP B-O
|
5088 |
+
retrieval NOUN B-O
|
5089 |
+
, PUNCT B-O
|
5090 |
+
we PRON B-O
|
5091 |
+
calculated VERB B-O
|
5092 |
+
percentage NOUN B-O
|
5093 |
+
change NOUN B-O
|
5094 |
+
( PUNCT B-O
|
5095 |
+
sleep NOUN B-O
|
5096 |
+
> SYM B-O
|
5097 |
+
+SDN PROPN B-AC
|
5098 |
+
) PUNCT B-O
|
5099 |
+
on ADP B-O
|
5100 |
+
each DET B-O
|
5101 |
+
plate NOUN B-O
|
5102 |
+
and CCONJ B-O
|
5103 |
+
then ADV B-O
|
5104 |
+
averaged VERB B-O
|
5105 |
+
the DET B-O
|
5106 |
+
data NOUN B-O
|
5107 |
+
( PUNCT B-O
|
5108 |
+
see VERB B-O
|
5109 |
+
S7 PROPN B-O
|
5110 |
+
Fig PROPN B-O
|
5111 |
+
) PUNCT B-O
|
5112 |
+
. PUNCT B-O
|
5113 |
+
|
5114 |
+
AOR PROPN B-AC
|
5115 |
+
= PUNCT B-O
|
5116 |
+
Adjusted ADJ B-O
|
5117 |
+
Adds NOUN B-O
|
5118 |
+
Ratio NOUN B-O
|
5119 |
+
, PUNCT B-O
|
5120 |
+
COR PROPN B-AC
|
5121 |
+
= PUNCT B-O
|
5122 |
+
Crude NOUN B-LF
|
5123 |
+
Odds NOUN I-LF
|
5124 |
+
Ratio NOUN I-LF
|
5125 |
+
. PUNCT B-O
|
5126 |
+
|
data/data_test.conll
ADDED
@@ -0,0 +1,5152 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
Abbreviations NOUN B-O
|
2 |
+
: PUNCT B-O
|
3 |
+
GEMS PROPN B-AC
|
4 |
+
, PUNCT B-O
|
5 |
+
Global PROPN B-LF
|
6 |
+
Enteric PROPN I-LF
|
7 |
+
Multicenter PROPN I-LF
|
8 |
+
Study PROPN I-LF
|
9 |
+
; PUNCT B-O
|
10 |
+
VIP PROPN B-AC
|
11 |
+
, PUNCT B-O
|
12 |
+
ventilated VERB B-LF
|
13 |
+
improved ADJ I-LF
|
14 |
+
pit NOUN I-LF
|
15 |
+
. PUNCT B-O
|
16 |
+
|
17 |
+
Fractions NOUN B-O
|
18 |
+
from ADP B-O
|
19 |
+
FPLC PROPN B-O
|
20 |
+
purification NOUN B-O
|
21 |
+
were AUX B-O
|
22 |
+
treated VERB B-O
|
23 |
+
with ADP B-O
|
24 |
+
Laemmli PROPN B-O
|
25 |
+
buffer NOUN B-O
|
26 |
+
[ X B-O
|
27 |
+
82 X B-O
|
28 |
+
] X B-O
|
29 |
+
with ADP B-O
|
30 |
+
10 NUM B-O
|
31 |
+
mM NOUN B-O
|
32 |
+
1,4 NUM B-O
|
33 |
+
- PUNCT B-O
|
34 |
+
dithiothreitol NOUN B-LF
|
35 |
+
( PUNCT B-O
|
36 |
+
DTT PROPN B-AC
|
37 |
+
) PUNCT B-O
|
38 |
+
and CCONJ B-O
|
39 |
+
heated VERB B-O
|
40 |
+
for ADP B-O
|
41 |
+
5 NUM B-O
|
42 |
+
m NOUN B-O
|
43 |
+
at ADP B-O
|
44 |
+
85 NUM B-O
|
45 |
+
° NOUN B-O
|
46 |
+
C NOUN B-O
|
47 |
+
then ADV B-O
|
48 |
+
analyzed VERB B-O
|
49 |
+
on ADP B-O
|
50 |
+
a DET B-O
|
51 |
+
4 NUM B-O
|
52 |
+
% NOUN B-O
|
53 |
+
to PART B-O
|
54 |
+
15 NUM B-O
|
55 |
+
% NOUN B-O
|
56 |
+
discontinuous ADJ B-O
|
57 |
+
SDS PROPN B-AC
|
58 |
+
gel NOUN B-O
|
59 |
+
with ADP B-O
|
60 |
+
a DET B-O
|
61 |
+
6 NUM B-O
|
62 |
+
% NOUN B-O
|
63 |
+
stacking NOUN B-O
|
64 |
+
gel NOUN B-O
|
65 |
+
run VERB B-O
|
66 |
+
at ADP B-O
|
67 |
+
ambient ADJ B-O
|
68 |
+
temperature NOUN B-O
|
69 |
+
at ADP B-O
|
70 |
+
a DET B-O
|
71 |
+
constant ADJ B-O
|
72 |
+
100 NUM B-O
|
73 |
+
V. NOUN B-O
|
74 |
+
Two NUM B-O
|
75 |
+
epithelial ADJ B-O
|
76 |
+
cytokines NOUN B-O
|
77 |
+
other ADJ B-O
|
78 |
+
than ADP B-O
|
79 |
+
IL33 NOUN B-O
|
80 |
+
, PUNCT B-O
|
81 |
+
IL25 NOUN B-O
|
82 |
+
, PUNCT B-O
|
83 |
+
and CCONJ B-O
|
84 |
+
thymic ADJ B-LF
|
85 |
+
stromal ADJ I-LF
|
86 |
+
lymphopoietin NOUN I-LF
|
87 |
+
( PUNCT B-O
|
88 |
+
TSLP PROPN B-AC
|
89 |
+
) PUNCT B-O
|
90 |
+
are AUX B-O
|
91 |
+
known VERB B-O
|
92 |
+
to PART B-O
|
93 |
+
activate VERB B-O
|
94 |
+
ILC2 PROPN B-AC
|
95 |
+
in ADP B-O
|
96 |
+
the DET B-O
|
97 |
+
lung NOUN B-O
|
98 |
+
[ PUNCT B-O
|
99 |
+
22,24 NUM B-O
|
100 |
+
] PUNCT B-O
|
101 |
+
. PUNCT B-O
|
102 |
+
|
103 |
+
We PRON B-O
|
104 |
+
developed VERB B-O
|
105 |
+
a DET B-O
|
106 |
+
variant NOUN B-O
|
107 |
+
of ADP B-O
|
108 |
+
gene NOUN B-LF
|
109 |
+
set NOUN I-LF
|
110 |
+
enrichment NOUN I-LF
|
111 |
+
analysis NOUN I-LF
|
112 |
+
( PUNCT B-O
|
113 |
+
GSEA PROPN B-AC
|
114 |
+
) PUNCT B-O
|
115 |
+
to PART B-O
|
116 |
+
determine VERB B-O
|
117 |
+
whether SCONJ B-O
|
118 |
+
a DET B-O
|
119 |
+
genetic ADJ B-O
|
120 |
+
pathway NOUN B-O
|
121 |
+
shows VERB B-O
|
122 |
+
evidence NOUN B-O
|
123 |
+
for ADP B-O
|
124 |
+
age NOUN B-O
|
125 |
+
regulation NOUN B-O
|
126 |
+
[ PUNCT B-O
|
127 |
+
23 NUM B-O
|
128 |
+
] PUNCT B-O
|
129 |
+
. PUNCT B-O
|
130 |
+
|
131 |
+
Red NOUN B-O
|
132 |
+
represents VERB B-O
|
133 |
+
samples NOUN B-O
|
134 |
+
having VERB B-O
|
135 |
+
the DET B-O
|
136 |
+
normalized VERB B-O
|
137 |
+
pY232 PROPN B-AC
|
138 |
+
and/or CCONJ B-O
|
139 |
+
pY291 NOUN B-O
|
140 |
+
values NOUN B-O
|
141 |
+
in ADP B-O
|
142 |
+
cancer NOUN B-O
|
143 |
+
tissues NOUN B-O
|
144 |
+
≥ PUNCT B-O
|
145 |
+
1.1 NUM B-O
|
146 |
+
folds NOUN B-O
|
147 |
+
of ADP B-O
|
148 |
+
normal ADJ B-O
|
149 |
+
tissues NOUN B-O
|
150 |
+
( PUNCT B-O
|
151 |
+
of ADP B-O
|
152 |
+
which PRON B-O
|
153 |
+
enhanced VERB B-O
|
154 |
+
pY232 PROPN B-AC
|
155 |
+
and/or CCONJ B-O
|
156 |
+
pY291 NOUN B-O
|
157 |
+
level NOUN B-O
|
158 |
+
may AUX B-O
|
159 |
+
be AUX B-O
|
160 |
+
indicative ADJ B-O
|
161 |
+
of ADP B-O
|
162 |
+
dominant ADJ B-O
|
163 |
+
survival NOUN B-O
|
164 |
+
mode NOUN B-O
|
165 |
+
of ADP B-O
|
166 |
+
Fas PROPN B-O
|
167 |
+
signaling NOUN B-O
|
168 |
+
) PUNCT B-O
|
169 |
+
; PUNCT B-O
|
170 |
+
blue NOUN B-O
|
171 |
+
represents VERB B-O
|
172 |
+
samples NOUN B-O
|
173 |
+
having VERB B-O
|
174 |
+
both CCONJ B-O
|
175 |
+
normalized VERB B-O
|
176 |
+
pY232 PROPN B-AC
|
177 |
+
and CCONJ B-O
|
178 |
+
pY291 NOUN B-O
|
179 |
+
values NOUN B-O
|
180 |
+
< ADP B-O
|
181 |
+
1.1 NUM B-O
|
182 |
+
( PUNCT B-O
|
183 |
+
of ADP B-O
|
184 |
+
which PRON B-O
|
185 |
+
pY232 PROPN B-AC
|
186 |
+
and CCONJ B-O
|
187 |
+
pY291 NOUN B-O
|
188 |
+
levels NOUN B-O
|
189 |
+
less ADJ B-O
|
190 |
+
than ADP B-O
|
191 |
+
or CCONJ B-O
|
192 |
+
equal ADJ B-O
|
193 |
+
to ADP B-O
|
194 |
+
normal ADJ B-O
|
195 |
+
may AUX B-O
|
196 |
+
be AUX B-O
|
197 |
+
indicative ADJ B-O
|
198 |
+
of ADP B-O
|
199 |
+
the DET B-O
|
200 |
+
apoptosis NOUN B-O
|
201 |
+
- NOUN B-O
|
202 |
+
ready ADJ B-O
|
203 |
+
mode NOUN B-O
|
204 |
+
of ADP B-O
|
205 |
+
Fas PROPN B-O
|
206 |
+
signaling NOUN B-O
|
207 |
+
) PUNCT B-O
|
208 |
+
. PUNCT B-O
|
209 |
+
|
210 |
+
( PUNCT B-O
|
211 |
+
D X B-O
|
212 |
+
) PUNCT B-O
|
213 |
+
Lysates NOUN B-O
|
214 |
+
of ADP B-O
|
215 |
+
rectal ADJ B-O
|
216 |
+
cancer NOUN B-O
|
217 |
+
tissues NOUN B-O
|
218 |
+
before ADP B-O
|
219 |
+
and CCONJ B-O
|
220 |
+
after ADP B-O
|
221 |
+
radiotherapy NOUN B-LF
|
222 |
+
( PUNCT B-O
|
223 |
+
RT PROPN B-AC
|
224 |
+
) PUNCT B-O
|
225 |
+
from ADP B-O
|
226 |
+
each PRON B-O
|
227 |
+
of ADP B-O
|
228 |
+
the DET B-O
|
229 |
+
nine NUM B-O
|
230 |
+
patients NOUN B-O
|
231 |
+
were AUX B-O
|
232 |
+
subjected VERB B-O
|
233 |
+
to ADP B-O
|
234 |
+
SDS PROPN B-O
|
235 |
+
- NOUN B-O
|
236 |
+
PAGE PROPN B-O
|
237 |
+
and CCONJ B-O
|
238 |
+
immunoblotting NOUN B-O
|
239 |
+
with ADP B-O
|
240 |
+
antibodies NOUN B-O
|
241 |
+
against ADP B-O
|
242 |
+
pY232 PROPN B-AC
|
243 |
+
, PUNCT B-O
|
244 |
+
pY291 NOUN B-O
|
245 |
+
, PUNCT B-O
|
246 |
+
and CCONJ B-O
|
247 |
+
C NOUN B-O
|
248 |
+
- NOUN B-O
|
249 |
+
terminal ADJ B-O
|
250 |
+
( PUNCT B-O
|
251 |
+
C NOUN B-O
|
252 |
+
- NOUN B-O
|
253 |
+
ter NOUN B-O
|
254 |
+
) PUNCT B-O
|
255 |
+
of ADP B-O
|
256 |
+
Fas PROPN B-O
|
257 |
+
. PUNCT B-O
|
258 |
+
|
259 |
+
Relative ADJ B-LF
|
260 |
+
risks NOUN I-LF
|
261 |
+
( PUNCT B-O
|
262 |
+
RRs PROPN B-AC
|
263 |
+
) PUNCT B-O
|
264 |
+
with ADP B-O
|
265 |
+
95 NUM B-O
|
266 |
+
% NOUN B-O
|
267 |
+
confidence NOUN B-LF
|
268 |
+
intervals NOUN I-LF
|
269 |
+
( PUNCT B-O
|
270 |
+
CIs PROPN B-AC
|
271 |
+
) PUNCT B-O
|
272 |
+
are AUX B-O
|
273 |
+
reported VERB B-O
|
274 |
+
. PUNCT B-O
|
275 |
+
|
276 |
+
Increasing VERB B-O
|
277 |
+
concentrations NOUN B-O
|
278 |
+
of ADP B-O
|
279 |
+
the DET B-O
|
280 |
+
p53 NOUN B-O
|
281 |
+
activators NOUN B-O
|
282 |
+
significantly ADV B-O
|
283 |
+
decrease NOUN B-O
|
284 |
+
the DET B-O
|
285 |
+
levels NOUN B-O
|
286 |
+
of ADP B-O
|
287 |
+
SOD1G85R PROPN B-O
|
288 |
+
but CCONJ B-O
|
289 |
+
not PART B-O
|
290 |
+
the DET B-O
|
291 |
+
endogenous ADJ B-O
|
292 |
+
WTSOD1 PROPN B-AC
|
293 |
+
proteins NOUN B-O
|
294 |
+
in ADP B-O
|
295 |
+
western ADJ B-O
|
296 |
+
blots NOUN B-O
|
297 |
+
of ADP B-O
|
298 |
+
both CCONJ B-O
|
299 |
+
supernatant NOUN B-O
|
300 |
+
and CCONJ B-O
|
301 |
+
pellet NOUN B-LF
|
302 |
+
fractions NOUN I-LF
|
303 |
+
. PUNCT B-O
|
304 |
+
|
305 |
+
( PUNCT B-O
|
306 |
+
B X B-O
|
307 |
+
) PUNCT B-O
|
308 |
+
A DET B-O
|
309 |
+
decrease NOUN B-O
|
310 |
+
in ADP B-O
|
311 |
+
p53 NOUN B-O
|
312 |
+
as SCONJ B-O
|
313 |
+
the DET B-O
|
314 |
+
result NOUN B-O
|
315 |
+
of ADP B-O
|
316 |
+
shRNA PROPN B-AC
|
317 |
+
knockdown NOUN B-O
|
318 |
+
increases VERB B-O
|
319 |
+
the DET B-O
|
320 |
+
levels NOUN B-O
|
321 |
+
of ADP B-O
|
322 |
+
SOD1G85R PROPN B-O
|
323 |
+
but CCONJ B-O
|
324 |
+
not PART B-O
|
325 |
+
WT PROPN B-AC
|
326 |
+
SOD1 PROPN B-AC
|
327 |
+
proteins NOUN B-O
|
328 |
+
in ADP B-O
|
329 |
+
the DET B-O
|
330 |
+
SOD1G85R PROPN B-O
|
331 |
+
aggregation NOUN B-O
|
332 |
+
assay NOUN B-O
|
333 |
+
, PUNCT B-O
|
334 |
+
as SCONJ B-O
|
335 |
+
shown VERB B-O
|
336 |
+
by ADP B-O
|
337 |
+
western ADJ B-O
|
338 |
+
blots NOUN B-O
|
339 |
+
of ADP B-O
|
340 |
+
both CCONJ B-O
|
341 |
+
supernatant NOUN B-O
|
342 |
+
( PUNCT B-O
|
343 |
+
S PROPN B-AC
|
344 |
+
) PUNCT B-O
|
345 |
+
( PUNCT B-O
|
346 |
+
n NOUN B-O
|
347 |
+
= SYM B-O
|
348 |
+
2 NUM B-O
|
349 |
+
) PUNCT B-O
|
350 |
+
and CCONJ B-O
|
351 |
+
pellet NOUN B-O
|
352 |
+
( PUNCT B-O
|
353 |
+
P PROPN B-AC
|
354 |
+
) PUNCT B-O
|
355 |
+
( PUNCT B-O
|
356 |
+
n NOUN B-O
|
357 |
+
= SYM B-O
|
358 |
+
3 NUM B-O
|
359 |
+
) PUNCT B-O
|
360 |
+
fractions NOUN B-O
|
361 |
+
. PUNCT B-O
|
362 |
+
|
363 |
+
( PUNCT B-O
|
364 |
+
C X B-O
|
365 |
+
) PUNCT B-O
|
366 |
+
A DET B-O
|
367 |
+
complete ADJ B-O
|
368 |
+
absence NOUN B-O
|
369 |
+
of ADP B-O
|
370 |
+
p53 NOUN B-O
|
371 |
+
increases VERB B-O
|
372 |
+
the DET B-O
|
373 |
+
accumulation NOUN B-O
|
374 |
+
of ADP B-O
|
375 |
+
SOD1G85R PROPN B-O
|
376 |
+
mutant ADJ B-O
|
377 |
+
proteins NOUN B-O
|
378 |
+
in ADP B-O
|
379 |
+
p53–/ NOUN B-O
|
380 |
+
– PUNCT B-O
|
381 |
+
HCT116 PROPN B-O
|
382 |
+
cells NOUN B-O
|
383 |
+
when SCONJ B-O
|
384 |
+
compared VERB B-O
|
385 |
+
with ADP B-O
|
386 |
+
controls NOUN B-O
|
387 |
+
. PUNCT B-O
|
388 |
+
|
389 |
+
Pravastatin ADJ B-LF
|
390 |
+
sodium NOUN I-LF
|
391 |
+
( PUNCT B-O
|
392 |
+
PSS PROPN B-AC
|
393 |
+
, PUNCT B-O
|
394 |
+
Fig NOUN B-O
|
395 |
+
2.9 NUM B-O
|
396 |
+
) PUNCT B-O
|
397 |
+
is AUX B-O
|
398 |
+
the DET B-O
|
399 |
+
only ADJ B-O
|
400 |
+
included VERB B-O
|
401 |
+
NP PROPN B-AC
|
402 |
+
of ADP B-O
|
403 |
+
microbial ADJ B-O
|
404 |
+
origin NOUN B-O
|
405 |
+
. PUNCT B-O
|
406 |
+
|
407 |
+
I PRON B-O
|
408 |
+
have VERB B-O
|
409 |
+
read VERB B-O
|
410 |
+
the DET B-O
|
411 |
+
journal NOUN B-O
|
412 |
+
's PART B-O
|
413 |
+
policy NOUN B-O
|
414 |
+
and CCONJ B-O
|
415 |
+
the DET B-O
|
416 |
+
authors NOUN B-O
|
417 |
+
of ADP B-O
|
418 |
+
this DET B-O
|
419 |
+
manuscript NOUN B-O
|
420 |
+
have VERB B-O
|
421 |
+
the DET B-O
|
422 |
+
following VERB B-O
|
423 |
+
competing VERB B-O
|
424 |
+
interests NOUN B-O
|
425 |
+
: PUNCT B-O
|
426 |
+
DF PROPN B-O
|
427 |
+
, PUNCT B-O
|
428 |
+
EJ PROPN B-O
|
429 |
+
, PUNCT B-O
|
430 |
+
and CCONJ B-O
|
431 |
+
NNL PROPN B-O
|
432 |
+
are AUX B-O
|
433 |
+
staff NOUN B-O
|
434 |
+
members NOUN B-O
|
435 |
+
of ADP B-O
|
436 |
+
the DET B-O
|
437 |
+
World PROPN B-LF
|
438 |
+
Health PROPN I-LF
|
439 |
+
Organization PROPN I-LF
|
440 |
+
( PUNCT B-O
|
441 |
+
WHO PROPN B-AC
|
442 |
+
) PUNCT B-O
|
443 |
+
. PUNCT B-O
|
444 |
+
|
445 |
+
Characteristics NOUN B-O
|
446 |
+
were AUX B-O
|
447 |
+
compared VERB B-O
|
448 |
+
across ADP B-O
|
449 |
+
the DET B-O
|
450 |
+
matched VERB B-O
|
451 |
+
groups NOUN B-O
|
452 |
+
using VERB B-O
|
453 |
+
standardized ADJ B-LF
|
454 |
+
mean ADJ I-LF
|
455 |
+
differences NOUN I-LF
|
456 |
+
( PUNCT B-O
|
457 |
+
SMDs PROPN B-AC
|
458 |
+
) PUNCT B-O
|
459 |
+
, PUNCT B-O
|
460 |
+
with ADP B-O
|
461 |
+
an DET B-O
|
462 |
+
SMD PROPN B-AC
|
463 |
+
> ADP B-O
|
464 |
+
0.1 NUM B-O
|
465 |
+
indicating VERB B-O
|
466 |
+
a DET B-O
|
467 |
+
clinically ADV B-O
|
468 |
+
important ADJ B-O
|
469 |
+
difference NOUN B-O
|
470 |
+
. PUNCT B-O
|
471 |
+
|
472 |
+
Nutrients NOUN B-O
|
473 |
+
that PRON B-O
|
474 |
+
are AUX B-O
|
475 |
+
rich ADJ B-O
|
476 |
+
in ADP B-O
|
477 |
+
seafood NOUN B-O
|
478 |
+
were AUX B-O
|
479 |
+
selected VERB B-O
|
480 |
+
to PART B-O
|
481 |
+
be AUX B-O
|
482 |
+
included VERB B-O
|
483 |
+
this DET B-O
|
484 |
+
study NOUN B-O
|
485 |
+
: PUNCT B-O
|
486 |
+
protein NOUN B-O
|
487 |
+
, PUNCT B-O
|
488 |
+
eicosapentaenoic NOUN B-LF
|
489 |
+
acid NOUN I-LF
|
490 |
+
( PUNCT B-O
|
491 |
+
EPA PROPN B-AC
|
492 |
+
) PUNCT B-O
|
493 |
+
and CCONJ B-O
|
494 |
+
docosahexaenoic NOUN B-LF
|
495 |
+
acid NOUN I-LF
|
496 |
+
( PUNCT B-O
|
497 |
+
DHA PROPN B-AC
|
498 |
+
) PUNCT B-O
|
499 |
+
, PUNCT B-O
|
500 |
+
vitamins NOUN B-O
|
501 |
+
( PUNCT B-O
|
502 |
+
A NOUN B-O
|
503 |
+
, PUNCT B-O
|
504 |
+
D NOUN B-O
|
505 |
+
, PUNCT B-O
|
506 |
+
B12 NOUN B-O
|
507 |
+
, PUNCT B-O
|
508 |
+
and CCONJ B-O
|
509 |
+
niacin NOUN B-O
|
510 |
+
) PUNCT B-O
|
511 |
+
, PUNCT B-O
|
512 |
+
and CCONJ B-O
|
513 |
+
minerals NOUN B-O
|
514 |
+
( PUNCT B-O
|
515 |
+
zinc NOUN B-O
|
516 |
+
and CCONJ B-O
|
517 |
+
selenium NOUN B-O
|
518 |
+
, PUNCT B-O
|
519 |
+
and CCONJ B-O
|
520 |
+
iron NOUN B-O
|
521 |
+
) PUNCT B-O
|
522 |
+
. PUNCT B-O
|
523 |
+
|
524 |
+
To PART B-O
|
525 |
+
test VERB B-O
|
526 |
+
if SCONJ B-O
|
527 |
+
this DET B-O
|
528 |
+
polymorphism NOUN B-O
|
529 |
+
modulates VERB B-O
|
530 |
+
CD24 NOUN B-O
|
531 |
+
mRNA NOUN B-O
|
532 |
+
stability NOUN B-O
|
533 |
+
, PUNCT B-O
|
534 |
+
we PRON B-O
|
535 |
+
constructed VERB B-O
|
536 |
+
two NUM B-O
|
537 |
+
plasmids NOUN B-O
|
538 |
+
( PUNCT B-O
|
539 |
+
pTracer PROPN B-O
|
540 |
+
CMV2 NOUN B-O
|
541 |
+
- PUNCT B-O
|
542 |
+
CD24TG NOUN B-O
|
543 |
+
and CCONJ B-O
|
544 |
+
pTracer PROPN B-O
|
545 |
+
CMV2 NOUN B-O
|
546 |
+
- PUNCT B-O
|
547 |
+
CD24del NOUN B-O
|
548 |
+
; PUNCT B-O
|
549 |
+
Figure PROPN B-O
|
550 |
+
5 NUM B-O
|
551 |
+
, PUNCT B-O
|
552 |
+
top ADJ B-O
|
553 |
+
panel NOUN B-O
|
554 |
+
) PUNCT B-O
|
555 |
+
and CCONJ B-O
|
556 |
+
transfected VERB B-O
|
557 |
+
Chinese ADJ B-LF
|
558 |
+
hamster NOUN I-LF
|
559 |
+
ovary NOUN I-LF
|
560 |
+
( PUNCT B-O
|
561 |
+
CHO PROPN B-AC
|
562 |
+
) PUNCT B-O
|
563 |
+
cells NOUN B-O
|
564 |
+
with ADP B-O
|
565 |
+
the DET B-O
|
566 |
+
two NUM B-O
|
567 |
+
constructs NOUN B-O
|
568 |
+
. PUNCT B-O
|
569 |
+
|
570 |
+
Blood NOUN B-LF
|
571 |
+
pressure NOUN I-LF
|
572 |
+
( PUNCT B-O
|
573 |
+
BP PROPN B-AC
|
574 |
+
) PUNCT B-O
|
575 |
+
will AUX B-O
|
576 |
+
be AUX B-O
|
577 |
+
controlled VERB B-O
|
578 |
+
after ADP B-O
|
579 |
+
each DET B-O
|
580 |
+
visit NOUN B-O
|
581 |
+
. PUNCT B-O
|
582 |
+
|
583 |
+
Briefly ADV B-O
|
584 |
+
, PUNCT B-O
|
585 |
+
Phenotypic ADJ B-O
|
586 |
+
Age PROPN B-O
|
587 |
+
is AUX B-O
|
588 |
+
calculated VERB B-O
|
589 |
+
using VERB B-O
|
590 |
+
chronological ADJ B-O
|
591 |
+
age NOUN B-O
|
592 |
+
and CCONJ B-O
|
593 |
+
9 NUM B-O
|
594 |
+
biomarkers NOUN B-O
|
595 |
+
( PUNCT B-O
|
596 |
+
albumin NOUN B-O
|
597 |
+
, PUNCT B-O
|
598 |
+
creatinine NOUN B-O
|
599 |
+
, PUNCT B-O
|
600 |
+
glucose NOUN B-O
|
601 |
+
, PUNCT B-O
|
602 |
+
[ PUNCT B-O
|
603 |
+
log X B-O
|
604 |
+
] PUNCT B-O
|
605 |
+
C NOUN B-LF
|
606 |
+
- NOUN I-LF
|
607 |
+
reactive ADJ I-LF
|
608 |
+
protein NOUN I-LF
|
609 |
+
[ PUNCT B-O
|
610 |
+
CRP PROPN B-AC
|
611 |
+
] PUNCT B-O
|
612 |
+
, PUNCT B-O
|
613 |
+
lymphocyte NOUN B-O
|
614 |
+
percent NOUN B-O
|
615 |
+
, PUNCT B-O
|
616 |
+
mean ADJ B-O
|
617 |
+
cell NOUN B-O
|
618 |
+
volume NOUN B-O
|
619 |
+
, PUNCT B-O
|
620 |
+
red ADJ B-O
|
621 |
+
blood NOUN B-O
|
622 |
+
cell NOUN B-O
|
623 |
+
distribution NOUN B-O
|
624 |
+
width NOUN B-O
|
625 |
+
, PUNCT B-O
|
626 |
+
alkaline ADJ B-O
|
627 |
+
phosphatase NOUN B-O
|
628 |
+
, PUNCT B-O
|
629 |
+
and CCONJ B-O
|
630 |
+
white ADJ B-O
|
631 |
+
blood NOUN B-O
|
632 |
+
cell NOUN B-O
|
633 |
+
count NOUN B-O
|
634 |
+
) PUNCT B-O
|
635 |
+
that PRON B-O
|
636 |
+
were AUX B-O
|
637 |
+
selected VERB B-O
|
638 |
+
using VERB B-O
|
639 |
+
a DET B-O
|
640 |
+
Cox PROPN B-O
|
641 |
+
proportional ADJ B-O
|
642 |
+
hazard NOUN B-O
|
643 |
+
elastic ADJ B-O
|
644 |
+
net NOUN B-O
|
645 |
+
model NOUN B-O
|
646 |
+
for ADP B-O
|
647 |
+
mortality NOUN B-O
|
648 |
+
based VERB B-O
|
649 |
+
on ADP B-O
|
650 |
+
10 ADJ B-O
|
651 |
+
- NOUN B-O
|
652 |
+
fold ADJ B-O
|
653 |
+
cross NOUN B-O
|
654 |
+
- NOUN B-O
|
655 |
+
validation NOUN B-O
|
656 |
+
. PUNCT B-O
|
657 |
+
|
658 |
+
However ADV B-O
|
659 |
+
, PUNCT B-O
|
660 |
+
c NOUN B-O
|
661 |
+
- PUNCT B-O
|
662 |
+
Fos NOUN B-O
|
663 |
+
, PUNCT B-O
|
664 |
+
PStat3 PROPN B-O
|
665 |
+
, PUNCT B-O
|
666 |
+
and CCONJ B-O
|
667 |
+
PIP3 PROPN B-AC
|
668 |
+
formation NOUN B-O
|
669 |
+
were AUX B-O
|
670 |
+
not PART B-O
|
671 |
+
elevated VERB B-O
|
672 |
+
in ADP B-O
|
673 |
+
response NOUN B-O
|
674 |
+
to ADP B-O
|
675 |
+
leptin NOUN B-O
|
676 |
+
in ADP B-O
|
677 |
+
obese ADJ B-O
|
678 |
+
GSL PROPN B-O
|
679 |
+
- PUNCT B-O
|
680 |
+
deficient ADJ B-O
|
681 |
+
mice NOUN B-O
|
682 |
+
6 NUM B-O
|
683 |
+
wk PROPN B-AC
|
684 |
+
p.i NOUN B-O
|
685 |
+
. PUNCT B-O
|
686 |
+
|
687 |
+
( PUNCT B-O
|
688 |
+
Figures NOUN B-O
|
689 |
+
7A NUM B-O
|
690 |
+
, PUNCT B-O
|
691 |
+
B NOUN B-O
|
692 |
+
and CCONJ B-O
|
693 |
+
S10A NOUN B-O
|
694 |
+
) PUNCT B-O
|
695 |
+
. PUNCT B-O
|
696 |
+
|
697 |
+
No DET B-O
|
698 |
+
significant ADJ B-O
|
699 |
+
changes NOUN B-O
|
700 |
+
were AUX B-O
|
701 |
+
found VERB B-O
|
702 |
+
in ADP B-O
|
703 |
+
mediobasal ADJ B-LF
|
704 |
+
hypothalamus NOUN I-LF
|
705 |
+
( PUNCT B-O
|
706 |
+
MBH PROPN B-AC
|
707 |
+
) PUNCT B-O
|
708 |
+
baseline NOUN B-O
|
709 |
+
mRNA NOUN B-O
|
710 |
+
expression NOUN B-O
|
711 |
+
of ADP B-O
|
712 |
+
Pomc PROPN B-O
|
713 |
+
and CCONJ B-O
|
714 |
+
cocaine- NOUN B-O
|
715 |
+
and CCONJ B-O
|
716 |
+
amphetamine NOUN B-O
|
717 |
+
- PUNCT B-O
|
718 |
+
regulated VERB B-O
|
719 |
+
transcript NOUN B-O
|
720 |
+
( PUNCT B-O
|
721 |
+
Cart PROPN B-O
|
722 |
+
) PUNCT B-O
|
723 |
+
mRNA NOUN B-O
|
724 |
+
6 NUM B-O
|
725 |
+
wk PROPN B-AC
|
726 |
+
p.i NOUN B-O
|
727 |
+
. PUNCT B-O
|
728 |
+
|
729 |
+
( PUNCT B-O
|
730 |
+
Figure NOUN B-O
|
731 |
+
S10B NOUN B-O
|
732 |
+
) PUNCT B-O
|
733 |
+
. PUNCT B-O
|
734 |
+
|
735 |
+
It PRON B-O
|
736 |
+
has AUX B-O
|
737 |
+
been AUX B-O
|
738 |
+
found VERB B-O
|
739 |
+
that SCONJ B-O
|
740 |
+
control NOUN B-O
|
741 |
+
has AUX B-O
|
742 |
+
been AUX B-O
|
743 |
+
centered VERB B-O
|
744 |
+
around ADP B-O
|
745 |
+
cyclin NOUN B-LF
|
746 |
+
- PUNCT I-LF
|
747 |
+
dependent ADJ I-LF
|
748 |
+
protein NOUN I-LF
|
749 |
+
kinases NOUN I-LF
|
750 |
+
( PUNCT B-O
|
751 |
+
CDKs PROPN B-AC
|
752 |
+
) PUNCT B-O
|
753 |
+
, PUNCT B-O
|
754 |
+
which PRON B-O
|
755 |
+
trigger VERB B-O
|
756 |
+
the DET B-O
|
757 |
+
major ADJ B-O
|
758 |
+
events NOUN B-O
|
759 |
+
of ADP B-O
|
760 |
+
the DET B-O
|
761 |
+
eukaryotic ADJ B-O
|
762 |
+
cell NOUN B-O
|
763 |
+
cycle NOUN B-O
|
764 |
+
. PUNCT B-O
|
765 |
+
|
766 |
+
The DET B-O
|
767 |
+
asparagine NOUN B-O
|
768 |
+
hydroxylase NOUN B-O
|
769 |
+
, PUNCT B-O
|
770 |
+
termed VERB B-O
|
771 |
+
factor NOUN B-LF
|
772 |
+
inhibiting VERB I-LF
|
773 |
+
HIF NOUN I-LF
|
774 |
+
HIF PROPN B-AC
|
775 |
+
( PUNCT B-O
|
776 |
+
FIH PROPN B-AC
|
777 |
+
) PUNCT B-O
|
778 |
+
( PUNCT B-O
|
779 |
+
Uniprot ADJ B-O
|
780 |
+
accession NOUN B-O
|
781 |
+
number NOUN B-O
|
782 |
+
: PUNCT B-O
|
783 |
+
Q9NWT6 NOUN B-O
|
784 |
+
) PUNCT B-O
|
785 |
+
, PUNCT B-O
|
786 |
+
hydroxylates VERB B-O
|
787 |
+
an DET B-O
|
788 |
+
asparagine NOUN B-O
|
789 |
+
residue NOUN B-O
|
790 |
+
within ADP B-O
|
791 |
+
HIFα NOUN B-O
|
792 |
+
subunits NOUN B-O
|
793 |
+
( PUNCT B-O
|
794 |
+
N803 NUM B-O
|
795 |
+
on ADP B-O
|
796 |
+
HIF-1α PROPN B-AC
|
797 |
+
) PUNCT B-O
|
798 |
+
, PUNCT B-O
|
799 |
+
resulting VERB B-O
|
800 |
+
in ADP B-O
|
801 |
+
steric ADJ B-O
|
802 |
+
inhibition NOUN B-O
|
803 |
+
of ADP B-O
|
804 |
+
its PRON B-O
|
805 |
+
interaction NOUN B-O
|
806 |
+
with ADP B-O
|
807 |
+
the DET B-O
|
808 |
+
transcriptional ADJ B-O
|
809 |
+
co NOUN B-O
|
810 |
+
- PUNCT B-O
|
811 |
+
activator NOUN B-O
|
812 |
+
p300 NOUN B-O
|
813 |
+
/ SYM B-O
|
814 |
+
CBP PROPN B-O
|
815 |
+
, PUNCT B-O
|
816 |
+
thereby ADV B-O
|
817 |
+
inhibiting VERB B-O
|
818 |
+
HIF PROPN B-AC
|
819 |
+
- PUNCT B-O
|
820 |
+
dependent ADJ B-O
|
821 |
+
transcription NOUN B-O
|
822 |
+
[ PUNCT B-O
|
823 |
+
2 NUM B-O
|
824 |
+
] PUNCT B-O
|
825 |
+
. PUNCT B-O
|
826 |
+
|
827 |
+
The DET B-O
|
828 |
+
manuscript NOUN B-O
|
829 |
+
by ADP B-O
|
830 |
+
Varma PROPN B-O
|
831 |
+
et PROPN B-O
|
832 |
+
al NOUN B-O
|
833 |
+
explores VERB B-O
|
834 |
+
the DET B-O
|
835 |
+
relationships NOUN B-O
|
836 |
+
between ADP B-O
|
837 |
+
bile NOUN B-LF
|
838 |
+
acid NOUN I-LF
|
839 |
+
( PUNCT B-O
|
840 |
+
BA PROPN B-AC
|
841 |
+
) PUNCT B-O
|
842 |
+
levels NOUN B-O
|
843 |
+
/ SYM B-O
|
844 |
+
synthesis NOUN B-O
|
845 |
+
and CCONJ B-O
|
846 |
+
dementia NOUN B-O
|
847 |
+
related VERB B-O
|
848 |
+
pathology NOUN B-O
|
849 |
+
, PUNCT B-O
|
850 |
+
such ADJ B-O
|
851 |
+
as ADP B-O
|
852 |
+
white ADJ B-LF
|
853 |
+
matter NOUN I-LF
|
854 |
+
lesions NOUN I-LF
|
855 |
+
( PUNCT B-O
|
856 |
+
WML PROPN B-AC
|
857 |
+
) PUNCT B-O
|
858 |
+
and CCONJ B-O
|
859 |
+
amyloid NOUN B-O
|
860 |
+
deposition NOUN B-O
|
861 |
+
, PUNCT B-O
|
862 |
+
as ADP B-O
|
863 |
+
well ADV B-O
|
864 |
+
as ADP B-O
|
865 |
+
vascular ADJ B-O
|
866 |
+
dementia NOUN B-O
|
867 |
+
risk NOUN B-O
|
868 |
+
and CCONJ B-O
|
869 |
+
sex NOUN B-O
|
870 |
+
related VERB B-O
|
871 |
+
differences NOUN B-O
|
872 |
+
. PUNCT B-O
|
873 |
+
|
874 |
+
However ADV B-O
|
875 |
+
, PUNCT B-O
|
876 |
+
current ADJ B-O
|
877 |
+
literature NOUN B-O
|
878 |
+
on ADP B-O
|
879 |
+
the DET B-O
|
880 |
+
stability NOUN B-O
|
881 |
+
of ADP B-O
|
882 |
+
the DET B-O
|
883 |
+
steroids NOUN B-O
|
884 |
+
in ADP B-O
|
885 |
+
DBS PROPN B-AC
|
886 |
+
is AUX B-O
|
887 |
+
very ADV B-O
|
888 |
+
limited ADJ B-O
|
889 |
+
, PUNCT B-O
|
890 |
+
dealing VERB B-O
|
891 |
+
exclusively ADV B-O
|
892 |
+
with ADP B-O
|
893 |
+
17OHP PROPN B-AC
|
894 |
+
[ PUNCT B-O
|
895 |
+
10–16 NUM B-O
|
896 |
+
] PUNCT B-O
|
897 |
+
or CCONJ B-O
|
898 |
+
cortisol NOUN B-LF
|
899 |
+
( PUNCT B-O
|
900 |
+
Cort PROPN B-AC
|
901 |
+
) PUNCT B-O
|
902 |
+
[ PUNCT B-O
|
903 |
+
17 NUM B-O
|
904 |
+
] PUNCT B-O
|
905 |
+
. PUNCT B-O
|
906 |
+
|
907 |
+
CD PROPN B-AC
|
908 |
+
is AUX B-O
|
909 |
+
the DET B-O
|
910 |
+
most ADV B-O
|
911 |
+
common ADJ B-O
|
912 |
+
form NOUN B-O
|
913 |
+
of ADP B-O
|
914 |
+
inflammatory ADJ B-O
|
915 |
+
bowel NOUN B-O
|
916 |
+
disease NOUN B-O
|
917 |
+
, PUNCT B-O
|
918 |
+
the DET B-O
|
919 |
+
other ADJ B-O
|
920 |
+
being AUX B-O
|
921 |
+
ulcerative ADJ B-LF
|
922 |
+
colitis NOUN I-LF
|
923 |
+
( PUNCT B-O
|
924 |
+
UC PROPN B-AC
|
925 |
+
) PUNCT B-O
|
926 |
+
. PUNCT B-O
|
927 |
+
|
928 |
+
We PRON B-O
|
929 |
+
genotyped VERB B-O
|
930 |
+
a DET B-O
|
931 |
+
cohort NOUN B-O
|
932 |
+
of ADP B-O
|
933 |
+
246 NUM B-O
|
934 |
+
Belgian ADJ B-O
|
935 |
+
UC PROPN B-AC
|
936 |
+
patients NOUN B-O
|
937 |
+
( PUNCT B-O
|
938 |
+
Caucasians PROPN B-O
|
939 |
+
) PUNCT B-O
|
940 |
+
for ADP B-O
|
941 |
+
IL23R NOUN B-O
|
942 |
+
( PUNCT B-O
|
943 |
+
rs11209026 NUM B-O
|
944 |
+
) PUNCT B-O
|
945 |
+
, PUNCT B-O
|
946 |
+
ATG16L1 NOUN B-O
|
947 |
+
( PUNCT B-O
|
948 |
+
rs2241880 NUM B-O
|
949 |
+
) PUNCT B-O
|
950 |
+
, PUNCT B-O
|
951 |
+
and CCONJ B-O
|
952 |
+
the DET B-O
|
953 |
+
novel ADJ B-O
|
954 |
+
5p13.1 NOUN B-O
|
955 |
+
locus NOUN B-O
|
956 |
+
( PUNCT B-O
|
957 |
+
rs4613763 NUM B-O
|
958 |
+
) PUNCT B-O
|
959 |
+
. PUNCT B-O
|
960 |
+
|
961 |
+
Endophthalmitis NOUN B-O
|
962 |
+
after ADP B-O
|
963 |
+
vitreous ADJ B-O
|
964 |
+
surgery NOUN B-O
|
965 |
+
is AUX B-O
|
966 |
+
an DET B-O
|
967 |
+
uncommon ADJ B-O
|
968 |
+
but CCONJ B-O
|
969 |
+
a DET B-O
|
970 |
+
devastating ADJ B-O
|
971 |
+
complication.[1 NOUN B-O
|
972 |
+
] PUNCT B-O
|
973 |
+
The DET B-O
|
974 |
+
reported VERB B-O
|
975 |
+
incidence NOUN B-O
|
976 |
+
of ADP B-O
|
977 |
+
endophthalmitis NOUN B-O
|
978 |
+
after ADP B-O
|
979 |
+
vitreous ADJ B-O
|
980 |
+
surgery NOUN B-O
|
981 |
+
ranges VERB B-O
|
982 |
+
from ADP B-O
|
983 |
+
0.05 NUM B-O
|
984 |
+
% NOUN B-O
|
985 |
+
to ADP B-O
|
986 |
+
0.02 NUM B-O
|
987 |
+
% NOUN B-O
|
988 |
+
with ADP B-O
|
989 |
+
20 NUM B-O
|
990 |
+
- ADJ B-O
|
991 |
+
G NOUN B-O
|
992 |
+
vitrectomy.[2–10 NOUN B-O
|
993 |
+
] PUNCT B-O
|
994 |
+
Initial ADJ B-O
|
995 |
+
reports NOUN B-O
|
996 |
+
showed VERB B-O
|
997 |
+
higher ADJ B-O
|
998 |
+
rates NOUN B-O
|
999 |
+
of ADP B-O
|
1000 |
+
post ADJ B-O
|
1001 |
+
- ADJ B-O
|
1002 |
+
minimally ADJ B-LF
|
1003 |
+
invasive ADJ I-LF
|
1004 |
+
vitreoretinal ADJ I-LF
|
1005 |
+
surgery NOUN I-LF
|
1006 |
+
( PUNCT B-O
|
1007 |
+
MIVS PROPN B-AC
|
1008 |
+
) PUNCT B-O
|
1009 |
+
endophthalmitis NOUN B-O
|
1010 |
+
, PUNCT B-O
|
1011 |
+
whereas SCONJ B-O
|
1012 |
+
recent ADJ B-O
|
1013 |
+
reports NOUN B-O
|
1014 |
+
have AUX B-O
|
1015 |
+
shown VERB B-O
|
1016 |
+
a DET B-O
|
1017 |
+
declining VERB B-O
|
1018 |
+
trend.[6,8,10,11 NUM B-O
|
1019 |
+
] PUNCT B-O
|
1020 |
+
Body NOUN B-LF
|
1021 |
+
mass NOUN I-LF
|
1022 |
+
index NOUN I-LF
|
1023 |
+
( PUNCT B-O
|
1024 |
+
BMI PROPN B-AC
|
1025 |
+
) PUNCT B-O
|
1026 |
+
was AUX B-O
|
1027 |
+
calculated VERB B-O
|
1028 |
+
as ADP B-O
|
1029 |
+
the DET B-O
|
1030 |
+
weight NOUN B-O
|
1031 |
+
in ADP B-O
|
1032 |
+
kilograms NOUN B-O
|
1033 |
+
divided VERB B-O
|
1034 |
+
by ADP B-O
|
1035 |
+
the DET B-O
|
1036 |
+
square NOUN B-O
|
1037 |
+
of ADP B-O
|
1038 |
+
the DET B-O
|
1039 |
+
height NOUN B-O
|
1040 |
+
in ADP B-O
|
1041 |
+
meters NOUN B-O
|
1042 |
+
. PUNCT B-O
|
1043 |
+
|
1044 |
+
Source NOUN B-O
|
1045 |
+
data NOUN B-O
|
1046 |
+
are AUX B-O
|
1047 |
+
available ADJ B-O
|
1048 |
+
from ADP B-O
|
1049 |
+
https://figshare.com/s/b14c8e6cb1fc5135dd87 X B-O
|
1050 |
+
. PUNCT B-O
|
1051 |
+
|
1052 |
+
# PUNCT B-O
|
1053 |
+
Cells NOUN B-O
|
1054 |
+
, PUNCT B-O
|
1055 |
+
number NOUN B-O
|
1056 |
+
of ADP B-O
|
1057 |
+
cells NOUN B-O
|
1058 |
+
; PUNCT B-O
|
1059 |
+
μ PUNCT B-O
|
1060 |
+
CA PROPN B-O
|
1061 |
+
, PUNCT B-O
|
1062 |
+
average ADJ B-O
|
1063 |
+
cell NOUN B-O
|
1064 |
+
area NOUN B-O
|
1065 |
+
; PUNCT B-O
|
1066 |
+
LATE PROPN B-AC
|
1067 |
+
, PUNCT B-O
|
1068 |
+
a DET B-LF
|
1069 |
+
timing NOUN I-LF
|
1070 |
+
factor NOUN I-LF
|
1071 |
+
; PUNCT B-O
|
1072 |
+
Leaf NOUN B-O
|
1073 |
+
A NOUN B-O
|
1074 |
+
, PUNCT B-O
|
1075 |
+
leaf NOUN B-O
|
1076 |
+
area NOUN B-O
|
1077 |
+
; PUNCT B-O
|
1078 |
+
spch PROPN B-AC
|
1079 |
+
, PUNCT B-O
|
1080 |
+
speechless ADJ B-LF
|
1081 |
+
. PUNCT B-O
|
1082 |
+
|
1083 |
+
The DET B-O
|
1084 |
+
best ADJ B-LF
|
1085 |
+
linear ADJ I-LF
|
1086 |
+
unbiased ADJ I-LF
|
1087 |
+
estimates NOUN I-LF
|
1088 |
+
( PUNCT B-O
|
1089 |
+
BLUEs PROPN B-AC
|
1090 |
+
) PUNCT B-O
|
1091 |
+
of ADP B-O
|
1092 |
+
the DET B-O
|
1093 |
+
481 NUM B-O
|
1094 |
+
BC1F3:4 NOUN B-O
|
1095 |
+
families NOUN B-O
|
1096 |
+
were AUX B-O
|
1097 |
+
estimated VERB B-O
|
1098 |
+
following VERB B-O
|
1099 |
+
the DET B-O
|
1100 |
+
model NOUN B-O
|
1101 |
+
: PUNCT B-O
|
1102 |
+
yijm NOUN B-O
|
1103 |
+
= SYM B-O
|
1104 |
+
μ+gi+ej+geij+δ(j)m+εijm X B-O
|
1105 |
+
, PUNCT B-O
|
1106 |
+
where SCONJ B-O
|
1107 |
+
yijm NOUN B-O
|
1108 |
+
is AUX B-O
|
1109 |
+
the DET B-O
|
1110 |
+
phenotype NOUN B-O
|
1111 |
+
of ADP B-O
|
1112 |
+
the DET B-O
|
1113 |
+
ith NOUN B-O
|
1114 |
+
( PUNCT B-O
|
1115 |
+
i NOUN B-O
|
1116 |
+
= SYM B-O
|
1117 |
+
1,2 NUM B-O
|
1118 |
+
… PUNCT B-O
|
1119 |
+
, PUNCT B-O
|
1120 |
+
481 NUM B-O
|
1121 |
+
) PUNCT B-O
|
1122 |
+
genotype NOUN B-O
|
1123 |
+
in ADP B-O
|
1124 |
+
the DET B-O
|
1125 |
+
jth NOUN B-O
|
1126 |
+
( PUNCT B-O
|
1127 |
+
j NOUN B-O
|
1128 |
+
= SYM B-O
|
1129 |
+
1,2,3,4 NUM B-O
|
1130 |
+
) PUNCT B-O
|
1131 |
+
environment NOUN B-O
|
1132 |
+
, PUNCT B-O
|
1133 |
+
the DET B-O
|
1134 |
+
mth NOUN B-O
|
1135 |
+
( PUNCT B-O
|
1136 |
+
m NOUN B-O
|
1137 |
+
= SYM B-O
|
1138 |
+
1,2 NUM B-O
|
1139 |
+
) PUNCT B-O
|
1140 |
+
replicate NOUN B-O
|
1141 |
+
effect NOUN B-O
|
1142 |
+
was AUX B-O
|
1143 |
+
nested VERB B-O
|
1144 |
+
in ADP B-O
|
1145 |
+
each DET B-O
|
1146 |
+
environment NOUN B-O
|
1147 |
+
. PUNCT B-O
|
1148 |
+
|
1149 |
+
μ PUNCT B-O
|
1150 |
+
is AUX B-O
|
1151 |
+
the DET B-O
|
1152 |
+
overall ADJ B-O
|
1153 |
+
mean NOUN B-O
|
1154 |
+
, PUNCT B-O
|
1155 |
+
gi NOUN B-O
|
1156 |
+
is AUX B-O
|
1157 |
+
the DET B-O
|
1158 |
+
genotype NOUN B-O
|
1159 |
+
effect NOUN B-O
|
1160 |
+
, PUNCT B-O
|
1161 |
+
ej NOUN B-O
|
1162 |
+
is AUX B-O
|
1163 |
+
the DET B-O
|
1164 |
+
environmental ADJ B-O
|
1165 |
+
effect NOUN B-O
|
1166 |
+
, PUNCT B-O
|
1167 |
+
geij NOUN B-O
|
1168 |
+
is AUX B-O
|
1169 |
+
the DET B-O
|
1170 |
+
G×E PROPN B-AC
|
1171 |
+
effect NOUN B-O
|
1172 |
+
, PUNCT B-O
|
1173 |
+
δ(j)m NOUN B-O
|
1174 |
+
is AUX B-O
|
1175 |
+
the DET B-O
|
1176 |
+
replicate NOUN B-O
|
1177 |
+
effect NOUN B-O
|
1178 |
+
, PUNCT B-O
|
1179 |
+
and CCONJ B-O
|
1180 |
+
εijm NOUN B-O
|
1181 |
+
~ PUNCT B-O
|
1182 |
+
N NOUN B-O
|
1183 |
+
( PUNCT B-O
|
1184 |
+
0 NUM B-O
|
1185 |
+
, PUNCT B-O
|
1186 |
+
σε2 NUM B-O
|
1187 |
+
) PUNCT B-O
|
1188 |
+
is AUX B-O
|
1189 |
+
the DET B-O
|
1190 |
+
error NOUN B-O
|
1191 |
+
term NOUN B-O
|
1192 |
+
. PUNCT B-O
|
1193 |
+
|
1194 |
+
KO PROPN B-AC
|
1195 |
+
, PUNCT B-O
|
1196 |
+
knockout NOUN B-LF
|
1197 |
+
; PUNCT B-O
|
1198 |
+
PSD PROPN B-AC
|
1199 |
+
, PUNCT B-O
|
1200 |
+
postsynaptic ADJ B-LF
|
1201 |
+
density NOUN I-LF
|
1202 |
+
. PUNCT B-O
|
1203 |
+
|
1204 |
+
Small ADJ B-O
|
1205 |
+
RNA NOUN B-O
|
1206 |
+
sequencing NOUN B-O
|
1207 |
+
was AUX B-O
|
1208 |
+
performed VERB B-O
|
1209 |
+
to PART B-O
|
1210 |
+
profile VERB B-O
|
1211 |
+
miRNA PROPN B-AC
|
1212 |
+
expression NOUN B-O
|
1213 |
+
in ADP B-O
|
1214 |
+
SW480 NUM B-O
|
1215 |
+
and CCONJ B-O
|
1216 |
+
SW620 NUM B-O
|
1217 |
+
cell NOUN B-LF
|
1218 |
+
lysates NOUN I-LF
|
1219 |
+
( PUNCT B-O
|
1220 |
+
CLs PROPN B-AC
|
1221 |
+
) PUNCT B-O
|
1222 |
+
and CCONJ B-O
|
1223 |
+
their PRON B-O
|
1224 |
+
released VERB B-O
|
1225 |
+
EVs PROPN B-AC
|
1226 |
+
. PUNCT B-O
|
1227 |
+
|
1228 |
+
Initially ADV B-O
|
1229 |
+
, PUNCT B-O
|
1230 |
+
a DET B-O
|
1231 |
+
total NOUN B-O
|
1232 |
+
of ADP B-O
|
1233 |
+
160.46 NUM B-O
|
1234 |
+
million NUM B-O
|
1235 |
+
raw ADJ B-O
|
1236 |
+
reads NOUN B-O
|
1237 |
+
were AUX B-O
|
1238 |
+
generated VERB B-O
|
1239 |
+
by ADP B-O
|
1240 |
+
an DET B-O
|
1241 |
+
Illumina PROPN B-O
|
1242 |
+
HiSeq-2000 PROPN B-O
|
1243 |
+
system NOUN B-O
|
1244 |
+
for ADP B-O
|
1245 |
+
all DET B-O
|
1246 |
+
the DET B-O
|
1247 |
+
samples NOUN B-O
|
1248 |
+
, PUNCT B-O
|
1249 |
+
yielding VERB B-O
|
1250 |
+
an DET B-O
|
1251 |
+
average ADJ B-O
|
1252 |
+
12.77 NUM B-O
|
1253 |
+
million NUM B-O
|
1254 |
+
clean ADJ B-O
|
1255 |
+
reads NOUN B-O
|
1256 |
+
. PUNCT B-O
|
1257 |
+
|
1258 |
+
Inter- ADJ B-O
|
1259 |
+
and CCONJ B-O
|
1260 |
+
intra ADJ B-O
|
1261 |
+
- PUNCT B-O
|
1262 |
+
rater ADJ B-O
|
1263 |
+
reliability NOUN B-O
|
1264 |
+
was AUX B-O
|
1265 |
+
determined VERB B-O
|
1266 |
+
by ADP B-O
|
1267 |
+
means NOUN B-O
|
1268 |
+
of ADP B-O
|
1269 |
+
intraclass NOUN B-LF
|
1270 |
+
correlation NOUN I-LF
|
1271 |
+
coefficients NOUN I-LF
|
1272 |
+
( PUNCT B-O
|
1273 |
+
ICC PROPN B-AC
|
1274 |
+
) PUNCT B-O
|
1275 |
+
using VERB B-O
|
1276 |
+
R PROPN B-O
|
1277 |
+
Studio PROPN B-O
|
1278 |
+
( PUNCT B-O
|
1279 |
+
Version PROPN B-O
|
1280 |
+
1.1.456 NUM B-O
|
1281 |
+
; PUNCT B-O
|
1282 |
+
RStudio PROPN B-O
|
1283 |
+
) PUNCT B-O
|
1284 |
+
based VERB B-O
|
1285 |
+
on ADP B-O
|
1286 |
+
a DET B-O
|
1287 |
+
mean NOUN B-O
|
1288 |
+
of ADP B-O
|
1289 |
+
2 NUM B-O
|
1290 |
+
raters NOUN B-O
|
1291 |
+
, PUNCT B-O
|
1292 |
+
consistency NOUN B-O
|
1293 |
+
, PUNCT B-O
|
1294 |
+
2 NUM B-O
|
1295 |
+
- PUNCT B-O
|
1296 |
+
way NOUN B-O
|
1297 |
+
mixed VERB B-O
|
1298 |
+
- PUNCT B-O
|
1299 |
+
effects NOUN B-O
|
1300 |
+
model NOUN B-O
|
1301 |
+
for ADP B-O
|
1302 |
+
the DET B-O
|
1303 |
+
qualitative ADJ B-O
|
1304 |
+
analysis NOUN B-O
|
1305 |
+
[ PUNCT B-O
|
1306 |
+
42 NUM B-O
|
1307 |
+
] PUNCT B-O
|
1308 |
+
. PUNCT B-O
|
1309 |
+
|
1310 |
+
The DET B-O
|
1311 |
+
signaling NOUN B-O
|
1312 |
+
molecule NOUN B-O
|
1313 |
+
secreted VERB B-O
|
1314 |
+
by ADP B-O
|
1315 |
+
the DET B-O
|
1316 |
+
hypothalamus NOUN B-O
|
1317 |
+
is AUX B-O
|
1318 |
+
arginine NOUN B-LF
|
1319 |
+
vasopressin NOUN I-LF
|
1320 |
+
( PUNCT B-O
|
1321 |
+
AVP PROPN B-AC
|
1322 |
+
) PUNCT B-O
|
1323 |
+
, PUNCT B-O
|
1324 |
+
which PRON B-O
|
1325 |
+
binds VERB B-O
|
1326 |
+
to ADP B-O
|
1327 |
+
a DET B-O
|
1328 |
+
specific ADJ B-O
|
1329 |
+
protein NOUN B-O
|
1330 |
+
on ADP B-O
|
1331 |
+
the DET B-O
|
1332 |
+
surface NOUN B-O
|
1333 |
+
of ADP B-O
|
1334 |
+
kidney NOUN B-O
|
1335 |
+
cells NOUN B-O
|
1336 |
+
, PUNCT B-O
|
1337 |
+
AVP PROPN B-AC
|
1338 |
+
receptor NOUN B-O
|
1339 |
+
( PUNCT B-O
|
1340 |
+
AVPR2 PROPN B-AC
|
1341 |
+
) PUNCT B-O
|
1342 |
+
. PUNCT B-O
|
1343 |
+
|
1344 |
+
The DET B-O
|
1345 |
+
results NOUN B-O
|
1346 |
+
described VERB B-O
|
1347 |
+
above ADV B-O
|
1348 |
+
show VERB B-O
|
1349 |
+
that PRON B-O
|
1350 |
+
membrane NOUN B-O
|
1351 |
+
- PUNCT B-O
|
1352 |
+
tethered VERB B-O
|
1353 |
+
δ PUNCT B-O
|
1354 |
+
- PUNCT B-O
|
1355 |
+
ACTX NOUN B-O
|
1356 |
+
- PUNCT B-O
|
1357 |
+
Hv1a PROPN B-O
|
1358 |
+
expression NOUN B-O
|
1359 |
+
in ADP B-O
|
1360 |
+
PDF PROPN B-AC
|
1361 |
+
- PUNCT B-O
|
1362 |
+
secreting VERB B-O
|
1363 |
+
LNVs PROPN B-AC
|
1364 |
+
induces VERB B-O
|
1365 |
+
a DET B-O
|
1366 |
+
phase NOUN B-O
|
1367 |
+
- PUNCT B-O
|
1368 |
+
advance NOUN B-O
|
1369 |
+
of ADP B-O
|
1370 |
+
both CCONJ B-O
|
1371 |
+
sLNV PROPN B-AC
|
1372 |
+
PDF PROPN B-AC
|
1373 |
+
secretion NOUN B-O
|
1374 |
+
rhythms NOUN B-O
|
1375 |
+
and CCONJ B-O
|
1376 |
+
morning ADJ B-O
|
1377 |
+
anticipatory ADJ B-O
|
1378 |
+
locomotor ADJ B-O
|
1379 |
+
behavior NOUN B-O
|
1380 |
+
in ADP B-O
|
1381 |
+
LD PROPN B-AC
|
1382 |
+
, PUNCT B-O
|
1383 |
+
and CCONJ B-O
|
1384 |
+
disrupts VERB B-O
|
1385 |
+
free ADV B-O
|
1386 |
+
- PUNCT B-O
|
1387 |
+
running VERB B-O
|
1388 |
+
locomotor ADJ B-O
|
1389 |
+
rhythms NOUN B-O
|
1390 |
+
in ADP B-O
|
1391 |
+
DD PROPN B-AC
|
1392 |
+
. PUNCT B-O
|
1393 |
+
|
1394 |
+
In ADP B-O
|
1395 |
+
order NOUN B-O
|
1396 |
+
to PART B-O
|
1397 |
+
determine VERB B-O
|
1398 |
+
the DET B-O
|
1399 |
+
relationship NOUN B-O
|
1400 |
+
between ADP B-O
|
1401 |
+
these DET B-O
|
1402 |
+
phenotypes NOUN B-O
|
1403 |
+
and CCONJ B-O
|
1404 |
+
cellular ADJ B-O
|
1405 |
+
transcriptional ADJ B-O
|
1406 |
+
feedback NOUN B-O
|
1407 |
+
oscillation NOUN B-O
|
1408 |
+
, PUNCT B-O
|
1409 |
+
par PROPN B-LF
|
1410 |
+
domain NOUN I-LF
|
1411 |
+
protein NOUN I-LF
|
1412 |
+
1 NUM I-LF
|
1413 |
+
( PUNCT B-O
|
1414 |
+
PDP1 PROPN B-AC
|
1415 |
+
) PUNCT B-O
|
1416 |
+
clock NOUN B-O
|
1417 |
+
protein NOUN B-O
|
1418 |
+
levels NOUN B-O
|
1419 |
+
were AUX B-O
|
1420 |
+
assayed VERB B-O
|
1421 |
+
in ADP B-O
|
1422 |
+
the DET B-O
|
1423 |
+
sLNV PROPN B-AC
|
1424 |
+
, PUNCT B-O
|
1425 |
+
dorsal ADJ B-LF
|
1426 |
+
lateral ADJ I-LF
|
1427 |
+
neuron NOUN I-LF
|
1428 |
+
( PUNCT B-O
|
1429 |
+
LND PROPN B-AC
|
1430 |
+
) PUNCT B-O
|
1431 |
+
, PUNCT B-O
|
1432 |
+
dorsal ADJ B-LF
|
1433 |
+
neuron NOUN I-LF
|
1434 |
+
( PUNCT B-O
|
1435 |
+
DN)1 PROPN B-AC
|
1436 |
+
, PUNCT B-O
|
1437 |
+
and CCONJ B-O
|
1438 |
+
DN2 NOUN B-O
|
1439 |
+
neurons NOUN B-O
|
1440 |
+
of ADP B-O
|
1441 |
+
flies NOUN B-O
|
1442 |
+
expressing VERB B-O
|
1443 |
+
membrane NOUN B-O
|
1444 |
+
- PUNCT B-O
|
1445 |
+
tethered VERB B-O
|
1446 |
+
δ PUNCT B-O
|
1447 |
+
- PUNCT B-O
|
1448 |
+
ACTX NOUN B-O
|
1449 |
+
- PUNCT B-O
|
1450 |
+
Hv1a PROPN B-O
|
1451 |
+
in ADP B-O
|
1452 |
+
the DET B-O
|
1453 |
+
LNVs PROPN B-AC
|
1454 |
+
. PUNCT B-O
|
1455 |
+
|
1456 |
+
PDP1 PROPN B-AC
|
1457 |
+
is AUX B-O
|
1458 |
+
an DET B-O
|
1459 |
+
oscillating VERB B-O
|
1460 |
+
transcription NOUN B-O
|
1461 |
+
factor NOUN B-O
|
1462 |
+
that PRON B-O
|
1463 |
+
has AUX B-O
|
1464 |
+
been AUX B-O
|
1465 |
+
implicated VERB B-O
|
1466 |
+
in ADP B-O
|
1467 |
+
a DET B-O
|
1468 |
+
second ADJ B-O
|
1469 |
+
interlocking VERB B-O
|
1470 |
+
circadian ADJ B-O
|
1471 |
+
transcriptional ADJ B-O
|
1472 |
+
feedback NOUN B-O
|
1473 |
+
loop NOUN B-O
|
1474 |
+
[ PUNCT B-O
|
1475 |
+
8 NUM B-O
|
1476 |
+
] PUNCT B-O
|
1477 |
+
. PUNCT B-O
|
1478 |
+
|
1479 |
+
Mosquitoes NOUN B-O
|
1480 |
+
were AUX B-O
|
1481 |
+
allowed VERB B-O
|
1482 |
+
to ADP B-O
|
1483 |
+
feed VERB B-O
|
1484 |
+
on ADP B-O
|
1485 |
+
a DET B-O
|
1486 |
+
human NOUN B-O
|
1487 |
+
, PUNCT B-O
|
1488 |
+
then ADV B-O
|
1489 |
+
, PUNCT B-O
|
1490 |
+
24 NUM B-O
|
1491 |
+
h NOUN B-O
|
1492 |
+
after ADP B-O
|
1493 |
+
the DET B-O
|
1494 |
+
blood NOUN B-O
|
1495 |
+
feeding NOUN B-O
|
1496 |
+
, PUNCT B-O
|
1497 |
+
gut NOUN B-O
|
1498 |
+
sections NOUN B-O
|
1499 |
+
were AUX B-O
|
1500 |
+
prepared VERB B-O
|
1501 |
+
for ADP B-O
|
1502 |
+
histology NOUN B-O
|
1503 |
+
and CCONJ B-O
|
1504 |
+
stained VERB B-O
|
1505 |
+
with ADP B-O
|
1506 |
+
hematoxylin NOUN B-LF
|
1507 |
+
and CCONJ I-LF
|
1508 |
+
eosin NOUN I-LF
|
1509 |
+
( PUNCT B-O
|
1510 |
+
HE PROPN B-AC
|
1511 |
+
) PUNCT B-O
|
1512 |
+
. PUNCT B-O
|
1513 |
+
|
1514 |
+
Compared VERB B-O
|
1515 |
+
to ADP B-O
|
1516 |
+
non ADJ B-O
|
1517 |
+
- PUNCT B-O
|
1518 |
+
transgenic ADJ B-O
|
1519 |
+
midguts NOUN B-O
|
1520 |
+
which PRON B-O
|
1521 |
+
were AUX B-O
|
1522 |
+
filled VERB B-O
|
1523 |
+
with ADP B-O
|
1524 |
+
intact ADJ B-O
|
1525 |
+
erythrocytes NOUN B-O
|
1526 |
+
( PUNCT B-O
|
1527 |
+
Figure PROPN B-O
|
1528 |
+
5A NUM B-O
|
1529 |
+
and CCONJ B-O
|
1530 |
+
5C NUM B-O
|
1531 |
+
) PUNCT B-O
|
1532 |
+
, PUNCT B-O
|
1533 |
+
erythrocytes NOUN B-O
|
1534 |
+
in ADP B-O
|
1535 |
+
the DET B-O
|
1536 |
+
midgut NOUN B-O
|
1537 |
+
of ADP B-O
|
1538 |
+
transgenic ADJ B-O
|
1539 |
+
mosquito NOUN B-O
|
1540 |
+
were AUX B-O
|
1541 |
+
extensively ADV B-O
|
1542 |
+
hemolyzed VERB B-O
|
1543 |
+
( PUNCT B-O
|
1544 |
+
Figure PROPN B-O
|
1545 |
+
5B NUM B-O
|
1546 |
+
and CCONJ B-O
|
1547 |
+
5D NUM B-O
|
1548 |
+
) PUNCT B-O
|
1549 |
+
. PUNCT B-O
|
1550 |
+
|
1551 |
+
Lymphocytes NOUN B-O
|
1552 |
+
were AUX B-O
|
1553 |
+
clearly ADV B-O
|
1554 |
+
contrasted VERB B-O
|
1555 |
+
in ADP B-O
|
1556 |
+
the DET B-O
|
1557 |
+
midgut NOUN B-O
|
1558 |
+
of ADP B-O
|
1559 |
+
transgenic ADJ B-O
|
1560 |
+
mosquito NOUN B-O
|
1561 |
+
( PUNCT B-O
|
1562 |
+
Figure PROPN B-O
|
1563 |
+
5D NUM B-O
|
1564 |
+
) PUNCT B-O
|
1565 |
+
, PUNCT B-O
|
1566 |
+
but CCONJ B-O
|
1567 |
+
not PART B-O
|
1568 |
+
amongst ADP B-O
|
1569 |
+
the DET B-O
|
1570 |
+
intact ADJ B-O
|
1571 |
+
erythrocytes NOUN B-O
|
1572 |
+
in ADP B-O
|
1573 |
+
the DET B-O
|
1574 |
+
midgut NOUN B-O
|
1575 |
+
of ADP B-O
|
1576 |
+
non ADJ B-O
|
1577 |
+
- PUNCT B-O
|
1578 |
+
transgenic ADJ B-O
|
1579 |
+
mosquito NOUN B-O
|
1580 |
+
( PUNCT B-O
|
1581 |
+
Figure PROPN B-O
|
1582 |
+
5C NUM B-O
|
1583 |
+
) PUNCT B-O
|
1584 |
+
. PUNCT B-O
|
1585 |
+
|
1586 |
+
These DET B-O
|
1587 |
+
results NOUN B-O
|
1588 |
+
are AUX B-O
|
1589 |
+
consistent ADJ B-O
|
1590 |
+
with ADP B-O
|
1591 |
+
the DET B-O
|
1592 |
+
data NOUN B-O
|
1593 |
+
shown VERB B-O
|
1594 |
+
in ADP B-O
|
1595 |
+
Figure PROPN B-O
|
1596 |
+
3C NUM B-O
|
1597 |
+
, PUNCT B-O
|
1598 |
+
where SCONJ B-O
|
1599 |
+
the DET B-O
|
1600 |
+
secretion NOUN B-O
|
1601 |
+
of ADP B-O
|
1602 |
+
CEL NOUN B-O
|
1603 |
+
- PUNCT B-O
|
1604 |
+
III NUM B-O
|
1605 |
+
into ADP B-O
|
1606 |
+
the DET B-O
|
1607 |
+
midgut NOUN B-O
|
1608 |
+
lumen NOUN B-O
|
1609 |
+
caused VERB B-O
|
1610 |
+
effective ADJ B-O
|
1611 |
+
hemolysis NOUN B-O
|
1612 |
+
. PUNCT B-O
|
1613 |
+
|
1614 |
+
PM2.5 PROPN B-AC
|
1615 |
+
, PUNCT B-O
|
1616 |
+
fine ADJ B-LF
|
1617 |
+
particulate ADJ I-LF
|
1618 |
+
matter NOUN I-LF
|
1619 |
+
( PUNCT B-O
|
1620 |
+
particulate ADJ B-O
|
1621 |
+
matter NOUN B-O
|
1622 |
+
with ADP B-O
|
1623 |
+
a DET B-O
|
1624 |
+
diameter NOUN B-O
|
1625 |
+
of ADP B-O
|
1626 |
+
< ADP B-O
|
1627 |
+
2.5 NUM B-O
|
1628 |
+
μm NOUN B-O
|
1629 |
+
) PUNCT B-O
|
1630 |
+
. PUNCT B-O
|
1631 |
+
|
1632 |
+
The DET B-O
|
1633 |
+
glycosphingolipid NOUN B-O
|
1634 |
+
isoglobotrihexosylceramide NOUN B-O
|
1635 |
+
, PUNCT B-O
|
1636 |
+
or CCONJ B-O
|
1637 |
+
isogloboside NOUN B-LF
|
1638 |
+
3 NUM I-LF
|
1639 |
+
( PUNCT B-O
|
1640 |
+
iGb3 PROPN B-AC
|
1641 |
+
) PUNCT B-O
|
1642 |
+
, PUNCT B-O
|
1643 |
+
is AUX B-O
|
1644 |
+
believed VERB B-O
|
1645 |
+
to PART B-O
|
1646 |
+
be AUX B-O
|
1647 |
+
critical ADJ B-O
|
1648 |
+
for ADP B-O
|
1649 |
+
natural ADJ B-LF
|
1650 |
+
killer NOUN I-LF
|
1651 |
+
T PROPN I-LF
|
1652 |
+
( PUNCT B-O
|
1653 |
+
NKT PROPN B-AC
|
1654 |
+
) PUNCT B-O
|
1655 |
+
cell NOUN B-O
|
1656 |
+
development NOUN B-O
|
1657 |
+
and CCONJ B-O
|
1658 |
+
self NOUN B-O
|
1659 |
+
- PUNCT B-O
|
1660 |
+
recognition NOUN B-O
|
1661 |
+
in ADP B-O
|
1662 |
+
mice NOUN B-O
|
1663 |
+
and CCONJ B-O
|
1664 |
+
humans NOUN B-O
|
1665 |
+
. PUNCT B-O
|
1666 |
+
|
1667 |
+
Other ADJ B-O
|
1668 |
+
authors NOUN B-O
|
1669 |
+
[ X B-O
|
1670 |
+
16,17 X B-O
|
1671 |
+
] X B-O
|
1672 |
+
have AUX B-O
|
1673 |
+
proposed VERB B-O
|
1674 |
+
different ADJ B-O
|
1675 |
+
methods NOUN B-O
|
1676 |
+
for ADP B-O
|
1677 |
+
continuous ADJ B-O
|
1678 |
+
nICP PROPN B-AC
|
1679 |
+
monitoring NOUN B-O
|
1680 |
+
based VERB B-O
|
1681 |
+
on ADP B-O
|
1682 |
+
the DET B-O
|
1683 |
+
waveform NOUN B-O
|
1684 |
+
analysis NOUN B-O
|
1685 |
+
of ADP B-O
|
1686 |
+
cerebral ADJ B-O
|
1687 |
+
blood NOUN B-O
|
1688 |
+
flow NOUN B-O
|
1689 |
+
velocity NOUN B-O
|
1690 |
+
from ADP B-O
|
1691 |
+
the DET B-O
|
1692 |
+
middle ADJ B-LF
|
1693 |
+
cerebral ADJ I-LF
|
1694 |
+
artery NOUN I-LF
|
1695 |
+
( PUNCT B-O
|
1696 |
+
MCA PROPN B-AC
|
1697 |
+
) PUNCT B-O
|
1698 |
+
and CCONJ B-O
|
1699 |
+
arterial ADJ B-O
|
1700 |
+
pressure NOUN B-O
|
1701 |
+
. PUNCT B-O
|
1702 |
+
|
1703 |
+
The DET B-O
|
1704 |
+
median ADJ B-O
|
1705 |
+
age NOUN B-O
|
1706 |
+
of ADP B-O
|
1707 |
+
women NOUN B-O
|
1708 |
+
screened VERB B-O
|
1709 |
+
was AUX B-O
|
1710 |
+
25 NUM B-O
|
1711 |
+
years NOUN B-O
|
1712 |
+
( PUNCT B-O
|
1713 |
+
interquartile ADJ B-LF
|
1714 |
+
range NOUN I-LF
|
1715 |
+
[ PUNCT B-O
|
1716 |
+
IQR PROPN B-AC
|
1717 |
+
] PUNCT B-O
|
1718 |
+
: PUNCT B-O
|
1719 |
+
22–29 NUM B-O
|
1720 |
+
) PUNCT B-O
|
1721 |
+
, PUNCT B-O
|
1722 |
+
8 NUM B-O
|
1723 |
+
% NOUN B-O
|
1724 |
+
( PUNCT B-O
|
1725 |
+
105/1,271 NUM B-O
|
1726 |
+
) PUNCT B-O
|
1727 |
+
were AUX B-O
|
1728 |
+
< ADP B-O
|
1729 |
+
20 NUM B-O
|
1730 |
+
years NOUN B-O
|
1731 |
+
old ADJ B-O
|
1732 |
+
, PUNCT B-O
|
1733 |
+
and CCONJ B-O
|
1734 |
+
49 NUM B-O
|
1735 |
+
% NOUN B-O
|
1736 |
+
( PUNCT B-O
|
1737 |
+
627/1,271 NUM B-O
|
1738 |
+
) PUNCT B-O
|
1739 |
+
were AUX B-O
|
1740 |
+
< ADP B-O
|
1741 |
+
24 NUM B-O
|
1742 |
+
years NOUN B-O
|
1743 |
+
old ADJ B-O
|
1744 |
+
; PUNCT B-O
|
1745 |
+
82 NUM B-O
|
1746 |
+
% NOUN B-O
|
1747 |
+
( PUNCT B-O
|
1748 |
+
1,026/1,271 NUM B-O
|
1749 |
+
) PUNCT B-O
|
1750 |
+
were AUX B-O
|
1751 |
+
married ADJ B-O
|
1752 |
+
, PUNCT B-O
|
1753 |
+
and CCONJ B-O
|
1754 |
+
more ADJ B-O
|
1755 |
+
than ADP B-O
|
1756 |
+
a DET B-O
|
1757 |
+
third ADJ B-O
|
1758 |
+
( PUNCT B-O
|
1759 |
+
427/1,271 NUM B-O
|
1760 |
+
) PUNCT B-O
|
1761 |
+
of ADP B-O
|
1762 |
+
the DET B-O
|
1763 |
+
women NOUN B-O
|
1764 |
+
did AUX B-O
|
1765 |
+
not PART B-O
|
1766 |
+
know VERB B-O
|
1767 |
+
their PRON B-O
|
1768 |
+
male ADJ B-O
|
1769 |
+
partners NOUN B-O
|
1770 |
+
’ PUNCT B-O
|
1771 |
+
HIV PROPN B-O
|
1772 |
+
status NOUN B-O
|
1773 |
+
( PUNCT B-O
|
1774 |
+
Table PROPN B-O
|
1775 |
+
1 NUM B-O
|
1776 |
+
) PUNCT B-O
|
1777 |
+
. PUNCT B-O
|
1778 |
+
|
1779 |
+
In ADP B-O
|
1780 |
+
a DET B-O
|
1781 |
+
' PUNCT B-O
|
1782 |
+
status X B-O
|
1783 |
+
quo X B-O
|
1784 |
+
' PUNCT B-O
|
1785 |
+
setting NOUN B-O
|
1786 |
+
, PUNCT B-O
|
1787 |
+
the DET B-O
|
1788 |
+
VMMC PROPN B-AC
|
1789 |
+
program NOUN B-O
|
1790 |
+
could AUX B-O
|
1791 |
+
be AUX B-O
|
1792 |
+
accompanied VERB B-O
|
1793 |
+
by ADP B-O
|
1794 |
+
continuations NOUN B-O
|
1795 |
+
of ADP B-O
|
1796 |
+
recent ADJ B-O
|
1797 |
+
trends NOUN B-O
|
1798 |
+
in ADP B-O
|
1799 |
+
antiretroviral ADJ B-LF
|
1800 |
+
therapy NOUN I-LF
|
1801 |
+
( PUNCT B-O
|
1802 |
+
ART PROPN B-AC
|
1803 |
+
) PUNCT B-O
|
1804 |
+
scale NOUN B-O
|
1805 |
+
- ADJ B-O
|
1806 |
+
up NOUN B-O
|
1807 |
+
, PUNCT B-O
|
1808 |
+
with ADP B-O
|
1809 |
+
constant ADJ B-O
|
1810 |
+
coverage NOUN B-O
|
1811 |
+
of ADP B-O
|
1812 |
+
prevention NOUN B-O
|
1813 |
+
interventions NOUN B-O
|
1814 |
+
and CCONJ B-O
|
1815 |
+
constant ADJ B-O
|
1816 |
+
rates NOUN B-O
|
1817 |
+
of ADP B-O
|
1818 |
+
risk NOUN B-O
|
1819 |
+
and CCONJ B-O
|
1820 |
+
( PUNCT B-O
|
1821 |
+
non ADJ B-O
|
1822 |
+
- ADJ B-O
|
1823 |
+
VMMC PROPN B-AC
|
1824 |
+
) PUNCT B-O
|
1825 |
+
protective ADJ B-O
|
1826 |
+
behaviors NOUN B-O
|
1827 |
+
. PUNCT B-O
|
1828 |
+
|
1829 |
+
This DET B-O
|
1830 |
+
study NOUN B-O
|
1831 |
+
included VERB B-O
|
1832 |
+
31 NUM B-O
|
1833 |
+
women NOUN B-O
|
1834 |
+
who PRON B-O
|
1835 |
+
delivered VERB B-O
|
1836 |
+
small ADJ B-LF
|
1837 |
+
for ADP I-LF
|
1838 |
+
gestational ADJ I-LF
|
1839 |
+
age NOUN I-LF
|
1840 |
+
( PUNCT B-O
|
1841 |
+
SGA PROPN B-AC
|
1842 |
+
) PUNCT B-O
|
1843 |
+
babies NOUN B-O
|
1844 |
+
( PUNCT B-O
|
1845 |
+
SGA PROPN B-AC
|
1846 |
+
, PUNCT B-O
|
1847 |
+
≤10th ADJ B-O
|
1848 |
+
percentile NOUN B-O
|
1849 |
+
) PUNCT B-O
|
1850 |
+
, PUNCT B-O
|
1851 |
+
28 NUM B-O
|
1852 |
+
who PRON B-O
|
1853 |
+
delivered VERB B-O
|
1854 |
+
large ADJ B-LF
|
1855 |
+
for ADP I-LF
|
1856 |
+
gestational ADJ I-LF
|
1857 |
+
age NOUN I-LF
|
1858 |
+
( PUNCT B-O
|
1859 |
+
LGA PROPN B-AC
|
1860 |
+
) PUNCT B-O
|
1861 |
+
babies NOUN B-O
|
1862 |
+
( PUNCT B-O
|
1863 |
+
≥90th ADJ B-O
|
1864 |
+
percentile NOUN B-O
|
1865 |
+
) PUNCT B-O
|
1866 |
+
, PUNCT B-O
|
1867 |
+
and CCONJ B-O
|
1868 |
+
31 NUM B-O
|
1869 |
+
who PRON B-O
|
1870 |
+
delivered VERB B-O
|
1871 |
+
appropriate ADJ B-LF
|
1872 |
+
for ADP I-LF
|
1873 |
+
gestational ADJ I-LF
|
1874 |
+
age NOUN I-LF
|
1875 |
+
( PUNCT B-O
|
1876 |
+
AGA PROPN B-AC
|
1877 |
+
) PUNCT B-O
|
1878 |
+
babies NOUN B-O
|
1879 |
+
( PUNCT B-O
|
1880 |
+
controls NOUN B-O
|
1881 |
+
, PUNCT B-O
|
1882 |
+
> NUM B-O
|
1883 |
+
10th ADJ B-O
|
1884 |
+
to PART B-O
|
1885 |
+
< NUM B-O
|
1886 |
+
90th NUM B-O
|
1887 |
+
percentile NOUN B-O
|
1888 |
+
) PUNCT B-O
|
1889 |
+
. PUNCT B-O
|
1890 |
+
|
1891 |
+
Most ADV B-O
|
1892 |
+
strikingly ADV B-O
|
1893 |
+
, PUNCT B-O
|
1894 |
+
the DET B-O
|
1895 |
+
strongly ADV B-O
|
1896 |
+
conserved VERB B-O
|
1897 |
+
proline NOUN B-LF
|
1898 |
+
( PUNCT B-O
|
1899 |
+
Pro PROPN B-AC
|
1900 |
+
) PUNCT B-O
|
1901 |
+
residue NOUN B-O
|
1902 |
+
at ADP B-O
|
1903 |
+
site NOUN B-O
|
1904 |
+
283 NUM B-O
|
1905 |
+
in ADP B-O
|
1906 |
+
NP PROPN B-AC
|
1907 |
+
is AUX B-O
|
1908 |
+
rendered VERB B-O
|
1909 |
+
highly ADV B-O
|
1910 |
+
unfit ADJ B-O
|
1911 |
+
by ADP B-O
|
1912 |
+
HSF1 PROPN B-AC
|
1913 |
+
inhibition NOUN B-O
|
1914 |
+
at ADP B-O
|
1915 |
+
febrile ADJ B-O
|
1916 |
+
temperatures NOUN B-O
|
1917 |
+
. PUNCT B-O
|
1918 |
+
|
1919 |
+
The DET B-O
|
1920 |
+
microRNA NOUN B-LF
|
1921 |
+
( PUNCT B-O
|
1922 |
+
miRNA PROPN B-AC
|
1923 |
+
) PUNCT B-O
|
1924 |
+
miR-148a NOUN B-O
|
1925 |
+
is AUX B-O
|
1926 |
+
a DET B-O
|
1927 |
+
17- NUM B-O
|
1928 |
+
to ADP B-O
|
1929 |
+
25 NUM B-O
|
1930 |
+
- ADJ B-O
|
1931 |
+
nucleotide NOUN B-O
|
1932 |
+
( PUNCT B-O
|
1933 |
+
nt)-long ADJ B-O
|
1934 |
+
highly ADV B-O
|
1935 |
+
conserved ADJ B-O
|
1936 |
+
single ADJ B-O
|
1937 |
+
- ADJ B-O
|
1938 |
+
stranded ADJ B-O
|
1939 |
+
non ADJ B-O
|
1940 |
+
- ADJ B-O
|
1941 |
+
coding ADJ B-O
|
1942 |
+
RNA NOUN B-O
|
1943 |
+
regulating VERB B-O
|
1944 |
+
the DET B-O
|
1945 |
+
expression NOUN B-O
|
1946 |
+
of ADP B-O
|
1947 |
+
target NOUN B-O
|
1948 |
+
genes NOUN B-O
|
1949 |
+
at ADP B-O
|
1950 |
+
the DET B-O
|
1951 |
+
post ADJ B-O
|
1952 |
+
- ADJ B-O
|
1953 |
+
transcriptional ADJ B-O
|
1954 |
+
level NOUN B-O
|
1955 |
+
by ADP B-O
|
1956 |
+
binding VERB B-O
|
1957 |
+
to ADP B-O
|
1958 |
+
the DET B-O
|
1959 |
+
complementary ADJ B-O
|
1960 |
+
sites NOUN B-O
|
1961 |
+
of ADP B-O
|
1962 |
+
the DET B-O
|
1963 |
+
mRNA NOUN B-O
|
1964 |
+
of ADP B-O
|
1965 |
+
specific ADJ B-O
|
1966 |
+
target NOUN B-O
|
1967 |
+
genes NOUN B-O
|
1968 |
+
[ PUNCT B-O
|
1969 |
+
4 NUM B-O
|
1970 |
+
] PUNCT B-O
|
1971 |
+
. PUNCT B-O
|
1972 |
+
|
1973 |
+
While SCONJ B-O
|
1974 |
+
FGF PROPN B-AC
|
1975 |
+
primarily ADV B-O
|
1976 |
+
induces VERB B-O
|
1977 |
+
the DET B-O
|
1978 |
+
Ras PROPN B-O
|
1979 |
+
– PUNCT B-O
|
1980 |
+
Mitogen PROPN B-LF
|
1981 |
+
- PUNCT I-LF
|
1982 |
+
Activated PROPN I-LF
|
1983 |
+
Protein PROPN I-LF
|
1984 |
+
Kinase PROPN I-LF
|
1985 |
+
( PUNCT B-O
|
1986 |
+
MAPK PROPN B-AC
|
1987 |
+
) PUNCT B-O
|
1988 |
+
axis NOUN B-O
|
1989 |
+
to PART B-O
|
1990 |
+
promote VERB B-O
|
1991 |
+
lens NOUN B-O
|
1992 |
+
cell NOUN B-O
|
1993 |
+
differentiation NOUN B-O
|
1994 |
+
, PUNCT B-O
|
1995 |
+
PDGF PROPN B-AC
|
1996 |
+
preferentially ADV B-O
|
1997 |
+
stimulates VERB B-O
|
1998 |
+
Phosphoinositide NOUN B-LF
|
1999 |
+
3 NUM I-LF
|
2000 |
+
- PUNCT I-LF
|
2001 |
+
kinase NOUN I-LF
|
2002 |
+
( PUNCT B-O
|
2003 |
+
PI3 PROPN B-AC
|
2004 |
+
) PUNCT B-O
|
2005 |
+
to PART B-O
|
2006 |
+
enhance VERB B-O
|
2007 |
+
Notch NOUN B-O
|
2008 |
+
signaling NOUN B-O
|
2009 |
+
, PUNCT B-O
|
2010 |
+
which PRON B-O
|
2011 |
+
is AUX B-O
|
2012 |
+
necessary ADJ B-O
|
2013 |
+
for ADP B-O
|
2014 |
+
maintaining VERB B-O
|
2015 |
+
the DET B-O
|
2016 |
+
lens NOUN B-O
|
2017 |
+
progenitor NOUN B-O
|
2018 |
+
cell NOUN B-O
|
2019 |
+
pool NOUN B-O
|
2020 |
+
. PUNCT B-O
|
2021 |
+
|
2022 |
+
To PART B-O
|
2023 |
+
begin VERB B-O
|
2024 |
+
to PART B-O
|
2025 |
+
establish VERB B-O
|
2026 |
+
such ADJ B-O
|
2027 |
+
links NOUN B-O
|
2028 |
+
between ADP B-O
|
2029 |
+
genotype NOUN B-O
|
2030 |
+
and CCONJ B-O
|
2031 |
+
growth NOUN B-O
|
2032 |
+
phenotype NOUN B-O
|
2033 |
+
, PUNCT B-O
|
2034 |
+
we PRON B-O
|
2035 |
+
developed VERB B-O
|
2036 |
+
a DET B-O
|
2037 |
+
computer NOUN B-O
|
2038 |
+
model NOUN B-O
|
2039 |
+
for ADP B-O
|
2040 |
+
the DET B-O
|
2041 |
+
intracellular ADJ B-O
|
2042 |
+
growth NOUN B-O
|
2043 |
+
of ADP B-O
|
2044 |
+
vesicular NOUN B-LF
|
2045 |
+
stomatitis NOUN I-LF
|
2046 |
+
virus NOUN I-LF
|
2047 |
+
( PUNCT B-O
|
2048 |
+
VSV PROPN B-AC
|
2049 |
+
) PUNCT B-O
|
2050 |
+
, PUNCT B-O
|
2051 |
+
a DET B-O
|
2052 |
+
well ADV B-O
|
2053 |
+
- PUNCT B-O
|
2054 |
+
studied VERB B-O
|
2055 |
+
, PUNCT B-O
|
2056 |
+
nonsegmented ADJ B-O
|
2057 |
+
, PUNCT B-O
|
2058 |
+
negative ADJ B-O
|
2059 |
+
- PUNCT B-O
|
2060 |
+
stranded ADJ B-O
|
2061 |
+
RNA NOUN B-O
|
2062 |
+
virus NOUN B-O
|
2063 |
+
. PUNCT B-O
|
2064 |
+
|
2065 |
+
Legend NOUN B-O
|
2066 |
+
: PUNCT B-O
|
2067 |
+
HCV PROPN B-AC
|
2068 |
+
: PUNCT B-O
|
2069 |
+
Chronic ADJ B-O
|
2070 |
+
hepatitis NOUN B-O
|
2071 |
+
C NOUN B-O
|
2072 |
+
; PUNCT B-O
|
2073 |
+
DAA PROPN B-AC
|
2074 |
+
: PUNCT B-O
|
2075 |
+
Direct ADV B-LF
|
2076 |
+
- PUNCT I-LF
|
2077 |
+
acting VERB I-LF
|
2078 |
+
antivirals NOUN I-LF
|
2079 |
+
; PUNCT B-O
|
2080 |
+
N NOUN B-O
|
2081 |
+
: PUNCT B-O
|
2082 |
+
Sample NOUN B-O
|
2083 |
+
size NOUN B-O
|
2084 |
+
; PUNCT B-O
|
2085 |
+
comorbidities NOUN B-O
|
2086 |
+
: PUNCT B-O
|
2087 |
+
Comorbidity NOUN B-O
|
2088 |
+
; PUNCT B-O
|
2089 |
+
comedications NOUN B-O
|
2090 |
+
: PUNCT B-O
|
2091 |
+
Comedication NOUN B-O
|
2092 |
+
. PUNCT B-O
|
2093 |
+
|
2094 |
+
Time NOUN B-O
|
2095 |
+
to ADP B-O
|
2096 |
+
ART PROPN B-AC
|
2097 |
+
initiation NOUN B-O
|
2098 |
+
was AUX B-O
|
2099 |
+
estimated VERB B-O
|
2100 |
+
using VERB B-O
|
2101 |
+
cumulative ADJ B-LF
|
2102 |
+
incidence NOUN I-LF
|
2103 |
+
functions NOUN I-LF
|
2104 |
+
( PUNCT B-O
|
2105 |
+
CIFs PROPN B-AC
|
2106 |
+
): PUNCT B-O
|
2107 |
+
mortality NOUN B-O
|
2108 |
+
and CCONJ B-O
|
2109 |
+
LTFU PROPN B-AC
|
2110 |
+
were AUX B-O
|
2111 |
+
considered VERB B-O
|
2112 |
+
competing VERB B-O
|
2113 |
+
events NOUN B-O
|
2114 |
+
to ADP B-O
|
2115 |
+
ART PROPN B-AC
|
2116 |
+
initiation NOUN B-O
|
2117 |
+
[ PUNCT B-O
|
2118 |
+
9 NUM B-O
|
2119 |
+
] PUNCT B-O
|
2120 |
+
, PUNCT B-O
|
2121 |
+
while SCONJ B-O
|
2122 |
+
those PRON B-O
|
2123 |
+
transferred VERB B-O
|
2124 |
+
out ADV B-O
|
2125 |
+
were AUX B-O
|
2126 |
+
right ADV B-O
|
2127 |
+
- PUNCT B-O
|
2128 |
+
censored VERB B-O
|
2129 |
+
, PUNCT B-O
|
2130 |
+
with ADP B-O
|
2131 |
+
the DET B-O
|
2132 |
+
assumption NOUN B-O
|
2133 |
+
that SCONJ B-O
|
2134 |
+
they PRON B-O
|
2135 |
+
remained VERB B-O
|
2136 |
+
in ADP B-O
|
2137 |
+
HIV PROPN B-O
|
2138 |
+
care NOUN B-O
|
2139 |
+
and CCONJ B-O
|
2140 |
+
had VERB B-O
|
2141 |
+
similar ADJ B-O
|
2142 |
+
outcomes NOUN B-O
|
2143 |
+
as ADP B-O
|
2144 |
+
patients NOUN B-O
|
2145 |
+
still ADV B-O
|
2146 |
+
in ADP B-O
|
2147 |
+
observation NOUN B-O
|
2148 |
+
. PUNCT B-O
|
2149 |
+
|
2150 |
+
FISH PROPN B-AC
|
2151 |
+
, PUNCT B-O
|
2152 |
+
fluorescence NOUN B-LF
|
2153 |
+
in ADP I-LF
|
2154 |
+
situ NOUN I-LF
|
2155 |
+
hybridization NOUN I-LF
|
2156 |
+
. PUNCT B-O
|
2157 |
+
|
2158 |
+
We PRON B-O
|
2159 |
+
included VERB B-O
|
2160 |
+
those PRON B-O
|
2161 |
+
with ADP B-O
|
2162 |
+
follow VERB B-O
|
2163 |
+
- PUNCT B-O
|
2164 |
+
up ADP B-O
|
2165 |
+
visits NOUN B-O
|
2166 |
+
and CCONJ B-O
|
2167 |
+
pulmonary ADJ B-LF
|
2168 |
+
function NOUN I-LF
|
2169 |
+
tests NOUN I-LF
|
2170 |
+
( PUNCT B-O
|
2171 |
+
PFTs PROPN B-AC
|
2172 |
+
) PUNCT B-O
|
2173 |
+
available ADJ B-O
|
2174 |
+
after ADP B-O
|
2175 |
+
hospitalization NOUN B-O
|
2176 |
+
. PUNCT B-O
|
2177 |
+
|
2178 |
+
WT PROPN B-O
|
2179 |
+
, PUNCT B-O
|
2180 |
+
wild ADJ B-O
|
2181 |
+
type NOUN B-O
|
2182 |
+
; PUNCT B-O
|
2183 |
+
TG PROPN B-AC
|
2184 |
+
, PUNCT B-O
|
2185 |
+
transgenic ADJ B-O
|
2186 |
+
; PUNCT B-O
|
2187 |
+
TSA PROPN B-AC
|
2188 |
+
, PUNCT B-O
|
2189 |
+
total ADJ B-LF
|
2190 |
+
salvianolic ADJ I-LF
|
2191 |
+
acid NOUN I-LF
|
2192 |
+
; PUNCT B-O
|
2193 |
+
n NOUN B-O
|
2194 |
+
= SYM B-O
|
2195 |
+
20 NUM B-O
|
2196 |
+
, PUNCT B-O
|
2197 |
+
error NOUN B-O
|
2198 |
+
bars NOUN B-O
|
2199 |
+
represent VERB B-O
|
2200 |
+
SEM NOUN B-O
|
2201 |
+
. PUNCT B-O
|
2202 |
+
|
2203 |
+
* NOUN B-O
|
2204 |
+
p<0.05 NUM B-O
|
2205 |
+
, PUNCT B-O
|
2206 |
+
* NOUN B-O
|
2207 |
+
* NOUN B-O
|
2208 |
+
p<0.01 NUM B-O
|
2209 |
+
versus ADP B-O
|
2210 |
+
WT PROPN B-O
|
2211 |
+
control NOUN B-O
|
2212 |
+
group NOUN B-O
|
2213 |
+
; PUNCT B-O
|
2214 |
+
# SYM B-O
|
2215 |
+
p<0.05 NUM B-O
|
2216 |
+
, PUNCT B-O
|
2217 |
+
# SYM B-O
|
2218 |
+
# SYM B-O
|
2219 |
+
p<0.01 NUM B-O
|
2220 |
+
versus ADP B-O
|
2221 |
+
vehicle NOUN B-O
|
2222 |
+
- PUNCT B-O
|
2223 |
+
treated VERB B-O
|
2224 |
+
APPswe PROPN B-O
|
2225 |
+
/ SYM B-O
|
2226 |
+
PS1dE9 PROPN B-O
|
2227 |
+
transgenic ADJ B-O
|
2228 |
+
group NOUN B-O
|
2229 |
+
. PUNCT B-O
|
2230 |
+
|
2231 |
+
M PROPN B-O
|
2232 |
+
, PUNCT B-O
|
2233 |
+
mirror NOUN B-O
|
2234 |
+
; PUNCT B-O
|
2235 |
+
P NOUN B-O
|
2236 |
+
, PUNCT B-O
|
2237 |
+
pinhole NOUN B-O
|
2238 |
+
; PUNCT B-O
|
2239 |
+
λ/2 NUM B-O
|
2240 |
+
, PUNCT B-O
|
2241 |
+
λ/2 NUM B-O
|
2242 |
+
plate NOUN B-O
|
2243 |
+
; PUNCT B-O
|
2244 |
+
PBS PROPN B-AC
|
2245 |
+
, PUNCT B-O
|
2246 |
+
polarizing VERB B-LF
|
2247 |
+
beam NOUN I-LF
|
2248 |
+
splitter NOUN I-LF
|
2249 |
+
; PUNCT B-O
|
2250 |
+
EOM PROPN B-O
|
2251 |
+
, PUNCT B-O
|
2252 |
+
electro ADJ B-O
|
2253 |
+
optical ADJ B-O
|
2254 |
+
modulator NOUN B-O
|
2255 |
+
; PUNCT B-O
|
2256 |
+
S NOUN B-O
|
2257 |
+
, PUNCT B-O
|
2258 |
+
shutter NOUN B-O
|
2259 |
+
; PUNCT B-O
|
2260 |
+
F NOUN B-O
|
2261 |
+
, PUNCT B-O
|
2262 |
+
filter NOUN B-O
|
2263 |
+
; PUNCT B-O
|
2264 |
+
Pol PROPN B-O
|
2265 |
+
, PUNCT B-O
|
2266 |
+
polarizer NOUN B-O
|
2267 |
+
; PUNCT B-O
|
2268 |
+
DC NOUN B-O
|
2269 |
+
, PUNCT B-O
|
2270 |
+
dichroic ADJ B-O
|
2271 |
+
mirror NOUN B-O
|
2272 |
+
. PUNCT B-O
|
2273 |
+
|
2274 |
+
In ADP B-O
|
2275 |
+
the DET B-O
|
2276 |
+
third ADJ B-O
|
2277 |
+
group NOUN B-O
|
2278 |
+
, PUNCT B-O
|
2279 |
+
the DET B-O
|
2280 |
+
variables NOUN B-O
|
2281 |
+
related VERB B-O
|
2282 |
+
to ADP B-O
|
2283 |
+
resuming VERB B-O
|
2284 |
+
dialysis NOUN B-O
|
2285 |
+
were AUX B-O
|
2286 |
+
: PUNCT B-O
|
2287 |
+
Charlson PROPN B-O
|
2288 |
+
comorbidity NOUN B-O
|
2289 |
+
index NOUN B-O
|
2290 |
+
[ PUNCT B-O
|
2291 |
+
18 NUM B-O
|
2292 |
+
] PUNCT B-O
|
2293 |
+
; PUNCT B-O
|
2294 |
+
dialysis NOUN B-O
|
2295 |
+
modality NOUN B-O
|
2296 |
+
and CCONJ B-O
|
2297 |
+
access NOUN B-O
|
2298 |
+
, PUNCT B-O
|
2299 |
+
such ADJ B-O
|
2300 |
+
as ADP B-O
|
2301 |
+
arterio ADJ B-O
|
2302 |
+
- PUNCT B-O
|
2303 |
+
venous ADJ B-O
|
2304 |
+
( PUNCT B-O
|
2305 |
+
AV PROPN B-AC
|
2306 |
+
) PUNCT B-O
|
2307 |
+
fistula NOUN B-O
|
2308 |
+
as ADP B-O
|
2309 |
+
access NOUN B-O
|
2310 |
+
for ADP B-O
|
2311 |
+
hemodialysis NOUN B-O
|
2312 |
+
, PUNCT B-O
|
2313 |
+
venous ADJ B-O
|
2314 |
+
catheters NOUN B-O
|
2315 |
+
, PUNCT B-O
|
2316 |
+
or CCONJ B-O
|
2317 |
+
peritoneal ADJ B-O
|
2318 |
+
catheters NOUN B-O
|
2319 |
+
for ADP B-O
|
2320 |
+
peritoneal ADJ B-O
|
2321 |
+
dialysis NOUN B-O
|
2322 |
+
; PUNCT B-O
|
2323 |
+
and CCONJ B-O
|
2324 |
+
biochemical ADJ B-O
|
2325 |
+
parameters NOUN B-O
|
2326 |
+
such ADJ B-O
|
2327 |
+
as ADP B-O
|
2328 |
+
creatinine NOUN B-O
|
2329 |
+
, PUNCT B-O
|
2330 |
+
hemoglobin NOUN B-O
|
2331 |
+
, PUNCT B-O
|
2332 |
+
urea NOUN B-O
|
2333 |
+
, PUNCT B-O
|
2334 |
+
potassium NOUN B-O
|
2335 |
+
, PUNCT B-O
|
2336 |
+
ionic ADJ B-O
|
2337 |
+
calcium NOUN B-O
|
2338 |
+
, PUNCT B-O
|
2339 |
+
phosphorus NOUN B-O
|
2340 |
+
, PUNCT B-O
|
2341 |
+
parathormone NOUN B-LF
|
2342 |
+
( PUNCT B-O
|
2343 |
+
PTH PROPN B-AC
|
2344 |
+
) PUNCT B-O
|
2345 |
+
, PUNCT B-O
|
2346 |
+
serum NOUN B-O
|
2347 |
+
albumin NOUN B-O
|
2348 |
+
and CCONJ B-O
|
2349 |
+
C NOUN B-O
|
2350 |
+
- PUNCT B-O
|
2351 |
+
reactive ADJ B-O
|
2352 |
+
protein NOUN B-O
|
2353 |
+
. PUNCT B-O
|
2354 |
+
|
2355 |
+
HPD PROPN B-AC
|
2356 |
+
, PUNCT B-O
|
2357 |
+
human ADJ B-LF
|
2358 |
+
population NOUN I-LF
|
2359 |
+
density NOUN I-LF
|
2360 |
+
. PUNCT B-O
|
2361 |
+
|
2362 |
+
PD PROPN B-AC
|
2363 |
+
; PUNCT B-O
|
2364 |
+
the DET B-O
|
2365 |
+
ERK PROPN B-O
|
2366 |
+
inhibitor NOUN B-O
|
2367 |
+
PD98059 PROPN B-LF
|
2368 |
+
. PUNCT B-O
|
2369 |
+
|
2370 |
+
β PUNCT B-O
|
2371 |
+
- PUNCT B-O
|
2372 |
+
Actin PROPN B-O
|
2373 |
+
served VERB B-O
|
2374 |
+
as ADP B-O
|
2375 |
+
an DET B-O
|
2376 |
+
input NOUN B-O
|
2377 |
+
control NOUN B-O
|
2378 |
+
. PUNCT B-O
|
2379 |
+
|
2380 |
+
( PUNCT B-O
|
2381 |
+
G NOUN B-O
|
2382 |
+
) PUNCT B-O
|
2383 |
+
Levels NOUN B-O
|
2384 |
+
of ADP B-O
|
2385 |
+
inflammatory ADJ B-O
|
2386 |
+
response NOUN B-O
|
2387 |
+
markers NOUN B-O
|
2388 |
+
( PUNCT B-O
|
2389 |
+
NF NOUN B-O
|
2390 |
+
- PUNCT B-O
|
2391 |
+
κB NOUN B-O
|
2392 |
+
p65 NOUN B-O
|
2393 |
+
activity NOUN B-O
|
2394 |
+
and CCONJ B-O
|
2395 |
+
TNFα PROPN B-O
|
2396 |
+
and CCONJ B-O
|
2397 |
+
IL-8 PROPN B-AC
|
2398 |
+
production NOUN B-O
|
2399 |
+
, PUNCT B-O
|
2400 |
+
by ADP B-O
|
2401 |
+
ELISA PROPN B-O
|
2402 |
+
) PUNCT B-O
|
2403 |
+
in ADP B-O
|
2404 |
+
control NOUN B-O
|
2405 |
+
medium NOUN B-O
|
2406 |
+
- PUNCT B-O
|
2407 |
+
treated VERB B-O
|
2408 |
+
or CCONJ B-O
|
2409 |
+
CSE PROPN B-AC
|
2410 |
+
- PUNCT B-O
|
2411 |
+
exposed VERB B-O
|
2412 |
+
H292 PROPN B-O
|
2413 |
+
cells NOUN B-O
|
2414 |
+
, PUNCT B-O
|
2415 |
+
pretreated VERB B-O
|
2416 |
+
with ADP B-O
|
2417 |
+
either CCONJ B-O
|
2418 |
+
Csn-B PROPN B-AC
|
2419 |
+
( PUNCT B-O
|
2420 |
+
10 NUM B-O
|
2421 |
+
μM NOUN B-O
|
2422 |
+
) PUNCT B-O
|
2423 |
+
or CCONJ B-O
|
2424 |
+
Veh PROPN B-AC
|
2425 |
+
. PUNCT B-O
|
2426 |
+
|
2427 |
+
( PUNCT B-O
|
2428 |
+
left ADJ B-O
|
2429 |
+
panel NOUN B-O
|
2430 |
+
) PUNCT B-O
|
2431 |
+
Spectrophotometric ADJ B-O
|
2432 |
+
reading NOUN B-O
|
2433 |
+
value NOUN B-O
|
2434 |
+
( PUNCT B-O
|
2435 |
+
A450 NOUN B-O
|
2436 |
+
) PUNCT B-O
|
2437 |
+
represents VERB B-O
|
2438 |
+
NF NOUN B-O
|
2439 |
+
- PUNCT B-O
|
2440 |
+
κB NOUN B-O
|
2441 |
+
p65 NOUN B-O
|
2442 |
+
activity NOUN B-O
|
2443 |
+
. PUNCT B-O
|
2444 |
+
|
2445 |
+
( PUNCT B-O
|
2446 |
+
middle ADJ B-O
|
2447 |
+
and CCONJ B-O
|
2448 |
+
right ADJ B-O
|
2449 |
+
panels NOUN B-O
|
2450 |
+
) PUNCT B-O
|
2451 |
+
The DET B-O
|
2452 |
+
levels NOUN B-O
|
2453 |
+
of ADP B-O
|
2454 |
+
cytokine NOUN B-O
|
2455 |
+
and CCONJ B-O
|
2456 |
+
chemokine NOUN B-O
|
2457 |
+
are AUX B-O
|
2458 |
+
shown VERB B-O
|
2459 |
+
as ADP B-O
|
2460 |
+
protein NOUN B-O
|
2461 |
+
concentrations NOUN B-O
|
2462 |
+
( PUNCT B-O
|
2463 |
+
pg NOUN B-O
|
2464 |
+
) PUNCT B-O
|
2465 |
+
in ADP B-O
|
2466 |
+
ml NOUN B-O
|
2467 |
+
of ADP B-O
|
2468 |
+
cell NOUN B-O
|
2469 |
+
culture NOUN B-O
|
2470 |
+
medium NOUN B-O
|
2471 |
+
. PUNCT B-O
|
2472 |
+
|
2473 |
+
The DET B-O
|
2474 |
+
EP3 NOUN B-O
|
2475 |
+
receptor NOUN B-O
|
2476 |
+
as ADP B-O
|
2477 |
+
a DET B-O
|
2478 |
+
PGE2 PROPN B-AC
|
2479 |
+
receptor NOUN B-O
|
2480 |
+
, PUNCT B-O
|
2481 |
+
same ADJ B-O
|
2482 |
+
as ADP B-O
|
2483 |
+
the DET B-O
|
2484 |
+
other ADJ B-O
|
2485 |
+
types NOUN B-O
|
2486 |
+
of ADP B-O
|
2487 |
+
EP PROPN B-O
|
2488 |
+
receptor NOUN B-O
|
2489 |
+
( PUNCT B-O
|
2490 |
+
EP1 NOUN B-O
|
2491 |
+
- PUNCT B-O
|
2492 |
+
2 NUM B-O
|
2493 |
+
and CCONJ B-O
|
2494 |
+
EP4 PROPN B-O
|
2495 |
+
) PUNCT B-O
|
2496 |
+
, PUNCT B-O
|
2497 |
+
is AUX B-O
|
2498 |
+
a DET B-O
|
2499 |
+
G PROPN B-LF
|
2500 |
+
- PUNCT I-LF
|
2501 |
+
protein NOUN I-LF
|
2502 |
+
- PUNCT I-LF
|
2503 |
+
coupled VERB I-LF
|
2504 |
+
receptor NOUN I-LF
|
2505 |
+
( PUNCT B-O
|
2506 |
+
GPCR PROPN B-AC
|
2507 |
+
) PUNCT B-O
|
2508 |
+
[ X B-O
|
2509 |
+
23 NUM B-O
|
2510 |
+
] PUNCT B-O
|
2511 |
+
and CCONJ B-O
|
2512 |
+
specifically ADV B-O
|
2513 |
+
contributes VERB B-O
|
2514 |
+
to ADP B-O
|
2515 |
+
the DET B-O
|
2516 |
+
cough NOUN B-O
|
2517 |
+
through ADP B-O
|
2518 |
+
activating VERB B-O
|
2519 |
+
airway NOUN B-O
|
2520 |
+
sensory ADJ B-O
|
2521 |
+
nerves NOUN B-O
|
2522 |
+
[ X B-O
|
2523 |
+
24 NUM B-O
|
2524 |
+
, PUNCT B-O
|
2525 |
+
25 NUM B-O
|
2526 |
+
] PUNCT B-O
|
2527 |
+
. PUNCT B-O
|
2528 |
+
|
2529 |
+
G6PD PROPN B-AC
|
2530 |
+
, PUNCT B-O
|
2531 |
+
glucose-6 NOUN B-LF
|
2532 |
+
- PUNCT I-LF
|
2533 |
+
phosphate NOUN I-LF
|
2534 |
+
dehydrogenase NOUN I-LF
|
2535 |
+
. PUNCT B-O
|
2536 |
+
|
2537 |
+
Partial ADJ B-LF
|
2538 |
+
least ADJ I-LF
|
2539 |
+
squares NOUN I-LF
|
2540 |
+
regression NOUN I-LF
|
2541 |
+
( PUNCT B-O
|
2542 |
+
PLSR PROPN B-AC
|
2543 |
+
) PUNCT B-O
|
2544 |
+
, PUNCT B-O
|
2545 |
+
a DET B-O
|
2546 |
+
technique NOUN B-O
|
2547 |
+
previously ADV B-O
|
2548 |
+
shown VERB B-O
|
2549 |
+
to ADP B-O
|
2550 |
+
be AUX B-O
|
2551 |
+
useful ADJ B-O
|
2552 |
+
for ADP B-O
|
2553 |
+
the DET B-O
|
2554 |
+
creation NOUN B-O
|
2555 |
+
of ADP B-O
|
2556 |
+
signal NOUN B-O
|
2557 |
+
– PUNCT B-O
|
2558 |
+
response NOUN B-O
|
2559 |
+
models NOUN B-O
|
2560 |
+
based VERB B-O
|
2561 |
+
on ADP B-O
|
2562 |
+
highly ADV B-O
|
2563 |
+
dimensional ADJ B-O
|
2564 |
+
datasets NOUN B-O
|
2565 |
+
, PUNCT B-O
|
2566 |
+
was AUX B-O
|
2567 |
+
used VERB B-O
|
2568 |
+
to ADP B-O
|
2569 |
+
correlate VERB B-O
|
2570 |
+
phosphorylation NOUN B-O
|
2571 |
+
events NOUN B-O
|
2572 |
+
to ADP B-O
|
2573 |
+
both CCONJ B-O
|
2574 |
+
migration NOUN B-O
|
2575 |
+
and CCONJ B-O
|
2576 |
+
proliferation NOUN B-O
|
2577 |
+
[ PUNCT B-O
|
2578 |
+
10 NUM B-O
|
2579 |
+
] PUNCT B-O
|
2580 |
+
. PUNCT B-O
|
2581 |
+
|
2582 |
+
Copper NOUN B-LF
|
2583 |
+
( PUNCT B-O
|
2584 |
+
Cu PROPN B-AC
|
2585 |
+
) PUNCT B-O
|
2586 |
+
and CCONJ B-O
|
2587 |
+
zinc NOUN B-LF
|
2588 |
+
( PUNCT B-O
|
2589 |
+
Zn PROPN B-AC
|
2590 |
+
) PUNCT B-O
|
2591 |
+
are AUX B-O
|
2592 |
+
essential ADJ B-O
|
2593 |
+
nutritional ADJ B-O
|
2594 |
+
metals NOUN B-O
|
2595 |
+
required VERB B-O
|
2596 |
+
for ADP B-O
|
2597 |
+
the DET B-O
|
2598 |
+
function NOUN B-O
|
2599 |
+
of ADP B-O
|
2600 |
+
numerous ADJ B-O
|
2601 |
+
enzymatic ADJ B-O
|
2602 |
+
molecules NOUN B-O
|
2603 |
+
active ADJ B-O
|
2604 |
+
in ADP B-O
|
2605 |
+
human ADJ B-O
|
2606 |
+
cell NOUN B-O
|
2607 |
+
metabolic ADJ B-O
|
2608 |
+
pathways NOUN B-O
|
2609 |
+
. PUNCT B-O
|
2610 |
+
|
2611 |
+
RNase NOUN B-O
|
2612 |
+
T NOUN B-O
|
2613 |
+
showed VERB B-O
|
2614 |
+
in ADP B-O
|
2615 |
+
in ADP B-O
|
2616 |
+
vitro ADJ B-O
|
2617 |
+
experiments NOUN B-O
|
2618 |
+
that SCONJ B-O
|
2619 |
+
it PRON B-O
|
2620 |
+
can AUX B-O
|
2621 |
+
serve VERB B-O
|
2622 |
+
as ADP B-O
|
2623 |
+
a DET B-O
|
2624 |
+
downstream ADJ B-O
|
2625 |
+
exonuclease NOUN B-O
|
2626 |
+
of ADP B-O
|
2627 |
+
Endonuclease NOUN B-LF
|
2628 |
+
V NOUN I-LF
|
2629 |
+
( PUNCT B-O
|
2630 |
+
alternative ADJ B-LF
|
2631 |
+
EndoV)–mediated PROPN B-AC
|
2632 |
+
base NOUN I-LF
|
2633 |
+
excision NOUN I-LF
|
2634 |
+
repair NOUN I-LF
|
2635 |
+
( PUNCT B-O
|
2636 |
+
AER PROPN B-AC
|
2637 |
+
) PUNCT B-O
|
2638 |
+
[ PUNCT B-O
|
2639 |
+
33 NUM B-O
|
2640 |
+
] PUNCT B-O
|
2641 |
+
. PUNCT B-O
|
2642 |
+
|
2643 |
+
Interestingly ADV B-O
|
2644 |
+
, PUNCT B-O
|
2645 |
+
incubation NOUN B-O
|
2646 |
+
of ADP B-O
|
2647 |
+
parasites NOUN B-O
|
2648 |
+
in ADP B-O
|
2649 |
+
the DET B-O
|
2650 |
+
presence NOUN B-O
|
2651 |
+
of ADP B-O
|
2652 |
+
0.5 NUM B-O
|
2653 |
+
μM NOUN B-O
|
2654 |
+
Cytochalasin NOUN B-LF
|
2655 |
+
D PROPN I-LF
|
2656 |
+
( PUNCT B-O
|
2657 |
+
CD PROPN B-AC
|
2658 |
+
; PUNCT B-O
|
2659 |
+
a DET B-O
|
2660 |
+
drug NOUN B-O
|
2661 |
+
used VERB B-O
|
2662 |
+
to PART B-O
|
2663 |
+
disrupt VERB B-O
|
2664 |
+
F NOUN B-O
|
2665 |
+
- ADJ B-O
|
2666 |
+
actin NOUN B-O
|
2667 |
+
) PUNCT B-O
|
2668 |
+
did AUX B-O
|
2669 |
+
not PART B-O
|
2670 |
+
result VERB B-O
|
2671 |
+
in ADP B-O
|
2672 |
+
significant ADJ B-O
|
2673 |
+
reduction NOUN B-O
|
2674 |
+
of ADP B-O
|
2675 |
+
bead NOUN B-O
|
2676 |
+
translocation NOUN B-O
|
2677 |
+
( PUNCT B-O
|
2678 |
+
Fig NOUN B-O
|
2679 |
+
1 NUM B-O
|
2680 |
+
G NOUN B-O
|
2681 |
+
) PUNCT B-O
|
2682 |
+
, PUNCT B-O
|
2683 |
+
confirming VERB B-O
|
2684 |
+
that SCONJ B-O
|
2685 |
+
retrograde ADJ B-O
|
2686 |
+
membrane NOUN B-O
|
2687 |
+
flow NOUN B-O
|
2688 |
+
can AUX B-O
|
2689 |
+
occur VERB B-O
|
2690 |
+
in ADP B-O
|
2691 |
+
the DET B-O
|
2692 |
+
absence NOUN B-O
|
2693 |
+
of ADP B-O
|
2694 |
+
a DET B-O
|
2695 |
+
functional ADJ B-O
|
2696 |
+
acto NOUN B-O
|
2697 |
+
- ADJ B-O
|
2698 |
+
myosin NOUN B-O
|
2699 |
+
system NOUN B-O
|
2700 |
+
, PUNCT B-O
|
2701 |
+
as SCONJ B-O
|
2702 |
+
reported VERB B-O
|
2703 |
+
previously ADV B-O
|
2704 |
+
[ X B-O
|
2705 |
+
5 NUM B-O
|
2706 |
+
] PUNCT B-O
|
2707 |
+
. PUNCT B-O
|
2708 |
+
|
2709 |
+
Focal ADJ B-O
|
2710 |
+
increases NOUN B-O
|
2711 |
+
in ADP B-O
|
2712 |
+
fMRI PROPN B-AC
|
2713 |
+
- PUNCT B-O
|
2714 |
+
activity NOUN B-O
|
2715 |
+
were AUX B-O
|
2716 |
+
observed VERB B-O
|
2717 |
+
in ADP B-O
|
2718 |
+
area NOUN B-O
|
2719 |
+
AIP PROPN B-AC
|
2720 |
+
, PUNCT B-O
|
2721 |
+
consisting VERB B-O
|
2722 |
+
of ADP B-O
|
2723 |
+
both DET B-O
|
2724 |
+
aAIP PROPN B-AC
|
2725 |
+
and CCONJ B-O
|
2726 |
+
pAIP PROPN B-AC
|
2727 |
+
( PUNCT B-O
|
2728 |
+
Fig NOUN B-O
|
2729 |
+
. PUNCT B-O
|
2730 |
+
|
2731 |
+
2A NUM B-O
|
2732 |
+
, PUNCT B-O
|
2733 |
+
left ADJ B-O
|
2734 |
+
column NOUN B-O
|
2735 |
+
, PUNCT B-O
|
2736 |
+
first ADJ B-O
|
2737 |
+
and CCONJ B-O
|
2738 |
+
second ADJ B-O
|
2739 |
+
row NOUN B-O
|
2740 |
+
) PUNCT B-O
|
2741 |
+
, PUNCT B-O
|
2742 |
+
in ADP B-O
|
2743 |
+
the DET B-O
|
2744 |
+
anterior ADJ B-O
|
2745 |
+
lateral ADJ B-O
|
2746 |
+
bank NOUN B-O
|
2747 |
+
of ADP B-O
|
2748 |
+
the DET B-O
|
2749 |
+
IPS PROPN B-AC
|
2750 |
+
. PUNCT B-O
|
2751 |
+
|
2752 |
+
Furthermore ADV B-O
|
2753 |
+
, PUNCT B-O
|
2754 |
+
aAIP PROPN B-AC
|
2755 |
+
- PUNCT B-O
|
2756 |
+
EM PROPN B-AC
|
2757 |
+
elicited VERB B-O
|
2758 |
+
significant ADJ B-O
|
2759 |
+
fMRI PROPN B-AC
|
2760 |
+
activations NOUN B-O
|
2761 |
+
in ADP B-O
|
2762 |
+
the DET B-O
|
2763 |
+
medial ADJ B-O
|
2764 |
+
bank NOUN B-O
|
2765 |
+
of ADP B-O
|
2766 |
+
the DET B-O
|
2767 |
+
IPS PROPN B-AC
|
2768 |
+
( PUNCT B-O
|
2769 |
+
area NOUN B-O
|
2770 |
+
MIP PROPN B-AC
|
2771 |
+
) PUNCT B-O
|
2772 |
+
, PUNCT B-O
|
2773 |
+
in ADP B-O
|
2774 |
+
area NOUN B-O
|
2775 |
+
PFG PROPN B-AC
|
2776 |
+
in ADP B-O
|
2777 |
+
the DET B-O
|
2778 |
+
rostral ADJ B-O
|
2779 |
+
portion NOUN B-O
|
2780 |
+
of ADP B-O
|
2781 |
+
the DET B-O
|
2782 |
+
inferior ADJ B-O
|
2783 |
+
parietal ADJ B-O
|
2784 |
+
lobule NOUN B-O
|
2785 |
+
, PUNCT B-O
|
2786 |
+
in ADP B-O
|
2787 |
+
the DET B-O
|
2788 |
+
most ADV B-O
|
2789 |
+
anterior ADJ B-O
|
2790 |
+
sector NOUN B-O
|
2791 |
+
of ADP B-O
|
2792 |
+
somatosensory ADJ B-O
|
2793 |
+
area NOUN B-O
|
2794 |
+
S2 PROPN B-O
|
2795 |
+
and CCONJ B-O
|
2796 |
+
in ADP B-O
|
2797 |
+
ventral ADJ B-LF
|
2798 |
+
premotor ADJ I-LF
|
2799 |
+
cortex NOUN I-LF
|
2800 |
+
( PUNCT B-O
|
2801 |
+
PMv PROPN B-AC
|
2802 |
+
, PUNCT B-O
|
2803 |
+
or CCONJ B-O
|
2804 |
+
area NOUN B-O
|
2805 |
+
F5 NUM B-O
|
2806 |
+
; PUNCT B-O
|
2807 |
+
Fig NOUN B-O
|
2808 |
+
. PUNCT B-O
|
2809 |
+
|
2810 |
+
2A NUM B-O
|
2811 |
+
, PUNCT B-O
|
2812 |
+
left ADJ B-O
|
2813 |
+
column NOUN B-O
|
2814 |
+
, PUNCT B-O
|
2815 |
+
rows NOUN B-O
|
2816 |
+
2–5 NUM B-O
|
2817 |
+
) PUNCT B-O
|
2818 |
+
. PUNCT B-O
|
2819 |
+
|
2820 |
+
Here ADV B-O
|
2821 |
+
, PUNCT B-O
|
2822 |
+
the DET B-O
|
2823 |
+
high ADJ B-O
|
2824 |
+
level NOUN B-O
|
2825 |
+
of ADP B-O
|
2826 |
+
HR PROPN B-AC
|
2827 |
+
is AUX B-O
|
2828 |
+
due ADJ B-O
|
2829 |
+
to ADP B-O
|
2830 |
+
the DET B-O
|
2831 |
+
programmed VERB B-O
|
2832 |
+
formation NOUN B-O
|
2833 |
+
of ADP B-O
|
2834 |
+
a DET B-O
|
2835 |
+
large ADJ B-O
|
2836 |
+
number NOUN B-O
|
2837 |
+
of ADP B-O
|
2838 |
+
DNA NOUN B-O
|
2839 |
+
double ADJ B-LF
|
2840 |
+
- PUNCT I-LF
|
2841 |
+
strand NOUN I-LF
|
2842 |
+
breaks NOUN I-LF
|
2843 |
+
( PUNCT B-O
|
2844 |
+
DSBs PROPN B-AC
|
2845 |
+
) PUNCT B-O
|
2846 |
+
[ PUNCT B-O
|
2847 |
+
4 NUM B-O
|
2848 |
+
] PUNCT B-O
|
2849 |
+
. PUNCT B-O
|
2850 |
+
|
2851 |
+
Natural ADJ B-LF
|
2852 |
+
killer NOUN I-LF
|
2853 |
+
T PROPN I-LF
|
2854 |
+
( PUNCT B-O
|
2855 |
+
NKT PROPN B-AC
|
2856 |
+
) PUNCT B-O
|
2857 |
+
cell NOUN B-O
|
2858 |
+
development NOUN B-O
|
2859 |
+
depends VERB B-O
|
2860 |
+
on ADP B-O
|
2861 |
+
recognition NOUN B-O
|
2862 |
+
of ADP B-O
|
2863 |
+
self NOUN B-O
|
2864 |
+
- PUNCT B-O
|
2865 |
+
glycolipids NOUN B-O
|
2866 |
+
via ADP B-O
|
2867 |
+
their PRON B-O
|
2868 |
+
semi ADJ B-O
|
2869 |
+
- PUNCT B-O
|
2870 |
+
invariant ADJ B-O
|
2871 |
+
Vα14i NOUN B-O
|
2872 |
+
- PUNCT B-O
|
2873 |
+
TCR PROPN B-O
|
2874 |
+
. PUNCT B-O
|
2875 |
+
|
2876 |
+
However ADV B-O
|
2877 |
+
, PUNCT B-O
|
2878 |
+
to PART B-O
|
2879 |
+
what DET B-O
|
2880 |
+
extent NOUN B-O
|
2881 |
+
TCR PROPN B-O
|
2882 |
+
- PUNCT B-O
|
2883 |
+
mediated VERB B-O
|
2884 |
+
signals NOUN B-O
|
2885 |
+
determine VERB B-O
|
2886 |
+
identity NOUN B-O
|
2887 |
+
and CCONJ B-O
|
2888 |
+
function NOUN B-O
|
2889 |
+
of ADP B-O
|
2890 |
+
mature ADJ B-O
|
2891 |
+
NKT PROPN B-AC
|
2892 |
+
cells NOUN B-O
|
2893 |
+
remains AUX B-O
|
2894 |
+
incompletely ADV B-O
|
2895 |
+
understood VERB B-O
|
2896 |
+
. PUNCT B-O
|
2897 |
+
|
2898 |
+
Inhalation NOUN B-O
|
2899 |
+
injury NOUN B-O
|
2900 |
+
predisposes VERB B-O
|
2901 |
+
these DET B-O
|
2902 |
+
patients NOUN B-O
|
2903 |
+
to ADP B-O
|
2904 |
+
respiratory ADJ B-O
|
2905 |
+
failure NOUN B-O
|
2906 |
+
, PUNCT B-O
|
2907 |
+
acute ADJ B-LF
|
2908 |
+
respiratory ADJ I-LF
|
2909 |
+
distress NOUN I-LF
|
2910 |
+
syndrome NOUN I-LF
|
2911 |
+
( PUNCT B-O
|
2912 |
+
ARDS PROPN B-AC
|
2913 |
+
) PUNCT B-O
|
2914 |
+
, PUNCT B-O
|
2915 |
+
and CCONJ B-O
|
2916 |
+
pneumonia NOUN B-O
|
2917 |
+
. PUNCT B-O
|
2918 |
+
|
2919 |
+
In ADP B-O
|
2920 |
+
support NOUN B-O
|
2921 |
+
of ADP B-O
|
2922 |
+
this DET B-O
|
2923 |
+
idea NOUN B-O
|
2924 |
+
we PRON B-O
|
2925 |
+
found VERB B-O
|
2926 |
+
that SCONJ B-O
|
2927 |
+
a DET B-O
|
2928 |
+
bacterially ADV B-O
|
2929 |
+
expressed VERB B-O
|
2930 |
+
p180 NOUN B-O
|
2931 |
+
lysine NOUN B-O
|
2932 |
+
- PUNCT B-O
|
2933 |
+
rich ADJ B-O
|
2934 |
+
region NOUN B-O
|
2935 |
+
, PUNCT B-O
|
2936 |
+
fused VERB B-O
|
2937 |
+
to ADP B-O
|
2938 |
+
glutathione NOUN B-LF
|
2939 |
+
s NOUN I-LF
|
2940 |
+
- PUNCT I-LF
|
2941 |
+
transferase NOUN I-LF
|
2942 |
+
( PUNCT B-O
|
2943 |
+
GST PROPN B-AC
|
2944 |
+
- PUNCT B-O
|
2945 |
+
p180 NOUN B-O
|
2946 |
+
- PUNCT B-O
|
2947 |
+
Lys PROPN B-O
|
2948 |
+
; PUNCT B-O
|
2949 |
+
Figure PROPN B-O
|
2950 |
+
7A NUM B-O
|
2951 |
+
) PUNCT B-O
|
2952 |
+
, PUNCT B-O
|
2953 |
+
could AUX B-O
|
2954 |
+
form VERB B-O
|
2955 |
+
a DET B-O
|
2956 |
+
complex NOUN B-O
|
2957 |
+
with ADP B-O
|
2958 |
+
a DET B-O
|
2959 |
+
32P NOUN B-O
|
2960 |
+
- PUNCT B-O
|
2961 |
+
labeled VERB B-O
|
2962 |
+
RNA NOUN B-O
|
2963 |
+
derived VERB B-O
|
2964 |
+
from ADP B-O
|
2965 |
+
the DET B-O
|
2966 |
+
human ADJ B-O
|
2967 |
+
insulin NOUN B-O
|
2968 |
+
SSCR PROPN B-AC
|
2969 |
+
( PUNCT B-O
|
2970 |
+
Figure PROPN B-O
|
2971 |
+
7B NUM B-O
|
2972 |
+
) PUNCT B-O
|
2973 |
+
. PUNCT B-O
|
2974 |
+
|
2975 |
+
In ADP B-O
|
2976 |
+
contrast NOUN B-O
|
2977 |
+
, PUNCT B-O
|
2978 |
+
no DET B-O
|
2979 |
+
complex NOUN B-O
|
2980 |
+
was AUX B-O
|
2981 |
+
formed VERB B-O
|
2982 |
+
between ADP B-O
|
2983 |
+
this DET B-O
|
2984 |
+
RNA NOUN B-O
|
2985 |
+
and CCONJ B-O
|
2986 |
+
a DET B-O
|
2987 |
+
control NOUN B-O
|
2988 |
+
protein NOUN B-O
|
2989 |
+
, PUNCT B-O
|
2990 |
+
GST PROPN B-AC
|
2991 |
+
- PUNCT B-O
|
2992 |
+
Ran PROPN B-O
|
2993 |
+
( PUNCT B-O
|
2994 |
+
Figure PROPN B-O
|
2995 |
+
7A NUM B-O
|
2996 |
+
– PUNCT B-O
|
2997 |
+
B NOUN B-O
|
2998 |
+
) PUNCT B-O
|
2999 |
+
. PUNCT B-O
|
3000 |
+
|
3001 |
+
By ADP B-O
|
3002 |
+
varying VERB B-O
|
3003 |
+
the DET B-O
|
3004 |
+
amount NOUN B-O
|
3005 |
+
of ADP B-O
|
3006 |
+
protein NOUN B-O
|
3007 |
+
in ADP B-O
|
3008 |
+
our PRON B-O
|
3009 |
+
binding VERB B-O
|
3010 |
+
assay NOUN B-O
|
3011 |
+
, PUNCT B-O
|
3012 |
+
we PRON B-O
|
3013 |
+
estimate VERB B-O
|
3014 |
+
that SCONJ B-O
|
3015 |
+
the DET B-O
|
3016 |
+
GST PROPN B-AC
|
3017 |
+
- PUNCT B-O
|
3018 |
+
p180 NOUN B-O
|
3019 |
+
- PUNCT B-O
|
3020 |
+
Lys PROPN B-O
|
3021 |
+
binds VERB B-O
|
3022 |
+
to ADP B-O
|
3023 |
+
RNA NOUN B-O
|
3024 |
+
with ADP B-O
|
3025 |
+
an DET B-O
|
3026 |
+
affinity NOUN B-O
|
3027 |
+
of ADP B-O
|
3028 |
+
about ADP B-O
|
3029 |
+
0.8 NUM B-O
|
3030 |
+
µM. NOUN B-O
|
3031 |
+
Here ADV B-O
|
3032 |
+
we PRON B-O
|
3033 |
+
report VERB B-O
|
3034 |
+
the DET B-O
|
3035 |
+
modulation NOUN B-O
|
3036 |
+
of ADP B-O
|
3037 |
+
the DET B-O
|
3038 |
+
structure NOUN B-O
|
3039 |
+
/ SYM B-O
|
3040 |
+
function NOUN B-O
|
3041 |
+
of ADP B-O
|
3042 |
+
recombinant ADJ B-O
|
3043 |
+
Ace PROPN B-AC
|
3044 |
+
by ADP B-O
|
3045 |
+
small ADJ B-O
|
3046 |
+
molecule NOUN B-O
|
3047 |
+
calcium NOUN B-LF
|
3048 |
+
- PUNCT I-LF
|
3049 |
+
activated VERB I-LF
|
3050 |
+
chloride NOUN I-LF
|
3051 |
+
channel NOUN I-LF
|
3052 |
+
( PUNCT B-O
|
3053 |
+
CaCC PROPN B-AC
|
3054 |
+
) PUNCT B-O
|
3055 |
+
inhibitors NOUN B-O
|
3056 |
+
, PUNCT B-O
|
3057 |
+
namely ADV B-O
|
3058 |
+
CaCCinh PROPN B-O
|
3059 |
+
- PUNCT B-O
|
3060 |
+
A01 PROPN B-O
|
3061 |
+
, PUNCT B-O
|
3062 |
+
digallic ADJ B-LF
|
3063 |
+
acid NOUN I-LF
|
3064 |
+
( PUNCT B-O
|
3065 |
+
DGA PROPN B-AC
|
3066 |
+
) PUNCT B-O
|
3067 |
+
and CCONJ B-O
|
3068 |
+
tannic NOUN B-O
|
3069 |
+
acid NOUN B-O
|
3070 |
+
. PUNCT B-O
|
3071 |
+
|
3072 |
+
IMD PROPN B-O
|
3073 |
+
, PUNCT B-O
|
3074 |
+
Index PROPN B-O
|
3075 |
+
of ADP B-O
|
3076 |
+
Multiple ADJ B-O
|
3077 |
+
Deprivation NOUN B-O
|
3078 |
+
, PUNCT B-O
|
3079 |
+
derived VERB B-O
|
3080 |
+
from ADP B-O
|
3081 |
+
the DET B-O
|
3082 |
+
Lower PROPN B-O
|
3083 |
+
Super PROPN B-O
|
3084 |
+
Output PROPN B-O
|
3085 |
+
Area PROPN B-O
|
3086 |
+
of ADP B-O
|
3087 |
+
the DET B-O
|
3088 |
+
patient NOUN B-O
|
3089 |
+
’s PART B-O
|
3090 |
+
home NOUN B-O
|
3091 |
+
address NOUN B-O
|
3092 |
+
; PUNCT B-O
|
3093 |
+
IQR PROPN B-AC
|
3094 |
+
, PUNCT B-O
|
3095 |
+
interquartile ADJ B-LF
|
3096 |
+
range NOUN I-LF
|
3097 |
+
. PUNCT B-O
|
3098 |
+
|
3099 |
+
Analyzed VERB B-O
|
3100 |
+
parameter NOUN B-O
|
3101 |
+
were AUX B-O
|
3102 |
+
immunoreactive ADJ B-LF
|
3103 |
+
area NOUN B-O
|
3104 |
+
( PUNCT B-O
|
3105 |
+
IR PROPN B-AC
|
3106 |
+
) PUNCT B-O
|
3107 |
+
in ADP B-O
|
3108 |
+
percent NOUN B-O
|
3109 |
+
of ADP B-O
|
3110 |
+
the DET B-O
|
3111 |
+
ROI NOUN B-O
|
3112 |
+
area NOUN B-O
|
3113 |
+
and CCONJ B-O
|
3114 |
+
summarized VERB B-O
|
3115 |
+
object NOUN B-O
|
3116 |
+
intensity NOUN B-O
|
3117 |
+
in ADP B-O
|
3118 |
+
a.u./mm2 X B-O
|
3119 |
+
. PUNCT B-O
|
3120 |
+
|
3121 |
+
Bovine ADJ B-LF
|
3122 |
+
serum NOUN I-LF
|
3123 |
+
albumin NOUN I-LF
|
3124 |
+
( PUNCT B-O
|
3125 |
+
BSA PROPN B-AC
|
3126 |
+
) PUNCT B-O
|
3127 |
+
medium NOUN B-O
|
3128 |
+
, PUNCT B-O
|
3129 |
+
containing VERB B-O
|
3130 |
+
no DET B-O
|
3131 |
+
peptides NOUN B-O
|
3132 |
+
, PUNCT B-O
|
3133 |
+
was AUX B-O
|
3134 |
+
used VERB B-O
|
3135 |
+
as ADP B-O
|
3136 |
+
a DET B-O
|
3137 |
+
negative ADJ B-O
|
3138 |
+
control NOUN B-O
|
3139 |
+
. PUNCT B-O
|
3140 |
+
|
3141 |
+
Recently ADV B-O
|
3142 |
+
, PUNCT B-O
|
3143 |
+
it PRON B-O
|
3144 |
+
has AUX B-O
|
3145 |
+
been AUX B-O
|
3146 |
+
shown VERB B-O
|
3147 |
+
that PRON B-O
|
3148 |
+
PD-L1 PROPN B-AC
|
3149 |
+
intracytoplasmic ADJ B-O
|
3150 |
+
tail NOUN B-O
|
3151 |
+
can AUX B-O
|
3152 |
+
trigger VERB B-O
|
3153 |
+
a DET B-O
|
3154 |
+
signal NOUN B-O
|
3155 |
+
cascade NOUN B-O
|
3156 |
+
that PRON B-O
|
3157 |
+
make VERB B-O
|
3158 |
+
cancer NOUN B-O
|
3159 |
+
cells NOUN B-O
|
3160 |
+
resistant ADJ B-O
|
3161 |
+
to ADP B-O
|
3162 |
+
interferon NOUN B-LF
|
3163 |
+
( PUNCT B-O
|
3164 |
+
IFN)-mediated PROPN B-AC
|
3165 |
+
cytotoxicity NOUN B-O
|
3166 |
+
through ADP B-O
|
3167 |
+
a DET B-O
|
3168 |
+
STAT3 NOUN B-O
|
3169 |
+
/ SYM B-O
|
3170 |
+
caspase-7 NOUN B-O
|
3171 |
+
- PUNCT B-O
|
3172 |
+
dependent ADJ B-O
|
3173 |
+
pathway NOUN B-O
|
3174 |
+
[ PUNCT B-O
|
3175 |
+
16 NUM B-O
|
3176 |
+
] PUNCT B-O
|
3177 |
+
. PUNCT B-O
|
3178 |
+
|
3179 |
+
Their PRON B-O
|
3180 |
+
transcripts NOUN B-O
|
3181 |
+
were AUX B-O
|
3182 |
+
generally ADV B-O
|
3183 |
+
classified VERB B-O
|
3184 |
+
into ADP B-O
|
3185 |
+
two NUM B-O
|
3186 |
+
groups NOUN B-O
|
3187 |
+
including VERB B-O
|
3188 |
+
long ADJ B-O
|
3189 |
+
non ADJ B-O
|
3190 |
+
- ADJ B-O
|
3191 |
+
coding ADJ B-O
|
3192 |
+
RNAs NOUN B-O
|
3193 |
+
( PUNCT B-O
|
3194 |
+
longer ADJ B-O
|
3195 |
+
than ADP B-O
|
3196 |
+
200 NUM B-O
|
3197 |
+
nt NOUN B-O
|
3198 |
+
) PUNCT B-O
|
3199 |
+
and CCONJ B-O
|
3200 |
+
small ADJ B-LF
|
3201 |
+
RNAs NOUN I-LF
|
3202 |
+
( PUNCT B-O
|
3203 |
+
sRNAs PROPN B-AC
|
3204 |
+
, PUNCT B-O
|
3205 |
+
shorter ADJ B-O
|
3206 |
+
than ADP B-O
|
3207 |
+
200 NUM B-O
|
3208 |
+
nt NOUN B-O
|
3209 |
+
) PUNCT B-O
|
3210 |
+
. PUNCT B-O
|
3211 |
+
|
3212 |
+
The DET B-O
|
3213 |
+
underlying VERB B-O
|
3214 |
+
data NOUN B-O
|
3215 |
+
can AUX B-O
|
3216 |
+
be AUX B-O
|
3217 |
+
found VERB B-O
|
3218 |
+
in ADP B-O
|
3219 |
+
S1 PROPN B-O
|
3220 |
+
Data PROPN B-O
|
3221 |
+
. PUNCT B-O
|
3222 |
+
|
3223 |
+
; PUNCT B-O
|
3224 |
+
eFSGM PROPN B-AC
|
3225 |
+
, PUNCT B-O
|
3226 |
+
extended ADJ B-LF
|
3227 |
+
FSGM PROPN I-LF
|
3228 |
+
FSGM PROPN B-AC
|
3229 |
+
; PUNCT B-O
|
3230 |
+
FBA PROPN B-AC
|
3231 |
+
, PUNCT B-O
|
3232 |
+
feature NOUN B-LF
|
3233 |
+
- PUNCT I-LF
|
3234 |
+
based VERB I-LF
|
3235 |
+
attention NOUN I-LF
|
3236 |
+
; PUNCT B-O
|
3237 |
+
HR PROPN B-AC
|
3238 |
+
, PUNCT B-O
|
3239 |
+
hit NOUN B-LF
|
3240 |
+
rate NOUN I-LF
|
3241 |
+
; PUNCT B-O
|
3242 |
+
RT PROPN B-AC
|
3243 |
+
, PUNCT B-O
|
3244 |
+
reaction NOUN B-LF
|
3245 |
+
time NOUN I-LF
|
3246 |
+
. PUNCT B-O
|
3247 |
+
|
3248 |
+
Results NOUN B-O
|
3249 |
+
of ADP B-O
|
3250 |
+
logistic ADJ B-O
|
3251 |
+
regression NOUN B-O
|
3252 |
+
models NOUN B-O
|
3253 |
+
are AUX B-O
|
3254 |
+
presented VERB B-O
|
3255 |
+
using VERB B-O
|
3256 |
+
adjusted ADJ B-LF
|
3257 |
+
Odds NOUN I-LF
|
3258 |
+
Ratio PROPN I-LF
|
3259 |
+
( PUNCT B-O
|
3260 |
+
aOR PROPN B-AC
|
3261 |
+
) PUNCT B-O
|
3262 |
+
and CCONJ B-O
|
3263 |
+
95 NUM B-LF
|
3264 |
+
% NOUN I-LF
|
3265 |
+
Confidence PROPN I-LF
|
3266 |
+
Interval NOUN I-LF
|
3267 |
+
( PUNCT B-O
|
3268 |
+
95 PROPN B-AC
|
3269 |
+
) PUNCT B-O
|
3270 |
+
. PUNCT B-O
|
3271 |
+
|
3272 |
+
To PART B-O
|
3273 |
+
handle VERB B-O
|
3274 |
+
missing VERB B-O
|
3275 |
+
data NOUN B-O
|
3276 |
+
of ADP B-O
|
3277 |
+
two NUM B-O
|
3278 |
+
covariates NOUN B-O
|
3279 |
+
, PUNCT B-O
|
3280 |
+
multivariate ADJ B-O
|
3281 |
+
logistic ADJ B-O
|
3282 |
+
regression NOUN B-O
|
3283 |
+
models NOUN B-O
|
3284 |
+
were AUX B-O
|
3285 |
+
performed VERB B-O
|
3286 |
+
using VERB B-O
|
3287 |
+
multiple ADJ B-O
|
3288 |
+
imputation NOUN B-O
|
3289 |
+
[ X B-O
|
3290 |
+
45,46 NUM B-O
|
3291 |
+
] PUNCT B-O
|
3292 |
+
. PUNCT B-O
|
3293 |
+
|
3294 |
+
F NOUN B-O
|
3295 |
+
- PUNCT B-O
|
3296 |
+
actin NOUN B-O
|
3297 |
+
induction NOUN B-O
|
3298 |
+
was AUX B-O
|
3299 |
+
plotted VERB B-O
|
3300 |
+
as ADP B-O
|
3301 |
+
mean NOUN B-O
|
3302 |
+
± SYM B-O
|
3303 |
+
standard ADJ B-O
|
3304 |
+
error NOUN B-O
|
3305 |
+
of ADP B-O
|
3306 |
+
the DET B-O
|
3307 |
+
mean NOUN B-O
|
3308 |
+
( PUNCT B-O
|
3309 |
+
SEM PROPN B-O
|
3310 |
+
) PUNCT B-O
|
3311 |
+
. PUNCT B-O
|
3312 |
+
|
3313 |
+
n NOUN B-O
|
3314 |
+
= SYM B-O
|
3315 |
+
3 NUM B-O
|
3316 |
+
. PUNCT B-O
|
3317 |
+
|
3318 |
+
* PUNCT B-O
|
3319 |
+
p NOUN B-O
|
3320 |
+
≤ PUNCT B-O
|
3321 |
+
0.05 NUM B-O
|
3322 |
+
, PUNCT B-O
|
3323 |
+
* PUNCT B-O
|
3324 |
+
* PUNCT B-O
|
3325 |
+
* PUNCT B-O
|
3326 |
+
p NOUN B-O
|
3327 |
+
≤ PUNCT B-O
|
3328 |
+
0.001 NUM B-O
|
3329 |
+
. PUNCT B-O
|
3330 |
+
|
3331 |
+
( PUNCT B-O
|
3332 |
+
D X B-O
|
3333 |
+
) PUNCT B-O
|
3334 |
+
Time NOUN B-O
|
3335 |
+
- PUNCT B-O
|
3336 |
+
lapse NOUN B-O
|
3337 |
+
total ADJ B-LF
|
3338 |
+
internal ADJ I-LF
|
3339 |
+
reflection NOUN I-LF
|
3340 |
+
fluorescence NOUN I-LF
|
3341 |
+
microscopy NOUN I-LF
|
3342 |
+
( PUNCT B-O
|
3343 |
+
TIRFM PROPN B-AC
|
3344 |
+
) PUNCT B-O
|
3345 |
+
of ADP B-O
|
3346 |
+
speckle NOUN B-O
|
3347 |
+
mCherry NOUN B-O
|
3348 |
+
- PUNCT B-O
|
3349 |
+
β PUNCT B-O
|
3350 |
+
- PUNCT B-O
|
3351 |
+
actin NOUN B-O
|
3352 |
+
in ADP B-O
|
3353 |
+
eNOS PROPN B-AC
|
3354 |
+
and CCONJ B-O
|
3355 |
+
G2A NOUN B-O
|
3356 |
+
T NOUN B-O
|
3357 |
+
cells NOUN B-O
|
3358 |
+
, PUNCT B-O
|
3359 |
+
stimulated VERB B-O
|
3360 |
+
on ADP B-O
|
3361 |
+
CD3 PROPN B-O
|
3362 |
+
Ab PROPN B-O
|
3363 |
+
- PUNCT B-O
|
3364 |
+
coated VERB B-O
|
3365 |
+
chambers NOUN B-O
|
3366 |
+
. PUNCT B-O
|
3367 |
+
|
3368 |
+
Free ADJ B-O
|
3369 |
+
fatty ADJ B-LF
|
3370 |
+
acid NOUN I-LF
|
3371 |
+
( PUNCT B-O
|
3372 |
+
FA PROPN B-AC
|
3373 |
+
) PUNCT B-O
|
3374 |
+
and CCONJ B-O
|
3375 |
+
polar ADJ B-O
|
3376 |
+
lipid NOUN B-O
|
3377 |
+
species NOUN B-O
|
3378 |
+
were AUX B-O
|
3379 |
+
determined VERB B-O
|
3380 |
+
in ADP B-O
|
3381 |
+
flowers NOUN B-O
|
3382 |
+
and CCONJ B-O
|
3383 |
+
caulinary ADJ B-O
|
3384 |
+
leaves NOUN B-O
|
3385 |
+
of ADP B-O
|
3386 |
+
7 NUM B-O
|
3387 |
+
- PUNCT B-O
|
3388 |
+
week NOUN B-O
|
3389 |
+
- PUNCT B-O
|
3390 |
+
old ADJ B-O
|
3391 |
+
, PUNCT B-O
|
3392 |
+
mature ADJ B-O
|
3393 |
+
flowering VERB B-O
|
3394 |
+
plants NOUN B-O
|
3395 |
+
. PUNCT B-O
|
3396 |
+
|
3397 |
+
The DET B-O
|
3398 |
+
substances NOUN B-O
|
3399 |
+
which PRON B-O
|
3400 |
+
mainly ADV B-O
|
3401 |
+
contributed VERB B-O
|
3402 |
+
to ADP B-O
|
3403 |
+
Ozone PROPN B-LF
|
3404 |
+
layer NOUN I-LF
|
3405 |
+
depletion NOUN I-LF
|
3406 |
+
( PUNCT B-O
|
3407 |
+
OLD PROPN B-AC
|
3408 |
+
) PUNCT B-O
|
3409 |
+
were AUX B-O
|
3410 |
+
Methane PROPN B-O
|
3411 |
+
, PUNCT B-O
|
3412 |
+
bromotrifluoro- NOUN B-O
|
3413 |
+
, PUNCT B-O
|
3414 |
+
Halon PROPN B-O
|
3415 |
+
1301 NUM B-O
|
3416 |
+
( PUNCT B-O
|
3417 |
+
7.16E-06 NUM B-O
|
3418 |
+
kg NOUN B-O
|
3419 |
+
CFC-11 NOUN B-O
|
3420 |
+
eq NOUN B-O
|
3421 |
+
) PUNCT B-O
|
3422 |
+
and CCONJ B-O
|
3423 |
+
Methane PROPN B-O
|
3424 |
+
, PUNCT B-O
|
3425 |
+
trichlorofluoro NOUN B-O
|
3426 |
+
CFC-11 NOUN B-O
|
3427 |
+
( PUNCT B-O
|
3428 |
+
7.28559E-11 NUM B-O
|
3429 |
+
kg NOUN B-O
|
3430 |
+
CFC-11 NOUN B-O
|
3431 |
+
eq NOUN B-O
|
3432 |
+
) PUNCT B-O
|
3433 |
+
. PUNCT B-O
|
3434 |
+
|
3435 |
+
There PRON B-O
|
3436 |
+
is VERB B-O
|
3437 |
+
an DET B-O
|
3438 |
+
increasing VERB B-O
|
3439 |
+
expectation NOUN B-O
|
3440 |
+
that SCONJ B-O
|
3441 |
+
CHWs PROPN B-AC
|
3442 |
+
will AUX B-O
|
3443 |
+
participate VERB B-O
|
3444 |
+
in ADP B-O
|
3445 |
+
disease NOUN B-O
|
3446 |
+
surveillance NOUN B-O
|
3447 |
+
and CCONJ B-O
|
3448 |
+
data NOUN B-O
|
3449 |
+
collection NOUN B-O
|
3450 |
+
, PUNCT B-O
|
3451 |
+
diagnosis NOUN B-O
|
3452 |
+
and CCONJ B-O
|
3453 |
+
referral NOUN B-O
|
3454 |
+
for ADP B-O
|
3455 |
+
care NOUN B-O
|
3456 |
+
, PUNCT B-O
|
3457 |
+
and CCONJ B-O
|
3458 |
+
antiretroviral ADJ B-LF
|
3459 |
+
therapy NOUN I-LF
|
3460 |
+
( PUNCT B-O
|
3461 |
+
ART PROPN B-AC
|
3462 |
+
) PUNCT B-O
|
3463 |
+
provision NOUN B-O
|
3464 |
+
[ PUNCT B-O
|
3465 |
+
10 NUM B-O
|
3466 |
+
] PUNCT B-O
|
3467 |
+
. PUNCT B-O
|
3468 |
+
|
3469 |
+
( PUNCT B-O
|
3470 |
+
A X B-O
|
3471 |
+
) PUNCT B-O
|
3472 |
+
Trimethoprim NOUN B-O
|
3473 |
+
+ SYM B-O
|
3474 |
+
sulfamethizole NOUN B-O
|
3475 |
+
. PUNCT B-O
|
3476 |
+
|
3477 |
+
( PUNCT B-O
|
3478 |
+
B X B-O
|
3479 |
+
) PUNCT B-O
|
3480 |
+
Trimethoprim NOUN B-O
|
3481 |
+
+ SYM B-O
|
3482 |
+
AZT PROPN B-AC
|
3483 |
+
. PUNCT B-O
|
3484 |
+
|
3485 |
+
Synergistic ADJ B-O
|
3486 |
+
fractional ADJ B-LF
|
3487 |
+
inhibitory ADJ I-LF
|
3488 |
+
concentration NOUN I-LF
|
3489 |
+
index NOUN I-LF
|
3490 |
+
( PUNCT B-O
|
3491 |
+
FICI PROPN B-AC
|
3492 |
+
) PUNCT B-O
|
3493 |
+
values NOUN B-O
|
3494 |
+
( PUNCT B-O
|
3495 |
+
≤0.5 NUM B-O
|
3496 |
+
) PUNCT B-O
|
3497 |
+
are AUX B-O
|
3498 |
+
marked VERB B-O
|
3499 |
+
with ADP B-O
|
3500 |
+
yellow ADJ B-O
|
3501 |
+
bars NOUN B-O
|
3502 |
+
, PUNCT B-O
|
3503 |
+
and CCONJ B-O
|
3504 |
+
nonsynergistic ADJ B-O
|
3505 |
+
( PUNCT B-O
|
3506 |
+
FICI PROPN B-AC
|
3507 |
+
> SYM B-O
|
3508 |
+
0.5 NUM B-O
|
3509 |
+
) PUNCT B-O
|
3510 |
+
FICI PROPN B-AC
|
3511 |
+
values NOUN B-O
|
3512 |
+
are AUX B-O
|
3513 |
+
marked VERB B-O
|
3514 |
+
with ADP B-O
|
3515 |
+
blue ADJ B-O
|
3516 |
+
bars NOUN B-O
|
3517 |
+
. PUNCT B-O
|
3518 |
+
|
3519 |
+
However ADV B-O
|
3520 |
+
, PUNCT B-O
|
3521 |
+
Zbtb7a NOUN B-O
|
3522 |
+
is AUX B-O
|
3523 |
+
not PART B-O
|
3524 |
+
restricted VERB B-O
|
3525 |
+
to PART B-O
|
3526 |
+
NFκB PROPN B-AC
|
3527 |
+
target NOUN B-O
|
3528 |
+
promoters NOUN B-O
|
3529 |
+
, PUNCT B-O
|
3530 |
+
and CCONJ B-O
|
3531 |
+
indeed ADV B-O
|
3532 |
+
, PUNCT B-O
|
3533 |
+
a DET B-O
|
3534 |
+
large ADJ B-O
|
3535 |
+
fraction NOUN B-O
|
3536 |
+
of ADP B-O
|
3537 |
+
all DET B-O
|
3538 |
+
genomic ADJ B-O
|
3539 |
+
promoters NOUN B-O
|
3540 |
+
are AUX B-O
|
3541 |
+
associated VERB B-O
|
3542 |
+
with ADP B-O
|
3543 |
+
overlapping VERB B-O
|
3544 |
+
— PUNCT B-O
|
3545 |
+
or CCONJ B-O
|
3546 |
+
nearby ADJ B-O
|
3547 |
+
— PUNCT B-O
|
3548 |
+
Zbtb7a NOUN B-O
|
3549 |
+
binding NOUN B-O
|
3550 |
+
( PUNCT B-O
|
3551 |
+
up ADP B-O
|
3552 |
+
to PART B-O
|
3553 |
+
17 NUM B-O
|
3554 |
+
% PUNCT B-O
|
3555 |
+
or CCONJ B-O
|
3556 |
+
41 NUM B-O
|
3557 |
+
% PUNCT B-O
|
3558 |
+
, PUNCT B-O
|
3559 |
+
respectively ADV B-O
|
3560 |
+
, PUNCT B-O
|
3561 |
+
of ADP B-O
|
3562 |
+
all DET B-O
|
3563 |
+
promoters NOUN B-O
|
3564 |
+
in ADP B-O
|
3565 |
+
fibroblasts NOUN B-O
|
3566 |
+
; PUNCT B-O
|
3567 |
+
Fig PROPN B-O
|
3568 |
+
2D NUM B-O
|
3569 |
+
) PUNCT B-O
|
3570 |
+
, PUNCT B-O
|
3571 |
+
with ADP B-O
|
3572 |
+
a DET B-O
|
3573 |
+
preference NOUN B-O
|
3574 |
+
for ADP B-O
|
3575 |
+
guanine NOUN B-LF
|
3576 |
+
- PUNCT I-LF
|
3577 |
+
cytosine NOUN I-LF
|
3578 |
+
( PUNCT B-O
|
3579 |
+
GC)-rich PROPN B-AC
|
3580 |
+
and CCONJ B-O
|
3581 |
+
CpG NOUN B-LF
|
3582 |
+
island NOUN I-LF
|
3583 |
+
( PUNCT B-O
|
3584 |
+
CGI)-containing PROPN B-AC
|
3585 |
+
promoters NOUN B-O
|
3586 |
+
( PUNCT B-O
|
3587 |
+
S2H PROPN B-O
|
3588 |
+
and CCONJ B-O
|
3589 |
+
S2I PROPN B-O
|
3590 |
+
Fig PROPN B-O
|
3591 |
+
) PUNCT B-O
|
3592 |
+
. PUNCT B-O
|
3593 |
+
|
3594 |
+
LUSC PROPN B-AC
|
3595 |
+
( PUNCT B-O
|
3596 |
+
lung NOUN B-LF
|
3597 |
+
squamous ADJ I-LF
|
3598 |
+
cell NOUN I-LF
|
3599 |
+
carcinoma NOUN I-LF
|
3600 |
+
) PUNCT B-O
|
3601 |
+
Based VERB B-O
|
3602 |
+
on ADP B-O
|
3603 |
+
observations NOUN B-O
|
3604 |
+
in ADP B-O
|
3605 |
+
Drosophila PROPN B-O
|
3606 |
+
[ PUNCT B-O
|
3607 |
+
5 NUM B-O
|
3608 |
+
] PUNCT B-O
|
3609 |
+
, PUNCT B-O
|
3610 |
+
we PRON B-O
|
3611 |
+
set VERB B-O
|
3612 |
+
out ADP B-O
|
3613 |
+
to PART B-O
|
3614 |
+
assess VERB B-O
|
3615 |
+
the DET B-O
|
3616 |
+
role NOUN B-O
|
3617 |
+
of ADP B-O
|
3618 |
+
stress NOUN B-O
|
3619 |
+
- PUNCT B-O
|
3620 |
+
response NOUN B-O
|
3621 |
+
pathways NOUN B-O
|
3622 |
+
, PUNCT B-O
|
3623 |
+
particularly ADV B-O
|
3624 |
+
of ADP B-O
|
3625 |
+
heat NOUN B-LF
|
3626 |
+
shock NOUN I-LF
|
3627 |
+
protein NOUN I-LF
|
3628 |
+
90 NUM I-LF
|
3629 |
+
( PUNCT B-O
|
3630 |
+
Hsp90 PROPN B-AC
|
3631 |
+
) PUNCT B-O
|
3632 |
+
function NOUN B-O
|
3633 |
+
, PUNCT B-O
|
3634 |
+
in ADP B-O
|
3635 |
+
phenotype NOUN B-O
|
3636 |
+
modification NOUN B-O
|
3637 |
+
, PUNCT B-O
|
3638 |
+
using VERB B-O
|
3639 |
+
zebrafish NOUN B-O
|
3640 |
+
as ADP B-O
|
3641 |
+
a DET B-O
|
3642 |
+
vertebrate ADJ B-O
|
3643 |
+
model NOUN B-O
|
3644 |
+
. PUNCT B-O
|
3645 |
+
|
3646 |
+
Driving VERB B-LF
|
3647 |
+
simulator NOUN I-LF
|
3648 |
+
( PUNCT B-O
|
3649 |
+
DS PROPN B-AC
|
3650 |
+
) PUNCT B-O
|
3651 |
+
systems NOUN B-O
|
3652 |
+
have VERB B-O
|
3653 |
+
advantages NOUN B-O
|
3654 |
+
in ADP B-O
|
3655 |
+
controlling VERB B-O
|
3656 |
+
traffic- NOUN B-O
|
3657 |
+
and CCONJ B-O
|
3658 |
+
automobile NOUN B-O
|
3659 |
+
- PUNCT B-O
|
3660 |
+
related VERB B-O
|
3661 |
+
conditions NOUN B-O
|
3662 |
+
[ PUNCT B-O
|
3663 |
+
1,13,14 NUM B-O
|
3664 |
+
] PUNCT B-O
|
3665 |
+
. PUNCT B-O
|
3666 |
+
|
3667 |
+
We PRON B-O
|
3668 |
+
assumed VERB B-O
|
3669 |
+
a DET B-O
|
3670 |
+
50 NUM B-O
|
3671 |
+
% NOUN B-O
|
3672 |
+
proportion NOUN B-O
|
3673 |
+
, PUNCT B-O
|
3674 |
+
80 NUM B-O
|
3675 |
+
% NOUN B-O
|
3676 |
+
power NOUN B-O
|
3677 |
+
, PUNCT B-O
|
3678 |
+
95 NUM B-O
|
3679 |
+
% NOUN B-O
|
3680 |
+
confidence NOUN B-LF
|
3681 |
+
interval NOUN I-LF
|
3682 |
+
( PUNCT B-O
|
3683 |
+
CI PROPN B-AC
|
3684 |
+
) PUNCT B-O
|
3685 |
+
and CCONJ B-O
|
3686 |
+
5 NUM B-O
|
3687 |
+
% NOUN B-O
|
3688 |
+
precision NOUN B-O
|
3689 |
+
. PUNCT B-O
|
3690 |
+
|
3691 |
+
All DET B-O
|
3692 |
+
known VERB B-O
|
3693 |
+
AP PROPN B-AC
|
3694 |
+
endonucleases NOUN B-O
|
3695 |
+
are AUX B-O
|
3696 |
+
grouped VERB B-O
|
3697 |
+
in ADP B-O
|
3698 |
+
two NUM B-O
|
3699 |
+
distinct ADJ B-O
|
3700 |
+
superfamilies NOUN B-O
|
3701 |
+
based VERB B-O
|
3702 |
+
on ADP B-O
|
3703 |
+
their PRON B-O
|
3704 |
+
structural ADJ B-O
|
3705 |
+
and CCONJ B-O
|
3706 |
+
sequence NOUN B-O
|
3707 |
+
similarity NOUN B-O
|
3708 |
+
to ADP B-O
|
3709 |
+
either CCONJ B-O
|
3710 |
+
Escherichia PROPN B-LF
|
3711 |
+
coli PROPN I-LF
|
3712 |
+
exonuclease NOUN I-LF
|
3713 |
+
III NUM I-LF
|
3714 |
+
( PUNCT B-O
|
3715 |
+
Xth PROPN B-AC
|
3716 |
+
; PUNCT B-O
|
3717 |
+
Endonuclease NOUN B-LF
|
3718 |
+
— PUNCT I-LF
|
3719 |
+
Exonuclease NOUN I-LF
|
3720 |
+
— PUNCT I-LF
|
3721 |
+
Phosphatase NOUN I-LF
|
3722 |
+
superfamily NOUN B-O
|
3723 |
+
, PUNCT B-O
|
3724 |
+
or CCONJ B-O
|
3725 |
+
EEP PROPN B-AC
|
3726 |
+
) PUNCT B-O
|
3727 |
+
or CCONJ B-O
|
3728 |
+
endonuclease NOUN B-O
|
3729 |
+
IV NUM B-O
|
3730 |
+
( PUNCT B-O
|
3731 |
+
Nfo PROPN B-O
|
3732 |
+
) PUNCT B-O
|
3733 |
+
[ PUNCT B-O
|
3734 |
+
10 NUM B-O
|
3735 |
+
] PUNCT B-O
|
3736 |
+
. PUNCT B-O
|
3737 |
+
|
3738 |
+
Arm PROPN B-AC
|
3739 |
+
, PUNCT B-O
|
3740 |
+
Armadillo PROPN B-LF
|
3741 |
+
; PUNCT B-O
|
3742 |
+
bGal PROPN B-AC
|
3743 |
+
, PUNCT B-O
|
3744 |
+
beta NOUN B-LF
|
3745 |
+
- PUNCT I-LF
|
3746 |
+
galactosidase NOUN I-LF
|
3747 |
+
; PUNCT B-O
|
3748 |
+
Cyt PROPN B-AC
|
3749 |
+
-Arm PROPN B-AC
|
3750 |
+
, PUNCT B-O
|
3751 |
+
Cytoplasm NOUN B-O
|
3752 |
+
- PUNCT B-O
|
3753 |
+
Armadillo PROPN B-LF
|
3754 |
+
; PUNCT B-O
|
3755 |
+
GBSC PROPN B-AC
|
3756 |
+
, PUNCT B-O
|
3757 |
+
glioblastoma NOUN B-LF
|
3758 |
+
multiforme ADJ I-LF
|
3759 |
+
stem NOUN I-LF
|
3760 |
+
- PUNCT I-LF
|
3761 |
+
like ADJ I-LF
|
3762 |
+
cell NOUN I-LF
|
3763 |
+
; PUNCT B-O
|
3764 |
+
GFP PROPN B-AC
|
3765 |
+
, PUNCT B-O
|
3766 |
+
green ADJ B-LF
|
3767 |
+
fluorescent ADJ I-LF
|
3768 |
+
protein NOUN I-LF
|
3769 |
+
; PUNCT B-O
|
3770 |
+
igl PROPN B-AC
|
3771 |
+
, PUNCT B-O
|
3772 |
+
igloo NOUN B-LF
|
3773 |
+
; PUNCT B-O
|
3774 |
+
myrRFP PROPN B-O
|
3775 |
+
, PUNCT B-O
|
3776 |
+
myristoilated PROPN B-O
|
3777 |
+
Red PROPN B-O
|
3778 |
+
Fluorescent PROPN B-O
|
3779 |
+
Protein PROPN B-O
|
3780 |
+
; PUNCT B-O
|
3781 |
+
nkd PROPN B-AC
|
3782 |
+
, PUNCT B-O
|
3783 |
+
-lacZnkd PROPN B-AC
|
3784 |
+
, PUNCT B-O
|
3785 |
+
transcriptional ADJ B-O
|
3786 |
+
beta NOUN B-LF
|
3787 |
+
- PUNCT I-LF
|
3788 |
+
galactosidase NOUN I-LF
|
3789 |
+
reporter NOUN B-O
|
3790 |
+
of ADP B-O
|
3791 |
+
naked ADJ B-O
|
3792 |
+
gene NOUN B-O
|
3793 |
+
NLGN3 PROPN B-O
|
3794 |
+
; PUNCT B-O
|
3795 |
+
NMRI PROPN B-O
|
3796 |
+
, PUNCT B-O
|
3797 |
+
Naval PROPN B-O
|
3798 |
+
Medical PROPN B-O
|
3799 |
+
Research PROPN B-O
|
3800 |
+
Institute PROPN B-O
|
3801 |
+
. PUNCT B-O
|
3802 |
+
|
3803 |
+
Very ADV B-LF
|
3804 |
+
- PUNCT I-LF
|
3805 |
+
long ADV I-LF
|
3806 |
+
- PUNCT I-LF
|
3807 |
+
chain NOUN I-LF
|
3808 |
+
fatty ADJ I-LF
|
3809 |
+
acid NOUN I-LF
|
3810 |
+
( PUNCT B-O
|
3811 |
+
VLCFA PROPN B-AC
|
3812 |
+
) PUNCT B-O
|
3813 |
+
accumulation NOUN B-O
|
3814 |
+
has AUX B-O
|
3815 |
+
long ADV B-O
|
3816 |
+
been AUX B-O
|
3817 |
+
suggested VERB B-O
|
3818 |
+
as ADP B-O
|
3819 |
+
a DET B-O
|
3820 |
+
major ADJ B-O
|
3821 |
+
disease NOUN B-O
|
3822 |
+
- PUNCT B-O
|
3823 |
+
mediating VERB B-O
|
3824 |
+
factor NOUN B-O
|
3825 |
+
, PUNCT B-O
|
3826 |
+
although SCONJ B-O
|
3827 |
+
the DET B-O
|
3828 |
+
exact ADJ B-O
|
3829 |
+
pathological ADJ B-O
|
3830 |
+
consequences NOUN B-O
|
3831 |
+
are AUX B-O
|
3832 |
+
unclear ADJ B-O
|
3833 |
+
. PUNCT B-O
|
3834 |
+
|
3835 |
+
Unexpectedly ADV B-O
|
3836 |
+
, PUNCT B-O
|
3837 |
+
we PRON B-O
|
3838 |
+
found VERB B-O
|
3839 |
+
that SCONJ B-O
|
3840 |
+
Notch1 NOUN B-O
|
3841 |
+
- PUNCT B-O
|
3842 |
+
expressing VERB B-O
|
3843 |
+
cells NOUN B-O
|
3844 |
+
invariably ADV B-O
|
3845 |
+
lacked VERB B-O
|
3846 |
+
the DET B-O
|
3847 |
+
expression NOUN B-O
|
3848 |
+
of ADP B-O
|
3849 |
+
ERα PROPN B-AC
|
3850 |
+
and CCONJ B-O
|
3851 |
+
PR PROPN B-AC
|
3852 |
+
( PUNCT B-O
|
3853 |
+
Fig PROPN B-O
|
3854 |
+
. PUNCT B-O
|
3855 |
+
|
3856 |
+
2F NUM B-O
|
3857 |
+
, PUNCT B-O
|
3858 |
+
G NOUN B-O
|
3859 |
+
) PUNCT B-O
|
3860 |
+
, PUNCT B-O
|
3861 |
+
and CCONJ B-O
|
3862 |
+
we PRON B-O
|
3863 |
+
confirmed VERB B-O
|
3864 |
+
these DET B-O
|
3865 |
+
results NOUN B-O
|
3866 |
+
by ADP B-O
|
3867 |
+
quantitative ADJ B-LF
|
3868 |
+
Real ADJ I-LF
|
3869 |
+
Time NOUN I-LF
|
3870 |
+
Polymerase PROPN I-LF
|
3871 |
+
Chain PROPN I-LF
|
3872 |
+
Reaction PROPN I-LF
|
3873 |
+
( PUNCT B-O
|
3874 |
+
qRT PROPN B-AC
|
3875 |
+
) PUNCT B-O
|
3876 |
+
in ADP B-O
|
3877 |
+
sorted ADJ B-O
|
3878 |
+
-PCRGFP PROPN B-AC
|
3879 |
+
- PUNCT B-O
|
3880 |
+
labeled VERB B-O
|
3881 |
+
cells NOUN B-O
|
3882 |
+
( PUNCT B-O
|
3883 |
+
S3B PROPN B-O
|
3884 |
+
, PUNCT B-O
|
3885 |
+
C PROPN B-O
|
3886 |
+
Fig PROPN B-O
|
3887 |
+
. PUNCT B-O
|
3888 |
+
|
3889 |
+
) PUNCT B-O
|
3890 |
+
. PUNCT B-O
|
3891 |
+
|
3892 |
+
In ADP B-O
|
3893 |
+
RSV PROPN B-AC
|
3894 |
+
infected VERB B-O
|
3895 |
+
animals NOUN B-O
|
3896 |
+
treated VERB B-O
|
3897 |
+
with ADP B-O
|
3898 |
+
EGY-2 PROPN B-AC
|
3899 |
+
, PUNCT B-O
|
3900 |
+
alveolar ADJ B-LF
|
3901 |
+
macrophages NOUN I-LF
|
3902 |
+
( PUNCT B-O
|
3903 |
+
AM PROPN B-AC
|
3904 |
+
) PUNCT B-O
|
3905 |
+
in ADP B-O
|
3906 |
+
the DET B-O
|
3907 |
+
high ADJ B-O
|
3908 |
+
dose NOUN B-O
|
3909 |
+
group NOUN B-O
|
3910 |
+
showed VERB B-O
|
3911 |
+
a DET B-O
|
3912 |
+
markedly ADV B-O
|
3913 |
+
enhanced VERB B-O
|
3914 |
+
phagocytic ADJ B-O
|
3915 |
+
function NOUN B-O
|
3916 |
+
at ADP B-O
|
3917 |
+
the DET B-O
|
3918 |
+
early ADJ B-O
|
3919 |
+
phase NOUN B-O
|
3920 |
+
of ADP B-O
|
3921 |
+
infection NOUN B-O
|
3922 |
+
, PUNCT B-O
|
3923 |
+
as ADP B-O
|
3924 |
+
both CCONJ B-O
|
3925 |
+
the DET B-O
|
3926 |
+
number NOUN B-O
|
3927 |
+
of ADP B-O
|
3928 |
+
phagocytic ADJ B-O
|
3929 |
+
AM PROPN B-AC
|
3930 |
+
as ADP B-O
|
3931 |
+
well ADV B-O
|
3932 |
+
as ADP B-O
|
3933 |
+
their PRON B-O
|
3934 |
+
phagocytic ADJ B-O
|
3935 |
+
activity NOUN B-O
|
3936 |
+
was AUX B-O
|
3937 |
+
significantly ADV B-O
|
3938 |
+
enhanced VERB B-O
|
3939 |
+
compared VERB B-O
|
3940 |
+
to ADP B-O
|
3941 |
+
untreated ADJ B-O
|
3942 |
+
animals NOUN B-O
|
3943 |
+
on ADP B-O
|
3944 |
+
day NOUN B-O
|
3945 |
+
1 NUM B-O
|
3946 |
+
p.i PROPN B-AC
|
3947 |
+
. PUNCT B-O
|
3948 |
+
|
3949 |
+
( PUNCT B-O
|
3950 |
+
Fig NOUN B-O
|
3951 |
+
4A NUM B-O
|
3952 |
+
and CCONJ B-O
|
3953 |
+
4B NOUN B-O
|
3954 |
+
, PUNCT B-O
|
3955 |
+
respectively ADV B-O
|
3956 |
+
) PUNCT B-O
|
3957 |
+
. PUNCT B-O
|
3958 |
+
|
3959 |
+
Finally ADV B-O
|
3960 |
+
, PUNCT B-O
|
3961 |
+
as ADP B-O
|
3962 |
+
a DET B-O
|
3963 |
+
sensitivity NOUN B-O
|
3964 |
+
analysis NOUN B-O
|
3965 |
+
, PUNCT B-O
|
3966 |
+
we PRON B-O
|
3967 |
+
constructed VERB B-O
|
3968 |
+
five NUM B-O
|
3969 |
+
different ADJ B-O
|
3970 |
+
genetic ADJ B-LF
|
3971 |
+
pigmentation NOUN I-LF
|
3972 |
+
scores NOUN I-LF
|
3973 |
+
, PUNCT B-O
|
3974 |
+
one NUM B-O
|
3975 |
+
for ADP B-O
|
3976 |
+
each DET B-O
|
3977 |
+
pigmentation NOUN B-O
|
3978 |
+
trait NOUN B-O
|
3979 |
+
( PUNCT B-O
|
3980 |
+
eye NOUN B-O
|
3981 |
+
color NOUN B-O
|
3982 |
+
, PUNCT B-O
|
3983 |
+
hair NOUN B-O
|
3984 |
+
color NOUN B-O
|
3985 |
+
, PUNCT B-O
|
3986 |
+
skin NOUN B-O
|
3987 |
+
phototype NOUN B-O
|
3988 |
+
, PUNCT B-O
|
3989 |
+
and CCONJ B-O
|
3990 |
+
the DET B-O
|
3991 |
+
presence NOUN B-O
|
3992 |
+
of ADP B-O
|
3993 |
+
freckles NOUN B-O
|
3994 |
+
and CCONJ B-O
|
3995 |
+
tanning NOUN B-O
|
3996 |
+
) PUNCT B-O
|
3997 |
+
, PUNCT B-O
|
3998 |
+
from ADP B-O
|
3999 |
+
our PRON B-O
|
4000 |
+
data NOUN B-O
|
4001 |
+
( PUNCT B-O
|
4002 |
+
S2 PROPN B-O
|
4003 |
+
Table PROPN B-O
|
4004 |
+
) PUNCT B-O
|
4005 |
+
we PRON B-O
|
4006 |
+
analyzed VERB B-O
|
4007 |
+
their PRON B-O
|
4008 |
+
relationship NOUN B-O
|
4009 |
+
with ADP B-O
|
4010 |
+
cancer NOUN B-O
|
4011 |
+
in ADP B-O
|
4012 |
+
the DET B-O
|
4013 |
+
same ADJ B-O
|
4014 |
+
way NOUN B-O
|
4015 |
+
we PRON B-O
|
4016 |
+
have AUX B-O
|
4017 |
+
described VERB B-O
|
4018 |
+
for ADP B-O
|
4019 |
+
the DET B-O
|
4020 |
+
GPS PROPN B-AC
|
4021 |
+
. PUNCT B-O
|
4022 |
+
|
4023 |
+
SDQ PROPN B-AC
|
4024 |
+
, PUNCT B-O
|
4025 |
+
Strengths NOUN B-LF
|
4026 |
+
and CCONJ I-LF
|
4027 |
+
Difficulties NOUN I-LF
|
4028 |
+
Questionnaire NOUN I-LF
|
4029 |
+
. PUNCT B-O
|
4030 |
+
|
4031 |
+
In ADP B-O
|
4032 |
+
Drosophila PROPN B-O
|
4033 |
+
, PUNCT B-O
|
4034 |
+
the DET B-O
|
4035 |
+
family NOUN B-O
|
4036 |
+
of ADP B-O
|
4037 |
+
gustatory ADJ B-LF
|
4038 |
+
receptors NOUN I-LF
|
4039 |
+
( PUNCT B-O
|
4040 |
+
Grs PROPN B-AC
|
4041 |
+
) PUNCT B-O
|
4042 |
+
is AUX B-O
|
4043 |
+
predicted VERB B-O
|
4044 |
+
to PART B-O
|
4045 |
+
consist VERB B-O
|
4046 |
+
of ADP B-O
|
4047 |
+
68 NUM B-O
|
4048 |
+
genes NOUN B-O
|
4049 |
+
[ PUNCT B-O
|
4050 |
+
4],[5 NUM B-O
|
4051 |
+
] PUNCT B-O
|
4052 |
+
. PUNCT B-O
|
4053 |
+
|
4054 |
+
DIC PROPN B-AC
|
4055 |
+
, PUNCT B-O
|
4056 |
+
differential ADJ B-LF
|
4057 |
+
interference NOUN I-LF
|
4058 |
+
contrast NOUN I-LF
|
4059 |
+
; PUNCT B-O
|
4060 |
+
SM PROPN B-O
|
4061 |
+
, PUNCT B-O
|
4062 |
+
Sperm NOUN B-O
|
4063 |
+
Medium NOUN B-O
|
4064 |
+
. PUNCT B-O
|
4065 |
+
|
4066 |
+
In ADP B-O
|
4067 |
+
October PROPN B-O
|
4068 |
+
2018 NUM B-O
|
4069 |
+
, PUNCT B-O
|
4070 |
+
we PRON B-O
|
4071 |
+
published VERB B-O
|
4072 |
+
a DET B-O
|
4073 |
+
systematic ADJ B-O
|
4074 |
+
review NOUN B-O
|
4075 |
+
of ADP B-O
|
4076 |
+
clinical ADJ B-LF
|
4077 |
+
practice NOUN I-LF
|
4078 |
+
guidelines NOUN I-LF
|
4079 |
+
( PUNCT B-O
|
4080 |
+
CPG PROPN B-AC
|
4081 |
+
) PUNCT B-O
|
4082 |
+
that PRON B-O
|
4083 |
+
provide VERB B-O
|
4084 |
+
recommendations NOUN B-O
|
4085 |
+
for ADP B-O
|
4086 |
+
the DET B-O
|
4087 |
+
care NOUN B-O
|
4088 |
+
and CCONJ B-O
|
4089 |
+
prevention NOUN B-O
|
4090 |
+
of ADP B-O
|
4091 |
+
adverse ADJ B-O
|
4092 |
+
events NOUN B-O
|
4093 |
+
associated VERB B-O
|
4094 |
+
with ADP B-O
|
4095 |
+
vascular ADJ B-O
|
4096 |
+
catheter NOUN B-O
|
4097 |
+
in ADP B-O
|
4098 |
+
adults NOUN B-O
|
4099 |
+
. PUNCT B-O
|
4100 |
+
|
4101 |
+
Aptima PROPN B-LF
|
4102 |
+
HIV-1 NOUN I-LF
|
4103 |
+
Aptima PROPN B-AC
|
4104 |
+
Quant NOUN I-LF
|
4105 |
+
Dx NOUN I-LF
|
4106 |
+
assay NOUN I-LF
|
4107 |
+
Equation NOUN B-O
|
4108 |
+
2 NUM B-O
|
4109 |
+
: PUNCT B-O
|
4110 |
+
Where SCONJ B-O
|
4111 |
+
RMSE PROPN B-AC
|
4112 |
+
is AUX B-O
|
4113 |
+
root NOUN B-LF
|
4114 |
+
mean ADJ I-LF
|
4115 |
+
square ADJ I-LF
|
4116 |
+
error NOUN I-LF
|
4117 |
+
, PUNCT B-O
|
4118 |
+
Yi PROPN B-O
|
4119 |
+
is AUX B-O
|
4120 |
+
ANN PROPN B-AC
|
4121 |
+
predicted VERB B-O
|
4122 |
+
values NOUN B-O
|
4123 |
+
; PUNCT B-O
|
4124 |
+
yi PROPN B-O
|
4125 |
+
is AUX B-O
|
4126 |
+
experimental ADJ B-O
|
4127 |
+
values NOUN B-O
|
4128 |
+
; PUNCT B-O
|
4129 |
+
n NOUN B-O
|
4130 |
+
is AUX B-O
|
4131 |
+
number NOUN B-O
|
4132 |
+
of ADP B-O
|
4133 |
+
predictions NOUN B-O
|
4134 |
+
. PUNCT B-O
|
4135 |
+
|
4136 |
+
Various ADJ B-O
|
4137 |
+
platforms NOUN B-O
|
4138 |
+
, PUNCT B-O
|
4139 |
+
such ADJ B-O
|
4140 |
+
as ADP B-O
|
4141 |
+
IHC PROPN B-AC
|
4142 |
+
, PUNCT B-O
|
4143 |
+
SS PROPN B-AC
|
4144 |
+
, PUNCT B-O
|
4145 |
+
pyrosequencing NOUN B-LF
|
4146 |
+
( PUNCT B-O
|
4147 |
+
PS PROPN B-AC
|
4148 |
+
) PUNCT B-O
|
4149 |
+
, PUNCT B-O
|
4150 |
+
and CCONJ B-O
|
4151 |
+
HRM PROPN B-AC
|
4152 |
+
, PUNCT B-O
|
4153 |
+
are AUX B-O
|
4154 |
+
available ADJ B-O
|
4155 |
+
to PART B-O
|
4156 |
+
analyze VERB B-O
|
4157 |
+
genetic ADJ B-O
|
4158 |
+
mutation NOUN B-O
|
4159 |
+
profiles NOUN B-O
|
4160 |
+
in ADP B-O
|
4161 |
+
clinical ADJ B-O
|
4162 |
+
tissue NOUN B-O
|
4163 |
+
samples NOUN B-O
|
4164 |
+
. PUNCT B-O
|
4165 |
+
|
4166 |
+
One NUM B-O
|
4167 |
+
compound NOUN B-O
|
4168 |
+
seemed VERB B-O
|
4169 |
+
a DET B-O
|
4170 |
+
particularly ADV B-O
|
4171 |
+
promising ADJ B-O
|
4172 |
+
candidate NOUN B-O
|
4173 |
+
for ADP B-O
|
4174 |
+
this DET B-O
|
4175 |
+
sort NOUN B-O
|
4176 |
+
of ADP B-O
|
4177 |
+
approach NOUN B-O
|
4178 |
+
: PUNCT B-O
|
4179 |
+
thiabendazole NOUN B-LF
|
4180 |
+
( PUNCT B-O
|
4181 |
+
TBZ PROPN B-AC
|
4182 |
+
) PUNCT B-O
|
4183 |
+
, PUNCT B-O
|
4184 |
+
which PRON B-O
|
4185 |
+
has AUX B-O
|
4186 |
+
been AUX B-O
|
4187 |
+
in ADP B-O
|
4188 |
+
clinical ADJ B-O
|
4189 |
+
use NOUN B-O
|
4190 |
+
as ADP B-O
|
4191 |
+
a DET B-O
|
4192 |
+
systemic ADJ B-O
|
4193 |
+
antifungal ADJ B-O
|
4194 |
+
and CCONJ B-O
|
4195 |
+
deworming NOUN B-O
|
4196 |
+
treatment NOUN B-O
|
4197 |
+
for ADP B-O
|
4198 |
+
40 NUM B-O
|
4199 |
+
years NOUN B-O
|
4200 |
+
. PUNCT B-O
|
4201 |
+
|
4202 |
+
Though SCONJ B-O
|
4203 |
+
long ADJ B-O
|
4204 |
+
endemic ADJ B-O
|
4205 |
+
in ADP B-O
|
4206 |
+
the DET B-O
|
4207 |
+
southeastern ADJ B-O
|
4208 |
+
U.S. PROPN B-O
|
4209 |
+
, PUNCT B-O
|
4210 |
+
raccoon NOUN B-O
|
4211 |
+
rabies NOUN B-O
|
4212 |
+
expanded VERB B-O
|
4213 |
+
rapidly ADV B-O
|
4214 |
+
along ADP B-O
|
4215 |
+
the DET B-O
|
4216 |
+
eastern ADJ B-O
|
4217 |
+
seaboard NOUN B-O
|
4218 |
+
during ADP B-O
|
4219 |
+
the DET B-O
|
4220 |
+
1980s NOUN B-O
|
4221 |
+
and CCONJ B-O
|
4222 |
+
1990s NOUN B-O
|
4223 |
+
from ADP B-O
|
4224 |
+
an DET B-O
|
4225 |
+
initial ADJ B-O
|
4226 |
+
focus NOUN B-O
|
4227 |
+
along ADP B-O
|
4228 |
+
the DET B-O
|
4229 |
+
West PROPN B-O
|
4230 |
+
Virginia PROPN B-O
|
4231 |
+
– PUNCT B-O
|
4232 |
+
Virginia PROPN B-O
|
4233 |
+
border NOUN B-O
|
4234 |
+
; PUNCT B-O
|
4235 |
+
the DET B-O
|
4236 |
+
initial ADJ B-O
|
4237 |
+
focus NOUN B-O
|
4238 |
+
was AUX B-O
|
4239 |
+
linked VERB B-O
|
4240 |
+
to ADP B-O
|
4241 |
+
the DET B-O
|
4242 |
+
long ADJ B-LF
|
4243 |
+
- PUNCT I-LF
|
4244 |
+
distance NOUN I-LF
|
4245 |
+
translocation NOUN I-LF
|
4246 |
+
( PUNCT B-O
|
4247 |
+
LDT PROPN B-AC
|
4248 |
+
) PUNCT B-O
|
4249 |
+
of ADP B-O
|
4250 |
+
rabid ADJ B-O
|
4251 |
+
animals NOUN B-O
|
4252 |
+
from ADP B-O
|
4253 |
+
Florida PROPN B-O
|
4254 |
+
[ PUNCT B-O
|
4255 |
+
5 NUM B-O
|
4256 |
+
] PUNCT B-O
|
4257 |
+
. PUNCT B-O
|
4258 |
+
|
4259 |
+
( PUNCT B-O
|
4260 |
+
A X B-O
|
4261 |
+
) PUNCT B-O
|
4262 |
+
Two NUM B-O
|
4263 |
+
- PUNCT B-O
|
4264 |
+
dimensional ADJ B-O
|
4265 |
+
representation NOUN B-O
|
4266 |
+
of ADP B-O
|
4267 |
+
the DET B-O
|
4268 |
+
mTufA PROPN B-AC
|
4269 |
+
5′ NUM B-O
|
4270 |
+
UTR NOUN B-O
|
4271 |
+
. PUNCT B-O
|
4272 |
+
|
4273 |
+
The DET B-O
|
4274 |
+
RNAfold ADJ B-O
|
4275 |
+
algorithm NOUN B-O
|
4276 |
+
predicted VERB B-O
|
4277 |
+
three NUM B-O
|
4278 |
+
structured VERB B-LF
|
4279 |
+
regions NOUN I-LF
|
4280 |
+
: PUNCT B-O
|
4281 |
+
SR PROPN B-AC
|
4282 |
+
I NOUN B-O
|
4283 |
+
( PUNCT B-O
|
4284 |
+
pink NOUN B-O
|
4285 |
+
) PUNCT B-O
|
4286 |
+
, PUNCT B-O
|
4287 |
+
SR PROPN B-AC
|
4288 |
+
II PROPN B-O
|
4289 |
+
( PUNCT B-O
|
4290 |
+
violet ADJ B-O
|
4291 |
+
) PUNCT B-O
|
4292 |
+
, PUNCT B-O
|
4293 |
+
SR PROPN B-AC
|
4294 |
+
IIIa NOUN B-O
|
4295 |
+
( PUNCT B-O
|
4296 |
+
yellow ADJ B-O
|
4297 |
+
) PUNCT B-O
|
4298 |
+
, PUNCT B-O
|
4299 |
+
and CCONJ B-O
|
4300 |
+
SR PROPN B-AC
|
4301 |
+
IIIb NOUN B-O
|
4302 |
+
( PUNCT B-O
|
4303 |
+
green NOUN B-O
|
4304 |
+
) PUNCT B-O
|
4305 |
+
. PUNCT B-O
|
4306 |
+
|
4307 |
+
However ADV B-O
|
4308 |
+
, PUNCT B-O
|
4309 |
+
in ADP B-O
|
4310 |
+
some DET B-O
|
4311 |
+
studies NOUN B-O
|
4312 |
+
, PUNCT B-O
|
4313 |
+
we PRON B-O
|
4314 |
+
investigated VERB B-O
|
4315 |
+
the DET B-O
|
4316 |
+
effects NOUN B-O
|
4317 |
+
of ADP B-O
|
4318 |
+
gp120 NOUN B-O
|
4319 |
+
on ADP B-O
|
4320 |
+
MDDC PROPN B-AC
|
4321 |
+
that PRON B-O
|
4322 |
+
were AUX B-O
|
4323 |
+
simultaneously ADV B-O
|
4324 |
+
induced VERB B-O
|
4325 |
+
to PART B-O
|
4326 |
+
mature VERB B-O
|
4327 |
+
by ADP B-O
|
4328 |
+
other ADJ B-O
|
4329 |
+
stimuli NOUN B-O
|
4330 |
+
, PUNCT B-O
|
4331 |
+
notably ADV B-O
|
4332 |
+
lipopolysaccharide NOUN B-LF
|
4333 |
+
( PUNCT B-O
|
4334 |
+
LPS PROPN B-AC
|
4335 |
+
) PUNCT B-O
|
4336 |
+
. PUNCT B-O
|
4337 |
+
|
4338 |
+
The DET B-O
|
4339 |
+
red ADJ B-O
|
4340 |
+
dots NOUN B-O
|
4341 |
+
represents VERB B-O
|
4342 |
+
LCI PROPN B-AC
|
4343 |
+
, PUNCT B-O
|
4344 |
+
the DET B-O
|
4345 |
+
bright ADJ B-O
|
4346 |
+
yellow ADJ B-O
|
4347 |
+
rectangle NOUN B-O
|
4348 |
+
represents VERB B-O
|
4349 |
+
RV PROPN B-AC
|
4350 |
+
, PUNCT B-O
|
4351 |
+
and CCONJ B-O
|
4352 |
+
the DET B-O
|
4353 |
+
black ADJ B-O
|
4354 |
+
triangle NOUN B-O
|
4355 |
+
represents VERB B-O
|
4356 |
+
the DET B-O
|
4357 |
+
/TLCnLCI PROPN B-AC
|
4358 |
+
. PUNCT B-O
|
4359 |
+
|
4360 |
+
LCI PROPN B-AC
|
4361 |
+
: PUNCT B-O
|
4362 |
+
lung NOUN B-LF
|
4363 |
+
clearance NOUN I-LF
|
4364 |
+
index NOUN I-LF
|
4365 |
+
; PUNCT B-O
|
4366 |
+
RV PROPN B-AC
|
4367 |
+
: PUNCT B-O
|
4368 |
+
the DET B-LF
|
4369 |
+
ratio NOUN I-LF
|
4370 |
+
of ADP I-LF
|
4371 |
+
residual ADJ I-LF
|
4372 |
+
volume NOUN I-LF
|
4373 |
+
to ADP I-LF
|
4374 |
+
total ADJ I-LF
|
4375 |
+
lung NOUN I-LF
|
4376 |
+
capacity NOUN I-LF
|
4377 |
+
; PUNCT B-O
|
4378 |
+
/TLCnLCI PROPN B-AC
|
4379 |
+
: PUNCT B-O
|
4380 |
+
normalized ADJ B-LF
|
4381 |
+
lung NOUN B-LF
|
4382 |
+
clearance NOUN I-LF
|
4383 |
+
index NOUN I-LF
|
4384 |
+
. PUNCT B-O
|
4385 |
+
|
4386 |
+
The DET B-O
|
4387 |
+
drug NOUN B-LF
|
4388 |
+
utilisation NOUN I-LF
|
4389 |
+
( PUNCT B-O
|
4390 |
+
DU PROPN B-AC
|
4391 |
+
) PUNCT B-O
|
4392 |
+
90 NUM B-O
|
4393 |
+
% NOUN B-O
|
4394 |
+
methodology NOUN B-O
|
4395 |
+
was AUX B-O
|
4396 |
+
used VERB B-O
|
4397 |
+
to PART B-O
|
4398 |
+
present VERB B-O
|
4399 |
+
the DET B-O
|
4400 |
+
antibiotics NOUN B-O
|
4401 |
+
accounting VERB B-O
|
4402 |
+
for ADP B-O
|
4403 |
+
90 NUM B-O
|
4404 |
+
% NOUN B-O
|
4405 |
+
of ADP B-O
|
4406 |
+
all DET B-O
|
4407 |
+
antibiotics NOUN B-O
|
4408 |
+
prescribed VERB B-O
|
4409 |
+
[ PUNCT B-O
|
4410 |
+
19 NUM B-O
|
4411 |
+
] PUNCT B-O
|
4412 |
+
. PUNCT B-O
|
4413 |
+
|
4414 |
+
AC PROPN B-AC
|
4415 |
+
and CCONJ B-O
|
4416 |
+
CaM PROPN B-AC
|
4417 |
+
peptides NOUN B-O
|
4418 |
+
were AUX B-O
|
4419 |
+
separated VERB B-O
|
4420 |
+
over ADP B-O
|
4421 |
+
an DET B-O
|
4422 |
+
8 NUM B-O
|
4423 |
+
- PUNCT B-O
|
4424 |
+
min NOUN B-O
|
4425 |
+
gradient NOUN B-O
|
4426 |
+
of ADP B-O
|
4427 |
+
5%–40 NUM B-O
|
4428 |
+
% NOUN B-O
|
4429 |
+
acetonitrile NOUN B-LF
|
4430 |
+
( PUNCT B-O
|
4431 |
+
ACN PROPN B-AC
|
4432 |
+
) PUNCT B-O
|
4433 |
+
at ADP B-O
|
4434 |
+
40 NUM B-O
|
4435 |
+
μL NOUN B-O
|
4436 |
+
/ SYM B-O
|
4437 |
+
min NOUN B-O
|
4438 |
+
and CCONJ B-O
|
4439 |
+
at ADP B-O
|
4440 |
+
0 NUM B-O
|
4441 |
+
° NOUN B-O
|
4442 |
+
C NOUN B-O
|
4443 |
+
. PUNCT B-O
|
4444 |
+
|
4445 |
+
In ADP B-O
|
4446 |
+
this DET B-O
|
4447 |
+
regard NOUN B-O
|
4448 |
+
, PUNCT B-O
|
4449 |
+
the DET B-O
|
4450 |
+
concept NOUN B-O
|
4451 |
+
of ADP B-O
|
4452 |
+
mild ADJ B-LF
|
4453 |
+
cognitive ADJ I-LF
|
4454 |
+
impairment NOUN I-LF
|
4455 |
+
( PUNCT B-O
|
4456 |
+
MCI PROPN B-AC
|
4457 |
+
) PUNCT B-O
|
4458 |
+
is AUX B-O
|
4459 |
+
interesting ADJ B-O
|
4460 |
+
since SCONJ B-O
|
4461 |
+
it PRON B-O
|
4462 |
+
is AUX B-O
|
4463 |
+
seen VERB B-O
|
4464 |
+
as ADP B-O
|
4465 |
+
a DET B-O
|
4466 |
+
transitional ADJ B-O
|
4467 |
+
zone NOUN B-O
|
4468 |
+
between ADP B-O
|
4469 |
+
normal ADJ B-O
|
4470 |
+
aging NOUN B-O
|
4471 |
+
and CCONJ B-O
|
4472 |
+
dementia NOUN B-O
|
4473 |
+
. PUNCT B-O
|
4474 |
+
|
4475 |
+
The DET B-O
|
4476 |
+
quantity NOUN B-O
|
4477 |
+
ρ PUNCT B-O
|
4478 |
+
is AUX B-O
|
4479 |
+
the DET B-O
|
4480 |
+
atmospheric ADJ B-O
|
4481 |
+
density NOUN B-O
|
4482 |
+
depending VERB B-O
|
4483 |
+
on ADP B-O
|
4484 |
+
altitude NOUN B-O
|
4485 |
+
and CCONJ B-O
|
4486 |
+
temperature NOUN B-LF
|
4487 |
+
We PRON B-O
|
4488 |
+
estimate VERB B-O
|
4489 |
+
the DET B-O
|
4490 |
+
prevalence NOUN B-O
|
4491 |
+
of ADP B-O
|
4492 |
+
both CCONJ B-O
|
4493 |
+
overall ADJ B-O
|
4494 |
+
psychiatric ADJ B-O
|
4495 |
+
disorders NOUN B-O
|
4496 |
+
and CCONJ B-O
|
4497 |
+
specific ADJ B-O
|
4498 |
+
diagnoses NOUN B-O
|
4499 |
+
based VERB B-O
|
4500 |
+
on ADP B-O
|
4501 |
+
the DET B-O
|
4502 |
+
International PROPN B-LF
|
4503 |
+
Classification PROPN I-LF
|
4504 |
+
of ADP I-LF
|
4505 |
+
Diseases PROPN I-LF
|
4506 |
+
( PUNCT B-O
|
4507 |
+
ICD PROPN B-AC
|
4508 |
+
) PUNCT B-O
|
4509 |
+
. PUNCT B-O
|
4510 |
+
|
4511 |
+
We PRON B-O
|
4512 |
+
used VERB B-O
|
4513 |
+
generalized ADJ B-LF
|
4514 |
+
linear ADJ I-LF
|
4515 |
+
model NOUN I-LF
|
4516 |
+
( PUNCT B-O
|
4517 |
+
GLM PROPN B-AC
|
4518 |
+
) PUNCT B-O
|
4519 |
+
estimation NOUN B-O
|
4520 |
+
, PUNCT B-O
|
4521 |
+
which PRON B-O
|
4522 |
+
is AUX B-O
|
4523 |
+
a DET B-O
|
4524 |
+
Maximum PROPN B-O
|
4525 |
+
Likelihood NOUN B-O
|
4526 |
+
generalization NOUN B-O
|
4527 |
+
of ADP B-O
|
4528 |
+
the DET B-O
|
4529 |
+
ordinary ADJ B-O
|
4530 |
+
linear ADJ B-O
|
4531 |
+
regression NOUN B-O
|
4532 |
+
approach NOUN B-O
|
4533 |
+
. PUNCT B-O
|
4534 |
+
|
4535 |
+
This DET B-O
|
4536 |
+
assay NOUN B-O
|
4537 |
+
was AUX B-O
|
4538 |
+
used VERB B-O
|
4539 |
+
to PART B-O
|
4540 |
+
screen NOUN B-O
|
4541 |
+
a DET B-O
|
4542 |
+
genome NOUN B-O
|
4543 |
+
- PUNCT B-O
|
4544 |
+
wide ADJ B-O
|
4545 |
+
long ADJ B-LF
|
4546 |
+
double ADJ I-LF
|
4547 |
+
- PUNCT I-LF
|
4548 |
+
stranded VERB I-LF
|
4549 |
+
RNA NOUN I-LF
|
4550 |
+
( PUNCT B-O
|
4551 |
+
dsRNA PROPN B-AC
|
4552 |
+
) PUNCT B-O
|
4553 |
+
library NOUN B-O
|
4554 |
+
for ADP B-O
|
4555 |
+
modulation NOUN B-O
|
4556 |
+
of ADP B-O
|
4557 |
+
pMAPK PROPN B-AC
|
4558 |
+
levels NOUN B-O
|
4559 |
+
induced VERB B-O
|
4560 |
+
by ADP B-O
|
4561 |
+
RASV12 NOUN B-O
|
4562 |
+
expression NOUN B-O
|
4563 |
+
( PUNCT B-O
|
4564 |
+
Figure NOUN B-O
|
4565 |
+
S1B NOUN B-O
|
4566 |
+
and CCONJ B-O
|
4567 |
+
S1C NOUN B-O
|
4568 |
+
) PUNCT B-O
|
4569 |
+
. PUNCT B-O
|
4570 |
+
|
4571 |
+
The DET B-O
|
4572 |
+
results NOUN B-O
|
4573 |
+
from ADP B-O
|
4574 |
+
this DET B-O
|
4575 |
+
primary ADJ B-O
|
4576 |
+
screen NOUN B-O
|
4577 |
+
and CCONJ B-O
|
4578 |
+
all DET B-O
|
4579 |
+
subsequent ADJ B-O
|
4580 |
+
screens NOUN B-O
|
4581 |
+
are AUX B-O
|
4582 |
+
made VERB B-O
|
4583 |
+
available ADJ B-O
|
4584 |
+
online ADV B-O
|
4585 |
+
at ADP B-O
|
4586 |
+
the DET B-O
|
4587 |
+
IRIC PROPN B-O
|
4588 |
+
RNAi PROPN B-AC
|
4589 |
+
database NOUN B-O
|
4590 |
+
( PUNCT B-O
|
4591 |
+
http://www.bioinfo.iric.ca/iricrnai X B-O
|
4592 |
+
) PUNCT B-O
|
4593 |
+
. PUNCT B-O
|
4594 |
+
|
4595 |
+
309 NUM B-O
|
4596 |
+
hit NOUN B-O
|
4597 |
+
genes NOUN B-O
|
4598 |
+
, PUNCT B-O
|
4599 |
+
which PRON B-O
|
4600 |
+
reproducibly ADV B-O
|
4601 |
+
altered VERB B-O
|
4602 |
+
pMAPK PROPN B-AC
|
4603 |
+
signal NOUN B-O
|
4604 |
+
, PUNCT B-O
|
4605 |
+
were AUX B-O
|
4606 |
+
identified VERB B-O
|
4607 |
+
in ADP B-O
|
4608 |
+
the DET B-O
|
4609 |
+
primary ADJ B-O
|
4610 |
+
screen NOUN B-O
|
4611 |
+
( PUNCT B-O
|
4612 |
+
Table NOUN B-O
|
4613 |
+
S1 NUM B-O
|
4614 |
+
) PUNCT B-O
|
4615 |
+
. PUNCT B-O
|
4616 |
+
|
4617 |
+
GLA PROPN B-AC
|
4618 |
+
, PUNCT B-O
|
4619 |
+
grape NOUN B-LF
|
4620 |
+
- PUNCT I-LF
|
4621 |
+
like ADJ I-LF
|
4622 |
+
aggregation NOUN I-LF
|
4623 |
+
. PUNCT B-O
|
4624 |
+
|
4625 |
+
We PRON B-O
|
4626 |
+
carried VERB B-O
|
4627 |
+
out ADP B-O
|
4628 |
+
a DET B-O
|
4629 |
+
prospective ADJ B-O
|
4630 |
+
multicentre ADJ B-O
|
4631 |
+
cohort NOUN B-O
|
4632 |
+
study NOUN B-O
|
4633 |
+
within ADP B-O
|
4634 |
+
the DET B-O
|
4635 |
+
Italian PROPN B-O
|
4636 |
+
Cystic PROPN B-LF
|
4637 |
+
Fibrosis PROPN I-LF
|
4638 |
+
Society PROPN B-O
|
4639 |
+
involving VERB B-O
|
4640 |
+
32 NUM B-O
|
4641 |
+
CF PROPN B-AC
|
4642 |
+
centres NOUN B-O
|
4643 |
+
following VERB B-O
|
4644 |
+
6597 NUM B-O
|
4645 |
+
patients NOUN B-O
|
4646 |
+
. PUNCT B-O
|
4647 |
+
|
4648 |
+
The DET B-O
|
4649 |
+
approach NOUN B-O
|
4650 |
+
relies VERB B-O
|
4651 |
+
on ADP B-O
|
4652 |
+
systematic ADJ B-O
|
4653 |
+
creation NOUN B-O
|
4654 |
+
of ADP B-O
|
4655 |
+
genetically ADV B-O
|
4656 |
+
modified VERB B-O
|
4657 |
+
strains NOUN B-O
|
4658 |
+
using VERB B-O
|
4659 |
+
the DET B-O
|
4660 |
+
synthetic ADJ B-LF
|
4661 |
+
genetic ADJ I-LF
|
4662 |
+
array NOUN I-LF
|
4663 |
+
( PUNCT B-O
|
4664 |
+
SGA PROPN B-AC
|
4665 |
+
) PUNCT B-O
|
4666 |
+
methodology NOUN B-O
|
4667 |
+
[ PUNCT B-O
|
4668 |
+
13],[14],[23 NUM B-O
|
4669 |
+
] PUNCT B-O
|
4670 |
+
, PUNCT B-O
|
4671 |
+
which PRON B-O
|
4672 |
+
is AUX B-O
|
4673 |
+
followed VERB B-O
|
4674 |
+
by ADP B-O
|
4675 |
+
acquisition NOUN B-O
|
4676 |
+
of ADP B-O
|
4677 |
+
fluorescent ADJ B-O
|
4678 |
+
images NOUN B-O
|
4679 |
+
of ADP B-O
|
4680 |
+
all DET B-O
|
4681 |
+
strains NOUN B-O
|
4682 |
+
using VERB B-O
|
4683 |
+
a DET B-O
|
4684 |
+
high ADJ B-O
|
4685 |
+
- PUNCT B-O
|
4686 |
+
throughput NOUN B-O
|
4687 |
+
automated VERB B-O
|
4688 |
+
microscopy NOUN B-O
|
4689 |
+
platform NOUN B-O
|
4690 |
+
. PUNCT B-O
|
4691 |
+
|
4692 |
+
Compared VERB B-O
|
4693 |
+
to ADP B-O
|
4694 |
+
the DET B-O
|
4695 |
+
normal ADJ B-O
|
4696 |
+
lung NOUN B-O
|
4697 |
+
function NOUN B-O
|
4698 |
+
group NOUN B-O
|
4699 |
+
, PUNCT B-O
|
4700 |
+
patients NOUN B-O
|
4701 |
+
with ADP B-O
|
4702 |
+
SAD PROPN B-AC
|
4703 |
+
and CCONJ B-O
|
4704 |
+
without ADP B-O
|
4705 |
+
AL PROPN B-AC
|
4706 |
+
had VERB B-O
|
4707 |
+
lower ADJ B-O
|
4708 |
+
spirometric ADJ B-O
|
4709 |
+
values NOUN B-O
|
4710 |
+
, PUNCT B-O
|
4711 |
+
poorer ADJ B-O
|
4712 |
+
quality NOUN B-O
|
4713 |
+
of ADP B-O
|
4714 |
+
life NOUN B-O
|
4715 |
+
and CCONJ B-O
|
4716 |
+
higher ADJ B-O
|
4717 |
+
levels NOUN B-O
|
4718 |
+
of ADP B-O
|
4719 |
+
C NOUN B-LF
|
4720 |
+
- PUNCT I-LF
|
4721 |
+
reactive ADJ I-LF
|
4722 |
+
protein NOUN I-LF
|
4723 |
+
( PUNCT B-O
|
4724 |
+
CRP PROPN B-AC
|
4725 |
+
) PUNCT B-O
|
4726 |
+
, PUNCT B-O
|
4727 |
+
as ADP B-O
|
4728 |
+
well ADV B-O
|
4729 |
+
as ADP B-O
|
4730 |
+
increased VERB B-O
|
4731 |
+
cardiovascular ADJ B-O
|
4732 |
+
risk NOUN B-O
|
4733 |
+
and CCONJ B-O
|
4734 |
+
more ADJ B-O
|
4735 |
+
vascular ADJ B-O
|
4736 |
+
age NOUN B-O
|
4737 |
+
. PUNCT B-O
|
4738 |
+
|
4739 |
+
Similarly ADV B-O
|
4740 |
+
, PUNCT B-O
|
4741 |
+
1,25 NUM B-O
|
4742 |
+
di NOUN B-O
|
4743 |
+
- NOUN B-O
|
4744 |
+
hydroxy NOUN B-O
|
4745 |
+
vitamin NOUN B-LF
|
4746 |
+
D NOUN I-LF
|
4747 |
+
D PROPN B-AC
|
4748 |
+
can AUX B-O
|
4749 |
+
act VERB B-O
|
4750 |
+
as ADP B-O
|
4751 |
+
a DET B-O
|
4752 |
+
modulator NOUN B-O
|
4753 |
+
of ADP B-O
|
4754 |
+
ERs PROPN B-AC
|
4755 |
+
and CCONJ B-O
|
4756 |
+
activate VERB B-O
|
4757 |
+
the DET B-O
|
4758 |
+
nuclear ADJ B-O
|
4759 |
+
signaling NOUN B-O
|
4760 |
+
of ADP B-O
|
4761 |
+
these DET B-O
|
4762 |
+
ERs PROPN B-AC
|
4763 |
+
in ADP B-O
|
4764 |
+
the DET B-O
|
4765 |
+
colonic ADJ B-O
|
4766 |
+
smooth ADJ B-O
|
4767 |
+
muscles[15 X B-O
|
4768 |
+
] PUNCT B-O
|
4769 |
+
. PUNCT B-O
|
4770 |
+
|
4771 |
+
Ethical ADJ B-O
|
4772 |
+
approval NOUN B-O
|
4773 |
+
was AUX B-O
|
4774 |
+
granted VERB B-O
|
4775 |
+
by ADP B-O
|
4776 |
+
the DET B-O
|
4777 |
+
North PROPN B-O
|
4778 |
+
West PROPN B-O
|
4779 |
+
Greater PROPN B-O
|
4780 |
+
Manchester PROPN B-O
|
4781 |
+
East PROPN B-O
|
4782 |
+
Research PROPN B-O
|
4783 |
+
Ethics PROPN B-O
|
4784 |
+
Committee PROPN B-O
|
4785 |
+
( PUNCT B-O
|
4786 |
+
reference NOUN B-O
|
4787 |
+
18 NUM B-O
|
4788 |
+
/ NUM B-O
|
4789 |
+
NW/0211 NUM B-O
|
4790 |
+
) PUNCT B-O
|
4791 |
+
and CCONJ B-O
|
4792 |
+
the DET B-O
|
4793 |
+
National PROPN B-LF
|
4794 |
+
Health PROPN I-LF
|
4795 |
+
Service PROPN I-LF
|
4796 |
+
( PUNCT B-O
|
4797 |
+
NHS PROPN B-AC
|
4798 |
+
) PUNCT B-O
|
4799 |
+
Health PROPN B-O
|
4800 |
+
Research PROPN B-O
|
4801 |
+
Authority PROPN B-O
|
4802 |
+
( PUNCT B-O
|
4803 |
+
project NOUN B-O
|
4804 |
+
reference NOUN B-O
|
4805 |
+
244772 NUM B-O
|
4806 |
+
) PUNCT B-O
|
4807 |
+
. PUNCT B-O
|
4808 |
+
|
4809 |
+
For ADP B-O
|
4810 |
+
pregnant ADJ B-O
|
4811 |
+
women NOUN B-LF
|
4812 |
+
living VERB I-LF
|
4813 |
+
with ADP I-LF
|
4814 |
+
HIV PROPN I-LF
|
4815 |
+
HIV PROPN B-AC
|
4816 |
+
( PUNCT B-O
|
4817 |
+
WLHIV PROPN B-AC
|
4818 |
+
) PUNCT B-O
|
4819 |
+
it PRON B-O
|
4820 |
+
is AUX B-O
|
4821 |
+
critical ADJ B-O
|
4822 |
+
that SCONJ B-O
|
4823 |
+
they PRON B-O
|
4824 |
+
remain VERB B-O
|
4825 |
+
in ADP B-O
|
4826 |
+
care NOUN B-O
|
4827 |
+
throughout ADP B-O
|
4828 |
+
their PRON B-O
|
4829 |
+
pregnancy NOUN B-O
|
4830 |
+
and CCONJ B-O
|
4831 |
+
after ADP B-O
|
4832 |
+
so SCONJ B-O
|
4833 |
+
that SCONJ B-O
|
4834 |
+
they PRON B-O
|
4835 |
+
receive VERB B-O
|
4836 |
+
the DET B-O
|
4837 |
+
full ADJ B-O
|
4838 |
+
package NOUN B-O
|
4839 |
+
of ADP B-O
|
4840 |
+
prevention NOUN B-O
|
4841 |
+
of ADP B-O
|
4842 |
+
mother NOUN B-O
|
4843 |
+
- PUNCT B-O
|
4844 |
+
to ADP B-O
|
4845 |
+
- PUNCT B-O
|
4846 |
+
child NOUN B-O
|
4847 |
+
transmission NOUN B-O
|
4848 |
+
of ADP B-O
|
4849 |
+
HIV PROPN B-AC
|
4850 |
+
( PUNCT B-O
|
4851 |
+
PMTCT PROPN B-AC
|
4852 |
+
) PUNCT B-O
|
4853 |
+
services NOUN B-O
|
4854 |
+
. PUNCT B-O
|
4855 |
+
|
4856 |
+
Primer NOUN B-O
|
4857 |
+
pairs NOUN B-O
|
4858 |
+
were AUX B-O
|
4859 |
+
designed VERB B-O
|
4860 |
+
for ADP B-O
|
4861 |
+
three NUM B-O
|
4862 |
+
different ADJ B-O
|
4863 |
+
open ADJ B-LF
|
4864 |
+
reading NOUN I-LF
|
4865 |
+
frame NOUN I-LF
|
4866 |
+
( PUNCT B-O
|
4867 |
+
ORF PROPN B-AC
|
4868 |
+
) PUNCT B-O
|
4869 |
+
regions NOUN B-O
|
4870 |
+
of ADP B-O
|
4871 |
+
ASH1 PROPN B-O
|
4872 |
+
, PUNCT B-O
|
4873 |
+
a DET B-O
|
4874 |
+
distinct ADJ B-O
|
4875 |
+
region NOUN B-O
|
4876 |
+
within ADP B-O
|
4877 |
+
the DET B-O
|
4878 |
+
ORF PROPN B-AC
|
4879 |
+
regions NOUN B-O
|
4880 |
+
of ADP B-O
|
4881 |
+
PMA1 PROPN B-O
|
4882 |
+
and CCONJ B-O
|
4883 |
+
FBA1 NOUN B-O
|
4884 |
+
, PUNCT B-O
|
4885 |
+
the DET B-O
|
4886 |
+
promoter NOUN B-O
|
4887 |
+
, PUNCT B-O
|
4888 |
+
coding VERB B-O
|
4889 |
+
and CCONJ B-O
|
4890 |
+
terminator NOUN B-O
|
4891 |
+
regions NOUN B-O
|
4892 |
+
of ADP B-O
|
4893 |
+
ADH1 PROPN B-O
|
4894 |
+
, PUNCT B-O
|
4895 |
+
as ADP B-O
|
4896 |
+
well ADV B-O
|
4897 |
+
as ADP B-O
|
4898 |
+
for ADP B-O
|
4899 |
+
a DET B-O
|
4900 |
+
heterochromatic ADJ B-O
|
4901 |
+
control NOUN B-O
|
4902 |
+
region NOUN B-O
|
4903 |
+
of ADP B-O
|
4904 |
+
chromosome NOUN B-O
|
4905 |
+
V. NOUN B-O
|
4906 |
+
Dahlbäck PROPN B-O
|
4907 |
+
et PROPN B-O
|
4908 |
+
al NOUN B-O
|
4909 |
+
. PUNCT B-O
|
4910 |
+
|
4911 |
+
observed VERB B-O
|
4912 |
+
that SCONJ B-O
|
4913 |
+
addition NOUN B-O
|
4914 |
+
of ADP B-O
|
4915 |
+
APC PROPN B-AC
|
4916 |
+
to ADP B-O
|
4917 |
+
plasma NOUN B-O
|
4918 |
+
of ADP B-O
|
4919 |
+
patients NOUN B-O
|
4920 |
+
with ADP B-O
|
4921 |
+
multiple ADJ B-O
|
4922 |
+
thrombotic ADJ B-O
|
4923 |
+
events NOUN B-O
|
4924 |
+
did AUX B-O
|
4925 |
+
not PART B-O
|
4926 |
+
result VERB B-O
|
4927 |
+
in ADP B-O
|
4928 |
+
the DET B-O
|
4929 |
+
expected VERB B-O
|
4930 |
+
prolongation NOUN B-O
|
4931 |
+
of ADP B-O
|
4932 |
+
the DET B-O
|
4933 |
+
coagulation NOUN B-O
|
4934 |
+
time NOUN B-O
|
4935 |
+
in ADP B-O
|
4936 |
+
an DET B-O
|
4937 |
+
activated VERB B-LF
|
4938 |
+
partial ADJ I-LF
|
4939 |
+
thromboplastin NOUN I-LF
|
4940 |
+
time NOUN I-LF
|
4941 |
+
( PUNCT B-O
|
4942 |
+
aPTT PROPN B-AC
|
4943 |
+
) PUNCT B-O
|
4944 |
+
assay NOUN B-O
|
4945 |
+
[ PUNCT B-O
|
4946 |
+
1 NUM B-O
|
4947 |
+
] PUNCT B-O
|
4948 |
+
. PUNCT B-O
|
4949 |
+
|
4950 |
+
Graphs NOUN B-O
|
4951 |
+
illustrate VERB B-O
|
4952 |
+
performance NOUN B-O
|
4953 |
+
for ADP B-O
|
4954 |
+
these DET B-O
|
4955 |
+
scenarios NOUN B-O
|
4956 |
+
, PUNCT B-O
|
4957 |
+
ranked VERB B-O
|
4958 |
+
in ADP B-O
|
4959 |
+
order NOUN B-O
|
4960 |
+
of ADP B-O
|
4961 |
+
relative ADJ B-O
|
4962 |
+
performance NOUN B-O
|
4963 |
+
for ADP B-O
|
4964 |
+
four NUM B-O
|
4965 |
+
metrics NOUN B-O
|
4966 |
+
: PUNCT B-O
|
4967 |
+
RMSE PROPN B-AC
|
4968 |
+
( PUNCT B-O
|
4969 |
+
Root NOUN B-O
|
4970 |
+
Mean NOUN B-O
|
4971 |
+
Square PROPN B-O
|
4972 |
+
Error NOUN B-O
|
4973 |
+
) PUNCT B-O
|
4974 |
+
, PUNCT B-O
|
4975 |
+
MAE PROPN B-AC
|
4976 |
+
( PUNCT B-O
|
4977 |
+
Mean NOUN B-LF
|
4978 |
+
Absolute PROPN I-LF
|
4979 |
+
Error NOUN I-LF
|
4980 |
+
) PUNCT B-O
|
4981 |
+
, PUNCT B-O
|
4982 |
+
R NOUN B-O
|
4983 |
+
- PUNCT B-O
|
4984 |
+
squared NOUN B-O
|
4985 |
+
and CCONJ B-O
|
4986 |
+
Spearman PROPN B-O
|
4987 |
+
correlation NOUN B-O
|
4988 |
+
coefficient NOUN B-O
|
4989 |
+
. PUNCT B-O
|
4990 |
+
|
4991 |
+
Risky ADJ B-O
|
4992 |
+
sexual ADJ B-O
|
4993 |
+
behavior NOUN B-O
|
4994 |
+
may AUX B-O
|
4995 |
+
result VERB B-O
|
4996 |
+
in ADP B-O
|
4997 |
+
serious ADJ B-O
|
4998 |
+
health NOUN B-O
|
4999 |
+
problems NOUN B-O
|
5000 |
+
such ADJ B-O
|
5001 |
+
as ADP B-O
|
5002 |
+
unintended ADJ B-O
|
5003 |
+
pregnancy NOUN B-O
|
5004 |
+
, PUNCT B-O
|
5005 |
+
abortion NOUN B-O
|
5006 |
+
, PUNCT B-O
|
5007 |
+
and CCONJ B-O
|
5008 |
+
sexually ADV B-LF
|
5009 |
+
transmitted VERB I-LF
|
5010 |
+
infections NOUN I-LF
|
5011 |
+
( PUNCT B-O
|
5012 |
+
STIs PROPN B-AC
|
5013 |
+
) PUNCT B-O
|
5014 |
+
including VERB B-O
|
5015 |
+
HIV PROPN B-AC
|
5016 |
+
[ PUNCT B-O
|
5017 |
+
19 NUM B-O
|
5018 |
+
] PUNCT B-O
|
5019 |
+
. PUNCT B-O
|
5020 |
+
|
5021 |
+
In ADP B-O
|
5022 |
+
low ADJ B-LF
|
5023 |
+
resource NOUN I-LF
|
5024 |
+
settings NOUN I-LF
|
5025 |
+
( PUNCT B-O
|
5026 |
+
LRSs PROPN B-AC
|
5027 |
+
) PUNCT B-O
|
5028 |
+
, PUNCT B-O
|
5029 |
+
treatment NOUN B-O
|
5030 |
+
of ADP B-O
|
5031 |
+
neonatal ADJ B-O
|
5032 |
+
jaundice NOUN B-O
|
5033 |
+
is AUX B-O
|
5034 |
+
often ADV B-O
|
5035 |
+
sub ADJ B-O
|
5036 |
+
- ADJ B-O
|
5037 |
+
optimal ADJ B-O
|
5038 |
+
[ PUNCT B-O
|
5039 |
+
4 NUM B-O
|
5040 |
+
, PUNCT B-O
|
5041 |
+
5 NUM B-O
|
5042 |
+
] PUNCT B-O
|
5043 |
+
. PUNCT B-O
|
5044 |
+
|
5045 |
+
In ADP B-O
|
5046 |
+
2015 NUM B-O
|
5047 |
+
, NOUN B-O
|
5048 |
+
the DET B-O
|
5049 |
+
prevalence NOUN B-O
|
5050 |
+
of ADP B-O
|
5051 |
+
low ADJ B-O
|
5052 |
+
birth NOUN B-O
|
5053 |
+
weight NOUN B-O
|
5054 |
+
per ADP B-O
|
5055 |
+
100 NUM B-O
|
5056 |
+
births NOUN B-O
|
5057 |
+
was AUX B-O
|
5058 |
+
greater ADJ B-O
|
5059 |
+
in ADP B-O
|
5060 |
+
southern ADJ B-O
|
5061 |
+
Asia PROPN B-O
|
5062 |
+
than ADP B-O
|
5063 |
+
in ADP B-O
|
5064 |
+
sub ADJ B-O
|
5065 |
+
- ADJ B-O
|
5066 |
+
Saharan ADJ B-O
|
5067 |
+
Africa PROPN B-O
|
5068 |
+
( PUNCT B-O
|
5069 |
+
26.4 NUM B-O
|
5070 |
+
% NOUN B-O
|
5071 |
+
; NOUN B-O
|
5072 |
+
uncertainty NOUN B-LF
|
5073 |
+
range NOUN I-LF
|
5074 |
+
[ PUNCT B-O
|
5075 |
+
UR PROPN B-AC
|
5076 |
+
] PUNCT B-O
|
5077 |
+
: PUNCT B-O
|
5078 |
+
18.6–35.2 NUM B-O
|
5079 |
+
versus ADP B-O
|
5080 |
+
14.0 NUM B-O
|
5081 |
+
% NOUN B-O
|
5082 |
+
, NOUN B-O
|
5083 |
+
UR PROPN B-AC
|
5084 |
+
: PUNCT B-O
|
5085 |
+
12.2–17.2 NUM B-O
|
5086 |
+
) PUNCT B-O
|
5087 |
+
[ PUNCT B-O
|
5088 |
+
28 NUM B-O
|
5089 |
+
] PUNCT B-O
|
5090 |
+
. PUNCT B-O
|
5091 |
+
|
5092 |
+
Three NUM B-O
|
5093 |
+
retinoic ADJ B-LF
|
5094 |
+
acid NOUN I-LF
|
5095 |
+
receptors NOUN B-O
|
5096 |
+
( PUNCT B-O
|
5097 |
+
RARα PROPN B-O
|
5098 |
+
, PUNCT B-O
|
5099 |
+
RARβ PROPN B-O
|
5100 |
+
and CCONJ B-O
|
5101 |
+
RARγ NOUN B-O
|
5102 |
+
) PUNCT B-O
|
5103 |
+
have AUX B-O
|
5104 |
+
been AUX B-O
|
5105 |
+
identified VERB B-O
|
5106 |
+
as ADP B-O
|
5107 |
+
cognate NOUN B-O
|
5108 |
+
receptors NOUN B-O
|
5109 |
+
for ADP B-O
|
5110 |
+
RA PROPN B-AC
|
5111 |
+
. PUNCT B-O
|
5112 |
+
|
5113 |
+
These DET B-O
|
5114 |
+
RARs NOUN B-O
|
5115 |
+
are AUX B-O
|
5116 |
+
structurally- ADV B-O
|
5117 |
+
and CCONJ B-O
|
5118 |
+
functionally ADV B-O
|
5119 |
+
- PUNCT B-O
|
5120 |
+
conserved VERB B-O
|
5121 |
+
nuclear ADJ B-O
|
5122 |
+
retinoid NOUN B-O
|
5123 |
+
receptors NOUN B-O
|
5124 |
+
[ PUNCT B-O
|
5125 |
+
36–39 NUM B-O
|
5126 |
+
] PUNCT B-O
|
5127 |
+
. PUNCT B-O
|
5128 |
+
|
5129 |
+
CCHQ PROPN B-AC
|
5130 |
+
= PUNCT B-O
|
5131 |
+
Care PROPN B-LF
|
5132 |
+
and CCONJ I-LF
|
5133 |
+
Comfort PROPN I-LF
|
5134 |
+
Hypertonicity PROPN I-LF
|
5135 |
+
Questionnaire PROPN I-LF
|
5136 |
+
; PUNCT B-O
|
5137 |
+
GMFCS PROPN B-AC
|
5138 |
+
= PUNCT B-O
|
5139 |
+
Gross ADJ B-LF
|
5140 |
+
motor NOUN I-LF
|
5141 |
+
functional ADJ I-LF
|
5142 |
+
classification NOUN I-LF
|
5143 |
+
scale NOUN I-LF
|
5144 |
+
; PUNCT B-O
|
5145 |
+
GMFM PROPN B-AC
|
5146 |
+
= PUNCT B-O
|
5147 |
+
Gross ADJ B-LF
|
5148 |
+
Motor PROPN I-LF
|
5149 |
+
Function NOUN I-LF
|
5150 |
+
Measure NOUN I-LF
|
5151 |
+
; PUNCT B-O
|
5152 |
+
MACS PROPN B-AC
|
data/data_train.conll
ADDED
The diff for this file is too large to render.
See raw diff
|
|